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A B S T R A C T
Background
Urinary incontinence is a very common and debilitating problem affecting about 50% of women at some point in their lives. Stress
urinary incontinence (SUI) is a predominant cause in 30% to 80% of these women imposing significant health and economic burden
on society and the women affected. Mid-urethral sling (MUS) operations are a recognised minimally invasive surgical treatment for
SUI. MUS involves the passage of a small strip of tape through either the retropubic or obturator space, with entry or exit points at the
lower abdomen or groin, respectively. This review does not include single-incision slings.
Objectives
To assess the clinical effects of mid-urethral sling (MUS) operations for the treatment of SUI, urodynamic stress incontinence (USI)
or mixed urinary incontinence (MUI) in women.
Search methods
We searched: Cochrane Incontinence Specialised Register (including: CENTRAL, MEDLINE, MEDLINE In-Process, ClinicalTri-
als.gov) (searched 26 June 2014); Embase Classic (January 1947 to Week 25 2014); WHO ICTRP (searched 30 June 2014); reference
lists.
Selection criteria
Randomised or quasi-randomised controlled trials amongst women with SUI, USI or MUI, in which both trial arms involve a MUS
operation.
Data collection and analysis
Two review authors independently assessed the methodological quality of potentially eligible studies and extracted data from included
trials.
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Main results
We included 81 trials that evaluated 12,113 women. We assessed the quality of evidence for outcomes using the GRADE assessment
tool; the quality of most outcomes was moderate, mainly due to risk of bias or imprecision.
Fifty-five trials with data contributed by 8652 women compared the use of the transobturator route (TOR) and retropubic route (RPR).
There is moderate quality evidence that in the short term (up to one year) the rate of subjective cure of TOR and RPR are similar (RR
0.98, 95% CI 0.96 to 1.00; 36 trials, 5514 women; moderate quality evidence) ranging from 62% to 98% in the TOR group, and from
71% to 97% in the RPR group. Short-term objective cure was similar in the TOR and RPR groups (RR 0.98, 95% CI 0.96 to 1.00;
40 trials, 6145 women). Fewer trials reported medium-term (one to five years) and longer-term (over five years) data, but subjective
cure was similar between the groups (RR 0.97, 95% CI 0.87 to 1.09; 5 trials, 683 women; low quality evidence; and RR 0.95, 95% CI
0.80 to 1.12; 4 trials, 714 women; moderate quality evidence, respectively). In the long term, subjective cure rates ranged from 43%
to 92% in the TOR group, and from 51% to 88% in the RPR group.
MUS procedures performed using the RPR had higher morbidity when compared to TOR, though the overall rate of adverse events
remained low. The rate of bladder perforation was lower after TOR (0.6% versus 4.5%; RR 0.13, 95% CI 0.08 to 0.20; 40 trials, 6372
women; moderate quality evidence). Major vascular/visceral injury, mean operating time, operative blood loss and length of hospital
stay were lower with TOR.
Postoperative voiding dysfunction was less frequent following TOR (RR 0.53, 95% CI 0.43 to 0.65; 37 trials, 6200 women; moderate
quality evidence). Overall rates of groin pain were higher in the TOR group (6.4% versus 1.3%; RR 4.12, 95% CI 2.71 to 6.27; 18
trials, 3221 women; moderate quality evidence) whereas suprapubic pain was lower in the TOR group (0.8% versus 2.9%; RR 0.29,
95% CI 0.11 to 0.78); both being of short duration. The overall rate of vaginal tape erosion/exposure/extrusion was low in both groups:
24/1000 instances with TOR compared with 21/1000 for RPR (RR 1.13, 95% CI 0.78 to 1.65; 31 trials, 4743 women; moderate
quality evidence). There were only limited data to inform the need for repeat incontinence surgery in the long term, but it was more
likely in the TOR group than in the RPR group (RR 8.79, 95% CI 3.36 to 23.00; 4 trials, 695 women; low quality evidence).
A retropubic bottom-to-top route was more effective than top-to-bottom route for subjective cure (RR 1.10, 95% CI 1.01 to 1.19; 3
trials, 477 women; moderate quality evidence). It incurred significantly less voiding dysfunction, and led to fewer bladder perforations
and vaginal tape erosions.
Short-and medium-term subjective cure rates between transobturator tapes passed using a medial-to-lateral as opposed to a lateral-to-
medial approach were similar (RR 1.00, 95% CI 0.96 to 1.06; 6 trials, 759 women; moderate quality evidence, and RR 1.06, 95%
CI 0.91 to 1.23; 2 trials, 235 women; moderate quality evidence). There was moderate quality evidence that voiding dysfunction was
more frequent in the medial-to-lateral group (RR 1.74, 95% CI 1.06 to 2.88; 8 trials, 1121 women; moderate quality evidence), but
vaginal perforation was less frequent in the medial-to-lateral route (RR 0.25, 95% CI 0.12 to 0.53; 3 trials, 541 women). Due to the
very low quality of the evidence, it is unclear whether the lower rates of vaginal epithelial perforation affected vaginal tape erosion (RR
0.42, 95% CI 0.16 to 1.09; 7 trials, 1087 women; very low quality evidence).
Authors’ conclusions
Mid-urethral sling operations have been the most extensively researched surgical treatment for stress urinary incontinence (SUI) in
women and have a good safety profile. Irrespective of the routes traversed, they are highly effective in the short and medium term, and
accruing evidence demonstrates their effectiveness in the long term. This review illustrates their positive impact on improving the quality
of life of women with SUI. However, a brief economic commentary (BEC) identified three studies suggesting that transobturator may
be more cost-effective compared with retropubic. Fewer adverse events occur with employment of a transobturator approach with the
exception of groin pain. When comparing transobturator techniques of a medial-to-lateral versus a lateral-to-medial insertion, there is
no evidence to support the use of one approach over the other. However, a bottom-to-top route was more effective than top-to-bottom
route for retropubic tapes.
A salient point illustrated throughout this review is the need for reporting of longer-term outcome data from the numerous existing
trials. This would substantially increase the evidence base and provide clarification regarding uncertainties about long-term effectiveness
and adverse event profile.
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Background information
Stress urinary incontinence (involuntary leakage of urine on effort or exertion; or on sneezing, coughing or laughing) is the commonest
form of incontinence in women and leads to a reduction in their quality of life. Women with stress urinary incontinence can also have
problems with sexual intercourse, as leakage of urine can occur. A significant amount of the woman’s and her family’s income can be
spent on managing the symptoms. One in three women over the age of 18 years will be affected by stress urinary incontinence at some
point in her lifetime.
Over the years, surgery to stop this problem has become less invasive. Mid-urethral sling operations are one of the various types of
surgeries available. These operations are suitable for women who are having their first operation and those who had previous unsuccessful
surgery. In a mid-urethral sling operation a tape is placed underneath the urethra, which is the tube that carries urine out of the bladder.
When the woman coughs, the tape compresses the tube, thus providing the support necessary to prevent urine leakage.
There are two main ways of carrying out these operations, either by inserting a tape behind the pubic bone through the abdomen
(’retropubic’), or through the groin (’transobturator’).
What this review tried to find out
We looked at the effects and costs of mid-urethral sling operations using the two different methods. We also compared different ways
of inserting the tape, and using tapes made from different materials. The purpose of this review was to find out how effective these
operations are in the treatment of stress urinary incontinence and help determine potential complications rate.
Main findings of this review
We performed a thorough literature search up to June 2014. We identified 81 trials that had a total of 12,113 women. These trials
showed that over 80% of women with stress urinary incontinence are cured, or have significant improvement in their symptoms, with
either operation, for up to five years after surgery, irrespective of the tapes used and the route of tape insertion. The studies used different
questionnaires to assess quality of life, which meant that we could not combine their results . However, the information available for
quality of life shows that it improves as a result of these operations, though there is no clear difference between the two procedures.
In terms of costs, a non-systematic review of economic studies suggested that transobturator had lower costs than retropubic methods.
Only a few trials provided information about the effectiveness of these tapes more than five years after surgery. The evidence that we
have been able to assess indicates that the positive effects persist.
Adverse effects
Tapes passing behind the pubic bone (retropubic) seem to carry a greater risk of injuring the bladder during the operation and of
women experiencing problems emptying their bladder completely after surgery. However, this operation leads to less groin pain in the
short term. There is some limited evidence that this way of inserting the tape has a lower risk of requiring a repeat operation in the
long term compared to tapes passing through the groin (transobturator). There is moderate quality evidence that overall reported rates
of tape-related complications are low, such as erosion of the tape into the vagina at about 2% for both routes of tape insertion. The
reported occurrence of problems with sexual intercourse including pain was low, and leakage of urine during intercourse are improved
following insertion of these tapes.
Limitations of the review
Most of our results are based on moderate quality evidence. Most trials did not describe their methods clearly, thus leading to some
degree of uncertainty in the findings. At present there are only a limited number of randomised controlled trials (these produce the
most reliable results) that have published data beyond five years after surgery. This means that evidence about how effective and safe
these procedures are in the longer term lags behind the evidence for them in the short and medium term (up to five years). Longer-
term data are required to help increase the reliability of longer-term results.
3Mid-urethral sling operations for stress urinary incontinence in women (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Transobturator (TOR) compared to retropubic (RPR) route for stress urinary incontinence in women
Patient or population: women with stress urinary incont inence
Settings: Secondary care
Intervention: t ransobturator (TOR)
Comparison: retropubic (RPR) route
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Retropubic (RPR) route Transobturator (TOR)
Subject ive cure (Short
term < 1 year)
Study populat ion RR 0.98
(0.96 to 1.00)
5514
(36 RCTs)
⊕⊕⊕©
MODERATE 1
844 per 1000 827 per 1000
(810 to 844)
Mean control group risk across studies
833 per 1000 816 per 1000
(800 to 833)
Subject ive
cure (medium term, 1 to
5 years)
Study populat ion RR 0.97
(0.92 to 1.03)
683
(5 RCTs)
⊕⊕©©
LOW 2,3
881 per 1000 854 per 1000
(810 to 907)
Mean control group risk across studies
869 per 1000 843 per 1000
(799 to 895)
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Subject ive cure (long
term, > 5 years)
Study populat ion RR 0.95
(0.87 to 1.04)
714
(4 RCTs)
⊕⊕⊕©
MODERATE 4
707 per 1000 671 per 1000
(615 to 735)
Mean control group risk across studies
843 per 1000 801 per 1000
(733 to 877)
Bladder or urethral per-
forat ion
Study populat ion RR 0.13
(0.08 to 0.20)
6372
(40 RCTs)
⊕⊕⊕©
MODERATE 5
49 per 1000 6 per 1000
(4 to 10)
Mean control group risk across studies
25 per 1000 3 per 1000
(2 to 5)
Voiding
dysfunct ion (short and
medium term, up to 5
years)
Study populat ion RR 0.53
(0.43 to 0.65)
6217
(37 RCTs)
⊕⊕⊕©
MODERATE 6
72 per 1000 38 per 1000
(31 to 47)
Mean control group risk across studies
55 per 1000 29 per 1000
(24 to 36)
De novo urgency or
urgency incont inence
(short term, up to 12
months)
Study populat ion RR 0.98
(0.82 to 1.17)
4923
(31 RCTs)
⊕⊕⊕©
MODERATE 7
82 per 1000 80 per 1000
(67 to 96)
Mean control group risk across studies
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83 per 1000 81 per 1000
(68 to 97)
Groin pain Study populat ion RR 4.62
(3.09 to 6.92)
3226
(18 RCTs)
⊕⊕⊕©
MODERATE 8
14 per 1000 66 per 1000
(44 to 99)
Mean control group risk across studies
45 per 1000 208 per 1000
(139 to 311)
Suprapubic pain Study populat ion RR 0.29
(0.11 to 0.78)
1105
(4 RCTs)
⊕⊕⊕©
MODERATE 9
29 per 1000 8 per 1000
(3 to 23)
Mean control group risk across studies
18 per 1000 5 per 1000
(2 to 14)
Vaginal tape erosion
(short and medium
term, up to 5 years)
Study populat ion RR 1.13
(0.78 to 1.65)
4743
(31 RCTs)
⊕⊕⊕©
MODERATE 10
20 per 1000 22 per 1000
(15 to 32)
Mean control group risk across studies
21 per 1000 24 per 1000
(16 to 34)
Repeat incont inence
surgery (short term,
within 12 months)
Study populat ion RR 1.64
(0.85 to 3.16)
1402
(9 RCTs)
⊕⊕⊕©
MODERATE 11
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19 per 1000 31 per 1000
(16 to 60)
mean control group across studies
24 per 1000 39 per 1000
(20 to 76)
Repeat incont inence
surgery (long term, > 5
years)
Study populat ion RR 8.79
(3.36 to 23.00)
695
(4 RCTs)
⊕⊕©©
LOW 12,13
11 per 1000 100 per 1000
(38 to 262)
Mean control group across studies
67 per 1000 589 per 1000
(225 to 1000)
Quality of lif e 16 dif ferent validated quest ionnaires were used
by dif ferent studies to assess QoL. This outcome
was reported in 11 RCTs, but reported in dif f erent
ways which precluded meta-analysis. In all but
one of the RCTs where QoL was assessed there
was improvement in the QoL in women af ter
the intervent ion, irrespect ive of which route was
used, with no signif icant dif f erence in scores be-
tween groups. Where assessment of sexual func-
t ion was performed, there was an equal amount
of improvement in sexual funct ion following sur-
gical treatment, irrespect ive of the route em-
ployed
- (11 RCTs)
* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95%CI).
CAD: Canadian dollars
CI: conf idence interval
RCT: randomised controlled trial7
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RPR: retropubic route
RR: risk rat io
QoL: quality of lif e
TOR: transobturator route
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect
Moderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate
Very low quality: We are very uncertain about the est imate
1Random sequence generat ion was unclear in 13 studies and at high risk of bias in 2 studies, and allocat ion concealment was
unclear in 20 studies and at high risk in 2/ 37 studies
2Allocat ion concealment was unclear in 2/ 5 trials and sequence generat ion was unclear in 1/ 5 trials, so we decided to
downgrade by 1 level
3There was potent ial substant ial heterogeneity with an I² value of 67%, so we downgraded the quality rat ing by 1 level
4There was potent ial substant ial heterogeneity among studies with an I² value of 65%, which lead us to downgrade by 1 level
5As allocat ion concealment was unclear in 18/ 40 trials and at high risk in 3/ 40, and sequence generat ion was unclear in 14/
40 trials and at high risk in 3/ 40, we decided to downgrade by 1 level
6As allocat ion concealment was unclear in 16/ 37 trials and at high risk in 2/ 37, and sequence generat ion was unclear in 11/
37 trials and at high risk in 2/ 37, we decided to downgrade by 1 level
7Random sequence generat ion was unclear in 10/ 31 studies and at high risk of bias in 2/ 31, and allocat ion concealment was
unclear in 15/ 31 studies and at high risk in 2/ 31, so we downgraded by 1 level
8Random sequence generat ion was unclear in 4/ 18 studies and at high risk in 2/ 18, and allocat ion concealment was unclear
in 9/ 18 studies and at high risk in 2/ 18, so we downgraded the quality of the evidence by 1 level
9Random sequence generat ion was at high risk in 1/ 4 studies, while allocat ion concealment was unclear in 2/ 4 and at high
risk in 1/ 4, so we downgraded by 1 level
10Allocat ion concealment was unclear in 12/ 31 trials and at high risk in 1/ 31, while sequence generat ion was unclear in 6/ 31
trials and at high risk in 1/ 31, so we decided to downgrade by 1 level
11The wide conf idence interval was judged to include a threshold for appreciable harm considered to be > 25% increase in RR,
in this case there was much more than a 25% increase in RR for harm, so we downgraded the level by 1
12There was potent ial substant ial heterogeneity with an I² value of 46%, so we downgraded the quality rat ing by 1 level
13Due to the low number of studies report ing data for this outcome, and the low number of events and wide CI around the
est imate of the ef fect, we downgraded the quality of evidence by 1 level due to imprecision
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B A C K G R O U N D
Urinary incontinence is a very common condition in women. It is
associated with significant physical morbidity, sexual dysfunction,
loss of independence and a reduction in psychological well being,
with consequent decreased participation in social and domestic ac-
tivities (Wetle 1995; Thom 1998; Van Oyen 2002; Salonia 2004;
Botlero 2010). Overall the prevalence of urinary incontinence in
adult women has been estimated to be between 10% and 40%,
and is considered severe in about 3% to 17%, with annual inci-
dence ranging from 2% to 11% (Hunskaar 2002; Milsom 2009).
The prevalence of stress urinary incontinence (SUI) in women is
between 12% to 46% (Botlero 2008; Coyne 2009; Irwin 2006).
This is a potentially debilitating social problem, with significant
cost implications to the individuals and the healthcare service. The
estimated annual cost to the healthcare system in the UK exceeds
GBP 700 million (1999/2000 GBP) (Turner 2004) while in the
USA, the annual total direct costs in both men and women is over
USD 16 billion (1995 USD) (Chong 2011) with societal costs of
USD 26.2 billion (1995 USD) (Wagner 1998). Approximately,
USD 13.12 billion (1995 USD) of the total direct costs of uri-
nary incontinence is spent on SUI (Chong 2011; Kunkle 2015).
In the USA,about 70% of this USD 13.12 billion is borne by the
patients mainly through routine care (purchasing pads and dis-
posable underwear (diapers), laundry and dry cleaning). Of the
remaining 30%, 14% is spent on nursing home admission, 9%
on treatment, 6% on addressing complications and 1% on diag-
nosis (Chong 2011). In the UK an estimated more than GBP 178
million (1999/2000 GBP) is borne by women on an individual
basis annually (Turner 2004; Papanicolaou 2005).This constitutes
a significant individual financial burden.
A study reported that about 1% of the median annual house-
hold income (USD 50,000 to USD 59,999) was spent by women
on incontinence management. This study estimated that women
spent an annual mean cost of USD 751 to USD 1277 (2006
USD) on incontinence. This cost increases based on the severity
of the symptoms (Subak 2008).The indirect cost associated ex-
erts social and psychological burdens which are unquantifiable.
(Chong 2011; Kilonzo 2004). Nevertheless, Birnbaum 2004 es-
timated that the annual average direct medical costs of SUI for
one year (1998 USD) was USD 5642 and USD 4208 for indirect
workplace costs.The cost of management and treatment of SUI
appears to have increased over time due to increasing prevalence
and an increased desire for improved quality of life (QOL). This
in turn has resulted from improved recognition of the condition,
as well as increased use of surgical and non-surgical managements.
Continence is achieved through interplay of the normal anatom-
ical and physiological properties of the bladder, urethra, urethral
sphincter and pelvic floor, with the nervous system co-ordinating
these organs. The urethra and its sphincter act as a closure mech-
anism during bladder filling to contain urine within the bladder,
thereby allowing storage of urine until a convenient time and place
to void is reached. The pelvic floor provides support to the bladder
and urethra, and allows normal abdominal pressure transmission
to the proximal urethra, which is essential in the maintenance of
continence. Crucial to the healthy functioning of the bladder, ure-
thra, sphincter and pelvic floor is co-ordination between them,
which is facilitated by an intact nervous system.
There are many theories hypothesizing the pathophysiology of
stress urinary incontinence. Historically Goran Enhorning was
first to measure simultaneous bladder and urethral pressures. He
suggested that during the cough impulse, pressure is transmission
from the abdomen to the urethra with a concurrent reduction in
urethral closure pressure that results in SUI (Enhorning 1961).
McGuire’s modified classification of SUI emphasizes the princi-
ple of intrinsic sphincter deficiency (ISD) as a cause of SUI. This
is said to occur due to poor urethral closure function resulting
fromdefective urethral mucosal coaptation. These two theories in-
formed procedures such as the Burch Colposuspension and Mar-
shall Marchetti Krantz operations. De Lancey’s ’hammock’ the-
ory suggested that abdominal pressure transmission to the blad-
der neck and urethra leads to the proximal urethra being com-
pressed against the pubo-vesical fascia and anterior vaginal wall,
thus maintaining continence (DeLancey 1994).
Recent findings on the pathophysiology of urinary incontinence
have demonstrated that mid-urethral support, provided by the
pubo-urethral ligaments, also plays an important role in maintain-
ing continence when the intra-abdominal pressure rises. This has
led to the ’integrated theory’ for the maintenance of continence
in female SUI (Petros 1990; Petros 1993). This theory, in turn,
is the basis for the current use of minimally invasive mid-urethral
tapes in the treatment of SUI.
When performing mid-urethral tape surgery there are different
types of synthetic materials used. Synthetic meshes are divided
into four groups:
• type 1 are macroporous, monofilament;
• type 2 are microporous;
• type 3 are macroporous, multifilament;
• type 4 are submicronic, coated biomaterials with pore sizes
of less than 1 µm.
Type 1 mesh has the highest biocompatibility with the least
propensity for infection. Differences in their efficacy and compli-
cations are likely to be due to several factors including the different
knits and weaves of the various tape materials, their biomechanical
properties and histological biocompatibility. Pore size affects the
inflammatory response and resultant connective tissue formation
within and into themesh, and the rearrangement of materials such
as collagen within the mesh structure. Macroporous meshes (pore
size in excess of 75 µm) easily allow macrophages, leukocytes, fi-
broblasts, blood vessels and collagen to transverse the pores: thus
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macroporous meshes promote tissue host ingrowth with resultant
biocompatibility and low risk of infection (Amid 1997). Monofil-
ament tapes are widely available and now predominate in current
clinical practice.
In contrast, microporous meshes (pore size greater than 10
µm) allow bacteria to pass through and replicate, but exclude
macrophages. Multifilament tapes have smaller pore sizes, and are
thus microporous. This perhaps explains why tape erosion was
more common in the multifilament tapes, though statistical sig-
nificance was not reached.
Description of the condition
Incontinence occurs when this normal relationship between the
lower urinary tract components is disrupted, as a result of nerve
damage or direct mechanical disruption to the pelvic organs.
Advancing age, higher parity, vaginal delivery, obesity and post
menopausal status are all associated with an increased risk of uri-
nary incontinence (Wilson 1996).
There are different forms of urinary incontinence of which SUI
is the most common type, accounting for at least 50% of cases
of urinary incontinence in women (Hannestad 2000). SUI is the
involuntary loss of urine that occurs with physical exertion (e.g.
sporting activities), or on sneezing or coughing (Haylen 2010).
Urodynamic stress incontinence (USI) is the involuntary leakage
of urine observed during filling cystometry, it is associated with
increased intra-abdominal pressure, in the absence of a detrusor
contraction (Haylen 2010). Two mechanisms for stress inconti-
nence are recognized: hyper-mobility or significant displacement
of the urethra and bladder neck during exertion, and intrinsic
urethral sphincter deficiency (Blaivas 1988). These mechanisms
may co-exist in women (O’Donnell 1994). Few clinical trials have
distinguished between the two conditions, probably because there
is currently no standardised and validated test available for this
(Blaivas 1988; McGuire 1993). We considered women whose in-
continence could be due to either mechanism together in this re-
view.
The diagnosis of urodynamic stress incontinence implies that uro-
dynamic investigation has been done to confirm stress inconti-
nence; it may also identify the presence of detrusor overactiv-
ity, in mixed urinary incontinence. Standard clinical assessment
includes history taking, physical examination, frequency/volume
charts and urine analysis. Some authors described women with the
symptom of stress urinary incontinence only (diagnosis made on
clinical evaluation without urodynamics). Women with stress uri-
nary incontinence and those with urodynamic stress incontinence
have been included in this review.
Urgency urinary incontinence (UUI) is a sudden, compelling de-
sire to pass urine, which is difficult to defer (urgency), accompa-
nied by the involuntary loss of urine. Detrusor overactivity (DO)
is a diagnosis that denotes involuntary detrusor contractions ob-
served during the filling phase of a urodynamic assessment. It
may be spontaneous or provoked and can be qualified according
to cause - neurogenic or idiopathic (Haylen 2010). We included
women with UUI and the formal urodynamic diagnosis of DO
in the review only if they had co-existing stress incontinence (so
called mixed urinary incontinence (MUI)).
Women with MUI who were included in this review had symp-
toms of SUI plus either urgency or UUI, or urodynamic stress
incontinence (USI) plus DO (urodynamic diagnosis).
Description of the intervention
Management of SUI includes conservative, mechanical, pharma-
cological and surgical interventions.
• Conservative management centres on lifestyle
modifications, physical methods including pelvic floor muscle
training, electrical stimulation, biofeedback and the use of
weighted cones.
• Mechanical devices that prevent or reduce urinary leakage
are available, and include metal plugs or patches and urethral or
vaginal inserts.
• Drug therapies, such as oestrogens and alpha adrenergic
agents, have been used in the past. Recently, inhibitors of
serotonin and norepinephrine reuptake have been proposed as
new drug therapy for SUI, used alone or in combination with
other conservative management (Ghoniem 2005).
A trial of such conservative treatments should be undertakenbefore
resorting to surgery. The following interventions are the subject
of separate Cochrane reviews.
• Lifestyle interventions for the treatment of urinary
incontinence in adults (Imamura 2010).
• Bladder training for urinary incontinence in adults (Wallace
2004).
• Comparisons of approaches to pelvic floor muscle training
for urinary incontinence in women (Hay-Smith 2011).
• Feedback or biofeedback to augment pelvic floor muscle
training for urinary incontinence in women (Herderschee 2011).
• Pelvic floor muscle training added to another active
treatment versus the same active treatment alone for urinary
incontinence in women (Ayeleke 2013).
• Pelvic floor muscle training versus no treatment, or inactive
control treatments, for urinary incontinence in women
(Dumoulin 2014).
• Combined conservative interventions for urge, stress or
mixed incontinence in adults (French 2010).
• Weighted vaginal cones for urinary incontinence (Herbison
2013).
• Mechanical devices for urinary incontinence in women
(Lipp 2011).
• Oestrogen therapy for urinary incontinence in post-
menopausal women (Cody 2012).
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• Adrenergic drugs for urinary incontinence in adults
(Alhasso 2005).
• Serotonin and noradrenaline reuptake inhibitors (SNRI)
for stress urinary incontinence in adults (Mariappan 2005).
• Acupuncture for stress urinary incontinence in adults
(Wang 2013).
Surgical procedures to remedy SUI generally aim to lift and sup-
port the urethro-vesical junction, but in the last decade the em-
phasis has been on suburethral support at the mid-urethral level.
Owing to disagreement on the precise mechanism by which con-
tinence is achieved, the choice of surgical procedure is influenced
by co-existent problems, surgeon’s preference and the physical fea-
tures of the person affected.
Numerous surgical methods for SUI have been described and eval-
uated in Cochrane reviews. Traditionally, they fall into seven cat-
egories:
• suburethral slings (including traditional suburethral slings
and minimally invasive sling operations; Rehman 2011);
• open abdominal retropubic suspension (e.g.
colposuspension (Burch/modified Burch), Marshall-Marchetti-
Krantz (MMK); Lapitan 2012);
• laparoscopic retropubic suspension (Dean 2006);
• anterior vaginal repair (anterior colporrhaphy; Glazener
2001);
• needle suspensions (Glazener 2004);
• urethral injections (Kirchin 2012); and
• artificial sphincters.
Suburethral slings have become the favourite primary continence
surgery in current clinical practice. Several developments in type
and technique have resulted in the separation of the original sling
review, Bezerra 2005, into three different reviews focusing on:
• traditional suburethral slings (Rehman 2011)
• minimally invasive slings such as TVT and TOT (Ogah
2009), and
• single incision slings, also known as mini-slings (Nambiar
2014).
The materials that have been used for slings may be biological or
synthetic. The first of these reviews concentrates on traditional
(biological) suburethral sling operations (Rehman 2011). A tradi-
tional suburethral sling operation requires a combined abdominal
and vaginal approach. Strips of material are tunnelled under the
proximal urethra. They are attached either to the rectus muscle or
the iliopectineal ligaments, resulting in a tightening of the sling
and increased bladder support every time the woman strains to
prevent leaking. They are applied under open surgery and are fixed
with sutures.
This current review is an update of the second of these reviews,
focusing on minimally invasive suburethral sling operations using
artifical (synthetic) non-absorbable sling materials (Ogah 2009).
The techniques of these procedures are described below. This re-
view does not include single incision slings.
The third of these reviews is a new, recently published review that
compares a new type of sling, the single incision sling, which is also
known as the mini-sling (Nambiar 2014). The technique differs
from that of the original synthetic slings in that a single incision
is made within the vagina using a significantly shorter tape and
there are no tape exit incisions.
How the intervention might work
The current review focuses onmid-urethral sling operations. These
involve the insertion of a tape covered by a plastic sheath around
the mid-urethra without suture fixation, performed in some cen-
tres under local anaesthesia (Ulmsten1995a;Ulmsten1996; Smith
2002). The aim is to restore or enhance the patient’s urethral
support during a sudden movement, such as a cough or sneeze,
which would prevent the involuntary loss of urine. Ultrasound
studies suggest that the mechanism of action is the intermittent
or dynamic obstruction of the urethra by the tape when increased
abdominal pressure occurs (such as when coughing or sneezing;
Dietz 2004).
There are two main types of surgical approaches.
• Retropubic: This procedure involves the insertion of two
needles passed through the retropubic space blindly from the
vagina to abdomen or from the abdomen to the vagina.
Cystoscopy is recommended to detect any perforation of the
bladder or urethra (Ulmsten 1995a; Ulmsten 1995b).
• Transobturator; This is another type of minimally invasive
synthetic suburethral sling operation in which the tape is
inserted in a horizontal plane underneath the middle of the
urethra between the two obturator foramina. The ends of the
tape are tunnelled percutaneously with a tunneller (curved
needle), again without suture fixation. As the retropubic space is
not breached, it is argued that cystoscopy is not required
(Delorme 2001; Delorme 2003; Delorme 2004). Shortly after
the development of this technique a similar operation was
described in which a tape is passed percutaneously through the
obturator foramina, using an inside-to-outside technique, i.e.
medio-lateral (de Leval 2003; de Leval 2005).
We included only mid-urethral sling operations, with synthetic
tape materials applied throughminimally invasive surgeries, either
through the retropubic space or the transobturator route in this
review. However, a number of modifications of transobturator
surgery using the same route have been described and we have
included these too.
In this update, in contrast to the original review in which trials of
minimally invasive slingswere compared to traditional slings, open
colposuspension, or laparoscopic colposuspension, these compara-
tor techniques have not been included, as these are now covered
by other Cochrane reviews (Dean 2006; Rehman 2011; Lapitan
2012).
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A concern of using synthetic material is the potential risk of com-
plications caused by infection and tissue reaction to the tapes.
Some aspects of the material that may vary include pore size,
mono- or multifilament design, and biocompatibility. We in-
cluded all types of mesh used in different minimally invasive slings
in this review, and assessed possible differences between the risk
of complications.
Why it is important to do this review
There is a plethora of minimally invasive synthetic tapes available
and used worldwide for treatment of SUI. The reported effective-
ness and safety of these procedures have made them very popular,
but in the past there has been controversy about which of these
procedures is best, as the introduction of many of these proce-
dures and tapes was market driven and was not accompanied by
rigorous prospective randomised controlled trials of effectiveness.
Now more randomised controlled trials that assess their effective-
ness have been published, but many trials are too small to draw
definitive conclusions, hence the need for the first review.
Our initial review, Ogah 2009, showed evidence of efficacy in the
short-term, as many trials only reported a 12-month follow-up. A
significant advantage of a Cochrane review is not only the rigorous
database search andmethodology, butmost importantly the ability
to update the review and meta-analysis as new evidence becomes
available. This meta-analysis of the trials available is necessary to
helpmake judgements onmedium- and longer-term efficacy, since
we now have 18 years-worth of data since the initial report of the
retropubic mid-urethral tape, and it is over 11 years since the first
randomised trials of the tension-free vaginal tape and transobtu-
rator tapes were published. It is also necessary to provide evidence
on medium- and longer-term safety of the devices both suspected
and expected, and the unexpected adverse events in the long-term.
This review update aims to clarify the uncertainty surrounding
the use mid-urethral slings in terms of surgical approach, route of
insertion and the type of tape used.
This current update analyses only the effects ofmid-urethral slings,
and excludes both single incision slings and other surgical proce-
dures e.g. traditional slings and colposuspension. The options of
no treatment, conservative treatment and pharmacological treat-
ment are also excluded, as this will be addressed in a future
Cochrane review.
O B J E C T I V E S
To assess the clinical effects of mid-urethral sling (MUS) opera-
tions for the treatment of stress urinary incontinence (SUI), uro-
dynamic stress incontinence (USI) or mixed urinary incontinence
(MUI) in women.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised or quasi-randomised controlled trials amongst
women with USI (urodynamic diagnosis), or symptoms of SUI or
MUI (clinical diagnosis), in which both trial arms involve a mid-
urethral sling operation.
Types of participants
Adult women with SUI due to hyper-mobility and intrinsic
sphincter deficiency, or both, diagnosed clinically or with urody-
namics, and women with MUI in which stress incontinence was
the predominant symptom. Classification of diagnoses were ac-
cepted as defined by the trialists.
Types of interventions
Both trial arms of a study must involve mid-urethral sling opera-
tions to treat SUI or MUI.
We made the following comparisons.
• Transobturator route (TOR) versus retropubic route (RPR).
• Retropubic bottom-to-top approach versus retropubic top-
to-bottom approach.
• Obturator medial-to-lateral approach versus obturator
lateral-to-medial approach.
• One method of mid-urethral tape insertion versus another
method, same route.
• One type of tape material versus another
Comparisons with other types of surgery (i.e. traditional slings,
single incision slings and colposuspension) for urinary inconti-
nence are covered in other recentCochrane reviews. The options of
no treatment, conservative treatment and pharmacological treat-
ment have also been removed as these will be addressed in a future
Cochrane review.
Types of outcome measures
Primary outcomes
We selected the outcome measures used in this review on the
basis of their relevance to the clinical cure or improvement of
incontinence. We regarded the principal measures of effectiveness
as being:
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1. Women’s observations
• the proportion of women cured (continent or dry)
following surgery;
• the proportion of women whose incontinence is improved;
• cure and improvement measured in the short term (less
than one year); medium term (one to five years); and long term
(more than five years).
Secondary outcomes
2. Women’s observations
• Urgency symptoms or urgency incontinence.
3. Quantification of symptoms
• Pad changes (from self-reported number of pads used).
• Incontinence episodes (from self-completed bladder chart).
• Pad tests of quantified leakage (mean volume or weight of
urine loss).
4. Clinician’s observations
• Objective cure rates in the short term (less than one year);
medium term (one to five years); and long term (more than five
years).
• De novo detrusor overactivity (urodynamic diagnosis).
5. Surgical outcome measures
• Duration of operation.
• Length of inpatient stay.
• Time to return to normal activity level.
• Operative blood loss.
6. Adverse events
• Major vascular or visceral injury.
• Bladder, urethral or bowel perforation.
• Nerve damage.
• Perioperative surgical complications (e.g. infection,
bacteriuria, haemorrhage with or without major vessel lesion).
• Voiding dysfunction or difficulty after three months (with
or without urodynamic confirmation) or need for long-term
catheterisation.
• Infection related to use of synthetic mesh.
• Tape erosion or extrusion or exposure into the vagina.
• Tape erosion or extrusion or exposure into the bladder or
urethra.
7. Need for further treatment
• Physiotherapy treatment.
• Drug treatment for urinary incontinence or symptoms.
• Pelvic organ prolapse (e.g. cystocoele, rectocoele,
enterocoele).
• Repeat incontinence surgery.
• Later prolapse surgery.
8. Quality of life
Quality of life assessed by means of:
• general health status measures (e.g. Short Form 36 (Ware
1993));
• condition-specific instruments designed to assess
incontinence, e.g. the Bristol Female Lower Urinary Tract
Symptoms questionnaire (BFLUTS; Jackson 1996);
• condition-specific sexual function assessment e.g. via Pelvic
Organ Prolapse/Urinary Incontinence Sexual Function
Questionnaire (PISQ-12;Rogers 2003);
• psychological measures.
9. Other outcomes
• Non-prespecified outcomes judged to be important when
performing the review.
Search methods for identification of studies
Unless otherwise stated we did not impose language or other re-
strictions on any of the searches which are described below.
Electronic searches
This review drew on the search strategy developed for the
Cochrane Incontinence Group. We identified relevant trials from
the Cochrane Incontinence Group Specialised Trials Register. For
more details of the search methods used to build the Specialised
Register please see the Group’s module in The Cochrane Library.
The Register contains trials identified from the Cochrane Cen-
tral Register of Controlled Trials (CENTRAL), MEDLINE, and
MEDLINE in process, ClinicalTrials.gov and handsearching of
journals and conference proceedings. Most of the trials in the
Cochrane Incontinence Group Specialised Register are also con-
tained in CENTRAL. The date of the last search was 26 June
2014.
The terms used to search the Incontinence Group Specialised Reg-
ister are given in Appendix 1.
Additionally the following electronic databases were searched, de-
tails of the searches and the terms used are given in Appendix 1.
• Embase and Embase Classic (January 1947 to Week 25
2014; searched on 26 June 2014; limited to those years not
searched via the CENTRAL search of Embase, i.e. 1 January
2010 to Week 25 2014 inclusive).
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• WHO ICTRP (searched on 30 June 2014)
Details of the searches performed for the previous version of this
review can be found in Appendix 2.
We performed additional searches for the Brief Economic Com-
mentaries (BECs). We conducted them in MEDLINE(1 January
1946 to March 2017), Embase (1 January 1980 to 2017 Week
12) and NHS EED (1st Quarter 2016). We ran all searches on 6
April 2017. Details of the searches run and the search terms used
can be found in Appendix 3.
Searching other resources
We searched the reference lists of relevant articles.
Data collection and analysis
Selection of studies
Randomised and quasi-randomised trials were identified using the
above search strategy. We excluded studies from the review if they
were not randomised or quasi-randomised controlled trials for
incontinent women, or if theymade comparisons other than those
pre-specified. Excluded studies are listed in the Characteristics of
excluded studies table along with reasons for their exclusion. We
evaluated all potentially eligible studies for appropriateness for
inclusion without prior consideration of the results. We retrieved
reports of potentially eligible trials in full.
Data extraction and management
We extracted data independently using a standard form containing
pre-specified outcomes. Where data may have been collected but
not reported, we sought clarification from the trialists. We pro-
cessed included trial data as described in the Cochrane Handbook
for Systematic Reviews of Interventions (Higgins 2011).We resolved
differences of opinion relating to study inclusion, methodological
quality or data extraction by discussion among the reviewers, and
when necessary, referred them to a third party for arbitration.
Assessment of risk of bias in included studies
Miss Abigail Ford and Mr Joseph Ogah (review authors) extracted
data and independently assessed the included trials for method-
ological quality and validity using the ’Risk of bias’ assessment
tool (Higgins 2011). We assessed the risk of bias in the results of
the included trials by examining the following features: selection
bias, which results from insecure random allocation of treatments;
performance bias that occurs when knowledge of the procedure
actually performed might have affected the participant or care
provider; attrition bias caused by incomplete reporting of outcome
data, or from dropouts or losses to follow-up, particularly if there
is a differential dropout rate between groups; and biased ascertain-
ment (detection bias) of outcome where knowledge of the alloca-
tion might have influenced the measurement of outcome. These
were assessed under the headings below:
• sequence generation;
• allocation sequence concealment;
• blinding of participants and personnel;
• blinding of outcome assessment;
• incomplete outcome data.
These were presented in the ’Risk of bias’ tables, graphs and sum-
mary figures.
The GRADE (Grades of Recommendation, Assessment, Devel-
opment and Evaluation) system was used to assess and grade the
quality of evidence for each individual outcome (Guyatt 2011a;
Guyatt 2011b; Guyatt 2013a; Guyatt 2013b).
Measures of treatment effect
The review was conducted using the standard Cochrane software
ReviewManager ’Revman’ version 5.2 (ReferenceManager 2012).
For categorical outcomes we related the numbers reporting an out-
come to the numbers at risk in each group to derive a summary risk
ratio (RR). For continuous variables we used means and standard
deviations to derive a mean difference (MD) if the outcomes were
measured in the same way between trials. Any continuous data
that were the product of a number of different scales (for example,
scales used to assess symptoms such as pain or quality of life) we
summarised as the standardised mean difference (SMD) using a
fixed-effect model. A fixed-effect model was used for calculation of
all summary estimates and 95% confidence intervals (CIs) except
when there was significant heterogeneity. When appropriate, we
undertook meta-analysis.
We undertook a narrative review of eligible trials where statistical
synthesis of data from more than one study was not possible, or
considered inappropriate.
Unit of analysis issues
We did not perform analysis of trials with non-standard designs,
such as cross-over trials and cluster-randomised trials, as there
were no such trials. We analysed trials with multiple treatment
groups by treating each pair of arms as a separate comparison, as
appropriate.
Dealing with missing data
We defined ’intention-to-treat analysis’ as meaning that all par-
ticipants were analysed in their randomised groups whether or
not they received the allocated intervention. We included data as
they were reported for each outcome and did not impute miss-
ing values, but used the data as presented by the trialists. Where
intraoperative outcomes were reported, we used the number of
patients undergoing the described procedure as the denominator.
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Follow-up outcomes were reported with the exclusion of patients
lost to follow-up. We would have performed sensitivity analyses
had there been differential dropout from the randomised groups,
or another reason to suspect systematic bias from missing data.
Assessment of heterogeneity
We used a fixed-effect approach for the analysis unless there was
evidence of heterogeneity across trials. Differences between trials
were investigated when apparent either through visual inspection
of the results, or when statistically significant heterogeneity was
demonstrated by using the Chi² test at the 10% probability level
or assessment of the I² statistic (Higgins 2003).
Assessment of reporting biases
We examined publication bias by means of a funnel plot where
there were 10 or more trials contributing to a meta-analysis.
Data synthesis
We used fixed-effect model analysis for the meta-analyses, except
when significant heterogeneity was suspected, when we used a
random-effects model.
Subgroup analysis and investigation of heterogeneity
Heterogeneity
Where there was no obvious reason for heterogeneity to exist (after
considerationof populations, interventions, outcomes and settings
of the individual trials), or it persisted despite the removal of trials
that were clearly different from the others, we used a random-
effects model.
Subgroup analysis
Clinical factors such as symptoms of SUI, USI, MUI, diagnosis
of intrinsic urethral sphincter deficiency or urethral hypermobil-
ity, obesity, previous incontinence surgery, presence or absence of
prolapse, anaesthesia used, or experience of the surgeon and other
concomitant surgical intervention, might all influence the out-
comes of surgery and consideration of subgroup analysis was taken
into account.
Sensitivity analysis
We performed sensitivity analysis to explore the robustness of the
results in some outcomes. We planned to carry out sensitivity
analysis for the primary outcomes by restricting our analysis to
trials assessed as having a low risk of bias for the of domain attrition
bias; if more than 30% of participants had been lost to follow-up,
these trials would have been excluded from sensitivity analyses.
This was not necessary.
Summary of findings
We employed the GRADE approach to interpret findings (Guyatt
2011a; Guyatt 2011b; Guyatt 2013a; Guyatt 2013b; Langendam
2013), and the GRADE profiler (GRADEpro) was used to import
data from RevMan 5.2 to create ’Summary of findings’ tables.
These tables provide outcome-specific information concerning the
overall quality of evidence from trials included in a comparison,
the magnitude of effect of the interventions examined, and the
sum of the available data on the outcomes we considered.
We included the following outcomes in the ’Summary of findings’
tables.
• Subjective cure: medium term (one to five years).
• Subjective cure: long term (more than 5 years).
• Bladder or urethral perforation.
• Voiding dysfunction: short term and medium term (up to
five years).
• De novo urgency or urgency incontinence: short term (less
than one year).
• Vaginal tape erosion: short term and medium term (up to
five years).
• Repeat continence surgery: short term (less than one year).
• Repeat continence surgery: long term (more than five years).
• Groin pain: short term (less than one year).
• Quality of life.
We assessed the overall quality of evidence for these outcomes and
downgraded the evidence level from high quality by one level for
serious, or by two levels for very serious study limitations (risk of
bias), indirectness of evidence, serious inconsistency, imprecision
of effect estimates or potential publication bias.
R E S U L T S
Description of studies
Results of the search
We screened the 841 records identified by the literature searches
and obtained a total of 290 full-text articles for further assessment.
Altogether 217 reports concerning 81 randomised trials met the
inclusion criteria. A further two trials were ongoing.
We excluded 551 records on the basis of either the title or abstract
alone, and 71 reports relating to 62 studies after retrieval of the
full text publication. Exclusion was either because they were not
randomised trials, they did not include a mid-urethral sling oper-
ation, or because the women included in the trial were not urinary
incontinent. A full description of these trials can be found in the
Characteristics of excluded studies section of this review. The flow
of literature through the assessment process is shown in Figure 1.
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Figure 1. PRISMA study flow diagram
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We analysed trials with multiple treatment groups by treating each
pair of arms as a separate comparison, as appropriate. There were
six trials in this review that supplied data and forwhich thismethod
was employed, thus leading to 87 comparisons. There were no tri-
als with non-standard designs, such as cross-over trials and cluster-
randomised trials.
Included studies
Further characteristics of the trials are reported in the
Characteristics of included studies table.
Comparisons and interventions
1. Transobturator (TOR) versus retropubic route (RPR)
This comparison of mid-urethral sling operations was based on
the routes that the tapes traverse, i.e. transobturator route (TOR)
versus retropubic route (RPR). There were 55 trials that in-
vestigated this (Aigmuller 2014; Alkady 2009; Andonian 2007;
Aniuliene 2009; Araco 2008; Barber 2008; Barry 2008; Cervigni
2006; Chen 2010; Chen 2012; Choe 2013; Darabi Mahboub
2012; David-Montefiore 2006; Deffieux 2010; de Tayrac 2004;
Diab 2012; El-Hefnawy 2010; Enzelsberger 2005; Freeman 2011;
Hammoud 2011; Jakimiuk 2012; Kamel 2009; Karateke 2009;
Kilic 2007; Kim 2005; Krofta 2010; Laurikainen 2007; Leanza
2009; Lee 2007; Liapis 2006; Mansoor 2003; Mehdiyev 2010;
Meschia 2007; Nerli 2009; Nyyssonen 2014; Oliveira 2006;
Palomba 2008; Porena 2007; Rechberger 2009; Richter 2010;
Riva 2006; Ross 2009; Salem 2014; Scheiner 2012; Schierlitz
2008; Tanuri 2010; Tarcan 2011; Teo 2011; van Leijsen 2013;
Wang 2006; Wang 2008; Wang 2009; Wang 2010; Wang 2011;
Zullo 2007).
2. Retropubic bottom-to-top approach versus retropubic
top-to-bottom approach
Trials in this group compared the retropubic bottom-to-top ap-
proach (e.g. tension-free vaginal tape (TVTTM ); tape inserted
from the vagina through the retropubic space and exiting onto
the abdominal skin in the suprapubic region) with a retropubic
top-to-bottom approach (e.g. suprapubic urethral support sling
(SPARCTM ); tape inserted from the abdomen in the suprapubic
region through the retropubic space and exiting in the vagina).
There were five such trials (Andonian 2005; Kim 2004; Lim 2005;
Lord 2006; Tseng 2005).
3. Obturator medial-to-lateral approach versus obturator
lateral-to-medial approach
Ten trials reported on this comparison which compared tapes
traversing the obturator route: obturator lateral-to-medial ap-
proach, (e.g. TOTTM tape inserted in the thigh crease and through
the obturator route exiting in the vagina) with obturator medial-
to-lateral approach (e.g. TVT-OTM tape inserted in the vagina
and through the obturator route exiting in the thigh crease;
Abdel-Fattah 2010; But 2008;Chen2010;Hassan 2013;Houwert
2009; Lee 2008; Liapis 2008; Park 2012; Peattie 2006; Scheiner
2012).
4. One method of mid-urethral tape insertion versus another
method, same route
Ten trials compared different methods of carrying out operations
using the same route (Cho 2010; de Leval 2011; Elbadry 2014;
Juang 2007; Naumann 2006; Paparella 2010; Rechberger 2011;
Tommaselli 2012; Ugurlucan 2013; Zhang 2011).
The trials compared the following operations.
Transobturator lateral to medial
• Monarc® TOT versus TOT® (Cho 2010).
• TOT versus adjustable TOT (Elbadry 2014).
• TOT versus TOT with two-point fixation sutures
(Rechberger 2011).
• Synthetic TOT versus biological TOT (Paparella 2010;
Ugurlucan 2013).
Transobturator medial to lateral
• TVT-O versus modified TVT-O (shorter tape and less
lateral dissection; de Leval 2011).
• TVT-O versus TVT-O plus Ingleman-Sundberg bladder
denervation procedure (Juang 2007).
• TVT-O versus modified TVT-O (reduced dissection;
Tommaselli 2012).
• TVT-O versus modified TVT-O (self-tailored mesh;
Zhang 2011).
Retropubic
• TVT versus modified TVT, bottom-to-top (suburethral
pad; Naumann 2006).
5. One type of tape material versus another
A final group compared different mid-urethral sling operations
based on the properties of the tapematerial. All used synthetic non-
absorbable mesh for the tape material, but differed in the structure
of thematerial, i.e. monofilament tapes versusmultifilament tapes.
There were four such trials (Lim 2005; Meschia 2006; Okulu
2013; Rechberger 2003), which made the following comparisons.
• Monofilament (TVT SPARC) verus multifilament (IVS;
Lim 2005).
• Monofilament (TVT) versus multifilament (IVS; Meschia
2006).
• Synthetic monofilament (prolene light mesh) versus a
combined synthetic mesh coated with a biological film (Ultrapro
mesh) versus a multifilament mesh (Vypro; Okulu 2013).
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• Monofilament (TVT) versus multifilament (IVS;
Rechberger 2003).
Publication type and sample characteristics
1. Retropubic route versus transobturator route
The sample sizes ranged from 20 to 597; with a median of 131.
Twelve of the 55 trials were reported only as abstracts (Cervigni
2006;Choe 2013;DarabiMahboub 2012;Diab 2012;Hammoud
2011; Kamel 2009; Leanza 2009; Mansoor 2003; Oliveira 2006;
Riva 2006; Salem 2014; Tarcan 2011).
Inclusion and exclusion criteria were not clearly stated in eight
trials (Cervigni 2006; Chen 2010; Darabi Mahboub 2012; Kamel
2009; Mansoor 2003; Mehdiyev 2010; Oliveira 2006; Tarcan
2011).
All trials had women either presenting with SUI or had USI con-
firmed. In addition other characteristics included:
• 23 trials included women with MUI (Alkady 2009;
Aigmuller 2014; Andonian 2007; Barber 2008; Barry 2008;
Cervigni 2006; David-Montefiore 2006; Deffieux 2010;
El-Hefnawy 2010; Freeman 2011; Kim 2005; Krofta 2010;
Laurikainen 2007; Lee 2007; Nerli 2009; Nyyssonen 2014;
Porena 2007; Richter 2010; Riva 2006; Scheiner 2012; Tarcan
2011; van Leijsen 2013; Wang 2011).
• ten trials included women with previous incontinence
surgery (Andonian 2007; Aniuliene 2009; Barber 2008; Barry
2008; David-Montefiore 2006; de Tayrac 2004; Kim 2005; Lee
2007; Richter 2010; Wang 2010).
• 28 trials included women with pelvic organ prolapse (POP;
Alkady 2009; Andonian 2007; Aniuliene 2009; Barber 2008;
Barry 2008; Cervigni 2006; Chen 2012; David-Montefiore
2006; El-Hefnawy 2010; Freeman 2011; Krofta 2010;
Laurikainen 2007; Mansoor 2003; Meschia 2007; Nerli 2009;
Porena 2007; Rechberger 2009; Richter 2010; Riva 2006;
Scheiner 2012; Schierlitz 2008; Tanuri 2010; Tarcan 2011; van
Leijsen 2013; Wang 2006; Wang 2008; Wang 2009; Wang
2010).
• in 13 trials women had concomitant pelvic or prolapse
surgery (Andonian 2007; Barber 2008; Barry 2008; Cervigni
2006; David-Montefiore 2006; Richter 2010; Riva 2006;
Scheiner 2012; Schierlitz 2008; Tarcan 2011; Wang 2008; Wang
2009; Wang 2010).
Follow-up for women ranged from one month to five years with
a median follow-up of 12 months.
2. Retropubic bottom-to-top approach versus retropubic
top-to-bottom approach
Five trials investigated a retropubic bottom-to-top approach versus
a retropubic top-to-bottomapproach (Andonian 2005;Kim2004;
Lim 2005; Lord 2006; Tseng 2005). One of the five trials was
reported only as an abstract (Kim 2004), and this was the only
study without clear inclusion and exclusion criteria.
The sample sizes ranged from 62 to 304; the average sample size,
’n’ (standard deviation), for retropubic in-out was 62 (49) and for
retropubic out-in was 64 (53).
All trials had women either presenting with SUI or had USI con-
firmed. All trials except Tseng 2005 included women with MUI.
Andonian 2005 and Lord 2006 included women with previous
incontinence surgery.
All the trials included women with POP and had concomitant
pelvic or POP surgery performed.
Follow-up for women ranged from 1.5 months to 2 years with a
median of 12 months.
3. Obturator medial-to-lateral approach versus obturator
lateral-to-medial approach
Nine trials compared the obturator medial-to-lateral approach
with the obturator lateral-to-medial approach (Abdel-Fattah 2010;
But 2008; Chen 2010; Hassan 2013; Houwert 2009; Lee 2008;
Liapis 2008; Park 2012; Scheiner 2012). With the exception of
Hassan 2013, which was reported only as an abstract, the other
eight trials were reported as full articles. Peattie 2006 appears in a
trials registry but its status is unclear; we have contacted the au-
thors and are awaiting a response.
The sample sizes ranged from 74 to 341 with a median size of 110.
Inclusion and exclusion criteria were not clearly stated in two trials
(But 2008; Hassan 2013).
All trials had women either presenting with SUI or had USI con-
firmed.
Five trials included women with MUI (Abdel-Fattah 2010; But
2008; Lee 2008; Park 2012; Scheiner 2012), and two trials in-
cluded women who had undergone previous incontinence surgery
(Abdel-Fattah 2010; Scheiner 2012). Scheiner 2012 included
women with POP and women with concomitant pelvic or POP
surgery.
Follow-up ranged from three months to three years with a median
follow up of 12 months.
4. One method of mid-urethral tape insertion versus
another method, same route
Ten trials investigated one method of mid-urethral tape versus
another method, using the same route (Cho 2010; de Leval
2011; Elbadry 2014; Juang 2007;Naumann 2006; Paparella 2010;
Rechberger 2011; Tommaselli 2012; Ugurlucan 2013; Zhang
2011). Three of these trials were reported only as abstract publi-
cations (Cho 2010; Elbadry 2014; Naumann 2006). The sample
sizes ranged from 72 to 463 with a median of 156.
All the trials included women with SUI or USI. Rechberger 2011
reported women with ISD. Inclusion and exclusion criteria were
not clearly defined in four of the ten trials (Cho 2010; Elbadry
2014; Juang 2007; Naumann 2006). Juang 2007, Tommaselli
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2012 and Ugurlucan 2013 included women with MUI, whilst de
Leval 2011 andUgurlucan 2013 included women who had under-
gone previous incontinence surgery. Women with prolapse were
included in de Leval 2011 and Ugurlucan 2013, but concomitant
POP surgery was performed only in Ugurlucan 2013.
Follow-up ranged from three months to three years.
5. One type of tape material versus another
Four trials investigated the use of monofilament tape versus multi-
filament tape (Lim 2005;Meschia 2006; Okulu 2013; Rechberger
2003). All four trials were reported as full article publications.
The sample sizes ranged from 70 to 182 with a median value of
144.
The trials had women either presenting with SUI or had USI
confirmed: all had clear inclusion and exclusion criteria. Three
trials included women with POP (Lim 2005; Meschia 2006;
Rechberger 2003). Two trials included women with MUI (Lim
2005; Meschia 2006). Three trials included women with previous
incontinence surgery (Lim 2005; Okulu 2013; Rechberger 2003),
whereas only Lim 2005 included women who had concomitant
pelvic or POP surgery.
Follow-up for women ranged from three months to three years.
Outcomes
The trials reported their outcomes in a variety of different ways.
The primary outcome, subjective cure of urinary incontinence
(UI), was defined as follows:
• no subjective report of UI (Aniuliene 2009; Barber 2008;
But 2008; Cho 2010; Darabi Mahboub 2012; de Leval 2011; de
Tayrac 2004; Deffieux 2010; El-Hefnawy 2010; Freeman 2011;
Hassan 2013; Houwert 2009; Jakimiuk 2012; Kim 2004;
Laurikainen 2007; Leanza 2009; Liapis 2006; Lim 2005; Lord
2006; Mansoor 2003; Naumann 2006; Nerli 2009; Okulu 2013;
Paparella 2010; Porena 2007; Richter 2010; Riva 2006; Scheiner
2012; Schierlitz 2008; Tanuri 2010; Tarcan 2011; Ugurlucan
2013; van Leijsen 2013; Wang 2010; Wang 2011; Zhang 2011);
• no subjective report of UI and negative stress test (Lee
2007; Meschia 2006; Meschia 2007; Park 2012; Rechberger
2003; Rechberger 2009; Wang 2008);
• no or improved subjective report of UI (Abdel-Fattah 2010;
Aigmuller 2014; Barry 2008; Karateke 2009; Ross 2009; Teo
2011; Zullo 2007).
Secondary outcome objective cure was defined by the trialists as
follows:
• absence of USI on urodynamics (UDS) (Abdel-Fattah 2010;
Araco 2008; Barry 2008; Cervigni 2006; Enzelsberger 2005;
Kamel 2009; Karateke 2009; Kilic 2007; Kim 2005; Krofta
2010; Lim 2005; Riva 2006; Schierlitz 2008; Zullo 2007);
• absence of SUI and negative stress test (Alkady 2009;
Paparella 2010; Porena 2007);
• one-hour pad test less than 2 g (Andonian 2005; Andonian
2007; But 2008; Ross 2009; Tseng 2005);
• 24-hour pad test less than 5 g (Darabi Mahboub 2012;
Okulu 2013; Teo 2011);
• negative stress test (Aigmuller 2014; Aniuliene 2009;
Barber 2008; Chen 2010; David-Montefiore 2006; de Leval
2011; de Tayrac 2004; Deffieux 2010; El-Hefnawy 2010; Juang
2007; Kim 2004; Kim 2005; Laurikainen 2007; Lord 2006;
Meschia 2007; Nerli 2009; Tarcan 2011; van Leijsen 2013;
Wang 2009; Wang 2011);
• multiple objective measures used (El-Hefnawy 2010; Juang
2007; Kamel 2009; Kim 2005; Krofta 2010; Liapis 2006; Liapis
2008; Mansoor 2003; Meschia 2006; Naumann 2006;
Nyyssonen 2014; Oliveira 2006; Rechberger 2011; Richter
2010; Scheiner 2012; Tanuri 2010; Tommaselli 2012; Wang
2006; Wang 2008; Wang 2010).
Excluded studies
We excluded 62 studies after retrieval of the full text publication
because they were not randomised trials, did not include a mid-
urethral sling operation, the participants did not have urinary in-
continence, or the participants were randomised to an interven-
tion other than a mid-urethral sling (such as no treatment, pelvic
floor muscle training, drugs, or a different class of surgery). The
details of the reasons for exclusion are given in the Characteristics
of excluded studies table.
Ongoing trials
There are two ongoing trials: Cavkaytar 2013 and Sung 2013.
Cavkaytar 2013 is a randomised controlled trial (RCT) compar-
ing RPR and TOR for the treatment of SUI in women with no
intrinsic sphincter deficiency. This study is currently recruiting
and includes women with SUI and excludes women with MUI
or detrusor overactivity (DO), previous incontinence surgery, and
women with a body mass index greater than 35. Fifty women have
been randomly assigned into each arm for evaluation.
Sung 2013 is an RCT comparing mid-urethral sling operations
and behavioural or pelvic floor therapy in combination versus sub-
urethral sling operations alone for women with MUI. The ES-
TEEM trial includes women over 18 years of age who have had
urodynamic investigation within the last 18 months, and excludes
women with prolapse, previous incontinence surgery, and women
currently on antimuscarinic medication. This trial is currently re-
cruiting participants.
Studies awaiting classification
There are no studies awaiting classification.
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New trials included in this update
Wehave included 48 new trials in this update (Abdel-Fattah 2010;
Aigmuller 2014; Alkady 2009; Andonian 2007; Aniuliene 2009;
Chen 2010; Chen 2012; Cho 2010; Choe 2013;DarabiMahboub
2012; de Leval 2011; Diab 2012; Elbadry 2014; El-Hefnawy
2010; Freeman 2011; Hassan 2013; Hammoud 2011; Jakimiuk
2012; Juang 2007;Kamel2009;Karateke 2009;Kilic 2007;Krofta
2010; Leanza 2009;Mehdiyev 2010; Naumann 2006; Nerli 2009;
Nyyssonen 2014; Okulu 2013; Palomba 2008; Paparella 2010;
Park 2012; Peattie 2006; Rechberger 2011; Richter 2010; Ross
2009; Salem 2014; Scheiner 2012; Tanuri 2010; Tarcan 2011;
Teo 2011; Tommaselli 2012; Ugurlucan 2013; van Leijsen 2013;
Wang 2008; Wang 2010; Wang 2011; Zhang 2011).
Previously included trials with new outcome data
We have included new data from 11 trials previously included
in this review, including the report of medium- or long-term
outcomes (Barber 2008; But 2008; David-Montefiore 2006;
Deffieux 2010; Houwert 2009; Laurikainen 2007; Porena 2007;
Rechberger 2009; Schierlitz 2008; Wang 2009; Zullo 2007).
Previously included trials with no new outcome data
Twenty-two trials included in the earlier version of this review
have not published new outcome data (Andonian 2005; Araco
2008; Barry 2008; Cervigni 2006; de Tayrac 2004; Enzelsberger
2005; Kim 2004; Kim 2005; Lee 2007; Lee 2008; Liapis 2006;
Liapis 2008; Lim2005; Lord 2006;Mansoor 2003;Meschia 2006;
Meschia 2007;Oliveira 2006; Rechberger 2003; Riva 2006; Tseng
2005; Wang 2006).
Risk of bias in included studies
Details of the criteria used to assess the risk of bias and the ratings
for each study are reported in the ’Risk of bias’ tables that accom-
pany the Characteristics of included studies. Further information
on the risk of bias in included trials is shown in Figure 2 the ’Risk
of bias’ graph and Figure 3 the ‘Risk of bias’ summary.
Figure 2. Risk of bias graph: review authors’ judgments about each risk of bias item presented as
percentages across all included studies.
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Figure 3. Risk of bias summary: review authors’ judgments about each risk of bias item for each included
study.
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The risk of bias in the trials included was variable, though overall
only few trials were judged to be at high risk of bias. In over
50% of trials the random sequence generation was judged to be
adequate, for examplewith the use of a computer-generated list or a
table of random numbers. Approximately 30% of trials confirmed
that secure concealment of the randomisation process was used,
for example allocation by a remote person or the use of sealed
envelopes.
Blinding of participantswas unclear in themajority of trials. This is
an obvious limitation with trials comparing surgical interventions,
though one trial described the use of a ’sham’ procedure (Jakimiuk
2012). Blinding of patients and the post-operative reviewer was
not reported in most trials. Loss to follow-up in most trials was
minimal, and in approximately 50% of included trials the risk of
attrition bias was judged to be low.
We judged that 39 trials had adequate random sequence generation
(Abdel-Fattah 2010; Aigmuller 2014; Alkady 2009; Andonian
2005; Araco 2008; Barber 2008; But 2008; Cervigni 2006; Chen
2012; David-Montefiore 2006; Deffieux 2010; de Tayrac 2004;
Freeman 2011; Jakimiuk 2012; Karateke 2009; Krofta 2010;
Laurikainen 2007; Lord 2006; Mansoor 2003; Meschia 2006;
Meschia 2007; Nyyssonen 2014; Okulu 2013; Paparella 2010;
Porena 2007; Richter 2010; Ross 2009; Scheiner 2012; Schierlitz
2008; Teo 2011; Tommaselli 2012; Tseng 2005; Ugurlucan 2013;
van Leijsen 2013; Wang 2006; Wang 2008; Wang 2009; Wang
2011; Zullo 2007).
We judged that adequate allocation concealment occurred in
26 trials (Abdel-Fattah 2010; Aigmuller 2014; Alkady 2009;
Andonian 2005; Araco 2008; Barber 2008; David-Montefiore
2006;Deffieux 2010; deTayrac 2004; El-Hefnawy 2010; Freeman
2011; Laurikainen 2007; Lord 2006; Mansoor 2003; Meschia
2006; Meschia 2007; Nyyssonen 2014; Okulu 2013; Paparella
2010; Porena 2007; Ross 2009; Teo 2011; Tommaselli 2012; van
Leijsen 2013; Wang 2011; Zullo 2007).
We judged that 24 trials had an adequate randomisation process
and secure concealment of the randomisation process (Aigmuller
2014; Alkady 2009; Andonian 2005; Araco 2008; Barber 2008;
David-Montefiore 2006;Deffieux 2010; de Tayrac 2004; Freeman
2011; Laurikainen 2007; Lord 2006; Mansoor 2003; Meschia
2006; Meschia 2007; Nyyssonen 2014; Okulu 2013; Paparella
2010; Porena 2007; Ross 2009; Teo 2011; Tommaselli 2012; van
Leijsen 2013; Wang 2011; Zullo 2007).
We judged that 22 trials adequately blinded outcome assessors (
Abdel-Fattah 2010; Andonian 2005; Andonian 2007; Araco2008;
Barber 2008; de Tayrac 2004; El-Hefnawy 2010; Karateke 2009;
Krofta 2010; Liapis 2006; Liapis 2008; Lord 2006; Paparella 2010;
Porena 2007; Rechberger 2003; Tseng 2005;Ugurlucan 2013; van
Leijsen 2013; Wang 2006; Wang 2009; Wang 2010; Zullo 2007).
We judged36 trials to be at a low risk of attritionbias (Abdel-Fattah
2010; Aigmuller 2014; Alkady 2009; Andonian 2005; Aniuliene
2009; Barber 2008; Barry 2008; But 2008; Deffieux 2010; de
Leval 2011; El-Hefnawy 2010; Freeman 2011; Karateke 2009;
Krofta 2010; Laurikainen 2007; Liapis 2006; Liapis 2008; Lord
2006;Meschia 2007;Nyyssonen 2014; Paparella 2010; Park 2012;
Porena 2007; Rechberger 2009; Ross 2009; Scheiner 2012; Tanuri
2010; Tommaselli 2012; Tseng 2005; Ugurlucan 2013; Wang
2006; Wang 2008; Wang 2009; Wang 2010; Wang 2011; Zullo
2007).
Effects of interventions
See: Summary of findings for the main comparison
Transobturator (TOR) compared to retropubic (RPR) route for
stress urinary incontinence in women; Summary of findings
2 Retropubic bottom-to-top approach compared to retropubic
top-to-bottom approach for stress urinary incontinence in
women; Summary of findings 3 Obturator medial-to-lateral
approach compared to obturator lateral-to-medial approach for
stress urinary incontinence in women; Summary of findings 4
Monofilament compared to multifilament tapes for stress urinary
incontinence in women
The results of all the included studies can be found in Table 1.
Comparison 1. Transobturator versus retropubic
route
Fifty-five trials addressed this comparison (Aigmuller 2014;
Alkady 2009; Andonian 2007; Aniuliene 2009; Araco 2008;
Barber 2008; Barry 2008; Cervigni 2006; Chen 2010; Chen 2012;
Choe 2013; Darabi Mahboub 2012; David-Montefiore 2006;
de Tayrac 2004; Deffieux 2010; Diab 2012; El-Hefnawy 2010;
Enzelsberger 2005; Freeman 2011; Hammoud 2011; Jakimiuk
2012; Kamel 2009; Karateke 2009; Kilic 2007; Kim 2005; Krofta
2010; Laurikainen 2007; Leanza 2009; Lee 2007; Liapis 2006;
Mansoor 2003; Mehdiyev 2010; Meschia 2007; Nerli 2009;
Nyyssonen 2014; Oliveira 2006; Palomba 2008; Porena 2007;
Rechberger 2009; Richter 2010; Riva 2006; Ross 2009; Salem
2014; Scheiner 2012; Schierlitz 2008; Tanuri 2010; Tarcan 2011;
Teo 2011; van Leijsen 2013;Wang 2006;Wang 2008;Wang 2009;
Wang 2010; Wang 2011; Zullo 2007).
1.1 Women’s observations
Subjective cure within 12 months was reported in 36 trials with a
total of 5514 participants. Assessment of cure was self-reported by
participants and by responses to symptom-based questionnaires.
The combined results from the 36 trials showed no statistically
significant difference in the subjective cure rates between the two
routes (RR 0.98, 95% CI 0.96 to 1.00; Analysis 1.1). The short-
term subjective cure ranged from 62% to 98% for TOR and from
71% to 97% for RPR.
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The mean subjective cure rate across both groups was 83.3% and,
using this as the assumed control subjective cure rate in the RPR
group, for every 1000 women there were 17 fewer cured in the
TOR group (95% CI from 0 fewer to 33 fewer per 1000). This
was not statistically significant and is also unlikely to be considered
to be a clinically significant difference. The funnel plot inspection
shows no strong evidence of publication bias Figure 4.
Figure 4. Funnel plot of comparison: 1 Transobturator (TOR) versus retropubic (RPR) route, outcome: 1.1
Subjective cure (short term, ≤ 1 year)
There was also no statistically significant difference between the
two groups in terms of symptomatic improvement and cure rate
(RR 0.98, 95% CI 0.96 to 1.00; Analysis 1.2).
Medium-term outcomes
Only seven trials provided information after the first year (
Deffieux 2010; Laurikainen 2007;Nyyssonen 2014; Porena 2007;
Schierlitz 2008; Tarcan 2011; Zullo 2007). Five trials (683 partic-
ipants) contributed medium-term data between one and five years
after surgery, which showed no significant difference in subjective
cure between the two groups (RR 0.97, 95% CI 0.87 to 1.09;
Analysis 1.3). Subjective cure rates ranged from 82% to 91% in
the TOR group and from 77% to 98% in the RPR group.
The average medium-term subjective cure rate across both groups
was 86.9% and, using this as the assumed control cure rate in the
RPR group, for every 1000 women there were 26 fewer women
cured in the TOR group (95% CI from 26 per 1000 more to 70
per 1000 fewer).
Long-term outcomes
Four trials (714 women) reported long-term results for subjective
cure after five years (Laurikainen 2007; Porena 2007; Richter
23Mid-urethral sling operations for stress urinary incontinence in women (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
2010; Zullo 2007); the difference between the groups was not
statistically significant (RR 0.95, 95% CI 0.80 to 1.12; Analysis
1.4). Subjective cure rates range from 43% to 92% in the TOR
group and from 51% to 88% in the RPR group.
The average long-term subjective cure rate across both groups was
84.3% and, using this as the assumed control cure rate in the RPR
group, for every 1000 women there were 42 fewer women cured
in the TOR group (95% CI from 110 per 1000 less to 34 per
1000 more).
Two trials with 340 women reported long-term data for subjec-
tive cure and improvement and the difference between the groups
was not statistically significant (RR 0.92, 95% CI 0.67 to 1.28;
Analysis 1.5); due to significant heterogeneity we also performed a
random-effects analysis that produced similar results and, as there
were only two trials, the fixed-effect analysis was maintained.
1.2 Quantification of symptoms
Only two trials provided data about pad test weights (Tanuri
2010 used a non standardised modified/simplified pad test and
Wang 2006 used the standard one-hour pad test). The information
provided was not suitable for meta-analysis, but each reported a
significant reduction in pad weight postoperatively in each group
without a significant difference between the groups.
1.3 Clinician’s observations
Objective cure was assessed by 40 trials with 6145 participants
in the short term using a variety of measures such as urodynamic
assessment, negative cough-stress test, one-hour pad test of 2 g or
less, one-hour pad test of 1 g or less, and 24-hour pad test of 5g
or less. The cure rate with the obturator route was 85.7% versus
87.2% for the RPR (RR 0.98, 95% CI 0.96 to 1.00, Analysis
1.6). The confidence interval was narrow and this statistically non
significant difference between the groups (2%) is unlikely to rep-
resent a clinically significant difference in outcome between the
two methods in the short term.
The small difference in the objective cure and improvement rate in
the short termwas not statistically - nor was it likely to be clinically
- significant (RR 0.98, 95% CI 0.96 to 1.01; 10 studies, 1478
women; Analysis 1.7). The same holds true for the medium-term
objective cure rates (RR 1.00, 95%CI 0.95 to 1.06; 5 studies, 596
women; Analysis 1.8), and long-term cure rates (RR 0.97, 95%
CI 0.90 to 1.06; 3 studies, 400 women; Analysis 1.9).
1.4 Surgical outcome measures
Duration of operation was significantly shorter, by an average of
approximately seven minutes, with the TOR compared with the
RPR (MD -7.54 minutes, 95% CI -9.31 to -5.77). There was
statistically significant heterogeneity, but all the trials reported a
shorter operating time with the TOR. This may be attributable to
most surgeons routinely performing a cystoscopy following a RPR
procedure, but not necessarily doing this after a TOR procedure.
To investigate this theory, we performed a sensitivity analysis to
assess the difference in operative time between the RPR and TOR
approach in trials where cystoscopy was performed in both com-
parison groups as defined by the trialists. In eight trials where cys-
toscopy was performed in both TOR and RPR groups we still
found a shorter operating time with the TOR in comparison to
the RPR (MD -6.50 95% CI -7.57 to -5.44) although high het-
erogeneity persisted. Using a random-effects method on the full
analysis of 31 trials still showed the duration of operation to be
statistically significantly shorter with TOR approach (MD -7.54
minutes, 95% CI -9.31 to -5.77; Analysis 1.10).
Intraoperative blood loss was small (mean loss ranged from 15
ml to 125 ml), but was significantly less with the TOR approach
(MD -6.49 ml, 95% CI -12.33 to -0.65; Analysis 1.11). There
was significant heterogeneity that was accounted for by three small
trials (Nerli 2009; Wang 2008; Zullo 2007). In view of the small
blood volumes involved, this is unlikely to be a clinically significant
finding.
Length of stay was also significantly shorter by an average of 0.17
days with the TOR compared with the retropubic route (MD -
0.17, 95% CI -0.25 to -0.10; Analysis 1.12). A high level of be-
tween-study heterogeneity (I² 94%) was present with the length of
stay, thus a random-effects model was used, which then showed no
significant difference (MD -0.25, 95% CI -0.59 to 0.09; Analysis
1.12).
Themean time thewomen took to return tonormal activity ranged
from under two weeks to just over five weeks, with no statistically
significant difference between the two surgical approaches (MD
-0.05, 95% CI -0.15 to 0.06; Analysis 1.13). This confirms the
minimally invasive nature of both operations, compared with a
more normal recovery period of three months after major abdom-
inal surgery.
1.5 Adverse events
In trials where overall perioperative complication rates were re-
ported there were no statistically significant differences in the rate
of perioperative complications between the TOR and RPR groups
(RR 0.91, 95% CI 0.73 to 1.14; Analysis 1.14).
In trials where specific complications were recorded there were
significant differences in the rate of each individual complication
sustained.
Major vascular/visceral injury
Major vascular injury such as retropubic haematoma or major
visceral injury, for example bowel perforation, was reported by 28
trials with 4676women. This occurred significantly less often with
TOR than with RPR (RR 0.33, 95% CI 0.19 to 0.55; Analysis
1.15).
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Bladder/urethral perforation
Forty trials assessed rate of bladder perforation. The rate was sig-
nificantly lower in the TOR group than the RPR group (RR 0.13,
95% CI 0.08 to 0.20; Analysis 1.16). The average bladder perfo-
ration rate across both groups was 2.54% and, using this as the
assumed control bladder perforation rate in the RPR group, there
were 22 fewer perforations per 1000 in the TOR group (95% CI
from 20 to 23 per 1000 fewer). There was some degree of asym-
metry in the funnel plot, which raised the possibility of some pub-
lication bias Figure 5.
Figure 5. Funnel plot of comparison: 1 Transobturator (TOR) versus retropubic (RPR) route, outcome: 1.16
Bladder or urethral perforation
Postoperative voiding dysfunction (POVD)
Rates of postoperative voiding dysfunction (POVD) was assessed
in 37 trials with 6200 participants. This showed significantly lower
rates in the TOR group than in the RPR group (RR 0.53 95%
CI 0.43 to 0.65; Analysis 1.17). The average POVD rate across
both groups was 5.53% and, using this as the assumed control rate
in the RPR group, there were 26 fewer POVD per 1000 in the
TOR group (95% CI from 19 to 32 per 1000 fewer). The funnel
plot showed symmetry on visual inspection, which suggests a low
likelihood of publication bias Figure 6.
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Figure 6. Funnel plot of comparison: 1 Transobturator (TOR) versus retropubic (RPR) route, outcome: 1.17
Voiding dysfunction
Urgency and urgency urinary incontinence (UUI)
The 31 trials (4923 women) that reported de novo urgency and
urgency urinary incontinence (UUI) showed no statistically sig-
nificant difference between the two groups (RR 0.98, 95% CI
0.82 to 1.17; Analysis 1.18). In the short term the average rate of
de novo urgency/UUI across both groups was 8.35% and, using
this as the assumed control rate in the RPR group, there were two
fewer cases per 1000 in the TOR group (95% CI from 15 per
1000 fewer to 14 per 1000 more).
Equally, in themedium term the rate of de novo urgency and UUI
was not significantly different (RR 0.98, 95% CI 0.55 to 1.73,
Analysis 1.19). Laurikainen 2007 reported long-term data for de
novo urgency and UUI for 253 women; this showed no difference
between the groups (RR 0.81, 95% CI 0.18 to 3.53; 253 women;
Analysis 1.20).
Four trials with 853 women with DO showed a rate of 8% in both
groups (RR 1.00, 95% CI 0.58 to 1.73; Analysis 1.21).
In one trial of women with MUI (Laurikainen 2007), 84% who
had pre-existingmoderate or severe urinary frequency and urgency
symptoms were cured of these symptoms post operatively at the
five-year follow-up.
Vaginal tape erosion
Vaginal tape erosion was assessed in 31 trials with 4743 partic-
ipants. No significant difference was demonstrated between the
groups (RR 1.13, 95% CI 0.78 to 1.65; Analysis 1.22). The av-
erage rate of vaginal tape erosion across both groups was 2.09%,
and, using this as the assumed control rate in the RPR group, there
were three more cases per 1000 in the TOR group (95% CI from
5 per 1000 fewer to 14 per 1000 more). The funnel plot showed
symmetry on visual inspection suggesting low likelihood of publi-
cation bias Figure 7. In the one trial that reported long-term tape
erosion (Laurikainen 2007), no tape erosion was reported in either
group. Bladder or urethral tape erosion was assessed in four trials
with 374 participants. No significant difference was demonstrated
between the groups (RR 0.34, 95% CI 0.01 to 8.13; Analysis
1.23).
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Figure 7. Funnel plot of comparison: 1 Transobturator (TOR) versus retropubic (RPR) route, outcome: 1.22
Vaginal tape erosion
Pain
Therewas a significantly higher occurrence of groin pain inwomen
who underwent a TOR procedure than in women who underwent
a RPR procedure (RR 4.12, 95% CI 2.71 to 6.27; Analysis 1.24).
The average rate of groin pain across both groups was 4.51% and,
using this as the assumed control rate in the RPR group, there were
163 more cases per 1000 in the TOR group (95% CI from 94 to
266 per 1000 more). Conversely, suprapubic pain was found to be
significantly lower in women who underwent a TOR procedure
than a RPR procedure (RR 0.29, 95% CI 0.11 to 0.78; Analysis
1.25). Both groin and suprapubic pain occurrence were short-last-
ing, with most resolving within the first six months. The duration
of pain ranged from two to 52 weeks, with a median duration
of eight weeks. The funnel plot for groin pain showed symmetry
on visual inspection, suggesting low likelihood of publication bias
Figure 8.
27Mid-urethral sling operations for stress urinary incontinence in women (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Figure 8. Funnel plot of comparison: 1 Transobturator (TOR) versus retropubic (RPR) route, outcome: 1.24
Groin pain
1.6 Need for further treatment
Nine trials (1402 women) reported the number of women who
required repeat incontinence surgery in the short term (up to one
year). The difference between the TOR and RPR groups was not
statistically significant (RR 1.64, 95% CI 0.85 to 3.16; Analysis
1.26). The average rate of repeat incontinence surgery in the short
term across both groups was 2.43% and, using this as the assumed
control rate in the RPR group, there were 12 more cases per 1000
in the TOR group (95% CI from 3 per 1000 fewer to 41 per 1000
more).
More women required repeat incontinence surgeries in the TOR
group in the medium term (RR 21.89, 95% CI 4.36 to 109.77;
two studies, 355 women; Analysis 1.27).
In the long term, three trials with data from 487 women, found
that more women required repeat incontinence surgery in the
TOR group (RR 8.79, 95%CI 3.36 to 23.00; Analysis 1.28). The
average rate of repeat incontinence surgery in the long term across
both groups was 5.34% and, using this as the assumed control
rate in the RPR group, there were 231 more cases per 1000 in the
TOR group (95% CI from 45 to 767/1000 more).
1.7 Quality of life
Thirty-three of the 55 trials in this comparison assessed quality of
life (QoL; Aigmuller 2014; Andonian 2007; Barber 2008; Barry
2008; Chen 2012; Darabi Mahboub 2012; David-Montefiore
2006;Deffieux 2010; deTayrac 2004; El-Hefnawy 2010; Freeman
2011; Jakimiuk 2012; Karateke 2009; Kim 2005; Krofta 2010;
Laurikainen 2007; Leanza 2009; Mansoor 2003; Meschia 2007;
Nerli 2009; Porena 2007; Richter 2010; Riva 2006; Ross 2009;
Scheiner 2012; Schierlitz 2008; Tanuri 2010; Tarcan 2011; Teo
2011;Wang 2008;Wang 2010;Wang 2011;Zullo 2007); however
only 11 of these trials reported QoL scores (Andonian 2007;
Barber 2008; Barry 2008; David-Montefiore 2006; de Tayrac
2004; Laurikainen 2007; Meschia 2007; Porena 2007; Riva 2006;
Schierlitz 2008; Wang 2008).
A wide variety of measures were used by different trials to assess
this outcome, including:
Condition-specific measures
• Incontinence Impact Questionnaire (IIQ-7).
• Urogenital Distress Inventory (UDI-6).
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• International Consultation on Incontinence Questionnaire
(ICIQ).
• Urinary Incontinence Quality of Life Scale (I-QOL).
• Kings Health Questionnaire (KHQ).
• Bristol Female Lower Urinary Tract Symptoms
questionnaire (BFLUTS).
• Women Irritative Prostate Symptoms Score (W-IPSS).
• Urinary Incontinence Severity Score (UISS).
• Detrusor Instability Score (DIS).
• A Visual Analogue Scale (VAS).
• CONTILIFE.
Generic measures
• EuroQoL 5-Dimensional Classification Component Scores
(EuroQoL-5D).
• Short-Form Health-Related QoL (SF-36).
• Patient Global Impression of Severity (PGI-S).
• Patient Global Impression of Improvement (PGI-I).
The data on quality of life outcomes were reported in different
ways, which precluded meta-analysis. In general, with the excep-
tion of Araco 2008, all trials found that women’s QoL improved
significantly post-operatively within each group, but no statisti-
cally significant differences were found between the randomised
groups. Only the Araco 2008 trial found the I-QOL scores to be
statistically significantly higher postoperatively after the retropu-
bic approach.
Sexual function quality of life measures
Sexual function was addressed in 10 trials (Barber 2008; Barry
2008; Deffieux 2010; de Tayrac 2004; Freeman 2011; Krofta
2010; Richter 2010; Ross 2009; Scheiner 2012; Schierlitz 2008),
which used a variety of measures including validated question-
naires and direct questioning. Questionnaires employed were:
• Prolapse/Incontinence Symptoms Questionairre (PISQ-
12);
• Bristol Female Lower Urinary Tract Symptoms
questionnaire (BFLUTS);
• International Consultation on Incontinence Questionnaire
Lower Urinary Tract Symptoms quality of life questionnaire
(ICIQ-LUTSqol); and
• Visual Analogue Scale (VAS).
In all the trials there was significant improvement in sexual func-
tion frombaseline scores during the follow-up period that spanned
six to 24 months. There were no significant differences between
the two groups. At 24-month follow-up, rates of superficial and
deep dyspareuniawere low, with no difference between the groups.
Comparison 2. Retropubic bottom-to-top approach
versus retropubic top-to-bottom approach
Five small trials, with 636 women in total, addressed this compar-
ison (Andonian 2005; Kim 2004; Lim 2005; Lord 2006; Tseng
2005).
2.1 Women’s observations
Three trials (477 women) investigated subjective cure defined as
self-reported absence of urinary leakage on stress (Kim 2004; Lim
2005; Lord 2006). In the 12 months following surgery, women
were significantlymore oftendrywith the bottom-to-top approach
(TVTTM ) compared to the top-to-bottom approach (SPARCTM;
87.34% versus 79.58%; RR 1.10, 95% CI 1.01 to 1.19; Analysis
2.1).
2.2 Quantification of symptoms
No data were reported for this outcome.
2.3 Clinician’s observation
Five trials assessed objective cure using a variety of measures (
Andonian 2005; Kim 2004; Lim 2005; Lord 2006; Tseng 2005):
one-hour pad test of 2g or less, negative stress test on urodynamics
(UDS), the observed absence of urinary leakage when the patient
coughed while supine and with a comfortably full bladder, and
one-hour pad test of 1g or less, respectively. In a total of 622
participants, the objective cure rate was similar between the two
groups (94.19% versus 89.10%; RR 1.06, 95% CI 0.97 to 1.17;
Analysis 2.2).
2.4 Surgical outcome measures
Two small trials, Kim 2004 and Tseng 2005, reported that there
were no statistically significant differences in duration of operation
(Analysis 2.3) or length of hospital stay (Analysis 2.4).
2.5 Adverse events
No statistically significant difference was seen in overall periop-
erative complications, but the confidence interval was wide (RR
0.98, 95% CI 0.53 to 1.84; Analysis 2.5).
Significantly fewer women experienced certain complicationswith
the bottom-to-top approach (TVTTM ), which included:
• bladder perforation (RR 0.55, 95% CI 0.31 to 0.98; 5
trials; Analysis 2.6);
• voiding dysfunction after the bottom-to-top approach
(TVTTM ; RR 0.40, 95% CI 0.18 to 0.90; 5 trials; Analysis 2.7);
• vaginal tape erosions (RR 0.27, 95% CI 0.08 to 0.95; 4
trials; Analysis 2.10).
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There were no statistically significant differences between the two
groups with respect to:
• postoperative de novo urgency symptoms and UUI (RR
0.84, 95% CI 0.52 to 1.34; 4 trials; Analysis 2.8); or
• DO (1 trial; Analysis 2.9).
However, the confidence intervals were wide for each of these five
outcomes, which reflects the small number of trials.
2.6 Need for further treatment
No data were reported on the need for further treatment.
2.7 Quality of life
Only one of the five trials, Andonian 2005, assessed the QoL
of women using the Incontinence Impact Questionnaire (IIQ;
Shumaker 1994), where a score of less than 50 represents a good
QoL, 50 to 70 represents moderate QoL, and over 70 indicates a
poor QoL. In this study the mean IIQ scores were similar in the
groups preoperatively and improved postoperatively, but there was
no significant difference between the groups after operation. At
one year follow-up, there was no statistically significant difference
in the mean IIQ scores (mean difference of -4.6; 95% CI: -7.5 to
16.7).
Comparison 3. Obturator medial-to-lateral approach
versus obturator lateral-to-medial approach
Ten trials reported this comparison (Abdel-Fattah 2010; But 2008;
Chen 2010; Hassan 2013; Houwert 2009; Lee 2008; Liapis 2008;
Park 2012; Peattie 2006; Scheiner 2012).
3.1 Women’s observations
Six trials investigated short-term subjective cure rate and five of
these assessed subjective cure and improvement in the short term
(within 12 months of surgery). There were no statistically signif-
icant differences in either subjective cure rates (RR 1.0, 95% CI
0.96 to 1.06; Analysis 3.1) or subjective cure and improvement
rates (RR 1.02, 95% CI 0.97 to 1.08 Analysis 3.2), and the confi-
dence intervals for each were quite narrow. Two trials reported no
statistically significant difference in subjective cure in the medium
term (RR 1.06, 95% CI 0.91 to 1.23; Analysis 3.3) and a further
two trials reported no significant difference in subjective cure and
improvement in the medium term (RR 1.00, 95% CI 0.90 to
1.11; Analysis 3.4). There are no published trials with long-term
data.
3.2 Quantification of symptoms
No data were reported for this comparison.
3.3 Clinician’s observation
Six trials assessed objective cure (short term, ≤ 1 year); there was
no statistically significant difference between the two groups (RR
0.99, 95% CI 0.95 to 1.04; Analysis 3.5), and the confidence in-
terval was narrow. There was also no statistically significant differ-
ence in the objective cure or improvement rate between the two
groups (RR 1.00, 95% CI 0.95 to 1.07; Analysis 3.6).
3.4 Surgical outcome measures
There were no statistically significant differences between the two
groups in terms of:
• duration of operation, (in minutes, MD 0.52, 95% CI -
1.09 to 2.13; 4 studies, 481 women; Analysis 3.7);
• operative blood loss (in ml, MD 1.11, 95% CI -6.01 to
8.22; 3 studies, 255 women; Analysis 3.8);
• length of hospital stay (in days, MD -0.77, 95% CI -2.54
to 0.99; 2 studies, 190 women; Analysis 3.9);
• time to return to normal activity (in weeks, MD -0.60,
95% CI -1.80 to 0.60; 1 study, 100 women; Analysis 3.10).
3.5 Adverse events
Vaginal perforation was significantly less likely to occur with the
medial-to-lateral approach (RR 0.25, 95% CI 0.12 to 0.53; I² of
43%; Analysis 3.13). The average rate of vaginal wall perforation
across both groups was 7.39% and, using this as the assumed
control rate in the lateral-to-medial group, there were 55 fewer
cases per 1000 in the medial-to-lateral group (95% CI from 35
per 1000 fewer to 65 per 1000 more).
Voiding dysfunction occurred significantly more in themedial-to-
lateral compared to the lateral-to-medial group (RR 1.74, 95%CI
1.06 to 2.88; I² of 0%; 8 studies, 1121women; Analysis 3.15). The
average rate of POVD across both groups was 5.53% and, using
this as the assumed control rate in the lateral-to-medial group,
there were 41 more cases per 1000 in the medial-to-lateral group
(95% CI from 3 to 104 per 1000 more).
There were no statistically significant differences between the two
groups in terms of:
• overall perioperative complication rate (RR 1.30, 95% CI
0.23 to 7.51; 2 studies, 214 women; Analysis 3.11);
• major vascular/visceral injury (RR 0.71, 95% CI 0.23 to
2.19; 4 studies, 622 women; Analysis 3.12);
• bladder perforation (RR 0.38, 95% CI 0.07 to 1.92; 6
studies, 794 women; Analysis 3.14);
• de novo urgency symptoms and UUI rates (RR 1.01, 95%
CI 0.46 to 2.20; 3 studies, 357 women; Analysis 3.16);
• detrusor overactivity (RR 0.87, 95% CI 0.27 to 2.84; 1
study, 114 women; Analysis 3.17);
• vaginal tape erosions (RR 0.42, 95% CI 0.16 to 1.09; 7
studies, 1087 women; Analysis 3.18);
• groin/thigh pain (9.2% versus 8%; RR 1.15, 95% CI 0.75
to 1.76; 6 studies, 837 women; Analysis 3.19).
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3.6 Need for further treatment
Two large trials showed no significant difference in the rates of
repeat incontinence surgery in the medium term (4.6% versus
7.1%; RR 0.64, 95% CI 0.32 to 1.30; Analysis 3.20).
3.7 Quality of life
Quality of life was assessed in five of the ten trials using validated
QoL questionnaires. All of these trials reported QoL scores.
Condition-specific QoL scores
• Houwert 2009 used the short forms of the IIQ-7 and UDI-
6. Within each group there was significant improvement
postoperatively compared to scores obtained preoperatively, but
no significant postoperative differences between the two groups
(MD 16.54, 95% CI 4.84 to 28.24; 1 study, 42 women).
• But 2008 assessed QoL with IIQ and UDI questionnaires
and VAS scores, but reported no results.
• Lee 2008 used a validated Korean version of the
Incontinence QoL questionnaire (I-QoL) and showed
improvements within the groups, but with no significant
differences between the groups after surgery.
• Scheiner 2012 used the KHQ and found no significantly
difference between the groups at baseline and postoperatively,
but with improvement following surgery compared to baseline
scores in all domains.
• Abdel-Fattah 2010 used the KHQ, Birmingham Bowel and
Urinary Symptoms Questionnaire (BBUSQ-22), PISQ-12, PGI-
I and the short form of the ICIQ (ICIQ-SF) to assess QoL.
Overall there was statistically significant improvement in total
scores, as well as in each of the nine domains of the KHQ. This
remained the case when comparing baseline score in each group
postoperatively; there was no significant difference in the QoL
scores between the two routes.
Sexual function
Sexual function was addressed in three trials that used a variety of
measures including validated questionnaires and direct question-
ing (Abdel-Fattah 2010; Houwert 2009; Park 2012). Question-
naires included: the PISQ-12, and BFLUTS (Abdel-Fattah 2010).
There was significant improvement in PISQ-12 scores following
surgery (improved sexual function compared to baseline), but no
significant difference between the two groups at follow-up. Rates
of dyspareunia following surgery were extremely low, with evi-
dence of resolution by 24 months.
Comparison 4. One method of mid-urethral tape
insertion versus another method, same route
Ten trials compared different methods of carrying out TOR and
RPR operations using the same route (Cho 2010; de Leval 2011;
Elbadry 2014; Juang 2007; Naumann 2006; Paparella 2010;
Rechberger 2011; Tommaselli 2012; Ugurlucan 2013; Zhang
2011). The following operations were compared.
Transobturator lateral-to-medial
• Monarc® TOT versus TOT® (Cho 2010).
• TOT versus adjustable TOT (Elbadry 2014).
• TOT versus TOT with two-point fixation sutures
(Rechberger 2011).
• Synthetic TOT versus biological TOT (Paparella 2010;
Ugurlucan 2013).
Transobturator medial-to-lateral
• TVT-O versus modified TVT-O (shorter tape and less
lateral dissection; de Leval 2011).
• TVT-O versus TVT-O plus Ingleman-Sundberg bladder
denervation procedure (Juang 2007).
• TVT-O versus modified TVT-O (reduced dissection;
Tommaselli 2012).
• TVT-O versus modified TVT-O (self-tailored mesh;
Zhang 2011).
Retropubic
• TVT versus modified TVT, bottom-to-top (suburethral
pad; Naumann 2006).
Each comparison group included only a small single trial, which
precluded anymeaningful statistical analysis of the outcomes mea-
sured, except for the synthetic versus biological TOT comparison,
for which there were two small trials (Analysis 4.1; Analysis 4.2;
Analysis 4.3; Analysis 4.5; Analysis 4.4; Analysis 4.6; Analysis 4.7;
Analysis 4.8; Analysis 4.10; Analysis 4.11; Analysis 4.12; Analysis
4.13; Analysis 4.14; Analysis 4.15; Analysis 4.16).Naumann 2006
reported no usable data.
For all outcomes measured in each trial, there were no statistically
significant differences reported, with the exception of Juang 2007,
where significant differences were found in favour of TVT-O plus
Ingleman-Sundberg bladder denervation procedure for objective
cure, operative time and intraoperative blood loss. Objecture cure
in the short term for synthetic versus biological TOT showed no
significant difference (RR 1.03, 95% CI 0.94 to 1.14; 2 trials;
Analysis 4.5.2)
Sexual function was assessed by Paparella 2010 and Tommaselli
2012 using the PISQ-12. The PISQ-12 scores decreased after the
procedure in both groups, indicating improved sexual function
after surgery. No significant differences were observed between
groups after the procedures.
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Comparison 5. One type of tape material versus
another
Four trials compared different mid-urethral sling operations based
on their tape properties, e.g. monofilament tapes versus multifil-
ament tapes (Lim 2005; Meschia 2006; Okulu 2013; Rechberger
2003). The interventions compared were:
• monofilament (TVT SPARC) verus multifilament (IVS;
Lim 2005);
• monofilament (TVT) versus multifilament (IVS; Meschia
2006);
• synthetic monofilament (prolene light mesh) versus
combined synthetic and biological (Ultrapro mesh) versus
multifilament mesh (Vypro; Okulu 2013);
• monofilament (TVT) versus multifilament (IVS;
Rechberger 2003).
5.1 Women’s observations
In the short and medium term there was no statistically signif-
icant difference between monofilament and multifilament tapes
in terms of their subjective cure rates; neither was there a signifi-
cant difference found where the combined synthetic and biolog-
ical tapes were compared to monofilament tapes (RR 1.03, 95%
CI 0.95 to 1.10; RR 0.91, 95% CI 0.79 to 1.05; RR 1.10, 95%
CI 0.96 to 1.26; Analysis 5.1: RR 1.03, 95% CI 0.85 to 1.23;
RR 0.91, 95% CI 0.78 to 1.06; RR 1.13, 95% CI 0.96 to 1.32;
Analysis 5.2).
5.2 Quantification of symptoms
No data were reported for this comparison.
5.3 Clinician’s observation
The objective cure rate for monofilament tape and multifilament
tapes show no significant difference between the groups (RR 1.07,
95% CI 0.96 to 1.19; Analysis 5.3).
5.4 Surgical outcome measures
There were no statistically significant differences in the duration
of operation or length of hospital stay reported (RR 0.00, 95%
CI -1.49 to 1.49; Analysis 5.4: RR 0.20, 95% CI -0.09 to 0.49;
Analysis 5.5).
5.5 Adverse events
There were few perioperative complications with no statistically
significant difference between the groups (RR 1.16, 95% CI 0.36
to 3.69; Analysis 5.6). No major vascular/visceral injury was re-
ported in any of the trials (Analysis 5.7). Bladder perforation oc-
curred in 4.49% of monofilament and 3.67% of multifilament
tape procedures (RR 1.15, 95% CI 0.49 to 2.70; Analysis 5.8).
There were no statistically significant differences between the
groups for:
• POVD (RR 2.10, 95% CI 0.96 to 4.59; Analysis 5.9);
• de novo urgency symptoms and UUI (RR 1.11, 95% CI
0.68 to 1.82; Analysis 5.10);
• DO (RR 0.70, 95% CI 0.12 to 4.06; Analysis 5.11).
In three trials, vaginal tape erosions were more common in the
multifilament group, but this did not reach statistical significance
(RR 0.79, 95% CI 0.09 to 6.84; Analysis 5.12).
5.6 Need for further treatment
No data were reported regarding the need for further treatment in
this comparison.
5.7 Quality of life
Only the Okulu 2013 study assessed QoL and showed improve-
ment from baseline scores, with no significant difference between
the comparison groups. At 48 months mean postoperative ICI-Q
QoL scores were significantly better in the monofilament group
than in the multifilament group (MD -0.06, 95% CI -0.76 to -
0.44; 1 study, 96 women; Analysis 5.13).
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
Retropubic bottom- to- top approach compared to retropubic top- to-bottom approach for stress urinary incontinence in women
Patient or population: women with stress urinary incont inence
Settings: Secondary care
Intervention: retropubic bottom-to-top approach
Comparison: retropubic top-to-bottom approach
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
retropubic top- to-bot-
tom approach
Retropubic bottom- to-
top approach
Subject ive cure (short
term,≤ 1 year)
Study populat ion RR 1.10
(1.01 to 1.20)
492
(3 RCTs)
⊕⊕⊕©
MODERATE 1
770 per 1000 847 per 1000
(778 to 924)
Mean control group across studies
890 per 1000 979 per 1000
(899 to 1000)
Subject ive
cure (medium term, 1 to
5 years)
No studies reported this outcome - (0 studies)
Subject ive cure long
term: > 5 years
No studies reported this outcome - (0 studies)
Bladder or urethral per-
forat ion
Study populat ion RR 0.55
(0.31 to 0.98)
631
(5 RCTs)
⊕⊕⊕©
MODERATE 2
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85 per 1000 47 per 1000
(26 to 83)
Mean control group across studies
115 per 1000 63 per 1000
(36 to 113)
Voiding dysfunct ion Study populat ion RR 0.40
(0.18 to 0.90)
631
(5 RCTs)
⊕⊕⊕©
MODERATE 2
60 per 1000 24 per 1000
(11 to 54)
Mean control group across studies
49 per 1000 20 per 1000
(9 to 44)
De novo urgency or ur-
gency incont inence
Study populat ion RR 0.84
(0.52 to 1.34)
547
(4 RCTs)
⊕⊕©©
LOW 3,4
123 per 1000 103 per 1000
(64 to 165)
Mean control group across studies
187 per 1000 157 per 1000
(97 to 250)
Vaginal tape erosion Study populat ion RR 0.27
(0.08 to 0.95)
569
(4 RCTs)
⊕⊕⊕©
MODERATE 5
35 per 1000 9 per 1000
(3 to 33)
Mean control group across studies
69 per 1000 19 per 1000
(6 to 65)34
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Repeat incont inence
surgery short term
No studies reported this outcome - (0 studies)
Repeat incont inence
surgery long term
No studies reported this outcome - (0 studies)
Quality of lif e (IIQ
scores)
The mean quality of lif e
(IIQ scores) in the con-
trol group was 49.9
The mean quality of lif e
(IIQ scores) in the inter-
vent ion group was 4.6
lower (14.17 lower to 4.
97 higher)
- 84
(1 RCT)
* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95%CI).
CI: conf idence interval
IIQ: Incont inence Impact quest ionnaire
RCT: randomised controlled trial
RR risk rat io;
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect
Moderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate
Very low quality: We are very uncertain about the est imate.
1Sequence generat ion and allocat ion concealment was unclear in 2/ 3 trials, so we downgraded by 1 level
2Sequence generat ion and allocat ion concealment was unclear in 3/ 5 trials, so we downgraded by 1 level
3Sequence generat ion was unclear in 2/ 4 studies and allocat ion concealment unclear in 3/ 4 studies, so we downgraded by 1
level
4The wide conf idence interval was judged to include a threshold for appreciable harm considered to be > 25% increase in RR,
in this case there was much more than a 25% increase in RR for harm, so we downgraded the level by 1
5Sequence generat ion unclear in 3/ 4 studies and allocat ion concealment unclear in 2/ 4 studies, so we downgraded by 1 level
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Obturator medial- to- lateral approach compared to obturator lateral- to-medial approach for stress urinary incontinence in women
Patient or population: women with stress urinary incont inence
Settings: Secondary care
Intervention: obturator medial-to-lateral approach
Comparison: obturator lateral-to-medial approach
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Obturator lateral- to-
medial approach
Obturator medial- to-
lateral approach
Subject ive cure (short
term ≤ 1 year)
Study populat ion RR 1.00
(0.96 to 1.06)
759
(6 RCTs)
⊕⊕©©
LOW 1
877 per 1000 877 per 1000
(842 to 930)
Mean control group risk across studies
880 per 1000 880 per 1000
(845 to 933)
Subject ive
cure (medium term, 1 to
5 years)
Study populat ion RR 1.06
(0.91 to 1.23)
235
(2 RCTs)
⊕⊕©©
LOW 2
711 per 1000 753 per 1000
(647 to 874)
Mean control group risk across studies
736 per 1000 780 per 1000
(670 to 905)
Subject ive cure No studies reported this outcome - (0 studies)
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Bladder or urethral per-
forat ion
Study populat ion RR 0.38
(0.07 to 1.92)
794
(6 RCTs)
⊕⊕⊕©
MODERATE 3
11 per 1000 4 per 1000
(1 to 20)
Mean control group risk across studies
6 per 1000 2 per 1000
(0 to 12)
Voiding
dysfunct ion (short and
medium term, up to 5
years)
Study populat ion RR 1.74
(1.06 to 2.88)
1121
(8 RCTs)
⊕⊕⊕©
MODERATE 4
40 per 1000 70 per 1000
(43 to 116)
Mean control group risk across studies
55 per 1000 96 per 1000
(58 to 158)
De novo urgency or
urgency incont inence
(short term, up to 12
months)
Study populat ion RR 1.01
(0.46 to 2.20)
357
(3 RCTs)
⊕⊕©©
LOW 5
63 per 1000 63 per 1000
(29 to 138)
Mean control group risk across studies
64 per 1000 65 per 1000
(29 to 141)
Groin pain Study populat ion RR 1.15
(0.75 to 1.76)
837
(6 RCTs)
⊕©©©
VERY LOW 6,7
80 per 1000 92 per 1000
(60 to 140)
Mean control group risk across studies
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74 per 1000 85 per 1000
(56 to 130)
Vaginal tape erosion
(short and medium
term, up to 5 years)
Study populat ion RR 0.42
(0.16 to 1.09)
1087
(7 RCTs)
⊕©©©
VERY LOW 7,8
24 per 1000 10 per 1000
(4 to 26)
Mean control group risk across studies
17 per 1000 7 per 1000
(3 to 19)
Repeat incont inence
surgery (short term, up
to 12 months)
Study populat ion RR 0.64
(0.32 to 1.30)
532
(2 RCTs)
⊕⊕©©
LOW 7,9
71 per 1000 45 per 1000
(23 to 92)
Mean control group risk across studies
58 per 1000 37 per 1000
(19 to 75)
Repeat incont inence
surgery
No studies reported this outcome - (0 studies)
Quality of lif e The mean quality of lif e
in the control group was
0
The mean quality of
lif e in the intervent ion
group was 16.54 higher
(4.84 higher to 28.24
higher)
- 46
(1 RCT)
⊕©©©
VERY LOW 10,11
* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95%CI).
CI: conf idence interval
RCT: randomised controlled trial
RR: risk rat io;38
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GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect
Moderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate
Very low quality: We are very uncertain about the est imate
1Random sequence generat ion was unclear in 4/ 6 studies, allocat ion concealment was unclear in5/ 6 and at high risk in 1/ 6
studies, so we downgraded the quality of evidence due to risk of bias by 2 levels
2Random sequence generat ion was unclear in all both studies, allocat ion concealment was unclear in 1 and high risk of bias
in the other study, so we downgraded by 2 levels
3Sequence generat ion was unclear in 2 studies and allocat ion concealment was unclear in 3 studies, so we downgraded the
quality rat ing by 1 level
4Sequence generat ion was unclear in 3 studies and at high risk in 1 study, while allocat ion concealment was unclear in 4
studies and at high risk in 1 study, so we downgraded by 1 level
5Sequence generat ion was unclear in 2/ 3 studies and at high risk in 1/ 3, allocat ion concealment was unclear in 2/ 3 studies
and high in 1/ 3, so we downgraded by 2 levels
6Random sequence generat ion was unclear in 2/ 5 and high in 1/ 5 studies, while allocat ion concealment was unclear in 2/ 5
and high in 2/ 5 studies, so we downgraded the quality of evidence due to high risk of bias by 2 levels
7The wide conf idence interval was judged to include a threshold for appreciable harm considered to be > 25% increase in RR,
in this case there was > 65% increase in RR for harm, so we downgraded by 1 level
8Sequence generat ion was unclear in 3/ 7 studies and at high risk in 1/ 7. Allocat ion concealment was unclear in 5/ 7 studies
and at high risk in 1/ 7. We downgraded the quality rat ing by 2 levels
9Sequence generat ion and allocat ion concealment were unclear in 1/ 2 studies, so we downgraded by 1 level
10Sequence generat ion and allocat ion concealment were unclear, so we downgraded by 1 level
11As there was only 1 study with very few events and CIs around est imates of ef fect included appreciable benef it and
appreciable harm, we downgraded by 2 levels
3
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Monofilament compared to multifilament tapes for stress urinary incontinence in women
Patient or population: women with stress urinary incont inence
Settings: Secondary care
Intervention: monof ilament
Comparison: mult if ilament tapes
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
multifilament tapes Monofilament
Subject ive cure (short
term ≤ 1 year)
Study populat ion RR 1.07
(0.98 to 1.16)
505
(4 RCTs)
⊕⊕⊕©
MODERATE 1
784 per 1000 839 per 1000
(768 to 909)
Mean control group risk across studies
810 per 1000 867 per 1000
(794 to 939)
Subject ive
cure (medium term: 1 to
5 years)
No studies reported this outcome - (0 studies)
Subject ive cure (long
term: > 5 years)
No studies reported this outcome - (0 studies)
Bladder or urethral per-
forat ion
Study populat ion RR 0.76
(0.29 to 1.99)
496
(4 RCTs)
⊕⊕⊕©
MODERATE 1
37 per 1000 28 per 1000
(11 to 73)
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Mean control group risk across studies
32 per 1000 25 per 1000
(9 to 64)
Voiding dysfunct ion Study populat ion RR 2.20
(0.98 to 4.92)
400
(3 RCTs)
⊕⊕©©
LOW 2,3
41 per 1000 89 per 1000
(40 to 200)
Mean control group risk across studies
65 per 1000 143 per 1000
(64 to 320)
De novo urgency or ur-
gency incont inence
Study populat ion RR 1.09
(0.66 to 1.82)
496
(4 RCTs)
⊕⊕©©
LOW 4,5
102 per 1000 111 per 1000
(67 to 186)
Mean control group risk across studies
107 per 1000 117 per 1000
(71 to 195)
Vaginal tape erosion Study populat ion RR 0.43
(0.16 to 1.14)
396
(3 RCTs)
⊕⊕⊕⊕
HIGH
62 per 1000 26 per 1000
(10 to 70)
Mean control group risk across studies
43 per 1000 18 per 1000
(7 to 49)
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Repeat incont inence
surgery (short term ≤ 1
year)
No studies reported this outcome - (0 studies)
Repeat incont inence
surgery (long term > 5
years)
No studies reported this outcome - (0 studies)
Quality of lif e scores
ICIQ
The mean quality of lif e
scores ICIQ in the con-
trol group was 2.1
The mean quality of lif e
scores ICIQ in the inter-
vent ion group was 0.6
lower (0.76 lower to 0.
44 lower)
- 96
(1 RCT)
⊕⊕⊕⊕
HIGH
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95%CI).
CI: conf idence interval
ICIQ: Internat ional Consultat ion on Incont inence quest ionnaire
RCT: randomised controlled trial
RR: risk rat io
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect
Moderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate
Very low quality: We are very uncertain about the est imate
1Random sequence generat ion and allocat ion concealment unclear in 2/ 4 studies, so we downgraded by 1 level
2Random sequence generat ion and allocat ion concealment unclear in 2/ 3 studies, so downgraded by 1 level
3The wide conf idence interval was judged to include a threshold for appreciable harm considered to be > 25% increase in RR,
in this case there was much more than a 25% increase in RR for harm, so we downgraded by 1 level
4Sequence generat ion and allocat ion concealment were unclear in 2/ 4 studies, so we downgraded the quality rat ing by 1 level
5The wide conf idence interval was judged to include a threshold for appreciable harm considered to be > 25% increase in RR,
in this case there was > 65% increase in RR for harm, so we downgraded by 1 level
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D I S C U S S I O N
Summary of main results
1. Transobturator (TOR) versus retropubic route
(RPR)
Comparison of the transobturator (TOR) versus retropubic route
(RPR) was addressed by 55 trials that included 8652 women.
Thirty-six of these trials (5514 women) contributed data to the
primary outcome of subjective cure, which showed that in the
short term there was no difference between TOR and RPR. Only
six of these 53 trials reported medium- or long-term data, again
with relatively small numbers of women showing no significant
difference in symptomatic cure. These small numbers limit the
judgements that canbemade about cure rates in the longer term for
both the efficacy of individual tapes, or for comparison of the route
of tape insertion. There was potential for at least 22 of these trials
to have published either medium- or longer-term outcomes, given
their dates of publication. Similarly, objective cure rates showed
no significant difference between the two routes.
Evidence from 40 trials (6372 women) showed a 30 fold percent-
age increase in the rate of bladder perforation with the RPR ap-
proach compared to the TOR approach. In practice, for this rea-
son, some clinicians favour the TOR for patients at higher risk
of bladder/urethral perforation, for example, those who have had
previous pelvic or incontinence surgery. Similarly, 37 trials (6217
women) that assessed postoperative voiding dysfunction (POVD)
showed this adverse outcome to be significantly less frequent when
the TOR was employed. However, the reported sequale for both
of these outcomes is usually of short duration.
Thirty-one trials (4743 women) that assessed vaginal tape erosion
showed no significant difference when either route was used.More
women experienced groin pain in the TOR group than in the RPR
group. This groin pain was usually of short duration and resolved
within eight weeks in most cases. The occurrence of suprapubic
pain following an RPR procedure was poorly reported. This was
more common in the RPR group; however, when data was pro-
vided, only a minority of women suffered this symptom and for a
short period of time.
Overall mid-urethral slings are a highly effective treatment for
stress urinary incontinence (SUI). In the short term there is equiv-
alence in the efficacy between the two routes, and this persists into
themedium and longer term, though the data for this is somewhat
limited by small numbers. There is some evidence that suggests
women are more likely to require repeat incontinence surgery in
the longer term with the TOR, but this requires cautious interpre-
tation, as there are extremely small numbers. There is an equal im-
provement in the overall quality of life of women for both routes.
Sexual function improved in both groups as a result of the surgery,
most probably from reduction in coital incontinence, with no sig-
nificant difference in sexual function between the two groups.
To supplement the main systematic review of effects, we sought to
identify economic evaluations which have compared TOR with
RPR in the treatment of SUI in women. A supplementary search
in Ovid MEDLINE, Embase and NHS EED, identified three
economic evaluations (Lier 2011; Lier 2016; Seklehner 2014).
The search strategies used are given in Appendix 3. Lier 2016
reported both a cost-utility and cost-effectiveness analysis while
Lier 2011 was a cost-effectiveness analysis. Both studies analysed
costs and resources used from public payer perspective (Alberta,
Canada) and used clinical data from the same RCT (Ross 2009)
with results presented at one year (Lier 2011) and five years (Lier
2016) post-surgery. Seklehner 2014 reported a decision model
based cost-effectiveness analysis with clinical evidence collected
from MEDLINE search of RCTs on TOR and RPR. This study
adopted a US healthcare system perspective with a 10-year time
horizon. Lier 2016, which was a further follow-up of Lier 2011,
reported that TOR was slightly more effective than RPR with a
mean QALY gain of 0.04 over five years (95% Cl -0.06 to 0.14).
Seklehner 2014 reported that on average TOR was slightly more
effective, with a QALY gain of 0.03 over 10 years. Both Lier 2016
and Lier 2011 reported no statistically significant difference in the
cure rate (81% for TOR versus 77% for RPR, P value not stated)
but there was a significant difference in the number of patients in
the TOR arm with groin pain and palpation of the surgical tape
on vaginal examination (26% difference, P = 0.001) even after five
years (Lier 2016). In all three studies TOR was less costly in when
compared with RPR (Lier 2011; Lier 2016; Seklehner 2014). In
Lier 2016, TOR was on average less costly, with an average total
cost difference which rose from CAD -414 (95% Cl -1415 to
587) (Lier 2011) to CAD -2368 (95% Cl -7166 to 2548) at five
years (2011 Canadian dollars). In Seklehner 2014 the average cost
difference was CAD -562 (Cl not stated).The three studies each
suggested that TOR may be cost-effective.
2. Retropubic bottom-to-top approach versus
retropubic top-to-bottom approach
Five trials with 636 women compared the retropubic bottom-to-
top with the retropubic top-to-bottom approach. These showed
that passage of the tape through the retropubic route in a bottom-
to-top path (e.g. TVTTM ) was more effective than passage in a
top-to-bottom path (e.g. SPARCTM ), and resulted in fewer intra
and postoperative adverse events.We took the same approach for
TOR versus RPR to identify economic evaluations, but found no
results.
3. Obturator medial-to-lateral approach versus
obturator lateral-to-medial approach
Ten trials with 1199 women compared the obturator medial-to-
lateral approach with the obturator lateral-to-medial approach.
Evidence from the ten trials, two of which reported medium-term
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data, showed no difference between the two approaches with re-
spect to most outcomes measured. The only exceptions were void-
ing dysfunction, where higher rates were reported in the medial-
to-lateral group, and vaginal perforation, which had higher rates
in the lateral-to-medial group. Despite this, there was no resultant
increase in the rate of tape erosion. It is, therefore, not unreason-
able to exercise operator preference when deciding which of these
two approaches to adopt. Notably, each route improved quality
of life and sexual function postoperatively. We took the same ap-
proach for TOR versus RPR to identify economic evaluations, but
found no results.
4. One method of mid-urethral tape insertion versus
another method, same route
Ten trials with 1569 women compared one method of mid-ure-
thral tape insertion with another using the same route. Despite
several design or procedural modifications to tapes traversing the
same route, there was no difference in the efficacy, surgical out-
comes or occurrence of adverse events.The same approach done
for TOR versus RPR was carried out to identify economic evalu-
ations but yielded no result.
5. One type of tape material versus another
Four trials with 505 women compared monofilament tapes with
multifilament tapes. There was no statistical difference in physi-
cian-observed cure rates or patient-reported cure between the
groups. There was no significant difference in the rate of vaginal
tape erosion. We took the same approach for TOR versus RPR to
identify economic evaluations, but found no results.
Overall completeness and applicability of
evidence
Many of the trials contributing to this review did provide evidence
regarding the primary outcome, which was to determine the ef-
fectiveness of mid-urethral sling operations in the treatment of
urinary incontinence. They confirm that mid-urethral sling oper-
ations for SUI are an effective surgical treatment available in cur-
rent practice. A major limitation was the variable quality of many
of the trials.
We did not attempt to analyse the data by subgroups according
to the clinical characteristics of the women, such as symptoms of
SUI, urodynamic stress incontinence, diagnosis of intrinsic ure-
thral sphincter deficiency or urethral hypermobility, obesity, pre-
vious incontinence surgery, presence or absence of prolapse, anaes-
thesia used, or experience of the surgeon. In fact the majority of
trials did not describe these characteristics of the women.
We did not subject the three identified economic evaluations to
critical appraisal and we do not attempt to draw any firm or gen-
eral conclusions about the relative costs or efficiency of TOR for
treatment of SUI.However, the economic evidence available sug-
gests that TOR is cost-effective when compared with RPR in the
treatment of SUI in women.
Complications
Major complications such as nerve, bowel or major vascular in-
juries, pelvic haematoma, necrotizing fasciitis, ischiorectal abscess
and death are uncommon and unlikely to be picked up by small
randomised controlled trials (RCTs). There is potential to de-
termine a more accurate incidence from large national registries
and voluntary reporting registries or databases for reporting com-
plications, such as the United States Food and Drug Adminis-
tration’s (FDA) manufacturer and user facility device experience
(MAUDE). One must bear in mind, though, the limitations of
this method. Several of these registries have reported their find-
ings (Collinet 2008; Dyrkorn 2010; Kuuva 2002; Koops 2005;
Tamussino 2001; Tamussino 2007; Tincello 2011).
Retropubic tapes
From the above list of registries, for tension-free vaginal tape the
number of procedures reported ranged from 809 to 4281, and
there were found to be low rates of major complications.
• Bladder perforation occurred in 2.7% to 3.9% of cases.
• Reoperation rates relating to tape insertion or postoperative
voiding dysfunction (POVD) ranged from 1.6% to 2.4%.
• Urinary retention rate was 1.6%.
• Pelvic haematoma occurred in 0.7% to 1.9% of women.
• Infection rate was 0.7%.
• Vaginal tape erosion/extrusion rate was 1.5%.
• Groin pain occurred in 0.4% of women.
These rates are largely of the same order as those reported in the
trials included in this review. There were also a few cases of major
visceral injuries such as bowel and urethral injuries.
Transobturator tapes
Registries of transobturator tapes reported much lower rates of
complications.
• Bladder perforation occurred in 0.4% of cases.
• Reoperation rates relating to tape insertion ranged from
0.8% to 2.2%.
• Urinary retention rate was 0.5%.
• Pelvic haematoma occurred in 0.5% of women.
• Infection rate was 0.6%.
• Vaginal tape erosion/extrusion rate was 0.4%.
• Groin pain occurred in 1.6% of women.
The FDA received 1876 reports of complications associated with
the use of slings for SUI in the period between 1 January 2008 to
30 September 2011. The most common complications reported
were pain, vaginal tape erosion (exposure, extrusion or protru-
sion), infection, urinary problems, recurrent incontinence, pain
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during sexual intercourse (dyspareunia), bleeding, organ perfo-
ration, neuro-muscular problems and vaginal scarring. Many of
these complications required further medical intervention, and
sometimes required surgical treatment or hospitalisation, or both.
With the exception of tape erosion, the above complications were
also found to occur following non-mesh surgical repairs for SUI.
It should be borne in mind that this sort of reporting system is a
passive surveillance system limited by the inclusion of the poten-
tial submission of incomplete or inaccurate data, under-reporting
of events, lack of denominator data (number of tapes), and the
lack of report timeliness.
It should be noted that the latest FDA white paper and safety
communications on meshes released in 2011 - unlike the previous
2008 release (FDA 2008) - relates to ongoing concern with mesh
used to treat pelvic organ prolapse (POP) and not the small strip of
mesh/tape/sling used to treat SUI (FDA 2011a; FDA 2011b). In
fact the FDA states that the safety and effectiveness ofmid-urethral
slings is well established in clinical trials with 1-year follow-up
(FDA 2013).
Equally, because of the increasing numbers of adverse events and
patient concerns reported, in 2012 the Medicines and Health-
care Products and Regulatory Agency (MHRA) in Europe pub-
lished a commissioned report on the most frequently reported ad-
verse events associated with different meshes/tapes/slings (MHRA
2012). The report showed that for the treatment of SUI the rate
of vaginal tape erosion was low, at between 1.1% to 2.5%. Even
in a selected cohort of women presenting primarily with adverse
events of mesh, those with mid-urethral sling were significantly
less likely to present with mesh erosions than those who had mesh
for POP repair. Presentation of mesh erosion following SUI treat-
ment is less severe, and less likely to require surgical treatment
under general anaesthesia than erosion following mesh insertion
for POP repair. This relates to complication classification severity
grade 4 (Abbott 2014; Strasberg 2009).
In their 2014 report, the MHRA concluded that from the review
of the information available, there appeared to be no evidence that
vaginal mesh implants for SUI are unsafe, nor was there evidence
to justify MHRA taking enforcement action to take them off the
market, or remove them from use. The report concluded that the
overall benefit outweighed the relatively low rate of complications
(MHRA 2014).
Although the number of adverse events was generally low and they
were rarely serious, it is recognised that the ability of RCTs to
identify rarer adverse effects is poor.With the increasingpopularity
of MUS procedures the occurrence of complications in the short
term is well established, but in general these are easily treated or
resolve spontaneously. However, because few trialists have carried
out long-term follow-up, there is very little information about
whether there is a hidden cache of serious adverse effects thatmight
be set against the benefits of curing incontinence.
Longer-term outcomes after MUS
Observational studies of MUS show data confirming effective-
ness in the long term with some data that cover 15 to 17 years
(Aigmueller 2011; Athanasiou 2014; Heinonen 2013; Nilsson
2013; Serati 2012; Serati 2013; Svenningsen 2013a; Svenningsen
2013b). These trials of MUS, like similar observational studies for
open colposuspension, show a decline in effectiveness that is time-
dependent, and also reveal high rates of de novo urgency symp-
toms (15%) and voiding difficulties (23%). It is difficult to elu-
cidate the reasons for these long-term symptoms, but they could
be age related, or due to new pathology, or a true consequence
of the surgery. Nevertheless, they emphasise the need for longer-
term data from RCTs to help counsel women appropriately.
With regard to long-term data from RCTs, there is a paucity of
trials that reported longer-term outcomes andmost long-termdata
reported for both open colposuspension and MUS are for five to
six years. If evidence from RCTs mirrors that from observational
studies, we will not only require the many RCTs that have been
published for MUS to report their longer-term data, but will in
fact need to follow these women up for at least 10 to 15 years.
This would allow us to discover whether there is a time-dependent
decline in effectiveness, and enable us to elucidate the development
in the long term of new adverse effects.
Comparisons with other methods of continence
surgery
’Gold standard’ surgical treatment for stress urinary
incontinence (SUI)
Open abdominal retropubic colposuspension used to be consid-
ered the gold standard treatment for SUI. It is noteworthy that
there are no randomised controlled trials of open colposuspension
versus no treatment. Two small trials that compared open colpo-
suspension with conservative treatment were unreliable because of
very small numbers of participant and a high risk of bias (Lapitan
2012). Equaliy the evidence for MUS versus no treatment or con-
servative treatment is limited and we will be addressing this in a
future Cochrane review.
Our initial review showed the effectiveness of MUS in the short
term and, as time has moved on, it was hoped that with reports
of long-term data it would become clear whether long-term ef-
ficacy of MUS could be compared with that of open retropubic
colposuspension. A Cochrane review of open retropubic colpo-
suspension identified 15 RCTs that compared the mid-urethral
sling operations (12 RPR and three TOR) with colposuspension
(Lapitan 2012). This review concluded that there was no signifi-
cant difference in incontinence rates between the two procedures
for all time periods assessed. Both procedures led to improvement
in the quality of life of women. While some complications, such
as bladder perforation, were reported more with MUS, the num-
bers were small. Other complications such as POVD, which were
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reported to be higher with MUS, were influenced by a large trial
that reported no risk of voiding difficulties at all after colposuspen-
sion, but consistent data from TVT trials showed no significant
difference in the risk of voiding dysfunction between MUS and
colposuspension. MUS had a shorter operating time, length of
hospital stay and cost. Only one RCT that compared MUS with
open colposuspension has reported results for a five-year follow-
up, and it failed to detect significant difference between the success
rates of MUS and colposuspension. It also showed that the effect
on cure of incontinence and improvement in quality of life was
maintained for both procedures at five years (Ward 2008).
Observational data for open colposuspension with follow-up of
10 to 20 years show high rates of effectiveness in the long term
(Alcalay 1995; Kjolhede 2005; Brubaker 2012). This long-term
cure is shown to be time-dependent with cure rates plateauing
at about 69% at 10 to 12 years. In addition some reports show
continence rates of only 44%at 14 years, with high rates of voiding
difficulties (of 36%) at 14-year follow-up.
Mid-urethral sling operations versus traditional slings
Historically, traditional suburethral sling procedures were used for
women who had recurrent stress incontinence (after a previous
failed continence operation). However, the review did not report
the results separately for women with new or recurrent inconti-
nence (Rehman 2011). These procedures were designed to restore
normal urethrovesical junction support by mechanical compres-
sion or kinking of the proximal urethra.
Minimally invasive synthetic suburethral slings appeared to be as
effective as traditional suburethral slings in short-term inconti-
nence rates (RR 0.97; 95% CI 0.78 to 1.20), although the confi-
dence interval is compatible with minimally invasive slings being
20% better or 12% worse. The operating time and length of stay
were also significantly shorter with minimally invasive synthetic
suburethral sling operations, and women had fewer perioperative
complications and less detrusor overactivity.
Mid-urethral sling operations versus open retropubic
colposuspension
Although 14 RCTs were found that compared TVT operations
with colposuspension (Lapitan 2012), data from five of them
showed no clear differences in the short- or medium-term chance
of incontinence compared with open colposuspension. While
there weremore complications after the sling operations, the num-
bers were small.
Mid-urethral sling operations versus laparoscopic
colposuspension
Another Cochrane review identified eight trials that compared
mid-urethral sling operations to laparoscopic colposuspension (
Dean 2006). Overall, the review showed that the subjective cure
rates were similar for both of these minimal access techniques in
the short term, while operation times were shorter for the slings.
Long-term data are lacking, however.
Mid-urethral sling operations versus single incision slings
Single-incision slings compared with retropubic mid-urethral
slings
Women were twice as likely to be incontinent after a single-inci-
sion sling as after a retropubic TVT (RR 2.08, 95% CI 1.04 to
4.14; Nambiar 2014), although the surgery took less time to per-
form. However, this finding mostly related to one type of single-
incision sling (TVT-Secur), which has now been withdrawn from
the market due to this lack of efficacy.
Single-incision slings compared with transobturator mid-
urethral slings
Womenwere twice as likely to be incontinent after a single-incision
sling procedure as after a transobturator sling procedure (RR 1.91,
95% CI 1.53 to 2.39; Nambiar 2014). In addition, they were
more likely to need a further operation for complications or repeat
surgery for their incontinence. However, the risks of postoperative
pain and long-term pain were slightly higher with transobturator
slings.
For the economic evidence, two cost-effectiveness analyses also
compared single-incision mini-slings with transobturator mid-
urethral slings. These adopted the perspective of the Spanish
(Castañeda 2014) and UK healthcare systems (Boyers 2013) re-
spectively. Boyers 2013 used clinical evidence from a prospective
RCT (Mostafa 2012), while Castañeda 2014 used evidence from
a retrospective observational study, using a one-year follow-up in
both cases. Both studies reported no statistically significant differ-
ences in the clinical outcomes: 6.7% difference, 95% Cl -6.6 to
20.0, P = 0.527 (Castañeda 2014); 5% difference, 95% Cl 0.38
to 2.26, P = 1.000 (Boyers 2013), and also no statistically signifi-
cant differences in intraoperative complications: P = 0.023 (Boyers
2013); P = 0.553 (Castañeda 2014). Boyers 2013 also reported
the impact on health-related quality of life reported as quality ad-
justed life years (QALYs). There was no significant difference in
QALYs (mean difference -0.003, 95%Cl -0.008 to 0.002) (Boyers
2013).However, in the single-incision sling arm, there were statis-
tically significant improved postoperative pain scores up to four
weeks with a pain score of zero compared with mid-urethral slings
with a total pain score of two (P < 0.001, 95% Cl 1.245 to 1.853).
There was also a statistically significant one day earlier return to
normal activities with single-incision slings (P = 0.025, 95% Cl
6.1 to 9.4 days) (Boyers 2013) and less repeated urinary tract in-
fections (Castañeda 2014). Single-incision mini-slings were less
costly in both studies. The mean total direct cost of single-incision
mini-sling in Boyers 2013 was GBP 1277 (2011 GBP) while that
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of transobturator sling procedure was GBP 1462 (2011 GBP),
with a 94% probability (95% Cl GBP -316.99 to GBP 32.17) of
being cost-saving compared to the transobturator sling procedure,
irrespective of whether single-incision mini-slings were performed
under local or general anaesthesia. In Castañeda 2014, the aver-
age cost of single-incision mini-slings (2013 euro) was EUR 2059
(95% Cl 1914 to 2285), while the cost of the transobturator sling
procedure was EUR 2821 (95% Cl 2661 to 2997). There was
a 100% probability of single-incision mini-slings being cost-sav-
ing. Both studies (Boyers 2013; Castañeda 2014) suggested that
the transobturator sling procedure is less cost-effective when com-
pared with mini-sling based on comparative effectiveness of both
interventions and lower costs associated with single-incision mini-
slings.
Mid-urethral sling operations versus anterior repair
To date, no trials have been identified that compared the original
operation for SUI, anterior repair (with urethral buttressing su-
tures, or Kelly sutures) directly to mid-urethral slings (Glazener
2001). However, in the current climate of concern about adverse
effects from the use of synthetic mesh or tape materials, perhaps
it is time to reassess the value of this operation, not least because
of its additional role in the management of prolapse.
Quality of the evidence
We judged the quality of evidence using the GRADE classifica-
tion as moderate for the majority of outcomes. The remaining
outcomes assessed were low level evidence. The main reason for
the decrease in the quality of evidence for many outcomes was
a high risk of bias where allocation concealment or random se-
quence generation were deemed uncertain. Imprecision of effects
estimates also contributed to the variable quality of evidence in
some outcomes.
In the main comparison between TOR and RPR, the quality of
evidence for most outcomes was moderate. The downgrade from
high quality to moderate quality evidence was mainly because of
a small proportion of trials in which there was a high risk of bias
from either study design or implementation, which then reduced
our confidence in the estimates of effects.
Potential biases in the review process
GRADE-specific outcomes were selected at the time of the orig-
inal review. These have been modified for this update. There is
potential for introduction of bias, as ideally theseGRADE-specific
outcomes should have been selected at the time of the protocol,
and there would have been consistency between the outcomes se-
lected in the original review and in the update.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Mid-urethral sling operations are now widely accepted as a routine
surgical treatment for stress urinary incontinence (SUI). This re-
view has identified evidence that addresses the comparative effects
of different ways of inserting tapes, including different insertion
routes, surgical approaches and tapes.
Irrespective of the routes traversed, these procedures are highly
effective in the short and medium term and mounting evidence
demonstrates their effectiveness in the long term.
There is low to moderate quality evidence that retropubic tapes
and transobturator tapes have comparable effects on cure of in-
continence between one and five years, and limited evidence for
the same in the long term. With the exception of a two-fold in-
crease in the incidence of groin pain, transobturator tapes have
fewer adverse events. Retropubic tapes have an eight-fold increase
in the incidence of bladder perforation and a two-fold increase
in the incidence of post operative voiding difficulties. Although
women’s outcomes for quality of life and sexual function improved
significantly after all surgical approaches, our analyses could not
establish whether there was any difference between retropubic and
transobturator tapes. Evidence for longer-term effects is required
to evaluate the need for further surgery following either approach.
There was moderate quality evidence that when a retropubic route
(RTR) is employed a bottom-to-top approach is more effective in
terms of subjective cure than a top-to-bottom approach. When
traversing the transobturator route (TOR), there was moderate
quality evidence showing that medial-to-lateral (’inside-out’) and
lateral-to-medial (’outside-in’) approaches have similar effects.
Implications for research
Many trials have evaluated the use of mid-urethral tapes in the
short term. However, the long-term effects of surgery, and how
the different insertion routes affect long-term outcome, have not
been established. It is unfortunate that although 35 of the 81 trials
included should be in a position to report their long-term data
(i.e. over five years), only three have done so. More of the trials
included in this review should publish the results of their longer-
term follow-up to increase the robustness of evidence supporting
the use of mid-urethral sling (MUS) in the long term, to provide
answers about the long-term adverse events of these operations,
including whether there is a significant decline in the effectiveness
of these procedures over time, and to identify the point at which
decline becomes significant enough to require women to need
repeat procedures.
More research is required into trials assessing the clinical effec-
tiveness of different routes (RPR or TOR) in women with uro-
dynamic stress incontinence where hypermobility is differentiated
from intrinsic urethral sphincter deficiency, as data for most of the
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outcomes are sparse. Equally, trials assessing the effectiveness of
RPR or TOR in a cohort of women presenting with recurrent SUI
after a failed MUS procedure are needed. More adequately pow-
ered trials are needed to address the issue of MUS in women who
also have symptomatic or asymptomatic pelvic organ prolapse, as
presently it is unclear whether concomitant pelvic organ prolapse
surgery is necessary, and, if performed, whether it enhances or
detracts from the effectiveness of the MUS. Conversely, there is
only indirect evidence to suggest thatMUS are more effective than
anterior repair, as no RCTs have compared them directly.
Future randomised controlled trials should be robustly designed
to be of good quality and adequately powered with standard-
isedwoman-reported (subjective) outcomemeasures and objective
outcomes. When reporting, these trials should follow the CON-
SORT guidelines (Moher 2001; Schulz 2010). There needs to
be long-term follow-up and adequate reporting of adverse effects.
It is essential that outcomes relevant to both women and policy
makers who commission treatments are incorporated into these
trials. In particular, quality of life, sexual function and economic
implications should be assessed.
A C K N OW L E D G E M E N T S
We thank Sheila Wallace for all her help and also for conducting
the literature search.
We thank Dr Muhammad Imran Omar and Professor Cathryn
Glazener for their input and help with arbitration of disagree-
ments.
We also thank Dr Michaela Weingarten who assisted us in the
translation of non-English manuscripts.
We would like to thank Dr Carlos Bezerra and Dr Mauricio S
Plata for their contribution to the original protocol.
R E F E R E N C E S
References to studies included in this review
Abdel-Fattah 2010 {published data only}
Abdel-Fattah M, Familusi A, Ramsay I, Ayansina D,Mostafa
A. Preoperative determinants for failure of transobturator
tapes in the management of female urodynamic stress
incontinence. International Journal of Gynaecology and
Obstetrics 2010;110(1):18–22. ETOT; NCT00136071;
srincont40971]
Abdel-Fattah M, Familusi A, Ramsay I, N’Dow J. A
randomised prospective single-blinded study comparing
“inside-out” versus “outside-in” transobturator tapes in
the management of female stress urinary incontinence
(E-TOT study); 3 years follow-up (Abstract number 18).
Neurourology and Urodynamics 2011;30(6):825–6. ETOT;
NCT00136071; srincont42168]
Abdel-Fattah M, Hasafa Z, Mostafa A. Correlation of
three validated questionnaires for assessment of outcomes
following surgical treatment of stress urinary incontinence
in women. European Journal of Obstetrics, Gynecology,
and Reproductive Biology 2011;157(2):226–9. ETOT;
NCT00136071; srincont41753]
Abdel-Fattah M, Mostafa A, Familusi A, Ramsay I, N’Dow
J. Prospective randomised controlled trial of transobturator
tapes in management of urodynamic stress incontinence
in women: 3-year outcomes from the evaluation of
transobturator tapes study. European Urology 2012;62(5):
843–51. ETOT; NCT00136071; srincont45947]
Abdel-Fattah M, Mostafa A, Young D, Ramsay I. Evaluation
of transobturator tension free vaginal tapes in management
of women with stress urinary incontinence and previous
failed incontinence surgery (Abstract number 156).
Neurourology and Urodynamics 2010;29(6):1027–9. ETOT;
NCT00136071; srincont40148]
Abdel-Fattah M, Mostafa A, Young D, Ramsay I. Evaluation
of transobturator tension-free vaginal tapes in the
management of women with mixed urinary incontinence:
one-year outcomes. American Journal of Obstetrics and
Gynecology 2011;205(2):150–6. ETOT; NCT00136071;
srincont42990]
Abdel-Fattah M, Mostafa A, Young D, Ramsay I. Impact
of transobturator tension free vaginal tapes on quality of
life and sexual function in women with mixed urinary
incontinence (Abstract number 28). Neurourology and
Urodynamics 2010;29(6):844–5. ETOT; NCT00136071;
srincont40119]
Abdel-Fattah M, Ramsay I. Transvaginal tension free vaginal
tape-obturator (TVT-O) versus transobturator tape-mentor
(TOT) in the management of urodynamic stress urinary
incontinence. ClinicalTrials.gov (http://ClinicalTrials.gov/
show/NCT00136071) (accessed 20 September 2010) 2005.
ETOT; NCT00136071; srincont40211]
∗ Abdel-Fattah M, Ramsay I, Pringle S, Hardwick C,
Ali H. Evaluation of transobturator tapes (E-TOT)
study: randomised prospective single-blinded study
comparing inside-out vs. outside-in transobturator tapes in
management of urodynamic stress incontinence: short term
outcomes. European Journal of Obstetrics, Gynecology, &
Reproductive Biology 2010;149(1):106–11. 39661; ETOT;
NCT00136071; srincont39661]
Abdel-Fattah M, Ramsay I, Pringle S, Hardwick C, Ali H,
Young D, et al. Evaluation of transobturator tension-free
vaginal tapes in management of women with recurrent stress
urinary incontinence. Urology 2011;77(5):1070–5. ETOT;
48Mid-urethral sling operations for stress urinary incontinence in women (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
NCT00136071; srincont41485]
Abdel-Fattah M, Ramsay I, Pringle S, Hardwick C, Ali
H, Young D, et al. Randomised prospective single-
blinded study comparing ’inside-out’ versus ’outside-in’
transobturator tapes in the management of urodynamic
stress incontinence: 1-year outcomes from the E-TOT
study. BJOG: an International Journal of Obstetrics &
Gynaecology 2010;117(7):870–8. ETOT; NCT00136071;
srincont39920]
Abdel-Fattah M, Ramsay I, Pringle S, Hardwick C, Tierney
J, Ali H. (E-TOT) Study: a randomised prospective single-
blinded study of two transobturator tapes in management
of urodynamic stress incontinence: objective & patient
reported outcomes (Abstract number 2). International
Urogynecology Journal 2008;19(Suppl 2):S2–3. ETOT;
NCT00136071; srincont31053]
Abdel-Fattah M, Ramsay I, Pringle S, Hardwick C, Tierney
J, Young D. (E-TOT) Study: a randomised prospective
single blinded study of two transobturator tapes in
management of urodynamic stress incontinence: quality
of life; sexual function at 1-year (Abstract number 200).
International Urogynecology Journal 2008; Vol. 19, issue
Suppl 2:S168–9. ETOT; NCT00136071; srincont31050]
Hopper LR, Mostafa A, Abdel-Fattah M. The effectiveness
of transobturator tapes in the surgical management of
women with mixed urinary incontinence: 3 year outcomes
(Abstract number 612). Proceedings of the 43rd Annual
Meeting of the International Continence Society (ICS),
2013 Aug 26-30, Barcelona, Spain. 2013. NCT00136071;
srincont60036]
Mostafa A, Madhuvrata P, Abdel-Fattah M. Preoperative
urodynamic predictors of short-term voiding dysfunction
following a transobturator tension-free vaginal tape
procedure. International Journal of Gynaecology and
Obstetrics 2011;115(1):49–52. NCT00136071;
srincont42671]
Aigmuller 2014 {published data only}
∗ Aigmuller T, Tammaa A, Tamussino K, Hanzal E, Umek
W, Kolle D, et al. Retropubic vs. transobturator tension-
free vaginal tape for female stress urinary incontinence:
3-month results of a randomized controlled trial.
International Urogynecology Journal 2014;25(8):1023–30.
[DOI: 10.1007/s00192-014-2384-z; NCT00441454;
sr–incont62534; PUBMED: 24819327
Bjelic Radisic V, Trutnovsky G, Tammaa A, Hanzal E,
Umek W, Koelle D, et al. Quality of life in patients with
stress incontinence: results of a randomized trial comparing
retropubic and transobturator tension-free vaginal tape
(Abstract number 042). International Urogynecology Journal
2013;24(Suppl 1):S36–7. sr–incont62184]
Tammaa A, Aigmueller T, Umek W, Hanzal E, Kropshofer
S, Lang P, et al. Retropubic versus transobturator TVT:
five-year results of the Austrian trial (Abstract number: Oral
Poster 18). Journal of Minimally Invasive Gynecology 2014;
21(2 Suppl 1):S21. sr–incont62148]
Tamussino K, Tammaa A, Hanzal E, Umek W, Bjelic V,
Koelle D. TVT vs. TVT-O for primary stress incontinence:
a randomized clinical trial (Abstract number 112).
International Urogynecology Journal 2008;19(Suppl 1):
S20–1. sr–incont26969]
Alkady 2009 {published data only}
Alkady HM, Eid A. Tension-free vaginal tape versus
transobturator vaginal tape inside-out for the treatment of
female stress urinary incontinence. Medical Journal of Cairo
University 2009;77(4):317–26. sr–incont50307]
Andonian 2005 {published data only}
∗ Andonian S, Chen T, St Denis B, Corcos J. Randomized
clinical trial comparing suprapubic arch sling (SPARC) and
tension-free vaginal tape (TVT): one-year results. European
Urology 2005;47(4):537–41. sr–incont20378]
Andonian S, Chen TY, Corcos J. Randomized clinical trial
comparing SPARC and TVT procedure for the treatment of
SUI: preliminary report on peri-operative and short term
complications (Abstract). Proceedings of the 33rd Annual
Meeting of the International Continence Society (ICS), 203
Oct 5-9, Florence, Italy. 2003:547–8. sr–incont17163]
Andonian 2007 {published data only}
Andonian S, St-Denis B, Lemieux MC, Corcos J.
Prospective clinical trial comparing Obtape and DUPS to
TVT: one-year safety and efficacy results. European Urology
2007;52(1):245-2. sr–incont23793]
Aniuliene 2009 {published data only}
Aniuliene R. Tension-free vaginal tape versus tension-
free vaginal tape obturator (inside-outside) in the surgical
treatment of female stress urinary incontinence. Medicina
(Kaunas, Lithuania) 2009;45(8):639–43. sr–incont34372]
Araco 2008 {published data only}
∗ Araco F, Gravante G, Sorge R, Overton J, De Vita D,
Sesti F, et al. TVT-O vs TVT: a randomized trial in patients
with different degrees of urinary stress incontinence.
International Urogynecology Journal 2008;19(7):917–26.
[DOI: 10.1007/s00192-007-0554-y; sr–incont27794
Araco F, Gravante G, Sorge R, Piccione E. TVT-O vs. TVT:
reply to comments by Burton et al [letter]. International
Urogynecology Journal 2009;20:371–2. DOI 10.1007/
s00192–008–0795–4; sr–incont27794]
Burton C, Latthe P, Toozs-Hobson P. Comments on Araco
et al: TVT-O vs TVT: a randomized trial in patients with
different degrees of urinary stress incontinence [comment]
[letter]. International Urogynecology Journal. 1920;20(3):
369. sr–incont27794; srincont31410]
Barber 2008 {published data only}
Barber M, Kleeman S, Karram M, Paraiso MF, Walters
M, Vasavada S, et al. A multi-center randomized trial
comparing the transobturator tape with tension-free vaginal
tape for the surgical treatment of stress urinary incontinence
(Abstract number 113). Neurourology and Urodynamics
2007;26(5):742–3. sr–incont23758]
Barber MD, Kleeman S, Karram MM, Paraiso MF,
Ellerkmann M, Vasavada S, et al. Risk factors associated
with failure 1 year after retropubic or transobturator
midurethral slings. American Journal of Obstetrics and
49Mid-urethral sling operations for stress urinary incontinence in women (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Gynecology 2008;199(6):666.e1–7. NCT00475839;
srincont29239]
∗ Barber MD, Kleeman S, KarramMM, ParaisoMF,Walters
MD, Vasavada S, et al. Transobturator tape compared with
tension-free vaginal tape for the treatment of stress urinary
incontinence: a randomized controlled trial. Obstetrics
and Gynecology 2008;111(3):611–21. NCT00475839;
srincont26837]
Barber MD, Kleeman SD, Karram MM, Paraiso MF,
Walters MD, Vasavada S, et al. A multi-center randomized
trial comparing the transobturator tape with tension-free
vaginal tape for the surgical treatment of stress urinary
incontinence (Abstract number 9 Oral). Journal of Pelvic
Medicine & Surgery 2007;13(5):234–5. srincont34199]
Chen CC, Rooney CM, Paraiso MF, Kleeman SD, Walters
MD, Karram MM, et al. Leak point pressure does not
correlate with incontinence severity or bother in women
undergoing surgery for urodynamic stress incontinence.
International Urogynecology Journal 2008;19(9):1193–8.
srincont27712]
Frick AC, Ridgeway B, Ellerkmann M, KarramMM, Paraiso
MF, Walters MD, et al. Comparison of responsiveness of
validated outcome measures after surgery for stress urinary
incontinence. Journal of Urology 2010;184(5):2013–7.
srincont40342]
Barry 2008 {published data only}
∗ Barry C, Lim YN, Muller R, Hitchins S, Corstiaans A,
Foote A, et al. A multi-centre, randomised clinical control
trial comparing the retropubic (RP) approach versus the
transobturator approach (TO) for tension-free, suburethral
sling treatment of urodynamic stress incontinence: the
TORP study. International Urogynecology Journal 2008;19
(2):171-8. sr–incont26462]
Barry CL, Lim Y, Muller R, Greenland H, Hitchens
S, Corstiaans A, et al. A multi-centre, prospective,
randomised trial comparing the retropubic (RP-SUS)
approach versus the transobturator approach (TO-SUS)
for tension free, suburethral sling treatment of urodynamic
stress incontinence - the TORP study (Abstract number
53). Neurourology and Urodynamics 2006;25(6):572–3.
sr–incont23754]
But 2008 {published data only}
∗ But I, Faganelj M. Complications and short-term
results of two different transobturator techniques for
surgical treatment of women with urinary incontinence:
a randomized study. International Urogynecology Journal
2008;19(6):857–61. srincont27423]
But I, Zegura B, Pakiz M, Rakic S. Outside-in vs inside-out
transobturator approach in women with stress and mixed
urinary incontinence: a prospective, randomized, head-to-
head comparison study (Abstract number 18). International
Urogynecology Journal and Pelvic Floor Dysfunction 2007;18
(Suppl 1):S11–2. srincont27320]
Cervigni 2006 {published data only}
Cervigni M, Natale F, La Penna C, Agostini M, Antomarchi
F, Lo Voi R, et al. Surgical correction of stress urinary
incontinence associated with pelvic organ prolapse: trans-
obturator approach (MONARC) versus retropubic approach
(TVT) (Abstract number 280). International Urogynecology
Journal 2006;17(Suppl 2):S215. srincont29660]
∗ Cervigni M, Natale F, La Penna C, Agostini M,
Antomarchi F, Lo Voi R, et al. Surgical correction of stress
urinary incontinence associated with pelvic organ prolapse:
trans-obturator approach (MONARC) versus retropubic
approach (TVT) (Abstract number 36). Neurourology and
Urodynamics 2006;25(6):552. sr–incont23756]
Chen 2010 {published data only}
Chen Z, Chen Y, Du GH, Yuan XY, Wu J, Zeng XY, et
al. Comparison of three kinds of mid-urethral slings for
surgical treatment of female stress urinary incontinence.
Urologia (Treviso) 2010;77(1):37–42. srincont40354]
Chen 2012 {published data only}
Chen H-X, Lv J-W, Leng J, Li J-Y, Bo J-J, Huang Y-R.
Efficacy and complications of TVT procedure and TVT-O
procedure in treatment of female stress urinary incontinence
[Chinese]. Journal of Shanghai Jiaotong University (Medical
Science) 2012;32(4):412–5. srincont59712]
Cho 2010 {published data only}
Cho ST, Lee ST, Kim K, Lee YG, Kim KK, Choi NG. A
sequential comparison of postoperative voiding pattern and
uroflowmetry between two transobturator midurethral tape
procedures (Monarc (trademark) and TOT (trademark))
(Abstract number 750). Proceedings of the Joint Meeting
of the International Continence Society (ICS) and the
International Urogynecological Association, 2010 Aug 23-
27, Toronto, Canada 2010. srincont40199]
Choe 2013 {published data only}
Choe JH, Lee HD, Park SH, Jo DG, Lee HS, Lee JS, et
al. Comparison of postoperative pain after transobturator
or retropubic suburethral sling for female stress urinary
incontinence: a prospective randomized study (Abstract
number MP17-08). Journal of Endourology 2013;27(S1):
A263. srincont62161]
Darabi Mahboub 2012 {published data only}
Darabi MR, Keshvari M, Sheikhi Z. Evaluation study
between tension-free vaginal tape (TVT) and transobturator
tape (TOT) in treatment stress incontinence in female
(Abstract number S88). European Urology Supplements
2013;12(4):e1196. sr–incont62158]
∗ Darabi Mahboub MR, Keshvari M, Sheikhi Z. Evaluation
study between tension - free vaginal tape (TVT) and
transobturator tape (TOT) in treatment stress incontinence
in female (Abstract number 788). Proceedings of the 42nd
Annual Meeting of the International Continence (ICS),
2012 Oct 15-19, Beijing, China 2012. srincont48402]
Mahbob MRD. Evaluation study between Tension-Free
Vaginal Tape and Transobturator Tape in treatment stress
incontinence in women. Iranian Registry of Clinical Trials
(IRCT) (available at: http://www.irct.ir/searchresult.php?
id=8228&number=4 ) 2009. sr–incont 62304]
Mahboub MRD, Keshvari M, Sheikhi Z. Evaluation study
between tension free vaginal tape and transobturator tape in
treatment stress incontinence in female (Abstract number
50Mid-urethral sling operations for stress urinary incontinence in women (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
BR03-09). Journal of Endourology 2011;25(Suppl 1):A12.
srincont62292]
David-Montefiore 2006 {published data only}
Ballester M, Bui C, Frobert JL, Grisard-Anaf M, Lienhart
J, Fernandez H, et al. Four-year functional results of the
suburethral sling procedure for stress urinary incontinence:
a French prospective randomized multicentre study
comparing the retropubic and transobturator routes. World
Journal of Urology 2012;30(1):117–22. srincont44520]
Darai E, Frobert JL, Grisard-Anaf M, Lienhart J, Fernandez
H, Dubernard G, et al. Functional results after the
suburethral sling procedure for urinary stress incontinence:
a prospective randomized multicentre study comparing the
retropubic and transobturator routes. European Urology
2007;51(3):795–802. srincont22550]
David-Montefiore E, Frobert JL, Grisard-Anaf M, Liehart J,
Fernandez H, Dubernard G, et al. Functional results after
suburethral sling procedure for urinary stress incontinence
at 1 year: a French prospective randomised multicentre
study comparing the retropubic and transobturator routes
(Abstract number 063). International Urogynecology Journal
2006;17(Suppl 2):S95. sr–incont49146]
∗ David-Montefiore E, Frobert JL, Grisard-Anaf M,
Lienhart J, Bonnet K, Poncelet C, et al. Peri-operative
complications and pain after the suburethral sling procedure
for urinary stress incontinence: a French prospective
randomised multicentre study comparing the retropubic
and transobturator routes. European Urology 2006;49(1):
133–8. srincont21623]
Deffieux 2010 {published data only}
Deffieux X, Daher N, Mansoor A, Debodinance P, Deval B,
Salet-Lizee D, et al. Tension-free vaginal tape (TVT) and
trans-obturator suburethral tape from inside to outside
(TVT-O) for surgical treatment of female stress urinary
incontinence: a multicenter randomised controlled trial
(Abstract number 33). International Urogynecology Journal
and Pelvic Floor Dysfunction 2007;18(Suppl 1):S19–20.
NCT00135616; srincont27322]
∗ Deffieux X, Daher N, Mansoor A, Debodinance
P, Muhlstein J, Fernandez H. Transobturator TVT-
O versus retropubic TVT: results of a multicenter
randomized controlled trial at 24 months follow-up.
International Urogynecology Journal 2010;21(11):1337–45.
NCT00135616; srincont40895; PUBMED: 20552165]
Deffieux X, Fernandez H. Female sexual function
following trans-obturator suburethral tape from inside to
outside (TVT-O) and tension-free vaginal tape (TVT):
a randomized controlled trial (Abstract number 70).
Journal of Minimally Invasive Gynecology 2009;16(6):S22.
NCT00135616; srincont40862]
Trichot C, Salet-Lizee D, Descamps P, Deval B, Hocke C,
Fatton B, et al. [Functional results following transobturator
and retropubic mid-urethral sling] [French]. Journal de
Gynecologie, Obstetrique et Biologie de la Reproduction 2010;
39(8):614–23. NCT00135616; srincont41067]
de Leval 2011 {published data only}
Thomas A, Waltregny D, de Leval J. One year results of a
prospective randomized trial comparing the original inside-
out transobturator (TVT-O) procedure and a modified
version using a shortened tape and reduced dissection for
the treatment of female stress urinary incontinence (Abstract
number 153). Neurourology and Urodynamics 2010;29(6):
1023–5. ISRCTN65635093; srincont40146]
Waltregny D. Clincial comparison between the original
TVT-O and a modified procedure (mini TVT-O) for the
surgical treatment of female stress urinary incontinence:
a randomised clinical trial with 1-year follow-up. http://
isrctn.org/ISRCTN65635093 2007. sr–incont62307]
Waltregny D, Thomas A, Blockx C, de Leval J. Three year
results of a prospective randomized trial comparing the
original inside-out transobturator (TVT-OTM ) procedure
with a modified version using a shortened tape and reduced
dissection for the treatment of female stress urinary
incontinence (Abstract number 254). Neurourology and
Urodynamics 2012;31(6):1056–7. ISRCTN65635093;
srincont46716]
Waltregny D, de Leval J. New surgical technique for
treatment of stress urinary incontinence TVT-ABBREVO
from development to clinical experience. Surgical Technology
International 2012;22:149–57. srincont49404]
∗ de Leval J, Thomas A, Waltregny D. The original
versus a modified inside-out transobturator procedure:
1-year results of a prospective randomized trial.
International Urogynecology Journal 2011;22(2):145–56.
ISRCTN65635093; srincont40993]
de Tayrac 2004 {published data only}
∗ de Tayrac R, Deffieux X, Droupy S, Chauveaud-Lambling
A, Calvanese-Benamour L, Fernandez H. A prospective
randomized trial comparing tension-free vaginal tape and
transobturator suburethral tape for surgical treatment of
stress urinary incontinence. American Journal of Obstetrics
and Gynecology 2004;190(3):602–8. sr–incont17259]
de Tayrac R, Droupy S, Calvanese L, Fernandez H.
A prospective randomized study comparing TVT and
transobturator suburethral tape (T.O.T.) for the surgical
treatment of stress incontinence (Abstract). Proceedings of
the 33rd Annual Meeting of the International Continence
Society (ICS), 203 Oct 5-9, Florence, Italy. 2003:266–7.
sr–incont17153]
Diab 2012 {published data only}
Diab DE, Zayed AM, Allam MN,Maroof AM, Ibraheem E,
El-Sayed DE. A prospective randomized study comparing
the safety and efficacy of transobturator tape (TOT) versus
tension free vaginal tape (TVT) in treatment of female stress
urinary incontinence (Abstract number 177). European
Urology Supplements 2012;11(1):e177. srincont62249]
Elbadry 2014 {published data only}
Elbadry M, Shaaban A, Gabre A. Adjustable versus ordinary
trans-obturator tape for female stress incontinence...is
there a difference? A randomized trial (Abstract number
MP75-09). Journal of Urology 2014;191(4 Suppl 1):e876.
srincont62136]
51Mid-urethral sling operations for stress urinary incontinence in women (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
El-Hefnawy 2010 {published data only}
El-Hefnawy AS, Wadie BS, El Mekresh M, Nabeeh
A, Bazeed MA. TOT for treatment of stress urinary
incontinence: how should we assess its equivalence with
TVT?. International Urogynecology Journal 2010;21(8):
947–53. srincont40077]
Wadie BS, Elhefnawy AS. TVT versus TOT, 2-year
prospective randomized study. World Journal of Urology
2013;31(3):645–9. srincont48133]
Enzelsberger 2005 {published data only}
Enzelsberger H, Schalupny J, Heider R, Mayer G. TVT
versus TOT - a prospective randomized study for the
treatment of female stress urinary incontinence at a follow-
up of 1 year [German]. Geburtshilfe und Frauenheilkunde
2005;65(5):506–11. srincont21007]
Freeman 2011 {published data only}
∗ Freeman R, Holmes D, Hillard T, Smith P, James M,
Sultan A, et al. What patients think: patient-reported
outcomes of retropubic versus trans-obturator mid-urethral
slings for urodynamic stress incontinence-a multi-centre
randomised controlled trial. International Urogynecology
Journal 2011;22(3):279–86. srincont41009]
Freeman R, Holmes D, Smith P, Hillard T, Yang Q, AgurW,
et al. Is trans-obturator tape (TOT) as effective as tension-
free vaginal tape (TVT) in the treatment of women with
urodynamic stress incontinence? Results of a multicentre
RCT (Abstract number 3). Neurourology and Urodynamics
2008;27(7):573–4. srincont31849]
Hammoud 2011 {published data only}
∗ Hammoud K, Elsheikh M, Haitham M, Fayad A,
Ghamrawy H, Aboumohamed A. Tension-free vaginal tape
versus transobturator vaginal tape in management of female
stress urinary incontinence. Long-term follow-up: which to
choose (Abstract number UP-01.075). Urology 2011;78(3
Suppl 1):S209–10. srincont62233]
Hammoud KM, El Sheikh MG, Haitham M, Fayad AS, El
Ghamrawy HK, Mohamed AARA. Tension-free vaginal
tape versus trans-obturator vaginal tape in the management
of female stress urinary incontinence long term follow-up:
which to choose (Abstract number MP07-01). Journal of
Endourology 2012;26(Suppl 1):A59. srincont62245]
Hassan 2013 {published data only}
∗ Hassan S, Aly H. Randomised Comparative study between
inside-out transobturator tape and outside-in transobturator
tape for urodynamic stress incontinence. Neurourology and
Urodynamics 2013;32(6):777. srincont49205]
Houwert 2009 {published data only}
Houwert M, Vos MC, Vervest HAM. Transobturator
tape (TOT), inside-out versus outside-in approaches:
outcome after 1 year (Abstract number 56). International
Urogynecology Journal and Pelvic Floor Dysfunction 2007;18
(Suppl 1):S33. srincont27326]
∗ Houwert RM, Renes-Zijl C, Vos MC, Vervest HA.
TVT-O versus Monarc after a 2-4-year follow-up: a
prospective comparative study. International Urogynecology
Journal and Pelvic Floor Dysfunction 2009;20(11):1327–33.
sr–incont50308; PUBMED: 19597718]
Vervest H, de Bruin JP, Renes-Zeijl CC. Transobturator
tape (TOT), inside-out or outside-in approaches: does it
matter? (Abstract number 167). International Urogynecology
Journal 2005;16(2 Suppl):S69–70. sr–incont27406]
Jakimiuk 2012 {published data only}
∗ Jakimiuk AJ, Issat T, Fritz-Rdzanek A, Maciejewski T,
Rogowski A, Baranowski W. Is there any difference? A
prospective, multicenter, randomized,single blinded clinical
trial, comparing TVT with TVT-O (POLTOS study) in
management of stress urinary incontinence. Short-term
outcomes. Pelviperineology 2012;31:5–9. sr–incont50305]
Jakimiuk AJJ, Maciejewski TM, Fritz AF, Baranowski
WB, Wladysiuk-Blicharz MWB. Single-blind randomized
clinical trial comparing efficacy and safety of TVT
(tension free vaginal tape) vs TVT-O (tension free vaginal
tape obturator system) in treatment of stress urinary
incontinence (POLTOS) preliminary report (Abstract
number 348). International Urogynecology Journal and Pelvic
Floor Dysfunction 2007;18(Suppl 1):S189. srincont27324]
Juang 2007 {published data only}
Juang CM, Yu KJ, Chou P, Yen MS, Twu NF, Horng HC, et
al. Efficacy analysis of trans-obturator tension-free vaginal
tape (TVT-O) plus modified Ingelman-Sundberg procedure
versus TVT-O alone in the treatment of mixed urinary
incontinence: a randomized study. European Urology 2007;
51(6):1671–9. srincont23260]
Kamel 2009 {published data only}
Kamel A. A comparison between TVT & TVTO as
regards safety. An African experience (Abstract number
830). Proceedings of the 39th Annual Meeting of the
International Continence Society (ICS), 2009 Sep 29 - Oct
3, San Francisco, CA 2009. srincont35630]
Karateke 2009 {published data only}
Karateke A, Haliloglu B, Cam C, Sakalli M. Comparison
of TVT and TVT-O in patients with stress urinary
incontinence: short-term cure rates and factors influencing
the outcome. A prospective randomised study. Australian &
New Zealand Journal of Obstetrics & Gynaecology 2009;49
(1):99–105. srincont31429]
Kilic 2007 {published data only}
Kilic G, Olgun G, Bilen MA, Orhan A, Dunn B. [The
comparison of TVT (tension free vaginal tape) and TOT
(trans-obturator vaginal tape) in the treatment of the urinary
incontinence and literature search]. Jinekoloji Ve Obstetrik
Dergisi 2007;21(1):26–31. srincont28036]
Kim 2004 {published data only}
Kim J, Baek U, Kwon S, Jung H, Moon K, Park T,
et al. The efficacy of Iris procedure in stress urinary
incontinence: comparison with TVT and SPARC
(Abstract). Proceedings of the International Continence
Society (34th Annual Meeting) and the International
Urogynecological Association, Joint Meeting, 23-27 Aug,
2004, Paris. 2004:Abstract number 313. srincont19058]
52Mid-urethral sling operations for stress urinary incontinence in women (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Kim 2005 {published data only}
∗ Kim Y-W, Na Y-G, Sul C-K. [Randomized prospective
study between pubovaginal sling using SPARC sling system
and MONARC sling system for the treatment of female
stress urinary incontinence: short term results]. Korean
Journal of Urology 2005;46(10):1078–82. srincont22116]
Na YG, Rob AS, Youk SM, Kim YW, Kim HS, Sul
CK, et al. A prospective multicentre randomized study
comparing transvaginal tapes (SPARC sling system) and
transobturator suburethral tapes (Monarc sling system)
for the surgical treatment of stress urinary incontinence
(Abstract number 49). European Urology Supplements 2005;
4(3):15. srincont26609]
Krofta 2010 {published data only}
Krofta L, Feyereisl J, Otcenasek M, Kasikova E, Pan
M. [Tension free vaginal tape and transobturator
suburethral tape for surgical treatment of stress urinary
incontinence] [Czech]. Ceska Gynekologie 2008;73(4):
231–9. sr–incont27504]
∗ Krofta L, Feyereisl J, Otcenasek M, Velebil P, Kasikova
E, Krcmar M. TVT and TVT-O for surgical treatment
of primary stress urinary incontinence: prospective
randomized trial. International Urogynecology Journal 2010;
21(2):141–8. sr–incont39511]
Laurikainen 2007 {published data only}
Brubaker L, Brincat C, Mueller E. Are we satisfied?
Perspective on five-year outcomes of midurethral slings
[editorial]. European Urology 2014;65(6):1115–6.
sr–incont67651; PUBMED: 24568893]
Laurikainen E, Takala T, Aukee P, Kivela A, Rinne K, Valpas
A, et al. Retropubic TVT compared with transobturator
TVT (TVT-O) in treatment of stress urinary incontinence:
five-year results of a randomized trial (Abstract number
2). Neurourology and Urodynamics 2011;30(6):803–5.
NCT00379314; srincont42162]
Laurikainen E, Valpas A, Aukee P, Kivela A, Rinne K, Takala
T, et al. Five-year results of a randomized trial comparing
retropubic and transobturator midurethral slings for stress
incontinence. European Urology 2014;65(6):1109–14.
sr–incont60594; PUBMED: 24508070]
Laurikainen E, Valpas A, Kiilholma P, Takala T, Kivela A,
Aukee P, et al. A prospective randomised trial comparing
TVT and TVT-O procedures for the treatment of SUI:
immediate outcome and complications (Abstract no 077).
International Urogynecology Journal 2006;17(Suppl 2):
S104–5. sr–incont49149]
∗ Laurikainen E, Valpas A, Kivela A, Kalliola T, Rinne K,
Takala T, et al. Retropubic compared with transobturator
tape placement in treatment of urinary incontinence: a
randomized controlled trial. Obstetrics and Gynecology
2007;109(1):4–11. sr–incont22553]
Nilsson CG. A randomized, prospective, multicenter trial
comparing TVT with TVT-O procedures in treatment of
female primary urinary stress incontinence (Trial registry
number: NCT00379314). http://clinicaltrials.gov/show/
NCT00379314 2004. NCT00379314; srincont49342]
Palva K, Nilsson CG. Prevalence of urinary urgency
symptoms decreases by mid-urethral sling procedures for
treatment of stress incontinence. International Urogynecology
Journal 2011;22(10):1241–7. NCT00379314;
srincont42695]
Palva K, Rinne K, Aukee P, Kivela A, Laurikainen E, Takala
T, et al. A randomized trial comparing tension-free vaginal
tape with tension-free vaginal tape-obturator: 36-month
results. International Urogynecology Journal 2010;21(9):
1049–55. NCT00379314; srincont40052]
Rinne K. Comparison of two mid-urethral sling operations
and their effect on urethral mobility assessed by dynamic
magnetic resonance imaging [dissertation]. Dissertations in
Health Sciences (Publications of the University of Eastern
Finland) 2010; Vol. 33:1–77. ISBN: 978–952–61–0236–8
(pdf); ISSN:1798–5714 (pdf); NCT00379314; srincont
60054]
Rinne K, Aukee P, Heikkinen AM, Kalliola T, Kiilholma P,
Kivela A, et al. A randomized clinical trial comparing TVT
with TVT-O for treatment of stress urinary incontinence:
12 months results (Abstract number 48). International
Urogynecology Journal and Pelvic Floor Dysfunction 2007;18
(Suppl 1):S28–9. srincont27323]
Rinne K, Laurikainen E, Kivela A, Aukee P, Takala T, Valpas
A, et al. A randomized trial comparing TVT with TVT-
O: 12-month results. International Urogynecology Journal
2008;19(8):1049–54. NCT000379314; srincont31311]
Leanza 2009 {published data only}
∗ Leanza V, Dati S, Gasbarro N. A multicenter randomized
trial of prepubic and retropubic Leanza-Gasbarro-
Caschetto tension-free procedures (Abstract number 001).
International Urogynaecology Journal 2009;20(Suppl 2):S73.
srincont39881]
Leanza V, Dati S, Gasbarro N, Leanza G. Retropubic versus
transobturator tension free procedures: a comparative study
(Abstract number 7). Neurourology and Urodynamics 2011;
30(S1):6–7. [DOI: 10.1002/nau.21134; sr–incont50306
Lee 2007 {published data only}
∗ Lee KS, Han DH, Choi YS, Yum SH, Song SH, Doo CK,
et al. A prospective trial comparing tension-free vaginal
tape and transobturator vaginal tape inside-out for the
surgical treatment of female stress urinary incontinence:
1-year follow up. Journal of Urology 2007;177(1):214–8.
sr–incont28039]
Ryu KH, Shin JS, Du JK, Choo MS, Lee KS. Randomized
trial of tension-free vaginal tape (TVT) vs. tension-free
vaginal tape obturator (TVT-O) in the surgical treatment
of stress urinary incontinence: comparison of operation
related morbidity (Abstract number 50). European Urology
Supplements 2005;4(3):15. srincont26610]
Lee 2008 {published data only}
Lee K-S, Choo M-S, Lee YS, Han J-Y, Kim J-Y, Jung
BJ, et al. Prospective comparison of the ‘inside-out’ and
‘outside-in’ transobturator tape procedures for the treatment
of female stress urinary incontinence. International
Urogynecology Journal Including Pelvic Floor Dysfunction
2008;19(4):577–82. sr–incont34482]
53Mid-urethral sling operations for stress urinary incontinence in women (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Liapis 2006 {published data only}
Liapis A, Bakas P, Giner M, Creatsas G. Tension-free vaginal
tape versus tension-free vaginal tape obturator in women
with stress urinary incontinence. Gynecologic and Obstetric
Investigation 2006;62(3):160–4. srincont22245]
Liapis 2008 {published data only}
Liapis A, Bakas P, Creatsas G. Monarc vs TVT-O for the
treatment of primary stress incontinence: a randomised
study. International Urogynecology Journal 2008;19:185–90.
sr–incont26461]
Lim 2005 {published data only}
Balakrishnan S, Lim YK, Barry C, Corstiaans A, Kannan
K, Rane A. Sling distress: a subanalysis of the IVS tapes
from the SUSPEND trial. Australian & New Zealand
Journal of Obstetrics & Gynaecology 2007;47(6):496–8.
sr–incont26475]
∗ Lim YN, Muller R, Corstiaans A, Dietz HP, Barry C,
Rane A. Suburethral slingplasty evaluation study in North
Queensland, Australia: the SUSPEND trial. Australian &
New Zealand Journal of Obstetrics & Gynaecology 2005;45
(1):52–9. srincont20403]
Lim YN, Rane A, Barry C, Corstiaans A, Dietz HP, Muller
R. The suburethral slingplasty evaluation study in North
Queensland (SUSPEND): a randomized controlled trial
(Abstract). Neurourology and Urodynamics 2004;23(5/6):
495–6. srincont19012]
Lord 2006 {published data only}
Lord HE, Taylor JD, Finn JC, Tsokos N, Jeffery JT,
Atherton MJ, et al. A randomized controlled equivalence
trial of short-term complications and efficacy of tension-
free vaginal tape and suprapubic urethral support sling for
treating stress incontinence. BJU International 2006;98(2):
367–76. srincont22369]
Mansoor 2003 {published data only}
Mansoor A, Vedrine N, Darcq C. Surgery of female
urinary incontinence using transobturator tape (TOT):
a prospective randomised comparative study with TVT
(Abstract). Neurourology and Urodynamics 2003;22(5):
488–9. sr–incont17107]
Mehdiyev 2010 {published data only}
Mehdiyev M, Itil IM, Sendag F, Akdemir A, Askar N.
Comparing the transvaginal tape (TVT) and transobturator
tape (TOT) in stress urinary incontinance for their efficiency
and their effects on quality of life. Turk Jinekoloji ve Obstetrik
Dernegi Dergisi 2010;7(2):117–24. srincont62297]
Meschia 2006 {published data only}
Meschia M, Pifarotti P, Bernasconi F, Magatti F, Vigano
R. Multicenter randomized trial of TVT and IVS for
the treatment of stress urinary incontinence in women
(Abstract). Proceedings of the 33rd Annual Meeting
International Continence Society (ICS), 2003 Oct 5-9,
Florence. 2003:318–9. sr–incont16339]
∗ Meschia M, Pifarotti P, Bernasconi F, Magatti F, Vigano
R, Bertozzi R, et al. Tension-free vaginal tape (TVT)
and intravaginal slingplasty (IVS) for stress urinary
incontinence: a multicenter randomized trial. American
Journal of Obstetrics and Gynecology 2006;195(5):1338–42.
sr–incont22268]
Pifarotti P, Meschia M, Gattei U, Bernasconi F, Magatti
F, Vigano R. Multicenter randomized trial of tension-free
vaginal tape (TVT) and intravaginal slingplasty (IVS) for
the treatment of stress urinary incontinence in women
(Abstract). Neurourology and Urodynamics 2004;23(5/6):
494–5. sr–incont19011]
Meschia 2007 {published data only}
∗ Meschia M, Bertozzi R, Pifarotti P, Baccichet R,
Bernasconi F, Guercio E, et al. Peri-operative morbidity
and early results of a randomised trial comparing TVT and
TVT-O. International Urogynecology Journal 2007;18(11):
1257–61. srincont23958]
Meschia M, Pifarotti P, Baccichet R, Bernasconi F, Cortese
P, Magatti F, et al. A multicenter randomized comparison
of tension-free vaginal tape (TVT) and trans-obturator
in-out technique (TVT-O) for the treatment of stress
urinary incontinence: one year results (Abstract number
3). International Urogynecology Journal and Pelvic Floor
Dysfunction 2007;18(Suppl 1):S2. srincont27318]
Meschia M, Pifarotti P, Bernasconi F, Baccichet R, Magatti
F, Cortese P, et al. A multicentre randomised comparison
of tension free vaginal tape (TVT) and transobturator
in-out technique (TVT-O) for the treatment of stress
urinary incontinence (Abstract number 059). International
Urogynecology Journal 2006;17(Suppl 2):S92–S93.
sr–incont49147]
Minassian VA, Parekh M, Langroudi MH. Comment on
Meschia et al: peri-operative morbidity and early results of a
randomised trial comparing TVT and TVT-O [comment].
International Urogynecology Journal 2008;19(12):1725.
srincont31222]
Naumann 2006 {published data only}
∗ Naumann G, Lobodasch K, Bettin S, Meyer P, Koelbl
H. Tension free vaginal tape (TVT) vs less invasive
free tape (LIFT) - a randomized multicentric study
of suburethral sling surgery (Abstract number 062).
International Urogynecology Journal 2006;17(Suppl 2):
S94–5. sr–incont49145]
Naumann G, Lobodasch K, Bettin S, Meyer P, Koelbl H.
Tension free vaginal tape (TVTTM ) vs less invasive free tape
(LIFTTM ) - a randomized multicentre study of suburethral
sling surgery (Abstract number 481). Proceedings of the
36th Annual Meeting of the International Continence
Society (ICS), 2006 Nov 27-Dec 1, Christchurch, New
Zealand. 2006. sr–incont23752]
Nerli 2009 {published data only}
Nerli RB, Kumar AG, Koura A, Prabha V, Alur SB.
Transobturator vaginal tape in comparison to tension-free
vaginal tape: a prospective trial with a minimum 12 months
follow-up. Indian Journal of Urology 2009;25(3):321–5.
srincont40242]
Nyyssonen 2014 {published data only}
Nyyssonen V, Talvensaari-Mattila A, Santala M. A
prospective randomized trial comparing tension-free
vaginal tape versus transobturator tape in patients with
54Mid-urethral sling operations for stress urinary incontinence in women (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
stress or mixed urinary incontinence: subjective cure
rate and satisfaction in median follow-up of 46 months.
Scandinavian Journal of Urology 2014;48(3):309–15.
sr–incont62072; PUBMED: 24286482]
Okulu 2013 {published data only}
Okulu E. Synthetic mesh materials in sling surgery.
www.ClinicalTrials.gov (accessed 19 December 2011) 2011.
NCT01348334; srincont42756]
∗ Okulu E, Kayigil O, Aldemir M, Onen E. Use of
three types of synthetic mesh material in sling surgery: a
prospective randomized clinical trial evaluating effectiveness
and complications. Scandinavian Journal of Urology 2013;
47(3):217–24. sr–incont48505; PUBMED: 23095128]
Oliveira 2006 {published data only}
Oliveira L, Sartori M, Castro R, Fonseca E, Rodrigues A,
Girao M. A prospective randomized study to compare TVT,
TVT-O and pre-pubic TVT for the treatment of women
with stress urinary incontinence, with or without intrinsic
sphincter deficiency (Abstract number 208). International
Urogynecology Journal 2008; Vol. 19, issue Suppl 2:
S173–4. srincont31051]
Oliveira LM, Girao MJBC, Sartori MGF, Castro RA,
Fonseca ESM. Comparison of retro-pubic TVT, pre-pubic
TVT and TVT transobturator in surgical treatment of
women with stress urinary incontinence (Abstract number
203). International Urogynecology Journal 2005;16(Suppl
2):S80. srincont27307]
∗ Oliveira LM, Girao MJBC, Sartori MGF, Castro RA,
Fonseca ESM, Prior EL. Comparison of retro pubic
TVT, pre pubic TVT and TVT transobturator in surgical
treatment of women with stress urinary incontinence
(Abstract number 354). International Urogynecology Journal
2006;17(Suppl 2):S253. srincont27309]
de Oliveira LM, Girao MJBC, Sartori MGF, Castro RA,
Fonseca ESM. Comparison of retro-pubic TVT, pre-pubic
TVT and TVT transobturator in surgical treatment of
women with stress urinary incontinence (Abstract number
328). International Urogynecology Journal 2007;18(Suppl
1):S180. srincont27310]
Palomba 2008 {published data only}
Palomba S, Zullo F. A Comparison in Terms of Efficacy
and Safety Between Transobturator and Transvaginal Tape
Performed at the Same Time of Anterior Defect Correction
With Mesh. http://clinicaltrials.gov/show/NCT00743535
2008. NCT00743535; srincont49348]
Paparella 2010 {published data only}
∗ Paparella R, Marturano M, Pelino L, Scarpa A, Scambia G,
La Torre G, et al. Prospective randomized trial comparing
synthetic vs biological out-in transobturator tape: a mean
3-year follow-up study. International Urogynecology Journal
2010;21(11):1327–36. srincont40360]
Riva D, Baccichet R, Paparella L, Cianci A, Simonazzi M,
Pisapia Cioffi G. Synthetic versus biological trans-obturator
sling for stress urinary incontinence: a randomized study
(Abstract number 1). International Urogynecology Journal
2008; Vol. 19, issue Suppl 2:S1. srincont31054]
Park 2012 {published data only}
Kim D, Jang HC. Randomized control study of Monarc
(trademark) vs. tension-free vaginal tape obturator
(TVT-O) (trademark) in the treatment of female urinary
incontinence in: comparison of medium term cure rate
(Abstract number: 219). Neurourology and Urodynamics
2010;29(6):1123–4. srincont40160]
∗ Park YJ, Kim DY. Randomized controlled study of
MONARC [Registered trademark] vs. tension-free vaginal
tape obturator (TVT-O [Registered trademark]) in the
treatment of female urinary incontinence: comparison of
3-year cure rates. Korean Journal of Urology 2012;53(4):
258–62. srincont44720]
Peattie 2006 {published data only}
Peattie A. Randomised controlled trial of transvaginal
tension-free vaginal tape-obturator (TVT-O) versus
Monarc in treatment of urodynamic stress incontinence.
ISRCTN (http://isrctn.org/ISRCTN71562338) 2006.
ISRCTN71562338; sr–incont62312]
Porena 2007 {published data only}
Costantini E, Kocjancic E, Saccomanni M, Giannantoni
A, Porena M, Frea B. Tension free vaginal tape vs trans
obturator tape as surgery for stress urinary incontinence:
results of a multicenter randomised trial (Abstract number
54). Neurourology and Urodynamics 2006;25(6):573–5.
sr–incont23753]
Costantini E, Lazzeri M, Giannantoni A, Bini V, Kocjancic
E, Porena M, et al. Retropubic versus transobturator mid-
urethral slings: in a randomised controlled trial preoperative
VLPP may not predict mid-term outcome (Abstract number
112). Neurourology and Urodynamics 2007;26(5):741–2.
sr–incont23757]
Costantini E, Lazzeri M, Giannantoni A, Bini V, Vianello A,
Kocjancic E, et al. Preoperative Valsava leak point pressure
may not predict outcome of mid-urethral slings. Analysis
from a randomized controlled trial of retropubic versus
transobturator mid-urethral slings. International Braz J Urol
2008;34(1):73-81; discussion 81-3. srincont27817]
Costantini E, Lazzeri M, Kocjancic E, Di Biase M, Salvini
E, Porena M. Prolonged follow-up shows continence
deterioration after trans-obturator tape: results from a
randomised controlled study. Neurourology and Urodynamics
2013;32(6):525–6. sr–incont49187]
Costantini E, Lazzeri M, Zucchi A, Bruno R, Salvini E,
Pietropaolo A, et al. Deterioration of continence after TOT
when the follow-up is extended: results from a randomised
controlled study (Abstract number 729). European Urology
Supplements 2013;12(1):e729. sr–incont62144]
Costantini E, Lazzeri M, Zucchi A, Di Biase M, Porena M.
Long-term efficacy of the transobturator and retropubic
midurethral slings for stress urinary incontinence: single-
center update from a randomized controlled trial. European
Urology 2014;66(3):599–603. sr–incont64001; PUBMED:
24768493]
Kocjancic E, Constantini E, Crivellaro S, Tosco L, Grossetti
B, Frea B, et al. Mixed incontinence: the best solution
for a difficult task (Abstract number 485). Proceedings of
55Mid-urethral sling operations for stress urinary incontinence in women (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
the 38th Annual Meeting of the International Continence
Society (ICS), 2008 Oct 20-24, Cairo, Egypt 2008.
srincont31875]
Kocjancic E, Costantini E, Giannantoni A, Crivellaro
S, Mearini L, Frea B, et al. Tension free vaginal tape
(TVT) and trans obturator suburethral tape (TOT) a
prospective randomized study (Poster abstract number
1462). Proceedings of the American Urological Association
(AUA) Annual Meeting, 2007 May 19-24, Anaheim, CA.
2007. sr–incont23765]
∗ Porena M, Costantini E, Frea B, Giannantoni A,
Ranzoni S, Mearini L, et al. Tension-free vaginal tape
versus transobturator tape as surgery for stress urinary
incontinence: results of a multicentre randomised trial.
European Urology 2007;52(5):1481–91. srincont23832]
Porena M, Kocjancic E, Costantini E, Cecchetti G, Bini
V, Crivellaro S, et al. Tension free vaginal tape vs trans
obturator tape as surgery for stress urinary incontinence:
results of a multicenter randomised trial (Abstract).
Neurourology and Urodynamics 2005;24(5/6):416–8.
sr–incont20982]
Rechberger 2003 {published data only}
Rechberger T, Rzezniczuk K, Skorupski P, Adamiak A,
Tomaszewski J, Baranowski W, et al. A randomized
comparison between monofilament and multifilament tapes
for stress incontinence surgery. International Urogynecology
Journal 2003;14(6):432–6. sr–incont16673]
Rechberger 2009 {published data only}
Rechberger T, Adamiak A, Jankiewicz K, Futyma K,
Skorupski P. The comparison of clinical effectiveness of
retropubic (IVS 02) and transobturator (IVS04) midurethral
slings (Abstract number 076). International Urogynecology
Journal 2006;17(Suppl 2):S104. sr–incont49148]
Rechberger T, Futyma K, Jankiewicz K, Adamiak A,
Bogusiewicz M, Skorupski P. Body mass index does not
influence the outcome of anti-incontinence surgery among
women whereas menopausal status and ageing do: a
randomised trial. International Urogynecology Journal 2010;
21(7):801–6. srincont40095]
∗ Rechberger T, Futyma K, Jankiewicz K, Adamiak A,
Skorupski P. The clinical effectiveness of retropubic
(IVS-02) and transobturator (IVS-04) midurethral slings:
randomized trial. European Urology 2009; Vol. 56, issue 1:
24–30. srincont35437]
Rechberger T, Jankiewicz K, Futyma K, Adamiak A,
Skorupski P. Clinical effectiveness of retropubic (IVS-02)
and transobturator (IVS-04) slings in the treatment of
female stress urinary incontinence - a semi-randomized trial
on 398 patients (Abstract number 515). Proceedings of
the 38th Annual Meeting of the International Continence
Society (ICS), 2008 Oct 20-24, Cairo, Egypt 2008.
srincont31877]
Rechberger T, Jankiewicz K, Skorupski P, Adamiak A,
Futyma K, Gogacz M, et al. Transobturator vs retropubic
vaginal tape for female stress urinary incontinence: one
year follow-up in 296 patients (Abstract number 288).
Proceedings of the 37th AnnualMeeting of the International
Continence Society (ICS), 2007 Aug 20-24, Rotterdam,
The Netherlands. 2007. sr–incont23763]
Rechberger 2011 {published data only}
Rechberger T, Futyma K, Jankiewicz K, Adamiak A,
Bogusiewicz M, Bartuzi A, et al. Tape fixation: an
important surgical step to improve success rate of anti-
incontinence surgery. Journal of Urology 2011;186(1):
180–4. srincont41735]
Richter 2010 {published data only}
Brubaker L, Norton PA, Albo ME, Chai TC, Dandreo
KJ, Lloyd KL, et al. Adverse events over two years after
retropubic or transobturator midurethral sling surgery:
findings from the Trial of Midurethral Slings (TOMUS)
study. American Journal of Obstetrics and Gynecology
2011;205(5):498.e1–6. NCT00325039; TOMUS;
srincont43397]
Brubaker L, Rickey L, Stoddard A, Lemack G, Xu Y, Ghetti
C, et al. Symptoms of combined prolapse and urinary
incontinence in large surgical cohorts (Abstract 020).
International Urogynaecology Journal 2009;20(Suppl 2):
S96–7. NCT00064662; srincont39882]
Chai TC, Huang L, Kenton K, Richter HE, Baker J, Kraus
S, et al. Association of baseline urodynamic measures of
urethral function with clinical, demographic, and other
urodynamic variables in women prior to undergoing
midurethral sling surgery. Neurourology and Urodynamics
2012;31(4):496–501. NCT00325039; TOMUS;
srincont49292]
Chai TC, Kenton K, Xu Y, Sirls L, Zyczynski H, Wilson TS,
et al. Effects of concomitant surgeries during midurethral
slings (MUS) on postoperative complications, voiding
dysfunction, continence outcomes, and urodynamic
variables. Urology 2012;79(6):1256–61. NCT00325039;
srincont44637]
Gormley A. TOMUS-Trial Of Mid-Urethral Slings [results
posted online] (Trials registry number: NCT00325039).
ClinicalTrials.gov (http://clinicaltrials.gov/show/
NCT00325039) 2006. NCT00325039; TOMUS;
srincont49293]
Kenton K, Stoddard A, Zyczynski H, Rickey L, Wai C,
Albo M, et al. 5-year outcomes after retropubic and
transobturator midurethral sling (Abstract number PII-
03). Journal of Urology 2014;191(4 Suppl 1):e493.
sr–incont62138]
Kenton K, Stoddard AM, Zyczynski H, Albo M, Rickey
L, Norton P, et al. 5-year longitudinal followup after
retropubic and transobturator mid urethral slings. The
Journal of Urology 2014;193:203–10. sr–incont64661;
PUBMED: 25158274]
Kraus S, Lemack G, Chai T, Leng W, Albo M, Mueller
E, et al. Urodynamic changes 12 months after retropubic
and transobturator midurethral slings (Abstract number
13). Neurourology and Urodynamics 2011;30(6):819–20.
NCT00325039; TOMUS; sr–incont42167]
Kraus S, Lemack G, Chai T, Leng W, Albo M, Mueller
E, et al. Urodynamic changes 12 months after retropubic
and transobturator midurethral slings (Abstract: Podium
56Mid-urethral sling operations for stress urinary incontinence in women (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
number 14). Neurourology and Urodynamics 2011;30(2):
210. NCT00325039; TOMUS; srincont41349]
Lemack GE, Litman HJ, Nager C, Brubaker L, Lowder J,
Norton P, et al. Preoperative clinical, demographic, and
urodynamic measures associated with failure to demonstrate
urodynamic stress incontinence in women enrolled in
two randomized clinical trials of surgery for stress urinary
incontinence. International Urogynecology Journal 2013;24
(2):269–74. NCT00064662; NCT00325039; SISTEr;
TOMUS; srincont47045]
Norton PA, Nager CW, Chai TC, Mueller E, Stoddard
A, Lowder J, et al. Risk factors for incomplete bladder
emptying after midurethral sling. Urology 2013;82(5):
1038–41. NCT00325039; srincont50470]
Nygaard I, Brubaker L, Chai TC, Markland AD, Menefee
SA, Sirls L, et al. Risk factors for urinary tract infection
following incontinence surgery. International Urogynecology
Journal 2011;22(10):1255–65. NCT00064662;
NCT00325039; SISTEr; TOMUS; srincont42698]
∗ Richter HE, Albo ME, Zyczynski HM, Kenton
K, Norton PA, Sirls LT, et al. Retropubic versus
transobturator midurethral slings for stress incontinence.
New England Journal of Medicine 2010;362(22):2066–76.
NCT00325039; TOMUS; srincont39867]
Richter HE, Litman HJ, Lukacz ES, Sirls LT, Rickey L,
Norton P, et al. Demographic and clinical predictors
of treatment failure one year after midurethral sling
surgery. Obstetrics and Gynecology 2011;117(4):913–21.
NCT00325039; TOMUS; srincont41490]
Rickey LM, Huang L, Rahn DD, Hsu Y, Litman HJ,
Mueller ER. Risk factors for urgency incontinence in
women undergoing stress urinary incontinence surgery.
Advances in Urology 2013;2013:567375. NCT00064662;
NCT00325039; srincont50474]
Sirls LT, Tennstedt S, Albo M, Chai T, Kenton K, Huang
L, et al. Factors associated with quality of life in women
undergoing surgery for stress urinary incontinence.
Journal of Urology 2010;184(6):2411–5. NCT00325039;
srincont49291]
Sirls LT, Tennstedt S, Lukacz E, Rickey L, Kraus SR,
Markland AD, et al. Condition-specific quality of life 24
months after retropubic and transobturator sling surgery
for stress urinary incontinence. Female Pelvic Medicine &
Reconstructive Surgery 2012;18(5):291–5. NCT00325039;
srincont45799]
Urinary Incontinence Treatment Network (UITN).
The trial of mid-urethral slings (TOMUS): design and
methodology. Journal of Applied Research 2008;8(1):1–13.
NCT00325039; srincont27938]
Wai CY, Curto TM, Zyczynski HM, Stoddard AM, Burgio
KL, Brubaker L, et al. Patient satisfaction after midurethral
sling surgery for stress urinary incontinence. Obstetrics
and Gynecology 2013;121(5):1009–16. NCT00325039;
srincont49289]
Zyczynski HM, Brubaker L. Sexual activity and function
in women for two years after midurethral slings (Abstract
number 176). European Urology Supplements 2012;11(1):
e176. sr–incont62250]
Zyczynski HM, Rickey L, Dyer KY, Wilson T, Stoddard
AM, Gormley EA, et al. Sexual activity and function in
women more than 2 years after midurethral sling placement.
American Journal of Obstetrics and Gynecology 2012;207(5):
421–6. NCT00325039; TOMUS; srincont45909]
Riva 2006 {published data only}
Riva D, Sacca V, Tonta A, Casolati E, Luerti M, Banfi G, et
al. TVT versus TOT a randomised study at 1 year follow up
(Abstract number 060). International Urogynecology Journal
2006;17(Suppl 2):S93. sr–incont49150]
Salem 2014 {published data only}
Salem H, Mostafa M, Diab DE, Abdulla A, Nageeb M,
Hashem SA. A prospective randomized study comparing
the safety and efficacy of transobturator tape (TOT) versus
tension free vaginal tape (TVT) in treatment of female stress
urinary incontinence (Abstract number MP33-13). Journal
of Urology 2014;191(4 Suppl 1):e342–3. srincont62143]
Scheiner 2012 {published data only}
Scheiner D, Betschart C, Kollbrunner S, Werder H, Fink
D, Perucchini D. Retropubic or transobturator out-in or
in-out sling? A prospective randomized study! (Abstract
number 484). Proceedings of the 38th Annual Meeting of
the International Continence Society (ICS), 2008 Oct 20-
24, Cairo, Egypt 2008. NCT00642109; srincont31874]
Scheiner D, Betschart C, Werder H, Fink D, Perucchini D.
Retropubic TVT vs transobturator outside-in TOT and
inside-out TVT-O one-year results from our prospective
randomized study (Abstract number 4). Neurourology
and Urodynamics 2009;28(7):585–6. NCT00642109;
srincont34588]
∗ Scheiner DA, Betschart C, Wiederkehr S, Seifert
B, Fink D, Perucchini D. Twelve months effect on
voiding function of retropubic compared with outside-
in and inside-out transobturator midurethral slings.
International Urogynecology Journal 2012;23(2):197–206.
srincont44532]
Schierlitz 2008 {published data only}
De Souza A, Dwyer PL, Rosamilia A, Hiscock R, Lim YN,
Murray C, et al. Sexual function following retropubic TVT
and transobturator Monarc sling in women with intrinsic
sphincter deficiency: a multicentre prospective study.
International Urogynecology Journal 2012;23(2):153–8.
srincont44534]
De Souza A, Schierlitz L, Rosamilia A, Dwyer P, Murray C,
Thomas E, et al. Sexual function following retropubic TVT
and transobturator Monarc sling in women with intrinsic
sphincter deficiency (Abstract). Australian and New Zealand
Continence Journal 2008;14(4):104. srincont29144]
Murray C, Schierlitz L, Dwyer PL, Rosamilia A, Hiscock
R, De Souza A, et al. Overactive bladder (OAB) symptoms
following retropubic TVT andMonarc TOT in women with
intrinsic sphincter deficiency (ISD) and stress incontinence
(Abstract). Australian and New Zealand Continence Journal
2008;14(4):102. srincont29145]
Plotti F, Calcagno M, Sansone M, Panici PB. Effectiveness
of tension-free vaginal tape compared with transobturator
57Mid-urethral sling operations for stress urinary incontinence in women (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
tape in women with stress urinary incontinence and
intrinsic sphincter deficiency: a randomized controlled trial
[comment] [letter]. Obstetrics and Gynecology 2009;113(6):
1368; author reply 1368-9. srincont31355]
Schierlitz L, Dwyer P, Rosamilia A, Murray C, Thomas
E, Fitzgerald E, et al. A randomized controlled study to
compare tension free vaginal tape (TVT) and Monarc
trans-obturator tape in the treatment of women with
urodynamic stress incontinence (USI) and intrinsic
sphincter deficiency (ISD): the three year follow up
(Abstract number 1). Neurourology and Urodynamics 2010;
29(6):805–6. srincont40112]
Schierlitz L, Dwyer PL, Rosamilia A, Hiscock R, De
Souza A, Lim YN, et al. A randomised controlled study
to compare tension-free vaginal tape (TVT) and Monarc
(trademark) transobturator tape in the treatment of women
with urodynamic stress incontinence (USI) and intrinsic
sphincter deficiency (ISD): the three-year follow-up
(Abstract). Australian and New Zealand Continence Journal
2010;16(4):120–2. srincont40800]
∗ Schierlitz L, Dwyer PL, Rosamilia A,Murray C, Thomas E,
De Souza A, et al. Effectiveness of tension-free vaginal tape
compared with transobturator tape in women with stress
urinary incontinence and intrinsic sphincter deficiency:
a randomized controlled trial. Obstetrics and Gynecology
2008;112(6):1253–61. ACTRN12608000093381;
srincont28699]
Schierlitz L, Dwyer PL, Rosamilia A, Murray C, Thomas
E, De Souza A, et al. Three-year follow-up of tension-free
vaginal tape compared with transobturator tape in women
with stress urinary incontinence and intrinsic sphincter
deficiency. Obstetrics and Gynecology 2012;119(2 Pt 1):
321–7. ACTRN12608000093381; srincont43343]
Schierlitz LHE, Dwyer PL, Rosamilia A, Murray C, Thomas
E, Taylor N, et al. A randomized controlled study to
compare tension free vaginal tape (TVT) and Monarc trans-
obturator tape in the treatment of women with urodynamic
stress incontinence (USI) and intrinsic sphincter deficiency
(ISD) (Abstract number 32). International Urogynecology
Journal and Pelvic Floor Dysfunction 2007;18(Suppl 1):S19.
srincont27321]
Tanuri 2010 {published data only}
Tanuri AL, Feldner PC Jr, Bella ZI, Castro RA, Sartori
MG, Girao MJ. [Retropubic and transobturator sling in
treatment of stress urinary incontinence.] [Portuguese].
Revista Da Associacao Medica Brasileira 2010;56(3):348–54.
srincont40054]
Tarcan 2011 {published data only}
∗ Tarcan T, Mangir N, Tanidir Y, Top T, IIker Y.
A randomised study comparing transvaginal and
transobturator mid-urethral sling surgeries in women
with stress urinary incontinence (Abstract number 845).
Proceedings of the 41st Annual Meeting of the International
Continence Society (ICS), 2011 Aug 29-Sept 2, Glasgow,
Scotland 2011. srincont42237]
Tarcan T, Sahan A, Sulukaya M, Mangir N, Ilker Y. 2-
year results of a randomized study comparing retropubic
and transobturator mid-urethral slings in the treatment of
urodynamic female stress urinary incontinence (Abstract
number 448). Proceedings of the 43rd Annual Meeting of
the International Continence Society (ICS), 2013 Aug 26-
30, Barcelona, Spain. 2013. srincont60034]
Teo 2011 {published data only}
Mayne C. Randomised trial of tension-free vaginal tape
and transobturator tape as treatment for urinary stress
incontinence in women. ISRCTN (http://isrctn.org/
ISRCTN34377436) 2004. sr–incont62313]
Teo R, Moran P, Mayne C, Tincello D. Randomised trial of
TVT and TVT-O for the treatment of urodynamic stress
incontinence in women (Abstract number 2). Neurourology
and Urodynamics 2008;27(7):572–3. srincont31848]
Teo R, Moran P, Mayne C, Tincello D. Randomised trial
of tension-free vaginal tape and transobturator tape for the
treatment of urodynamic stress incontinence in women
(Abstract number 283). Proceedings of the 37th Annual
Meeting of the International Continence Society (ICS),
2007 Aug 20-24, Rotterdam, The Netherlands. 2007.
srincont23761]
∗ Teo R, Moran P, Mayne C, Tincello D. Randomized trial
of tension-free vaginal tape and tension-free vaginal tape-
obturator for urodynamic stress incontinence in women.
Journal of Urology 2011;185(4):1350–5. srincont41497]
Tommaselli 2012 {published data only}
Tommaselli GA, D’Afiero A, Di CC, Formisano C, Fabozzi
A, Nappi C. Efficacy of a modified technique for TVT-
O positioning: a 12 month, randomized, single-blind,
multicentre, non inferiority study. European Journal of
Obstetrics, Gynecology, and Reproductive Biology 2013;167
(2):225–9. sr–incont47602]
Tommaselli GA, D’Afiero A, Di Carlo C, Formisano C,
Fabozzi A, Nappi C. Effect of a modified surgical technique
for the positioning of TVT-O on post-operative pain
(Abstract number 110). International Urogynecology Journal
and Pelvic Floor Dysfunction 2011;22(Suppl 1):S110.
sr–incont62263]
∗ Tommaselli GA, Formisano C, Di Carlo C, Fabozzi A,
Nappi C. Effects of a modified technique for TVT-O
positioning on postoperative pain: single-blind randomized
study. International Urogynecology Journal 2012;23(9):
1293–9. srincont45107]
Tseng 2005 {published data only}
Tseng LH, Wang AC, Lin YH, Li SJ, Ko YJ. Randomized
comparison of the suprapubic arc sling procedure vs
tension-free vaginal taping for stress incontinent women.
International Urogynecology Journal 2005;16(3):230–5.
srincont20354]
Ugurlucan 2013 {published data only}
Ugurlucan FG, Erkan HA, Onal M, Yalcin O. Randomized
trial of graft materials in transobturator tape operation:
biological versus synthetic. International Urogynecology
Journal 2013;24(8):1315–23. sr–incont48489; PUBMED:
23184140]
58Mid-urethral sling operations for stress urinary incontinence in women (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
van Leijsen 2013 {published data only}
Mengerink BB. The impact of midurethral sling operation
on sexual function in women with stress urinary
incontinence, a multicenter prospective study (Abstract
number 193). International Urogynecology Journal and Pelvic
Floor Dysfunction 2013;24(1 Suppl):S147. sr–incont62175]
∗ van Leijsen SA, Kluivers KB, Mol BW, Hout Ji, Milani
AL, Roovers JP, et al. Value of urodynamics before stress
urinary incontinence surgery: a randomized controlled
trial. Obstetrics and Gynecology 2013;121(5):999–1008.
sr–incont47434; PUBMED: 23635736]
van Leijsen SA, Kluivers KB, Mol BWJ, Broekhuis SR,
Milani FL, Vaart CHvan D, et al. Protocol for the value of
urodynamics prior to stress incontinence surgery (VUSIS)
study: a multicenter randomized controlled trial to assess
the cost effectiveness of urodynamics in women with
symptoms of stress urinary incontinence in whom surgical
treatment is considered. BMC Women’s Health 2009;9:22.
sr–incont32078; PUBMED: 19622153]
Wang 2006 {published data only}
Wang AC, Lin YH, Tseng LH, Chih SY, Lee CJ. Prospective
randomized comparison of transobturator suburethral
sling (Monarc) vs suprapubic arc (Sparc) sling procedures
for female urodynamic stress incontinence. International
Urogynecology Journal 2006;17(5):439–43. srincont22217]
Wang 2008 {published data only}
Wang WY, Zhu L, Lang JH, Sun ZJ, Hai N. [Clinical study
on tension-free vaginal tape and tension-free vaginal tape
obturator for surgical treatment of severe stress urinary
incontinence] [Chinese]. Chung-Hua Fu Chan Ko Tsa Chih
[Chinese Journal of Obstetrics & Gynecology] 2008;43(3):
180–4. srincont27746]
Wang 2009 {published data only}
∗ Wang W, Zhu L, Lang J. Transobturator tape procedure
versus tension-free vaginal tape for treatment of stress
urinary incontinence. International Journal of Gynaecology
and Obstetrics 2009;104(2):113–6. srincont29200]
Wang WY, Zhu L, Lang JH, Li B. [A prospective
randomized trial of comparing the clinical outcome of
tension-free vaginal tape and transobturator tape for stress
urinary incontinence] [Chinese]. Chung-Hua i Hsueh Tsa
Chih [Chinese Medical Journal] 2011;91(13):898–901.
srincont41799]
Zhu I, Lang J. A prospective randomised trial comparing
tension free vaginal tape and transobturator suburethral
tape for surgical treatment of slight and moderate
stress urinary incontinence (Abstract number 461).
International Urogynecology Journal 2006;17(Suppl 2):S307.
sr–incont49151]
Zhu I, Lang J, Chen R, Hai N, Wong F. Comparing TVT
and TVT-O sub urethral tape for treatment patients with
mild and moderate stress urinary incontinence (Abstract
number 364). International Urogynecology Journal and Pelvic
Floor Dysfunction 2007;18(Suppl 1):S198. srincont27325]
Zhu L, Lang J, Hai N, Wong F. Comparing vaginal tape and
transobturator tape for the treatment of mild and moderate
stress incontinence. International Journal of Gynaecology and
Obstetrics 2007;99(1):14–7. srincont23870]
Wang 2010 {published data only}
Wang F, Song Y, Huang H. Prospective randomized trial
of TVT and TOT as primary treatment for female stress
urinary incontinence with or without pelvic organ prolapse
in Southeast China. Archives of Gynecology and Obstetrics
2010; Vol. 281, issue 2:279–86. srincont35408]
Wang 2011 {published data only}
Wang YJ, Li FP, Wang Q, Yang S, Cai XG, Chen YH.
Comparison of three mid-urethral tension-free tapes
(TVT, TVT-O, and TVT-Secur) in the treatment of
female stress urinary incontinence: 1-year follow-up.
International Urogynecology Journal 2011;22(11):1369–74.
srincont42639]
Zhang 2011 {published data only}
Zhang Y, Jiang M, Tong XW, Fan BZ, Li HF, Chen XL.
The comparison of an inexpensive-modified transobturator
vaginal tape versus TVT-O procedure for the surgical
treatment of female stress urinary incontinence. Taiwanese
Journal of Obstetrics & Gynecology 2011;50(3):318–21.
srincont42665]
Zullo 2007 {published data only}
Angioli R, Plotti F, Muzii L, Montera R, Panici PB,
Zullo MA. Tension-free vaginal tape versus transobturator
suburethral tape: five-year follow-up results of a prospective,
randomised trial. European Urology 2010;58(5):671–7.
srincont41500]
∗ Zullo MA, Plotti F, Calcagno M, Marullo E, Palaia I,
Bellati F, et al. One-year follow-up of tension-free vaginal
tape (TVT) and trans-obturator suburethral tape from
inside to outside (TVT-O) for surgical treatment of female
stress urinary incontinence: a prospective randomised trial.
European Urology 2007;51(5):1376-82; discussion 1383-4.
srincont23246]
References to studies excluded from this review
Al-Tayyem 2007 {published data only}
Al-Tayyem A, Benness C, Korda A, Farnsworth B, Burton
G. TVT vs TVT-O: a study comparing early complications
(Abstract number 062). International Urogynecology Journal
2007;18(Suppl 1):S37. 27330]
Amat 2007 {published data only}
Amat LL, Martinez F, Hernandez S, Vela M. Needleless: a
new technique for the correction of urinary incontinence.
Randomised controlled trial compared with TVT-O.
Preliminary results (Abstract number 225). International
Urogynecology Journal 2007;18(Suppl 1):S128.
Ballert 2010 {published data only}
Ballert KN, Rose AE, Biggs GY, Rosenblum N, Nitti VW.
Outcomes of patients lost to followup after mid urethral
synthetic slings--successes or failures?. The Journal of
Urology 2010;183(4):1455–8. PUBMED: 20171698]
Bekker 2009 {published data only}
Bekker M, Beck J, Putter H, Venema P, Nijeholt A, Pelger
R, et al. Sexual function improvement following surgery for
59Mid-urethral sling operations for stress urinary incontinence in women (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
stress incontinence: the relevance of coital incontinence.
Journal of Sexual Medicine 2009;6(11):3208–13.
Borrell 2005 {published data only}
Borrell PA, Chicote FP, Beltran MJF, Queipo ZJA, Esteve
Claramunt J, Pastor Sempere F. Comparison of different
suburethral slings for the treatment of stress urinary
incontinence. Actas Urologicas Espa olas 2005;29:757–63.
Bracken 2012 {published data only}
∗ Bracken JN, Huffaker RK, Yandell PM, Handcock T,
Higgins EW, Kuehl TJ, et al. A randomized comparison
of bupivacaine versus saline during placement of tension-
free vaginal tape. Female Pelvic Medicine & Reconstructive
Surgery 2012;18(2):93–6. PUBMED: 22453319]
Huffaker RK, Bracken JN, Yandell PM, Handcock T,
Higgins EW, Kuehl TJ, et al. A randomised, double-blind
comparison of bupivacaine containing saline with saline
only hydrodissection on voiding function and pain control
in the postoperative interval following placement of tension-
free vaginal tape (Abstract number 854). Proceedings of
the 41st Annual Meeting of the International Continence
Society (ICS), 2011 Aug 29-Sept 2, Glasgow, Scotland.
2011. Sricont42239]
Bruschini 2005 {published data only}
Bruschini H, Nunes R, Truzzi JC, Simonetti R, Cury J,
Otiz V, et al. Low cost polypropylene sling procedure
for correction of stress urinary incontinence: a possible
solution for developing countries? (Abstract number 360).
Proceedings of the International Continence Society (ICS),
35th Annual Meeting, 2005 Aug 28-Sep 2, Montreal,
Canada. 2005. Srincont21055]
Chen 2008 {published data only}
Chen HY, Ho M, Hung YC, Huang LC. Analysis of risk
factors associated with vaginal erosion after synthetic sling
procedures for stress urinary incontinence. International
Urogynecology Journal 2008;19(1):117–21. srincont27217]
Chen 2011 {published data only}
Chen X, Jiang M, Tong X, Li H, Qiu J, Shao L, et
al. A modified inexpensive transobturator vaginal tape
inside-out procedure versus tension-free vaginal tape for
the treatment of SUI: a prospective comparative study.
Archives of Gynecology and Obstetrics 2011;284(6):1461–6.
srincont59743]
Chene 2009 {published data only}
Chene G, Tardieu A-S, Cotte B, Chauleur C, Savary D,
Krief M, et al. [Health-related quality of life in women
operated on by surgical anti-incontinence procedures:
comparison of three techniques]. Gynecologie Obstetrique
Fertilite 2009;36(1):3–10. srincont40235]
Chong 2003 {published data only}
Chong C, Bane A, Corstiaans A. Intraoperative division of
tensionless vaginal tape (TVT) - prospective randomized
trial (Abstract). Singapore Journal of Obstetrics & Gynaecology
2003;34(Suppl 1):55. 17187]
Corcos 2001 {published data only}
Corcos J, Collet JP, Shapiro S, Schick E, Macramallah
E, Tessier J, et al. Surgery vs collagen for the treatment
of female stress urinary incontinence (SUI): results of a
multicentric randomized trial (Abstract). Journal of Urology
2001;165(5 Suppl):198. 12912]
Corcos 2005 {published data only}
Corcos J, Collet JP, Shapiro S, Herschorn S, Radomski
SB, Schick E, et al. Multicenter randomized clinical trial
comparing surgery and collagen injections for treatment of
female stress urinary incontinence. Urology 2005;65(5):
898–904. 20346]
Cotte 2006 {published data only}
Cotte B, Dumousset E, Boda C, Mansoor A. Comparison
of transobturator tape (TO) and tension free vaginal tape
(TVT) using perineal ultrasound. Gynecologie, Obstetrique
& Fertilite 2006;34:298–303.
Courtney-Watson 2002 {published data only}
Courtney-Watson C. Comparison of two surgical methods
for curing stress incontinence (recurrent). Data on file
2002. 16382]
Debodinance 2006 {published data only}
Debodinance P. Transobturator urethral sling for surgical
correction of female urinary incontinence: outside-in
(Monarc) versus inside-out (TVT-O). Are both ways
safe?. Journal de Gynecologie Obstetrique et Biologie de la
Reproduction 2006;35(6):571–7.
Dietz 2005 {published data only}
Dietz HP, Barry C, Lim Y, Rane A. 2D and 3D ultrasound
imaging of suburethral slings: data from the ’suspend’
randomized controlled trial (Abstract number 674).
Proceedings of the International Continence Society (34th
Annual Meeting) and the International Urogynecological
Association, 2004 Aug 25-27, Paris. 2004. 19084]
∗ Dietz HP, Barry C, Lim YN, Rane A. Two-dimensional
and three-dimensional ultrasound imaging of suburethral
slings. Ultrasound in Obstetrics & Gynecology 2005;26(2):
175–9. 20763]
Du 2008 {published data only}
Du G-H, Chen Z, HU WF, Zhang C-H, Zhang J-Y,
Zhu Z-Q, et al. [A multicenter study of mid urethral
sling procedures in treatment of female stress urinary
incontinence] [Chinese]. Chung-Hua Wai Ko Tsa Chih
[Chinese Journal of Surgery] 2008;46(20):1529–32.
srincont29216]
Falconer 2001 {published data only}
Falconer C, Rosblad P-G. A randomized comparative study
between local and low spinal anesthesia for tension-free
vaginal tape operation. International Urogynecology Journal
2001;12(Suppl 3):S21. 15455]
Fischer 2005 {published data only}
Fischer A, Fink T, Zachmann S, Eickenbusch U.
Comparison of retropubic and outside-in transoburator
sling systems for the cure of female genuine stress urinary
incontinence. European Urology 2005;48(5):799–804.
60Mid-urethral sling operations for stress urinary incontinence in women (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Foote 2012 {published data only}
Foote A. A randomised trial comparing two vaginal
prolene sling surgeries for female urinary incontinence.
www.anzctr.org (accessed 19 Sep 2012) 2012.
ACTRN12612000314820 ; srincont45458]
Goldberg 2001 {published data only}
Goldberg RP, Koduri S, Lobel RW, Culligan PJ, Tomezsko
JE, Winkler HA, et al. Long-term effects of three different
anti-incontinence procedures on the posterior compartment
(Abstract number 243). Proceedings of the 31st Annual
Meeting of the International Continence Society (ICS),
2001 Sept 18-21, Seoul, Korea. 2001. 14471]
Gopinath 2013 {published data only}
Gopinath D, Smith AR, Holland C, Reid FM. Why
don’t women participate? A qualitative study on non-
participation in a surgical randomised controlled trial.
International Urogynecology Journal 2013;24(6):969–75.
srincont48114]
Harmanli 2011 {published data only}
Harmanli O, Boyer R, Metz S, Jones K, Tunitsky
E. Double-blinded randomized trial of preoperative
antibiotics in midurethral sling procedures (Abstract
number 1184). Proceedings of the Joint Meeting of
the International Continence Society (ICS) and the
International Urogynecological Association, 2010 Aug 23-
27, Toronto, Canada. 2010. Srincont 40210]
∗ Harmanli O, Boyer RL, Metz S, Tunitsky E, Jones KA.
Double-blinded randomized trial of preoperative antibiotics
in midurethral sling procedures and review of the literature.
International Urogynecology Journal 2011;22(10):1249–53.
PUBMED: 21789661]
Jackson 2013 {published data only}
Jackson D, Higgins E, Bracken J, Yandell PM, Shull B,
Foster RT Sr. Antibiotic prophylaxis for urinary tract
infection after midurethral sling: a randomized controlled
trial. Female Pelvic Medicine & Reconstructive Surgery 2013;
19(3):137–41. CARPET; NCT00734968; srincont48136]
Jeon 2008 {published data only}
Jeon MJ, Chung da J, Park JH, Kim SK, Kim JW, Bai
SW. Surgical therapeutic index of tension-free vaginal tape
and transobturator tape for stress urinary incontinence.
Gynecologic and Obstetric Investigation 2008;65(1):41–6.
srincont26783]
Jones 2010 {published data only}
Jones R, Abrams P, Hilton P,Ward K, DrakeM. Risk of tape-
related complications after TVT is at least 4%. Neurourology
and Urodynamics 2010;29(1):40–1. srincont39866;
PUBMED: 20025030]
Karagkounis 2007 {published data only}
Karagkounis SC, Pantelis A, Parashou GC, Paplomata E,
Madenis N, Chrisanthoupoulos C, et al. Stress urinary
incontinence: TVT OB system versus Duloxetine-HCL
and the winner is? (Abstract number 005). International
Urogynecology Journal 2007;18(Suppl 1):S3–4.
Kim 2005a {published data only}
Kim YB, Jeon YT, Jee BC, Park KH, Suh CS. The
efficacy and safety of tension-free vaginal tape and
transobturator suburethral tape in the surgical treatment
of stress urinary incontinence (Abstract number 237).
International Urogynecology Journal 2005;16(Suppl 2):S87.
srincont27308]
Kim 2006 {published data only}
Kim WT, Kim KT, Kim JW, Choe JH, Lee JS, Seo JT.
[Comparative study of the tension-free vaginal tape (TVT)
procedure and the suprapubic arc sling (SPARC) procedure
for treating female stress urinary incontinence: A 1-year
follow-up]. Korean Journal of Urology 2006;47(4):397–401.
srincont27044]
Kulseng-Hanssen 2004 {published data only}
Kulseng-Hanssen S. Do preoperative objective and
subjective findings predict the outcome of TVT operations
in females complaining of mixed urinary incontinence?
(Abstract number 310). Proceedings of the International
Continence Society (34th Annual Meeting) and the
International Urogynecological Association, 2004, Aug 23-
27, Paris. 2004. 19057]
Kulseng-Hanssen 2007 {published data only}
Kulseng-Hanssen S, Husby H, Schiotz HA. The tension
free vaginal tape operation for women with mixed
incontinence: do preoperative variables predict the
outcome?. Neurourology and Urodynamics 2007;26:115–21.
Kwon 2002 {published data only}
Kwon C, Goldberg R, Sanjay G, Sumana K, Krotz S,
Sand P. Protective effect of transvaginal slings on recurrent
anterior vaginal wall prolapse after pelvic reconstructive
surgery (Abstract). Neurourology and Urodynamics 2002;21
(4):321–2. 14540]
Liapis 2007 {published data only}
Liapis A, Bakas P, Creatsas G. Assessment of TVT
efficacy in the management of patients with genuine stress
incontinence with the use of epidural vs intravenous
anesthesia. International Urogynecology Journal 2007;18:
1197-200.
Liapis 2010 {published data only}
Liapis A, Bakas P, Georgantopoulou C, Creatsas G. The use
of oestradiol therapy in postmenopausal women after TVT-
O anti-incontinence surgery. Maturitas 2010;66(1):101–6.
srincont39604]
Markland 2007 {published data only}
Kirby AC, Nager CW, Litman HJ, FitzGerald MP, Kraus S,
Norton P, et al. Preoperative voiding detrusor pressures and
stress incontinence surgery outcomes (Abstract number 38).
Neurourology and Urodynamics 2010;29(6):860–1. Srincont
40122]
Kirby AC, Nager CW, Litman HJ, FitzGerald MP, Kraus
S, Norton P, et al. Preoperative voiding detrusor pressures
do not predict stress incontinence surgery outcomes.
61Mid-urethral sling operations for stress urinary incontinence in women (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
International urogynecology journal 2011;22(6):657–63.
PUBMED: 21153471]
∗ Markland AD, Kraus SR, Richter HE, Nager CW,
Kenton K, Kerr L, et al. Prevalence and risk factors of fecal
incontinence in women undergoing stress incontinence
surgery. American Journal of Obstetrics and Gynecology 2007;
197(6):662.e1–7. PUBMED: 18060972]
McClure 2006 {published data only}
McClure LA, Brown MB. A likelihood approach to
analyzing clinical trial data when treatments favour different
outcomes. Contemporary Clinical Trials 2006;27(4):
340–52. 22391]
Meschia 2002 {published data only}
Meschia M, Pifarotti P, Gattei U, Ronchetti A, Stoppelli S,
Lampugnani F. TVT and prolapse repair for treatment of
occult stress urinary incontinence: a randomized study
(Abstract). Proceedings of the 32nd Annual Meeting of the
International Continence Society (ICS), 2002 Aug 28-30,
Heidelberg, Germany. 2002:198–9. 14518]
Osman 2003 {published data only}
Osman T. Stress incontinence surgery for patients presenting
with mixed incontinence and a normal cystometrogram.
BJU International 2003;92(9):964–8. 16660]
Pace 2008 {published data only}
Pace G, Vicentini C. Female sexual function evaluation
of the tension-free vaginal tape (TVT) and transobturator
suburethral tape (TOT) incontinence surgery: results of a
prospective study. Journal of Sexual Medicine 2008;5(2):
387–93. srincont27116]
Padilla-Fernández 2013 {published data only}
Padilla-Fernandez B, Garcia-Cenador MB, Collazos-Robles
RE, Garcia-Sanchez MH, Garcia-Sanchez A, Lorenzo-
Gomez MF. Transobturator tape with whipstitch edges for
urinary incontinence allows postoperative adjustment and
improves outcomes (Abstract number 606). Proceedings of
the 43rd Annual Meeting of the International Continence
Society (ICS), 2013 Aug 26-30, Barcelona, Spain. 2013.
srincont60035]
Park 2008 {published data only}
Park HK, Lee HW, Kim HG, Lee KS. Does tape tension
have an effect on the success rate of transobturator tape
surgery? (Abstract number 122). Neurourology and
Urodynamics 2008;27(7):714–5. srincont31858]
Sabadell 2008 {published data only}
Sabadell J, Luis Poza J, Sanchez-Iglesias JL, Martinez-
Gomez X, Pla F, Xercavins J. [Comparison of the outside-
in and inside-out routes in the use of transobturator
tapes for the treatment of stress urinary incontinence].
Progresos en Obstetricia y Ginecologia 2008;51(8):464–70.
srincont40241]
Schierlitz 2007 {published data only}
Schierlitz L, Dwyer P, Rosamilia A, Murray C, Thomas E,
Taylor N, et al. A prospective randomised controlled study
comparing vaginal prolapse repair with and without tension
free vaginal tape (TVT) in women with severe pelvic organ
prolapse and occult stress incontinence (Abstract number
114). Neurourology and Urodynamics 2007;26(5):743–4.
23759]
Schostak 2001 {published data only}
Schostak M, Gottfried HW, Heicappell R, Muller M, Sauter
T, Steiner U, et al. Minimally invasive bone anchoring
for female stress incontinence: a treatment with moderate
results (Abstract). European Urology 2001;39(Suppl 5):3.
16374]
Seo 2007 {published data only}
Seo JH, Lee JW, Kim DY, Lee YG, Seo YJ, Kwon TG,
et al. Treatment of obstructive voiding dysfunction after
transobturator sling surgery: results of multicenter study
(Abstract number 287). Proceedings of the 37th Annual
Meeting of the International Continence Society (ICS),
2007 Aug 20-24, Rotterdam, The Netherlands. 2007.
23762]
Shin 2010 {published data only}
Shin JH, Lim JS, Song KH, Sul CK, Na YG. Prospective
study comparing the suprapubic arc (Sparc) procedure and
the transobturator (Monarc) procedure for treating female
stress urinary incontinence. LUTS: Lower Urinary Tract
Symptoms 2010;2(1):37–42. srincont59687]
Sivaslioglu 2007 {published data only}
Sivaslioglu AA, Unlubilgin E, Dolen I, Kaplan M.
The comparison of tissue fixation system (TFS) with
transobturator tape (TOT) in the treatment of stress
urinary incontinence (Abstract no. 061). International
Urogynecology Journal 2007;18(Suppl 1):S36.
Surkont 2007 {published data only}
Surkont G, Wlazlak E, Kazimierak W, Dunicz-Sokolowska
A, Suzin J. The influence of SUI operative treatment with
use of IVS tape on quality of life. Ginekologia Polska 2007;
78(5):381–3.
Takeyama 2006 {published data only}
Takeyama M, Fukumoto Y, Noma M, Yamamoto K,
Yamanaka M, Uesaka Y. A prospective study about trans-
obturator-tape (TOT) procedures with the tape from the
Gynecare TVT device and a C-shape tunneller - comparison
between outside-in and inside-out procedures (Abstract
number 489). Proceedings of the 36th Annual Meeting of
the International Continence Society (ICS), 2006 Nov 27-
Dec 1, Christchurch, New Zealand. 2006. 23751]
Tantanasis 2013 {published data only}
Tantanasis T, Daniilidis A, Pantelis A, Chatzis P, Vrachnis
N. Minimally invasive techniques for female stress urinary
incontinence, how, why, when. Archives of Gynecology and
Obstetrics 2013;288(5):995–1001. srincont49470]
Tincello 2009 {published data only}
Bakali E, Pitchforth E, Tincello DG, Kenyon S, Slack M,
Toozs-Hobson P, et al. Clinicians’ views on the feasibility
of surgical randomized trials in urogynecology: results of a
questionnaire survey. Neurourology and Urodynamics 2011;
30(1):69–74. PUBMED: 20658541]
Jackson CJ, Dixon-Woods M, Eborall H, Kenyon S, Toozs-
Hobson P, Tincello DG. Women’s views and experiences of
a patient preference trial in surgery: a qualitative study of
62Mid-urethral sling operations for stress urinary incontinence in women (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
the CARPET1 trial. Clinical Trials 2010;7(6):696–704.
CARPET1; ISRCTN34759911; srincont40885]
∗ Tincello DG, Kenyon S, Slack M, Toozs-Hobson P,
Mayne C, Jones D, et al. Colposuspension or TVT with
anterior repair for urinary incontinence and prolapse:
results of and lessons from a pilot randomised patient-
preference study (CARPET 1). BJOG : an international
journal of obstetrics and gynaecology 2009;116(13):1809–14.
PUBMED: 19781044]
Tinelli 2007 {published data only}
Tinelli A, Malvasi A, D’Anna L, Tinelli R, Perrone A, Tinelli
FG. Presurgical promestriene therapy in postmenopausal
women with stress urinary incontinence. Gynecological
Endocrinology 2007;23(8):445–50. srincont23949]
Trezza 2001 {published data only}
Trezza G, Rotondi M, Palmisano B, Iervolino P.
Uterovaginal prolapse and occult urinary incontinence: a
prospective randomized study on the necessity to associate
reconstructive surgery and antiincontinence procedure.
[Italian]. Urogynaecologia International Journal 2001;15(1
Suppl):152–4. 13713]
Wang 2001 {published data only}
Wang AC, Chen MC. Randomized comparison of local
versus epidural anesthesia for tension-free vaginal tape
operation. Journal of Urology 2001;165(4):1177–80.
12424]
Wei 2012 {published data only}
Wei J. A midurethral sling prevents incontinence among
women undergoing vaginal prolapse repair - the OPUS
trial. Neurourology and Urodynamics 2011;30(6):809–10.
SRINCONT 42165]
Wei J, Nygaard I, Richter H, Brown M, Barber M, Xiao Xu,
et al. Outcomes following vaginal prolapse repair and mid
urethral sling (OPUS) trial--design and methods. Clinical
Trials 2009;6(2):162–71. srincont31120]
∗ Wei JT, Nygaard I, Richter HE, Nager CW, Barber MD,
Kenton K, et al. A midurethral sling to reduce incontinence
after vaginal prolapse repair. The New England Journal of
Medicine 2012;366(25):2358–67. PUBMED: 22716974]
Williams 2003 {published data only}
Williams JG, Cheung WY, Cohen DR, Hutchings HA,
Longo MF, Russell IT. Can randomised trials rely on
existing electronic data? A feasibility study to explore the
value of routine data in health technology assessment.
Health Technology Assessment (Winchester, England) 2003;7
(26):1–117. 16488]
Yang 2012 {published data only}
Yang X, Jiang M, Chen X, Tong X, Li H, Qiu J, et al. TVT-
O vs. TVT for the treatment of SUI: a non-inferiority
study. International Urogynecology Journal 2012;23(1):
99–104. srincont44553]
Yoo 2007 {published data only}
Yoo ES, Jung HC, Shin HS, Seo JH, Seo YJ. Comparison
of the two different approaches for the treatment of
female stress urinary incontinence (Abstract number
282). Proceedings of the 37th Annual Meeting of the
International Continence Society (ICS), 2007 Aug 20-24,
Rotterdam, The Netherlands. 2007. 23760]
Yoon 2011 {published data only}
Yoon H, Lee DH, Kim YJ. Early results of comparison
of Contasure-needleless (trademark) and TOT outside-in
midurethral slings (Abstract number 852). Proceedings of
the 41st Annual Meeting of the International Continence
Society (ICS), 2011 Aug 29-Sept 2, Glasgow, Scotland.
2011.
Zaccardi 2010 {published data only}
Zaccardi JE, Wilson L, Mokrzycki ML. The effect of pelvic
floor re-education on comfort in women having surgery for
stress urinary incontinence. Urologic Nursing 2010;30(2):
137-46, 148. PUBMED: 20469573]
Zullo 2005 {published data only}
Zullo MA, Plotti F, Calcagno M, Palaia I, Muzii L, Manci
N, et al. Vaginal estrogen therapy and overactive bladder
symptoms in postmenopausal patients after a tension-
free vaginal tape procedure: a randomized clinical trial.
Menopause 2005;12(4):421–7. 20805]
References to ongoing studies
Cavkaytar 2013 {published data only}
Cavkaytar S, Aksakal SO, Kokanali MK, Topcu HO,
Doganay M. Prospective randomized study comparing TVT
and TOT in female stress urinary incontinence with no
intrinsic sphincter deficiency. http://clinicaltrials.gov/show/
NCT01903590 2013. NCT01903590; srincont49363]
Sung 2013 {published data only}
Sung VW, Wallace D. Effects of Surgical Treatment
Enhanced with Exercise for Mixed Urinary Incontinence
(ESTEEM). http://clinicaltrials.gov/show/NCT01959347
2013. ESTEEM; NCT01959347; srincont49234]
Additional references
Abbott 2014
Abbott S, Unger CA, Evans JM, Jallad K, Mishra K, Karram
MM, et al. Evaluation and management of complications
from synthetic mesh after pelvic reconstructive surgery:
a multicenter study. American Hournal of Obstetrics and
Gynecology 2014;210(2):163.e1–8. [PUBMED: 24126300]
Aigmueller 2011
Aigmueller T, Trutnovsky G, Tamussino K, Kargl J,
Wittmann A, Surtov M, et al. Ten-year follow-up after
the tension-free vaginal tape procedure. American Journal
of Obstetrics and Gynecology 2011;205(5):496.e1–5.
[PUBMED: 21944223]
Alcalay 1995
Alcalay M, Monga A, Stanton SL. Burch colposuspension:
a 10-20 year follow up. British Journal of Obstetrics and
Gynaecology 1995;102(9):740–5. [PUBMED: 7547767]
Alhasso 2005
Alhasso A, Glazener CMA, Pickard R, N’dow J. Adrenergic
drugs for urinary incontinence in adults. Cochrane Database
63Mid-urethral sling operations for stress urinary incontinence in women (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
of Systematic Reviews 2005, Issue 3. [DOI: 10.1002/
14651858.CD001842.pub2
Amid 1997
Amid P. Classification of biomaterials and their related
complications in abdominal wall hernia surgery. Hernia
1997;1(1):15–21.
Athanasiou 2014
Athanasiou S, Grigoriadis T, Zacharakis D, Skampardonis
N, Lourantou D, Antsaklis A. Seven years of objective and
subjective outcomes of transobturator (TVT-O) vaginal
tape: why do tapes fail?. International Urogynecology Journal
2014;25(2):219–25. [PUBMED: 23892532]
Ayeleke 2013
Ayeleke RO, Hay-Smith EJ, Omar MI. Pelvic floor muscle
training added to another active treatment versus the same
active treatment alone for urinary incontinence in women.
Cochrane Database of Systematic Reviews 2013, Issue 11.
[DOI: 10.1002/14651858.CD010551.pub2; PUBMED:
24259154
Bezerra 2005
Bezerra CCB, Bruschini H, Cody JD. Traditional
suburethral sling operations for urinary incontinence in
women. Cochrane Database of Systematic Reviews 2005,
Issue 3. [DOI: 10.1002/14651858.CD001754.pub2
Birnbaum 2004
Birnbaum HG, Leong SA, Oster EF, Kinchen K, Sun P.
Cost of stress urinary incontinence: a claims data analysis..
Pharmacoeconomics 2004;22(2):95–105. [PUBMED:
14731051]
Blaivas 1988
Blaivas JG, Olsson CA. Stress-incontinence - classification
and surgical approach. Journal of Urology 1988;139(4):
727–31.
Botlero 2008
Botlero R, Urquhart DM, Davis SR, Bell RJ. Prevalence
and incidence of urinary incontinence in women: review
of the literature and investigation of methodological
issues. International Journal of Urology : official journal
of the Japanese Urological Association 2008;15(3):230–4.
[PUBMED: 18304218]
Botlero 2010
Botlero R, Bell RJ, Urquhart DM, Davis SR. Urinary
incontinence is associated with lower psychological general
well-being in community-dwelling women. Menopause
(New York, N.Y.) 2010;17(2):332–7. [PUBMED:
20216275]
Boyers 2013
Boyers D, Kilonzo M, Mostafa A, Abdel-Fattah M.
Comparison of an adjustable anchored single-incision mini-
sling, Ajust((R)) , with a standard mid-urethral sling, TVT-
O(TM) : a health economic evaluation. BJU international
2013;112(8):1169–77.
Brubaker 2012
Brubaker L, Richter HE, Norton PA, Albo M, Zyczynski
HM, Chai TC, et al. 5-year continence rates, satisfaction
and adverse events of burch urethropexy and fascial sling
surgery for urinary incontinence. The Journal of Urology
2012;187(4):1324–30. [PUBMED: 22341290]
Castañeda 2014
Castañeda E, Sanz-Granda Á, HidalgoÁ, Meza D, Carreras
M, MarquetaJ. Cost Effectiveness analysis of surgical
treatment of stress urinary incontinence using single-
incision mini-slings vs. tension-free vaginal obturator in
Spain. Surgical Research - Open Journal 2014;1(1):17–24.
[DOI: 10.17140/SROJ-1-103; PUBMED: 27201564
Chong 2011
Chong E, Khan A, Anger J. The financial burden of
stress urinary incontinence among women in the United
States. Current Urology Reports 2011;12(5):358–62. [DOI:
10.1007/s11934-011-0209-x.
Cody 2012
Cody JD, Jacobs ML, Richardson K, Moehrer B,
Hextall A. Oestrogen therapy for urinary incontinence
in post-menopausal women. Cochrane Database of
Systematic Reviews 2012, Issue 10. [DOI: 10.1002/
14651858.CD001405.pub3; PUBMED: 23076892
Collinet 2008
Collinet P, Ciofu C, Costa P, Cosson M, Deval B, Grise
P, et al. The safety of the inside-out transobturator
approach for transvaginal tape (TVT-O) treatment in stress
urinary incontinence: French registry data on 984 women.
International Urogynecology Journal 2008;19(5):711–5.
Coyne 2009
Coyne KS, Sexton CC, Thompson CL, Milsom I, Irwin
D, Kopp ZS, et al. The prevalence of lower urinary tract
symptoms (LUTS) in the USA, the UK and Sweden:
results from the Epidemiology of LUTS (EpiLUTS) study.
BJU international 2009;104(3):352–60. [PUBMED:
19281467]
de Leval 2003
de Leval J. Novel surgical technique for the treatment of
female stress urinary incontinence: transobturator vaginal
tape inside-out. European Urology 2003;44(6):724–30.
de Leval 2005
de Leval J, Waltregny D. New surgical technique for
treatment of stress urinary incontinence TVT-Obturator:
new developments and results. Surgical Technology
International 2005;14:212–21.
Dean 2006
Dean NM, Ellis G, Wilson PD, Herbison PH. Laparoscopic
colposuspension for urinary incontinence in women.
Cochrane Database of Systematic Reviews 2006, Issue 3.
[DOI: 10.1002/14651858.CD002239.pub2
DeLancey 1994
DeLancey JO. Structural support of the urethra as it relates
to stress urinary incontinence: the hammock hypothesis.
American Journal of Obstetrics and Gynecology 1994;170(6):
1713-20; discussion 1720-3. [PUBMED: 8203431]
Delorme 2001
Delorme E. [Transobturator urethral suspension: mini-
invasive procedure in the treatment of stress urinary
64Mid-urethral sling operations for stress urinary incontinence in women (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
incontinence in women]. Progres en Urologie 2001;11(6):
1306–13.
Delorme 2003
Delorme E, Droupy S, de Tayrac R, Delmas V.
[Transobturator tape (Uratape). A new minimally invasive
method in the treatment of urinary incontinence in
women]. Progres en Urologie 2003;13(4):656–9.
Delorme 2004
Delorme E, Droupy S, de Tayrac R, Delmar V.
Transobturator tape (Uratape): a new minimally invasive
procedure to treat female urinary incontinence. European
Urology 2004;45(2):203–7.
Dietz 2004
Dietz HP, Wilson PD. The ’iris effect’: how two-
dimensional and three-dimensional ultrasound can help us
understand anti-incontinence procedures. Ultrasound in
Obstetrics & Gynecology 2004;23(3):267–71.
Dumoulin 2014
Dumoulin C, Hay-Smith EJ, Mac Habee-Seguin G. Pelvic
floor muscle training versus no treatment, or inactive
control treatments, for urinary incontinence in women.
Cochrane Database of Systematic Reviews 2014, Issue 5.
[DOI: 10.1002/14651858.CD005654.pub3; PUBMED:
24823491
Dyrkorn 2010
Dyrkorn OA, Kulseng-Hanssen S, Sandvik L. TVT
compared with TVT-O and TOT: results from the
Norwegian National Incontinence Registry. International
Urogynecology Journal 2010;21(11):1321–6. [PUBMED:
20559618]
Enhorning 1961
Enhorning G. Simultaneous recording of intravesical and
intra-urethral pressure. A study on urethral closure in
normal and stress incontinent women. Acta Chirurgica
Scandinavica. Supplementum 1961;Suppl 276:1–68.
[PUBMED: 13696922]
FDA 2008
US Food, Drug Administration (FDA). FDA Public
Health Notification: serious complications associated with
transvaginal placement of surgical mesh in repair of pelvic
organ prolapse and stress urinary incontinence. FDA Public
Health Notification (www.fda.gov/MedicalDevices/Safety/
AlertsandNotices/ucm262435.htm) 2008. [srincont47910]
FDA 2011a
US Food, Drug Administration (FDA). FDA Safety
Communication: UPDATE on serious complications
associated with transvaginal placement of surgical mesh for
pelvic organ prolapse. FDA Public Health Notification
(www.fda.gov/MedicalDevices/Safety/AlertsandNotices/
ucm262435.htm) 2011. [srincont47910]
FDA 2011b
FDA. Urogynecologic Surgical Mesh; Update on the Safety
and Effectiveness of Vaginal Placement for Pelvic Organ
Prolapse. www.fda.gov/downloads/medicaldevices/safety/
alertsandnotices/UCM262760.pdf 2011.
FDA 2013
FDA. Considerations about surgical mesh
for SUI. www.fda.gov/MedicalDevices/
ProductsandMedicalProcedures/ImplantsandProsthetics/
UroGynSurgicalMesh/ucm345219.htm 2013.
French 2010
French B, Thomas LH, Leathley MJ, Sutton CJ, Booth
J, Brittain K, et al. Combined conservative interventions
for urge, stress or mixed incontinence in adults. Cochrane
Database of Systematic Reviews 2010, Issue 12. [DOI:
10.1002/14651858.CD008910; CD008910
Ghoniem 2005
Ghoniem GM, Van Leeuwen JS, Elser DM, Freeman RM,
Zhao YD, Yalcin I, et al (Duloxetine/Pelvic Floor Muscle
Training Clinical Trial Group). A randomized controlled
trial of duloxetine alone, pelvic floor muscle training alone,
combined treatment and no active treatment in women
with stress urinary incontinence. Journal of Urology 2005;
173(5):1453–4.
Glazener 2001
Glazener CMA, Cooper K. Anterior vaginal repair for
urinary incontinence in women. Cochrane Database
of Systematic Reviews 2001, Issue 1. [DOI: 10.1002/
14651858.CD001755
Glazener 2004
Glazener CMA, Cooper K. Bladder neck needle suspension
for urinary incontinence in women. Cochrane Database
of Systematic Reviews 2004, Issue 2. [DOI: 10.1002/
14651858.CD003636.pub2
Guyatt 2011a
Guyatt GH, Oxman AD, Schunemann HJ, Tugwell P,
Knottnerus A. GRADE guidelines: a new series of articles
in the Journal of Clinical Epidemiology. Journal of Clinical
Epidemiology 2011;64(4):380–2.
Guyatt 2011b
Guyatt GH, Oxman AD, Sultan S, Glasziou P, Akl EA,
Alonso-Coello P, et al. GRADE guidelines: 9. Rating up
the quality of evidence. Journal of Clinical Epidemiology
2011;64(12):1311–6.
Guyatt 2013a
Guyatt GH, Thorlund K, Oxman AD, Walter SD, Patrick
D, Furukawa TA, et al. GRADE guidelines: 13. Preparing
summary of findings tables and evidence profiles-continuous
outcomes. Journal of Clinical Epidemiology 2013;66(2):
173–83.
Guyatt 2013b
Guyatt GH, Oxman AD, Santesso N, Helfand M, Vist G,
Kunz R, et al. GRADE guidelines: 12. Preparing Summary
of Findings tables-binary outcomes. Journal of Clinical
Epidemiology 2013;66(2):158–72.
Hannestad 2000
Hannestad YS, Rortveit G, Sandvik H, Hunskaar S.
A community-based epidemiological survey of female
urinary incontinence: the Norwegian EPINCONT study.
Epidemiology of Incontinence in the County of Nord-
65Mid-urethral sling operations for stress urinary incontinence in women (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Trondelag. Journal of Clinical Epidemiology 2000;53(11):
1150–7. [PUBMED: 11106889]
Hay-Smith 2011
Hay-Smith EJ, Herderschee R, Dumoulin C, Herbison GP.
Comparisons of approaches to pelvic floor muscle training
for urinary incontinence in women. Cochrane Database
of Systematic Reviews 2011, Issue 12. [DOI: 10.1002/
14651858.CD009508; PUBMED: 22161451
Haylen 2010
Haylen BT, deRidder D, Freeman RM, Swift SE, Berghmans
B, Lee J, et al. An International Urogynecological
Association (IUGA)/International Continence Society
(ICS) joint report on the terminology for female pelvic floor
dysfunction. Neurourology and Urodynamics 2010;29(1):
4–20. [PUBMED: 19941278]
Heinonen 2013
Heinonen P, Ala-Nissila S, Raty R, Laurikainen E, Kiilholma
P. Objective cure rates and patient satisfaction after the
transobturator tape procedure during 6.5-year follow-up.
Journal of Minimally Invasive Gynecology 2013;20(1):73–8.
[PUBMED: 23312245]
Herbison 2013
Herbison GP, Dean N. Weighted vaginal cones for urinary
incontinence. Cochrane Database of Systematic Reviews 2013,
Issue 7. [DOI: 10.1002/14651858.CD002114.pub2;
PUBMED: 23836411
Herderschee 2011
Herderschee R, Hay-Smith EJ, Herbison GP, Roovers
JP, Heineman MJ. Feedback or biofeedback to augment
pelvic floor muscle training for urinary incontinence in
women. Cochrane Database of Systematic Reviews 2011, Issue
7. [DOI: 10.1002/14651858.CD009252; PUBMED:
21735442
Higgins 2003
Higgins JP, Thompson SG, Deeks JJ, Altman DG.
Measuring inconsistency in meta-analyses. BMJ 2003;327
(7414):557–60.
Higgins 2011
Higgins JPT, Green S (editors). Cochrane Handbook
for Systematic Reviews of Interventions Version 5.1.0
[updated March 2011]. The Cochrane Collaboration,
2011. Available from www.cochrane-handbook.org.
Hunskaar 2002
Hunskaar S, Burgio K, Diokno AC, Herzog AR, Hjalmas
K, Lapitan MC. Epidemiology and natural history of
urinary incontinence (UI). Incontinence: 2nd International
Consultation on Incontinence. Recommendations of the
International Scientific Committee: the evaluation and
treatment of urinary incontinence. 2001 Jul 1-3, Paris.
Plymouth, UK, 2002.
Imamura 2010
Imamura M, Williams K, Wells M, McGrother C. Lifestyle
interventions for the treatment of urinary incontinence
in adults. Cochrane Database of Systematic Reviews 2010,
Issue 9. [DOI: 10.1002/14651858.CD003505.pub4;
CD003505
Irwin 2006
Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z,
Herschorn S, et al. Population-based survey of urinary
incontinence, overactive bladder, and other lower urinary
tract symptoms in five countries: results of the EPIC study.
European Urology 2006;50(6):1306-14; discussion 1314-5.
[PUBMED: 17049716]
Jackson 1996
Jackson S, Donovan J, Brookes S, Eckford S, Swithinbank
L, Abrams P. The Bristol Female Lower Urinary Tract
Symptoms questionnaire: development and psychometric
testing. British Journal of Urology 1996;77(6):805–12.
Kilonzo 2004
Kilonzo M, Vale L, Stearns S, Grant A, Cody J, Glazener
C, et al. Cost effectiveness of tension-free vaginal tape for
the surgical management of female stress incontinence.
International Journal of Technology Assessment in Health Care
2004;20(4):455–63.
Kirchin 2012
Kirchin V, Page T, Keegan PE, Atiemo K, Cody
JD, McClinton S. Urethral injection therapy for
urinary incontinence in women. Cochrane Database
of Systematic Reviews 2012, Issue 2. [DOI: 10.1002/
14651858.CD003881.pub3; PUBMED: 22336797
Kjolhede 2005
Kjolhede P. Long-term efficacy of Burch colposuspension:
a 14-year follow-up study. Acta Obstetricia et Gynecologica
Scandinavica 2005;84(8):767–72. [PUBMED: 16026403]
Koops 2005
Schraffordt Koops SE, Bisseling TM, Heintz AP, Vervest
HAM. Prospective analysis of complications of tension-
free vaginal tape from the Netherlands Tension-free Vaginal
Tape study. American Journal of Obstetrics and Gynecology
2005;193(1):45–52.
Kunkle 2015
Kunkle C, Hallock J, Hu X, Blomquist J, Thung S, Werner
E. Cost utility analysis of urethral bulking agents versus
midurethral sling in stress urinary incontinence. Female
Pelvic Medicine & Reconstructive Surgery 2015;21(3):154–9.
Kuuva 2002
Kuuva N, Nilsson CG. A nationwide analysis of
complications associated with the tension-free vaginal
tape (TVT) procedure. Acta Obstetricia et Gynecologica
Scandinavica 2002;81(1):72–7. [DOI: 10.1034/
j.1600-0412.2002.810113.x
Langendam 2013
Langendam MW, Akl EA, Dahm P, Glasziou P, Guyatt G,
Schunemann HJ. Assessing and presenting summaries of
evidence in Cochrane Reviews. Systematic Reviews 2013;2:
81. [PUBMED: 24059250]
Lapitan 2012
Lapitan MCM, Cody JD. Open retropubic colposuspension
for urinary incontinence in women. Cochrane Database
of Systematic Reviews 2012, Issue 6. [DOI: 10.1002/
14651858.CD002912.pub5; PUBMED: 22696331
66Mid-urethral sling operations for stress urinary incontinence in women (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Lier 2011
Lier D, Ross S, Tang S, Robert M, Jacobs P, Calgary
Women’s Pelvic Health Research Group. Trans-obturator
tape compared with tension-free vaginal tape in the surgical
treatment of stress urinary incontinence: a cost utility
analysis. BJOG 2011;118(5):550–6. [sr–incont41520]
Lier 2016
Lier D, Robert M, Tang S, Ross S. Surgical treatment of
stress urinary incontinence-trans-obturator tape compared
with tension-free vaginal tape-5-year follow up: an
economic evaluation. BJOG: An International Journal of
Obstetrics & Gynaecology 2016 Aug 10 [Epub ahead of
print]. [DOI: 10.1111/1471-0528.14227
Lipp 2011
Lipp A, Shaw C, Glavind K. Mechanical devices for
urinary incontinence in women. Cochrane Database
of Systematic Reviews 2011, Issue 7. [DOI: 10.1002/
14651858.CD001756.pub5; PUBMED: 21735385
Mariappan 2005
Mariappan P, Ballantyne Z, N’Dow JMO, Alhasso AA.
Serotonin and noradrenaline reuptake inhibitors (SNRI) for
stress urinary incontinence in adults. Cochrane Database
of Systematic Reviews 2005, Issue 3. [DOI: 10.1002/
14651858.CD004742.pub2
McGuire 1993
McGuire EJ, Fitzpatrick CC, Wan J, Bloom D,
Sanvordenker J, Ritchey M, et al. Clinical assessment of
urethral sphincter function. Journal of Urology 1993;150(5
Pt 1):1452–4. [PUBMED: 8411422]
MHRA 2012
Mahon J, Cikalo M, Varley D, Glanville J, York Health
Economics Consortium. Summaries of the safety/adverse
effects of vaginal tapes/slings/meshes for stress urinary
incontinence and prolapse. Final report. November 2012
[report]. London: MHRA, Medicines and Healthcare
Products Regulatory Agency, Department of Health, 2012.
Available at: https://www.mhra.gov.uk/home/groups/
comms–ic/documents/websiteresources/con205383.pdf
(accessed 21 May 2015).
MHRA 2014
Medicines and Healthcare Products Regulatory Agency
(MHRA). A summary of the evidence on the benefits
and risks of vaginal mesh implants [report]. London:
Medicines and Healthcare Products Regulatory
Agency (MHRA), 28 October 2014. Document
available at: https://www.gov.uk/government/uploads/
system/uploads/attachment˙data/file/402162/Sum-
mary˙of˙the˙evidence˙on˙the˙benefits˙and˙risks˙of˙vaginal˙mesh˙implants.pdf.
Relevant MHRA webpage: https://www.gov.uk/
government/publications/vaginal–mesh–implants–
summary–of–benefits–and–risks.
Milsom 2009
Milsom I, Altman D, Lapitan MC, Nelson R, Sillen
U, Thom D. Epidemiology of urinary incontinence
(UI) anal incontinence (AI) and pelvic organ prolapse
(POP). Incontinence: 4th International Consultation on
Incontinence (ICI). Recommendations of the International
Scientific Committee: evaluation and treatment of urinary
incontinence, pelvic organ prolapse and faecal incontinence,
2008 Jul 5-8, Paris, France. Plymouth, UK: Health
Publication Ltd, 2008.
Moher 2001
Moher D, Schulz KF, Altman DG. The CONSORT
statement: revised recommendations for improving the
quality of reports of parallel group randomized trials. BMC
Medical Research Methodology 2001;1:2.
Mostafa 2012
Mostafa A, Agur W, Abdel-All M, Guerrero K, Lim C,
Allam M, et al. A multicentre prospective randomised
study of single-incision mini-sling (Ajust) versus tension-
free vaginal tape-obturator (TVT-O) in the management of
female stress urinary incontinence: pain profile and short-
term outcomes. European Journal of Obstetrics & Gynecology
and Reproductive Biology 2012;165(1):115–21.
Nambiar 2014
Nambiar A, Cody JD, Jeffery ST. Single-incision sling
operations for urinary incontinence in women. Cochrane
Database of Systematic Reviews. John Wiley & Sons, Ltd,
2014, issue 6. [DOI: 10.1002/14651858.CD008709.pub2
Nilsson 2013
Nilsson CG, Palva K, Aarnio R, Morcos E, Falconer C.
Seventeen years’ follow-up of the tension-free vaginal
tape procedure for female stress urinary incontinence.
International Urogynecology Journal 2013;24(8):1265–9.
[PUBMED: 23563892]
O’Donnell 1994
O’Donnell P. Goals of therapy and mechanisms of urethral
incontinence. In: McGuire EJ, Kursh ED editor(s). Female
Urology. 1st Edition. Philadelphia, Pensylvania, USA: J B
Lippincott Company, 1994:175–201.
Papanicolaou 2005
Papanicolaou S, Pons ME, Hampel C, Monz B, Quail
D, Schulenburg MG, et al. Medical resource utilisation
and cost of care for women seeking treatment for urinary
incontinence in an outpatient setting: examples from three
countries participating in the PURE study. Maturitas 2005;
52(Supplement 2):35–47.
Petros 1990
Petros PE, Ulmsten UI. An integral theory of female urinary
incontinence. Experimental and clinical considerations.
Acta Obstetricia et Gynecologica Scandinavica. Supplement
1990;153:7–31. [PUBMED: 2093278]
Petros 1993
Petros PE, Ulmsten UI. An integral theory and its method
for the diagnosis and management of female urinary
incontinence. Scandinavian Journal of Urology and
Nephrology. Supplementum 1993;153:1–93. [PUBMED:
8108659]
Reference Manager 2012 [Computer program]
Thomson Reuters. Reference Manager Professional Edition
Version 12. New York: Thomson Reuters, 2012.
67Mid-urethral sling operations for stress urinary incontinence in women (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Rehman 2011
Rehman H, Bezerra CC, Bruschini H, Cody JD. Traditional
suburethral sling operations for urinary incontinence in
women. Cochrane Database of Systematic Reviews 2011,
Issue 1. [DOI: 10.1002/14651858.CD001754.pub3;
PUBMED: 21249648
Rogers 2003
Rogers RG, Coates KW, Kammerer-Doak D, Khalsa S,
Qualls C. A short form of the Pelvic Organ Prolapse/
Urinary Incontinence Sexual Questionnaire (PISQ-
12). International Urogynecology Journal and Pelvic Floor
Dysfunction 2003;14(3):164-8; discussion 168. [PUBMED:
12955337]
Ross 2009
Ross S, Robert M, Swaby C, Dederer L, Lier D, Tang
S, et al. Randomized trial of trans-obturator tape versus
tension-free vaginal tape for stress incontinence. Obstetrics
and Gynecology 2009;114(6):1287–94. [DOI: 10.1097/
AOG.0b013e3181c2a151; PUBMED: 19935032
Salonia 2004
Salonia A, Zanni G, Nappi RE, Briganti A, Deho F, Fabbri
F, et al. Sexual dysfunction is common in women with
lower urinary tract symptoms and urinary incontinence:
results of a cross-sectional study. European Urology 2004;45
(5):642-8; discussion 648. [PUBMED: 15082208]
Schulz 2010
Schulz KF, Altman DG, Moher D. CONSORT 2010
statement: updated guidelines for reporting parallel group
randomised trials. PLoS medicine 2010;7(3):e1000251.
[PUBMED: 20352064]
Seklehner 2014
Seklehner S, Laudano MA, Te AE, Kaplan SA, Chughtai
B, Lee RK. A cost-effectiveness analysis of retropubic
midurethral sling versus transobturator midurethral sling
for female stress urinary incontinence. Neurourology and
Urodynamics 2014;33(8):1186–92. [DOI: 10.1002/
nau.22483
Serati 2012
Serati M, Ghezzi F, Cattoni E, Braga A, Siesto G, Torella
M, et al. Tension-free vaginal tape for the treatment
of urodynamic stress incontinence: efficacy and adverse
effects at 10-year follow-up. European Urology 2012;61(5):
939–46. [PUBMED: 22305110]
Serati 2013
Serati M, Bauer R, Cornu JN, Cattoni E, Braga A, Siesto
G, et al. TVT-O for the treatment of pure urodynamic
stress incontinence: efficacy, adverse effects, and prognostic
factors at 5-year follow-up. European Urology 2013;63(5):
872–8. [PUBMED: 23274106]
Shumaker 1994
Shumaker SA, Wyman JF, Uebersax JS, McClish D, Fantl
JA. Health-related quality of life measures for women
with urinary incontinence: the Incontinence Impact
Questionnaire and the Urogenital Distress Inventory.
Continence Program in Women (CPW) Research Group.
Quality of Life Research 1994;3(5):291–306.
Smith 2002
Smith ARB, Daneshgari F, Dmochowski R, Ghoniem G,
Jarvis GJ, Nitti V, et al. Surgical treatment of incontinence
in women. In: Abrams P, Cardozo L, Khoury S, Wein A
editor(s). Incontinence. 2nd International Consultation on
Incontinence, 2001 Jul 1-3, Paris, France. Plymouth, UK:
Health Publication Ltd, 2002:823–63.
Strasberg 2009
Strasberg SM, Linehan DC, Hawkins WG. The accordion
severity grading system of surgical complications. Annals of
Surgery 2009;250(2):177–86. [PUBMED: 19638919]
Subak 2008
Subak L, Brubaker, L, Chai T, Creasman J, Diokno A,
Goode P, et al. High costs of urinary incontinence among
women electing surgery to treat stress incontinence.
Obstetrics & Gynecology 2008;111(4):899–907. [DOI:
10.1097/AOG.0b013e31816a1e12
Svenningsen 2013a
Svenningsen R, Staff AC, Schiotz HA, Western K, Sandvik
L, Kulseng-Hanssen S. Risk factors for long-term failure
of the retropubic tension-free vaginal tape procedure.
Neurourology and Urodynamics 2014; Vol. 33, issue
7:1140–6. [DOI: 10.1002/nau.22466; PUBMED:
23946255
Svenningsen 2013b
Svenningsen R, Staff AC, Schiotz HA, Western K, Kulseng-
Hanssen S. Long-term follow-up of the retropubic tension-
free vaginal tape procedure. International Urogynecology
Journal 2013;24(8):1271–8. [PUBMED: 23417313]
Tamussino 2001
Tamussino KF, Engelbert H, Kolle D, Ralph G, Riss PA.
Tension-free vaginal tape operation: results of the Austrian
registry. Obstetrics and Gynecology 2001;98(5 (Pt 1)):732–6.
Tamussino 2007
Tamussino K, Hanzal E, Koelle D, Tammaa A, Preyer O,
Umek W, et al. Transobturator tapes for stress urinary
incontinence: results of the Austrian registry. American
Journal of Obstetrics and Gynecology 2007;197(6):634–5.
Thom 1998
Thom DH, Brown JS. Reproductive and hormonal risk
factors for urinary incontinence in later life: a review of the
clinical and epidemiologic literature. Journal of the American
Geriatrics Society 1998;46(11):1411–7. [PUBMED:
9809764]
Tincello 2011
Tincello DG, Botha T, Grier D, Jones P, Subramanian D,
Urquhart C, et al. The TVT Worldwide Observational
Registry for Long-Term Data: safety and efficacy of
suburethral sling insertion approaches for stress urinary
incontinence in women. The Journal of Urology 2011;186
(6):2310–5. [PUBMED: 22014817]
Turner 2004
Turner DA, Shaw C, McGrother CW, Dallosso HM,
Cooper NJ. The cost of clinically significant urinary storage
68Mid-urethral sling operations for stress urinary incontinence in women (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
symptoms for community dwelling adults in the UK. BJU
International 2004;93(9):1246–52.
Ulmsten 1995a
Ulmsten U. Intravaginal slingplasty (IVS): an ambulatory
surgical procedure for treatment of female urinary
incontinence. Scandinavian Journal of Urology and
Nephrology 1995;29(1):75–82.
Ulmsten 1995b
Ulmsten U, Petros P. Intravaginal slingplasty (IVS): an
ambulatory surgical procedure for treatment of female
urinary incontinence. Scandinavian Journal of Urology and
Nephrology 1995;29(1):75–82. [PUBMED: 7618052]
Ulmsten 1996
Ulmsten U, Henriksson L, Johnson P, Varhos G. An
ambulatory surgical procedure under local anesthesia for
treatment of female urinary incontinence. International
Urogynecology Journal including Pelvic Floor Dysfunction
1996;7(2):81–5.
Van Oyen 2002
Van OyenH, Van Oyen P. Urinary incontinence in Belgium;
prevalence, correlates and psychosocial consequences.
Acta Clinica Belgica 2002;57(4):207–18. [PUBMED:
12462797]
Wagner 1998
Wagner T, Hu T. Economic costs of urinary incontinence in
1995. Urology 1998;51(3):355–61.
Wallace 2004
Wallace SA, Roe B, Williams K, Palmer M. Bladder training
for urinary incontinence in adults. Cochrane Database
of Systematic Reviews 2004, Issue 1. [DOI: 10.1002/
14651858.CD001308.pub2
Wang 2013
Wang Y, Zhishun L, Peng W, Zhao J, Liu B. Acupuncture
for stress urinary incontinence in adults. Cochrane Database
of Systematic Reviews 2013, Issue 7. [DOI: 10.1002/
14651858.CD009408.pub2; PUBMED: 23818069
Ward 2008
Ward KL, Hilton P. Tension-free vaginal tape versus
colposuspension for primary urodynamic stress
incontinence: 5-year follow up. BJOG : an international
journal of obstetrics and gynaecology 2008;115(2):226–33.
[PUBMED: 17970791]
Ware 1993
Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health
survey manual and interpretation guide. Boston (MA): The
Health Institute, New England Medical Centre, 1993.
Wetle 1995
Wetle T, Scherr P, Branch LG, Resnick NM, Harris T, Evans
D, et al. Difficulty with holding urine among older persons
in a geographically defined community: prevalence and
correlates. Journal of the American Geriatrics Society 1995;43
(4):349–55. [PUBMED: 7706622]
Wilson 1996
Wilson PD, Herbison RM, Herbison GP. Obstetric practice
and the prevalence of urinary incontinence three months
after delivery. British Journal of Obstetrics and Gynaecology
1996;103(2):154–61.
References to other published versions of this review
Ogah 2009
Ogah J, Cody JD, Rogerson L. Minimally invasive synthetic
suburethral sling operations for stress urinary incontinence
in women. Cochrane Database of Systematic Reviews 2009,
Issue 4. [DOI: 10.1002/14651858.CD006375.pub2;
PUBMED: 19821363
∗ Indicates the major publication for the study
69Mid-urethral sling operations for stress urinary incontinence in women (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Abdel-Fattah 2010
Methods RCT of TVT-O vs TOT-ARIS
Participants 341 women from the west of Scotland, UK, Urogynaecology tertiary referral centre
Inclusion criteria: women with USI or MUI (but with SUI as the predominant trouble-
some symptom). Women with previous incontinence surgery were included. All women
had failed or declined pelvic floor muscle training
Exclusion criteria: predominant OAB symptoms; or had specific co-morbidities such as
known neurological conditions (e.g. multiple sclerosis); diabetes; ≥ stage 2 POP-Q or
concomitant surgery, or both
There were no significant differences in participant characteristics between the 2 groups
Mean age (years): Group A: 51.5; Group B: 52.1
Mean BMI kg/m²: Group A: 28.1; Group B: 28.9
MUI: Group A: 40/170; Group B: 43/171
Previous incontinence surgery: Group A: 28/170; Group B: 18/171
Interventions Group A: TVT-O (n = 170)
Group B: TOT (n = 171)
Outcomes Primary outcome: absence of USI on UDS
Secondary outcome measures:
• patient-reported success rates on the PGI-I
• objective cure (ICS 1-hr pad test)
• subjective success on PGI-I
• bladder/urethral perforation
• voiding dysfunction
• tape erosion
• groin pain
• repeat continence surgery
• QoL assessed via: KHQ, Birmingham Bowel Urinary Symptom (BBUSQ-22)and
PISQ-12. In addition PGI-I and ICIQ-SF questionnaires.
• sexual dysfunction: PISQ-12 employed
• intermediate (3 year) subjective success on PGI-I
Notes Loss to follow up at 1 year: Group A: 18/170, Group B: 24/171
Loss to follow up at 3 years: Group A: 44/170, Group B: 59/171
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “A single-blinded, prospective, randomized
study … Women were assigned to either procedure
by random allocation (computer generated)”
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Abdel-Fattah 2010 (Continued)
Allocation concealment (selection bias) Low risk Quote: “Allocationwas concealed using opaque sealed
envelopes, which were opened by the nursing staff on
the morning of the operation”
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Quote: “a single-blinded, prospective, randomized
study…Women were informed about the type of op-
eration if they wished, for ethical considerations, but
they were instructed not to disclose this information
to the clinician at follow-up”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “Post-operative assessment at 6 months was
performed by an independent clinician who was
blinded to the type of surgery … “
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “No woman assigned to an arm asked to
change her operation or to withdraw from the study
prior to the operation. Withdrawals, unattendants
and untraceables were accounted for without signifi-
cant inter group differences”
Aigmuller 2014
Methods RCT of Gynecare TVT vs Gynecare TVT-O; Gynecare, Ethicon
Participants Trial conducted by Austrian Urogynecology Working Group in 25 gynaecology units in
Austria and Germany
554 women
Inclusion criteria: women with USI (positive cough stress test at bladder filling of 300
ml); no concomitant prolapse surgery or hysterectomy
Exclusion criteria: DO or a predominant complaint of OAB; concomitant prolapse
surgery; other major concomitant surgery (e.g. hysterectomy); previous incontinence
surgery other than colporrhaphy; residual urine ≥100 ml; neurologic disease; allergy to
local anaesthetic agents; and coagulation disorders or other contraindications for surgery
Age (years): Group A: 59.7 ± 11.3; Group B: 58.6 ± 10.7
BMI kg/m²: Group A: 27.7 ± 5.3; Group B: 28.5 ± 4.9
Parity: Group A: 2.2 ± 1.2; Group B: 2.2 ± 1.3
Interventions Group A: TVT: (n = 285; 38 of whom were lost to follow-up)
Group B: TVT-O: (n = 269; 36 of whom were lost to follow-up)
Outcomes Participants were evaluated at 3 months, with a further evaluation scheduled at 5 years
• Objective cure of SUI: defined as a negative cough stress test and stable
cystometry to 300 ml
• Subjective cure defined on PGI as ’very much better’ and ’better’
• Objective cure
• Subjective cure
• Subjective cure and improvement
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Aigmuller 2014 (Continued)
• Operating time
• Bladder perforation
• Vascular injury
• Voiding dysfunction
• Major visceral injury
• Infection
• De novo OAB
Notes QoL: Short-Form Health Survey (SF-12), EuroQol-5D (EQ-5D) condition-specific
QoL was assessed with the German language version of the KHQ, the Incontinence
Outcome Questionnaire (IOQ), and PGI-S and PGI-I
Cystoscopy was performed with all retropubic placements but not routinely with tran-
sobturator insertions
The number of women in each group seen at 5-year follow-up was not available, so the
data reported could not be used for meta-analysis
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “randomized according to a com-
puter generated
random list allocating trial identification
number
and treatment group. Randomization was
by fax through the central office”
Allocation concealment (selection bias) Low risk Quote: “computer generated random list
allocating trial identification number and
treatment group”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Patients, surgeons, andphysicians perform-
ing
follow-up exams were not blinded to the
type of surgery
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Patients, surgeons, andphysicians perform-
ing
follow-up exams were not blinded to the
type of surgery
Incomplete outcome data (attrition bias)
All outcomes
Low risk Accounted for and no differentials in the
groups in terms of loss to follow-up
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Alkady 2009
Methods RCT of TVT vs TVT-O
Participants 30 women with SUI in Kuwait Maternity Hospital
Inclusion criteria: SUI with or without a prolapse; USI with or without urethral hyper-
mobility; MUI without urodynamic DO; absence of a contractile urinary bladder or
obstruction
Exclusion criteria: acute cystitis; predominant urge incontinence; urodynamic DO;
maximum flow (Qmax) less than 15 ml/s and/or PVR urine of more than 20% of the
volume voided; genital prolapse of stage 4 or 5
Menopausal: Group A: 3/15; Group B: 4/15
Interventions Group A: TVT (n = 15)
Group B: TVT-O (n = 15)
Outcomes • Objectively cure: absence of SUI and a negative stress test
• Objective improvement: lower volume and frequency of SUI, but positive stress
test
• Objectively cure
• Objective cure & improvement
• Mean blood loss
• Mean hospital stay
• Bladder perforation
• Major vascular injury
• Voiding dysfunction
• Tape erosion
Notes No participants lost to follow-up at 6 and 12 months
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Women were randomised using numbered, opaque, sealed
envelopes containing computer-generated random alloca-
tions in a ratio of 1:1 in balanced blocks of 10
Allocation concealment (selection bias) Low risk Women were randomised using numbered, opaque, sealed
envelopes containing computer-generated random alloca-
tions in a ratio of 1:1 in balanced blocks of 10
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
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Alkady 2009 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “All accounted for”
Andonian 2005
Methods RCT comparing TVT with SPARC
Participants 84 women presenting with SUI, or SUI with MUI if cystometrogram showed normal
capacity, compliance and no uninhibited contractions. Women with previous failed anti-
incontinence surgeries or bulking agents treatments were also eligible for the study. Both
groups were similar in terms of age, severity of symptoms, 1-h pad test and preoperative
IIQ (of Shumaker)
Interventions Group A: SPARC (n = 41)
Group B: TVT (n = 43)
Outcomes Primary endpoint: objective cure defined as 1-h pad test of 2g
Secondary endpoint: QoL assessed through Shumaker’s IIQ, a score of <50 represented
good QoL, 50-70 moderate QoL, and >70 poor QoL
Notes Follow-up assessment of cure at 1 year was unavailable in 1 woman (Group B) who died
from a myocardial infarct
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “Patients were blinded to the procedure
and had envelope randomization immediately
prior to the start of the surgery”
Allocation concealment (selection bias) Low risk Adequate
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Both groups and outcome assessors were said to
have been blinded but how this was achieved was
not clear. Quote: “Patients were blinded to the
procedure and had envelope randomization im-
mediately prior to the start of the surgery”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Outcome assessors blinded, quote: “dedicated
UDS nurse (BS), who was blinded to the proce-
dure”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Addressed
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Andonian 2007
Methods RCT of TOT (Obtape) versus distal urethral polypropylene sling (DUPS) versus TVT
Participants 190 women
Inclusion criteria: womenwith SUIwith orwithout POPor pelvic surgery; previous failed
anti-incontinence surgeries or bulking agent treatments permitted; women with MUI
were not excluded as long as their cystometrogram showed normal capacity; compliance
and no uninhibited contractions
Exclusion criteria: obstruction; unstable bladder function, or neurogenic bladder; UTI
Interventions Group A: Obtape (n = 78)
Group B: DUPS (n = 32)
Group C: TVT (n = 80)
1 participant in the Obtape group had a urethral diverticulum, which was repaired, but
the Obtape procedure was cancelled, leaving 77 patients in the Obtape group for the
final analysis
Outcomes Primary outcome: objective cure defined by 1-h pad test of ≤ 2 g
Secondary outcome: subjective cure rates determined by the ICIQ-SF
Postoperatively, all women were re-evaluated by history and physical examination at 1,
6, and 12 months. At the 12-month visit, participants completed the ICIQ-SF, and
underwent the 1-h pad test conducted by the dedicated UDS nurse who was blinded to
the procedure
Notes Mentor’s Obtape is a non woven monofilament thermally bonded micropore (50 µm)
polypropylene mesh which was withdrawn by its manufacturers in 2006. There have
been many reports of tape erosions and some cases of ischiorectal abscess and necrotizing
fasciitis
DUPS is not a minimally invasive sling, but a woven polypropylene mesh (by Ethicon,
New Jersey). Absorbable sutures are used to fix the sling into position until adhesions
form and adhere it naturally to the retropubic space. As it was not a minimally invasive
sling there was no need to compare DUPS in the review
The DUPS procedure was discontinued because of a higher postoperative retention rate
combined with several complaints of suprapubic abdominal discomfort on straining
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “Randomization was performed by
an envelope method immediately before
the start of surgery.”
Allocation concealment (selection bias) Unclear risk Not mentioned
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk The patients were blinded to the procedure
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Andonian 2007 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Outcome assessors blinded, but how this
was achieved was not explained
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Unclear
Aniuliene 2009
Methods A prospective RCT of TVT-O vs TVT
Participants 264 women with SUI in Lithuania hospital setting. The degree of incontinence was 2-
3 according to the Ingelman-Sundberg scale
Inclusion criteria: women with SUI
Exclusion criteria: urogenitale prolapse greater than stage 2; urinary retention; OAB and
psychiatric problems
Post menopausal: Group A: 47/150; Group B: 48/114
Mean BMI kg/m² (SD): Group A: 28.2 (3.8); Group B: 27.9 (4.0)
Previous incontinence surgery: Group A: 18/150; Group B: 16/114
POP-Q stage 2: Group A: 29/150; Group B: 22/114
Interventions Group A: TVT-O (n = 150)
Group B: TVT (n = 114)
Outcomes • Objective cure: negative stress provocation test with 300 ml of urine in the bladder
• Subjective cure: self-reported absence of SUI with or without mild urgency
incontinence.
• Mean duration of procedure
• Mean hospital stay days
• Bladder perforation
• Post operative urinary retention
• Haematoma
Notes Urodynamics assessment was not performed in all participants
Cystoscopy and cough test were routinely performed only in the TVT group
No patients were lost to follow-up
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No information
Allocation concealment (selection bias) Unclear risk No information
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Aniuliene 2009 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Low risk No participants lost to follow-up
Araco 2008
Methods RCT of TVT-O versus TVT
Participants 240 women with different degrees of SUI
Inclusion criteria: symptomatic SUI grades 1 and 2a (McGuire classification)
Exclusion criteria: women with ISD; OAB; associated prolapses; neurovegetative disor-
ders and recurrent SUI or under rehabilitative/medical therapies
Diagnosis based on ambulatory UDS
Average age of 54 years
Interventions Group A: TVT-O (n = 120)
Group B: TVT (n = 120)
Outcomes Primary outcome: cure rate of SUI evaluated with the postoperative ambulatory urody-
namic tests 1 year after surgery
Secondary outcomes:
• operating times
• length of hospitalisation
• number of catheterization days
• postoperative pain
• other complications (haematomas, bladder obstructions/perforations, vaginal
perforations)
• number of additional operations required
A positive pad weight result was defined as > 2g of leakage
Notes The participants were classified according to the SUI system on the basis of urodynamics
studies (McGuire classification), performed at 250 ml bladder volume. SUI was classified
into 3 grades considering the severity of symptoms referred (SUI1 = loss of urine during
excessive strains, SUI2 = during minor strains, SUI3 = at rest) and the urodynamic
evaluation (McGuire classification: SUI1 = abdominal leak-point pressure (ALPP) > 90
cm water, SUI2 = ALPP of 60-90 cm water, SUI 3 = intrinsic sphincter deficiency and
ALPP < 60 cm water)
Cystoscopy was performed in all cases
Loss to follow-up: 32 women were lost to follow-up due to work commitments, Group
A:12/120 TVT, Group B: 20/120
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Araco 2008 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: ”A stratified randomisation was carried out. Pre-
sented two identical closed envelopes to patients, one
containing the paper “TVT” and the other “TVT-O”.
After choosing and opening of the envelope, further
stratification was performedwith a sampling chart. Four
groups were formed on the basis of which operation they
were going to receive.“
Allocation concealment (selection bias) Low risk Quote: ”Presented two identical closed envelopes to pa-
tients, one containing the paper “TVT” and the other
“TVT-O”
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “Data was analysed by a surgeon who was not
involved in the surgical intervention”
Incomplete outcome data (attrition bias)
All outcomes
High risk Disproportionately higher numbers lost to follow-up in
TVT-O group
Barber 2008
Methods RCT of TVT vs Monarc TOT
Participants Setting: 3 USA tertiary academic medical centres
Inclusion criteria: 170 women aged over 21 years with USI with or without concurrent
POP
Exlusion criteria: DO; previous incontinence surgery; PVR > 100 ml; desiring future
childbearing; history of hidradenitis suppurativa, inguinal lymphadenopathy, or an in-
guinal or vulvar mass; history of a bleeding diathesis or ongoing anticoagulation therapy;
current genitourinary fistula or urethral diverticulum
Mean age in years (SD): Group A: 52 (11); Group B: 53 (12)
Mean BMI kg/m² (SD): Group A: 30 (7); Group B: 29 (6)
Postmenopausal: Group A: 53/88; Group B: 58/82
Previous continence surgery: Group A: 5/88; Group B: 10/82
MUI: Group A: 76/88; Group B: 66/82
VLPP: < 60 cm/H2O: Group A: 14/88; Group B: 16/82
Interventions Group A: TVT (n = 88)
Group B: TOT (n = 82)
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Barber 2008 (Continued)
Outcomes Primary outcome: presence or absence of ’abnormal bladder function’, a composite
outcome defined as the presence of any the following: incontinence symptoms - any
type (ISI > 0), a positive cough-stress test, re-treatment for SUI or postoperative urinary
retention assessed 1-year after surgery
Secondary outcomes: assessed by use of SF12, PISQ-12, bladder diary at 12 and 24
months:
• subjective cure (self-reported)
• objective cure (negative cough stress test)
• mean operating time
• bladder perforation
• major vascular injury
• tape erosion
• de novo urgency/UUI
• voiding dysfunction
• re-operation
• QoL: overall improvement in QoL and sexual function scores at follow-up
assessments compared with preoperative baseline scores. No difference between the
groups. Used PFDI-20, PFIQ-7, PISQ-12
• sexual dysfunction assessed using PISQ-12. Scores improved post operatively and
at 12 months follow up in both groups, though the relative change in scores post-
operatively was small (1.9%) showing moderate responsiveness to incontinence specific
outcome measures. There was no significant difference reported between the two
groups.
Notes Intraoperative cystoscopy performed in both groups
Concomitant surgery performed in Group A: 48/88; Group B: 45/82
Loss to follow-up: Group A: 3/88; Group B: 7/82
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “were randomised using computer generated
random allocation”
Allocation concealment (selection bias) Low risk Quote: “group assignment were concealed in consec-
utively numbered sealed opaque envelopes”
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Quote: “blinding of surgeon and participants was not
possible ...”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “all post op assessments were performed by
research nurses who were blinded to treatment given”
Incomplete outcome data (attrition bias)
All outcomes
Low risk All accounted for
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Barry 2008
Methods RCT of TOT (Monarc) versus TVT
Random allocation of participants but method of sequence generation and allocation
concealment not described
Participants 140 women diagnosed with USI
Participants in both groups had similar background characteristics including age, BMI,
parity, HRT use, menopausal status, previous incontinence surgery, prolapse etc
Inclusion criteria: participants had either failed conservative management for symp-
tomatic stress incontinence or required prophylactic incontinence surgery during pro-
lapse repair for occult stress incontinence (no preoperative subjective complaint of uri-
nary stress leakage but found to have USI)
Exclusion criteria: significant voiding dysfunction (maximum urine flow rate < 10th
percentile according to Liverpool nomogram and PVR volume > 50 ml); known allergy
to polypropylene; immunosuppressant therapy and a past history of neurological disease;
urogenital malignancy; fistula or pelvic radiotherapy
Interventions Group A: TOT (n = 58)
Group B: TVT (n = 82)
Outcomes Outcomes included Immediate- and short-term complications, cure rates and patient
satisfaction
Primary outcome: reduction in incidence of bladder injury
Secondary outcomes:
• other intra-operative complications
• improvement of symptomatology
• incontinence impact
• improvement in incontinence episodes and pad usage
• objective improvement on UDS: defined as no visible leakage on coughing at the
external urethral meatus
• postoperative complications, such as sling erosion;
• blood loss: surgeon’s subjective estimate of blood volume lost
• sexual dysfunction via the BFLUTS questionnaire
Improvement of a particular symptom denoted at least 50% reduction in frequency of
occurrence in 3-day bladder diary when compared to preoperative state
Measures used for assessment included:
• symptomatology (using standardised, validated BFLUTS)
• incontinence impact (using standardised, validated short IIQ-7)
• 3-day bladder diary findings and pad usage
• clinical examination findings (POP-Q ICS)
• UDS findings
Notes 23 women from the TVT group and 21 from TOT group were lost to follow-up. Thus,
at follow-up complete data set available for 82 women in TVT group and 58 in the
TOT group. There were no differences between the group unavailable for analysis when
compared to those finally analysed
No mention of intraoperative cystoscopy in either group
Risk of bias
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Barry 2008 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Participants were blinded and randomly al-
located in a balanced way (blocks of 20)
Randomisation was stratified according to
a history of previous incontinence surgery
Allocation concealment (selection bias) Unclear risk Unclear
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Participants were blinded. How this was
achieved was not explained
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Low risk No differential loss to follow-up or differ-
ential attrition
But 2008
Methods RCT of TVT-O versus TOT (Monarc)
Participants 120 women with SUI (31) and MUI (89)
Inclusion criteria: women with SUI, or MUI, with SUI as the predominant symptom
Exclusion criteria: MUI with predominant UUI
Performed under local anaesthesia
Mean age years (SD): 52.6 (6.8)
Interventions Group A: TVT-O (n = 60)
Group B: TOT (n = 60)
Outcomes • Objective cure rates: negative pad test
• Subjective cure rates: absence of reported SUI
• Post operative voiding difficulties
• Tape erosion
• Duration of operation
• Duration and intensity of postoperative pain according to a modified VAS
• QoL (UDI) significantly improved post operatively in each group with no
significant intergroup difference.
Notes Follow-up 3 months
All women attended for follow-up
Risk of bias
Bias Authors’ judgement Support for judgement
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But 2008 (Continued)
Random sequence generation (selection
bias)
Low risk Quote: “Before the beginning of the study,
the computer-generated list of 120 random
numbers (from one to 120) was made for two
groups (60 random numbers for each group,
optimum allocation ratio 1)”
Allocation concealment (selection bias) Unclear risk Quote: “the consecutive study numbers were
given after admission, and based on this ad-
mission number, either inside-out or outside-
in procedure was selected later in the OR ac-
cording to a computer- generated list of ran-
dom number”
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Low risk All data/information accounted for at follow-
up
Cervigni 2006
Methods RCT of TVT versus Monarc TOT
Participants 118 women
Inclusion criteria: women with SUI and POP-Q ≥ stage 2
Mean age 57.43 years
All women had cystocoele repair and levator myorraphy
73 women were post menopausal
Interventions Group A: TVT
Group B: TOT
(exact numbers in each group not reported)
Outcomes Cure rates: TVT (98.3%), TOT (97.1%) as exact number of women in each group was
not given there were no data that could be extracted
Intraoperative and postoperative complications
Notes Numbers in each group unreported. It was, thus, impossible to abstract results
Risk of bias
Bias Authors’ judgement Support for judgement
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Cervigni 2006 (Continued)
Random sequence generation (selection
bias)
Low risk Women randomised into 2 groups (computer gen-
erated randomisation list)
Allocation concealment (selection bias) Unclear risk No information
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No information
Chen 2010
Methods RCT comparing TVT, TOT and TVT-O
Participants 187 women
Inclusion criteria: women with urodynamically proven SUI in the urology department
of a Chinese hospital
Interventions Group A: TVT (n = 77)
Group B: TOT (n = 45)
Group C: TVT-O (n = 65)
Outcomes • Objective cure: negative stress test
• Mean operative time in minutes
• Mean postoperative hospital stay days (SD)
• Bladder perforation
• Vascular injury
• Voiding dysfunction
Notes No quality of life measures undertaken
Cystoscopy performed in TVT group
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No information
Allocation concealment (selection bias) Unclear risk No information
83Mid-urethral sling operations for stress urinary incontinence in women (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Chen 2010 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No information
Chen 2012
Methods RCT of TVT vs TVT-O
Recruitment Feb 2009-Feb 2010
Participants 205 women with SUI
Inclusion criteria: women with urodynamically proven SUI with or without prolapse
Exclusion criteria: DO; MUI
All women had similar background characteristics
Interventions A: TVT (n = 102)
B: TVT-O (n = 103)
Outcomes Follow-up 12-24 months
• Objective cure: negative pad test and stress test
• Objective cure
• Cure and improvement
• Operative time
• Blood loss (ml)
• Length of stay (days)
• QoL via questionnaires
• Adverse effects:
◦ Bladder injury
◦ Voiding dysfunction
◦ Groin pain
Notes Needs translation for further information
Article written in Chinese and translated to English for interpretation and extraction
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Stated: ‘randomly allocated ’
Allocation concealment (selection bias) Unclear risk Stated: ‘randomized’
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Chen 2012 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No information
Cho 2010
Methods RCT of Monarc system and TOT system
Participants 93 women having urodynamic evaluation
Interventions Group A: Monarc TOT (n = 48)
Group B: TOT (n = 45)
Outcomes Outcomes assessed 12 months postoperatively
• Subjective cure
• Voiding dysfunction
• Tape erosion
Notes Monarc is outside-to-in TOT with open edge polypropylene mesh that contains an
absorbable tensioning suture threaded into the length of the mesh. The tension free
obturator tape (TOT) system used here is the same outside-in type, but has a closed edge
polypropylene mesh without absorbable tensioning suture
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “93 female patients were prospec-
tively, randomly assigned to the study”
Allocation concealment (selection bias) Unclear risk No information
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
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Cho 2010 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No information
Choe 2013
Methods RCT OF TVT vs TOT
Participants 41 women
Inclusion criteria: women with SUI; able to complete a questionnaire
Exclusion criteria: prior spine surgery; back pain; scoliosis; traumatic spine injury; neu-
rological disease; or hip or knee surgery
Interventions 41 women, number in each group was not given
Outcomes Postoperative pain was assessed using a 10-point visual analogue scale (VAS) at fixed
time-points: 30 minutes, 3hr and 24hr after surgery
Length of procedure (minutes)
Notes We were not able to use the data provided, as the number in each group was not specified
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “were randomized to receive”
Allocation concealment (selection bias) Unclear risk No information
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No information
Darabi Mahboub 2012
Methods RCT of TOT versus TVT
Participants Women with SUI
Age in years (SD): Group A: 52.02 (0.88); Group B: 52.27 (7.34)
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Darabi Mahboub 2012 (Continued)
Interventions Group A: TOT (n = 40)
Group B: TVT (n = 40)
Outcomes A validated stress and urge incontinence questionnaire
24-h pad test
6-month follow-up of ICIQ
Operative time
Mean hospital stay
Notes Intraoperative cystoscopy not mentioned in either group
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “In this randomised clinical trial, eighty female pa-
tients with SUI were randomly allocated to “
Allocation concealment (selection bias) Unclear risk No information
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No information
David-Montefiore 2006
Methods RCT comparing TOR and RTR of sling procedures for SUI using the I-STOP device
Participants Multicentre (3 gynaecology and 2 urology departments in France)
88 women
Inclusion criteria: women > 18 years with SUI, proven by clinical and urodynamic
examinations, or MUI
Exclusion criteria: women with previous history of radio- or chemotherapy; on antico-
agulant or antipsychotic treatment; or pregnant
Mean age: Group A: 58.8 years; Group B: 53.4 years
Interventions Group A: RPR (n = 42)
Group B: TOR (n = 46)
The I-STOP device (CL Medical, Lyon, France) was used for both the RPR and the
TOR procedures
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David-Montefiore 2006 (Continued)
Outcomes • Objective cure (success or improved):
◦ participants considered cured (success) if they had no stress incontinence by
clinical and urodynamic examinations, no incontinence during the stress provocation
test, and no urinary retention or a residual urine volume of < 150 ml
◦ participants were considered cured (improved) if no incontinence occurred
during stress provocation test. All other cases were considered failures
• QoL via validated questionnaires: UDI, IIQ at first postoperative visit (4-6 weeks
after surgery), and 3, 6, 12, and 24 months postoperatively. Quality of life as measured
by UDI and IIQ questionnaires showed significant improvement following both RPR
and TOR tape insertion at 1 year. At 4 yr review, there was a reduction in the initial
improvement in quality of life.
• Reported results for within 1 year, though follow-up was at 1, 3, 6 and 12 months
and 4 years
• De novo urgency and urge incontinence
Notes Loss to follow-up at 4 years: Group A: 8/42; Group B: 9/46
Length of follow-up ranged from 48 months to 61 months (RPR) and 48 months to 63
months (TOR)
The mean follow-up was 10 months, with 37 women having 6 months of follow-up and
51 women having at least 12 months of follow-up
Cystoscopy was performed for both procedures
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “ ... Prospective randomised Multicentre
study .... using a predetermined computer
generated randomisation code ...”
Allocation concealment (selection bias) Low risk Surgeon informed of allocated procedures
by an uninvolved third-party immediately
before the operation
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Unclear
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Unclear
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de Leval 2011
Methods QRCT of TVT-O vs modified TVT-O
Participants 175 women
Inclusion criteria: women aged 25-85 years with USI;
positive stress test with at least a maximum cystometric capacity of 300 ml
Exclusion criteria: DO or detrusor acontractility; neurogenic bladder; or POP stage 3 or
above
Mean age years (SD): Group A: 60.0 (11.7); Group B: 57.2 (2.7)
BMI kg/m² (SD): Group A: 26.4 (4.8) Group B: 26.8 (5.3)
Previous surgery for SUI: Group A: 4/87; B Group: 4/88
Previous surgery for POP: Group A: 4/87; Group B: 2/88
Interventions Group A: TVT-O (n = 87)
Group B: modified TVT-O (n = 88)
Outcomes At 1 -year follow-up:
• objective cure: negative cough test
• subjective cure: disappearance of SUI using symptom scoring system
• subjective cure and improvement:
• Intraoperative complications
• de novo urgency
• mesh erosion
• groin pain
At 3-year follow-up:
• objective cure: negative cough test
• subjective cure
Notes The modified TVT-O was shortened to a total tape length of 12 cm and had a reduction
in the depth of lateral dissection, the obturator membrane was not perforated with the
scissors or the guide
Follow-up assessments carried out at 1, 6, 12 months, and 3 years
Lost to follow-up:
• at 1 year: Group A: 3/87; Group B: 2/88
• at 3-year follow-up: Group A: 13/87; Group B: 9/88
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Quote: “The randomisation process was per-
formedwith five sequential patients undergo-
ing one approach before alternating surgical
modality”
Allocation concealment (selection bias) Unclear risk No information
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Patients were blinded to the type of surgery
they underwent
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de Leval 2011 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “no patients withdrew from the study
prior to their operation”. 2 participants were
completely lost to follow-up after the 1-
month visit and 2 more after the 6-month
visit. One patient died before the 6-month
visit; the cause of death was unrelated to the
surgery
de Tayrac 2004
Methods RCT comparing TVT with TOT
Participants 61 women
Inclusion criteria: USI
Exclusion criteria: predominant urge incontinence; urodynamic detrusor instability; or
prolapse
Mean age (years; SD): Group A: 54.7 (11.9); Group B: 53.6 (12.5)
Mean BMI kg/m² (SD): Group A: 24 (3.2); Group B: 25.2 (4.3)
Postmenopausal status: Group A: 18/30; Group B: 16/31
Previous continence surgery: Group A: 4/30; Group B: 1/31
Previous prolapse surgery: Group A: 4/30; Group B: 1/31
ISD: Group A: 4/30; Group B: 3/31
Interventions Group: A: TOT (n = 30)
Group: B: TVT (n = 31)
Outcomes • Subjective cure
• Objective cure (negative cough stress test)
• Objective cure and improvement
• Mean operating time
• Mean length of hospital stay
• Bladder perforation
• Vaginal tape erosion
• Urethral tape erosion
• De novo urgency/UUI
• Voiding dysfunction
• Sexual dysfunction measured using mean VAS score. No significant difference
between the 2 groups in terms of improvement of sexual function
Notes The full article was retracted at the request of authors because appropriate ethics com-
mittee approval was not received prior to starting study. Nevertheless, participants did
give written consent to be included in the trial and consented for the procedures. No
methodological flaws were identified: the review authors therefore decided to include
the data
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de Tayrac 2004 (Continued)
TOT: Uratape mentor-porges
Cystoscopy performed following TVT procedure
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Women were randomised using numbered, opaque
sealed envelopes containing computer-generated
random allocations in a ratio of 1:1 in balanced
blocks of 10. Envelopes were opened in the operat-
ing room by a nurse just before starting the proce-
dure
Allocation concealment (selection bias) Low risk Adequate
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Outcome assessors were blinded
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No information
Deffieux 2010
Methods RCT of TVT and TVT-O
Participants Multicentred RCT, 14 centres in France (university hospitals and 3 general hospitals)
149 women with SUI
Inclusion criteria: age >18 years; isolated or mixed USI; indication for surgical treatment
of USI; positive cough stress test
Exclusion criteria: concomitant POP surgery; concomitant hysterectomy; previous in-
continence surgery; pregnancy; anticoagulant therapy; higher than stage 1 urogenital
prolapse (POP-Q ICS)
All women had similar background characteristics
Mean age (years; SD): Group A: 54.6 (10.9); Group B: 52.8 (9.8)
Mean BMI kg/m² (SD): Group A: 26.3 (4.5); Group B: 26.3 (5.7)
Postmenopausal: Group A: 43/75; Group B: 40/74
POP-Q stage 1: Group A: 245/75; Group B: 24/74
Interventions Group A: TVT (n = 75)
Group B: TVT-O (n = 74)
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Deffieux 2010 (Continued)
Outcomes Outcomes assessed at 2, 6, 12 and 24 months
• Subjective cure: self-reported via questionnaires
• Objective cure: negative cough stress test
• Bladder injury
• Major vascular injury
• Tape erosion
• Voiding dysfunction
• Groin/suprapubic pain
• Re-operation rates
• QoL and sexual function: CONTILIFE questionnaire and use of VAS to
determine sexual activity satisfaction and reported dyspareunia
Notes Cystoscopy performed in both groups
Loss to follow-up: at 12 months: Group A: 6/75; Group B: 5/74
Loss to follow-up at 24 months: Group A: 8/75; Group B: 9/74
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “The patients were randomized using sealed
opaque envelopes, following computer-generated random
allocations”
Allocation concealment (selection bias) Low risk Quote: “The patients were randomized using sealed
opaque envelopes, following computer-generated random
allocations, with a ratio of 1:1 in balanced blocks of four.
The envelopes were opened just before each participant’s
surgical procedure”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Quote: “blinding of surgeons and participants not possi-
ble”
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Low risk Data complete
Diab 2012
Methods RCT of TOT vs TVT
Participants 70 women with SUI
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Diab 2012 (Continued)
Interventions Group A: TOT (n = 31)
Group B: TVT (n = 32)
Outcomes • Cure rates
• Voiding dysfunction
• De novo urgency
• Reoperation rate
• Postoperative groin/thigh pain
• Impact of incontinence on QoL assessed by I-QoL questionnaire
• Operative time
• Estimated blood loss
• Operative complications
• Retropubic haematoma
• Vaginal tape extrusion
Notes Mean follow up in months (SD): A: 28 (12.3) and B: 26 (13.6)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “were randomly distributed to two groups”
Allocation concealment (selection bias) Unclear risk No information
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No information
El-Hefnawy 2010
Methods RCT comparing Gynecare TVT R and Aris TOTR outside-in
Participants 40 women
Inclusion criteria: women with urodynamically proven SUI
Exclusion criteria: women who reported urgency incontinence as predominant com-
plaint; had pelvic or vaginal surgery within the preceding 6 months; had associated
urethral and/or bladder pathology or active UTI; neuropathic bladder; POP > stage 2
(Baden Walker classification)
Mean age (years; SD): Group A:47 (5); Group B: 45 (7)
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El-Hefnawy 2010 (Continued)
Concomitant POP stage 1-2: Group A: 10; Group B: 13
Mean BMI kg/m² (SD): Group A: 34 (5); Group B: 32(5)
Interventions Preliminary results:
Group A: TVT: (n = 19)
Group B: TOT: (n = 21)
At 24 months:
Group A: TVT: (n = 45)
Group B: TOT: (n = 42)
Outcomes Follow-up at 3, 6, 12 and 24 months
• Objective cure: negative stress test, 1-h pad test <2g, and no re-treatment for stress
incontinence
• 12 months negative stress test
• 24 months negative stress test
• 24 months negative 1hr pad test
• Subjective cure: no reported SUI
• Mean operative time
• Mean blood loss
• Vascular injury
• Bladder injury
• Groin pain (no report of suprapubic pain)
• Tape erosion
• De novo urgency
• QOL measured using UDI-6 and IIQ-7 at baseline, 12 and 24 months
Notes Intraoperative cystoscopy carried out only in the TVT group to exclude bladder or
urethral injury
Concomittant surgery was performed in 9 participants; 5 participants underwent ab-
dominal hysterectomy, 4 participants underwent anterior colporrhaphy
Lost to follow-up at 12 months: Group A: 0/19; Group B: 0/21
Lost to follow-up at 24 months: Group A: 9/45; Group B: 7/42
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Patient’s randomisation is accomplished
through closed envelopes. A randomly se-
lected envelope is dispatched to a running
nurse with the patient’s name and ID hand
typed on the envelope”
Allocation concealment (selection bias) Low risk Quote: “randomisation is accomplished
through closed envelopes. A randomly se-
lected envelope is dispatched to a running
nurse with the patient’s name and ID hand
typed on the envelope”
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El-Hefnawy 2010 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “Follow up was carried out by a
nurse blinded to the procedure”
Incomplete outcome data (attrition bias)
All outcomes
Low risk All outcomes included
Elbadry 2014
Methods RCT of adjustable TOT vs TOT
Participants 96 women with SUI, with a mean age of 53 + 9.9 years
Interventions Group A: adjustable TOT (n = 48)
Group B: TOT: (n = 48)
Outcomes • Cure
• Mean operative time
• Operative blood loss
• bladder injury
• number of tape ajdustments
• Length of hospital stay
Notes The advantage of the adjustable tape is that it can be adjusted postoperatively to address
over- or under-correction
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “Patients were randomized into 2 equal
groups”
Allocation concealment (selection bias) Unclear risk No information
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
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Elbadry 2014 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No information
Enzelsberger 2005
Methods QRCT comparing TVT and TOT
Participants 110 women
Inclusion criteria: women with SUI, all had preoperative stress test
Exclusion criteria: previous surgery for SUI;mixed incontinence; renal disease; metabolic
disorders; or POP
Mean age was 51 years
Interventions Group A: TOT (n = 56)
Group B: TVT (n = 54)
Outcomes • Operative time
• Objective cure rate
• Operative complications
• Bladder perforation
• Voiding dysfunction
• Detrusor overactivity
• Tape erosion
• Groin pain
Notes No mention of intraoperative cystoscopy
Followed-up at 15 months
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Quasi-RCT
Allocation concealment (selection bias) High risk Inadequate
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No information
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Freeman 2011
Methods RCT comparing TOT and TVT
Participants Multicentre RCT - 21 centres across the UK
192 women
Inclusion criteria: women >21 years of age; USI or MUI for which SUI was the predom-
inant symptom; must have failed with conservative measures
Exclusion criteria: women with neurological disease; previous surgery for USI (those
with previous prolapse surgery were not excluded); urodynamic DO or low compliance;
POP extending beyond the hymen
Interventions Group A: Monarc TOT (n = 100)
Group B: Gynaecare TVT (n = 92)
Outcomes Follow-up at 4 weeks, 6 months and 12 months
• Subjective cure: self-reported via response to ICIQ-FLUTS questionnaire:
• Mean operation time
• Operative blood loss
• Bladder perforation
• Vaginal perforation
• Tape erosion
• Voiding dysfunction
• De novo OAB
• Groin pain
• Sexual function: assessed via ICIQ-LUTSqol scores.
Notes The trial was a non-inferiority design. Outcome measures calculated by intention-to-
treat
Assessed via ICIQ-FLUTS long form, ICIQ
LUTSqol; KHQ questionnaires and 4-day urinary diary
Sexual function assessed by ICIQ-LUTSqol question, ‘does your urinary problem affect
your sex life?’
Cystoscopy: not mentioned whether routinely performed in either group
Lost to follow-up: Group A: 5/100; Group B: 7/92 (and 1 excluded as she did not have
the operation)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “randomisation list was stratified by study
sites, using
randomly permuted blocks of varying sizes of 4, 6
and 8”
Allocation concealment (selection bias) Low risk Quote: “The study co-ordinator placed a treatment
into consecutively
numbered opaque envelopes whichwere opened im-
mediately before surgery by someone other than the
surgeon. Allocation concealment was therefore en-
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Freeman 2011 (Continued)
sured”
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Quote: “Patients and ward staff were blinded to the
intervention group by ensuring that dressings were
applied both suprapubically and to the obturator
areas”
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Low risk Patients and their data accounted for
Hammoud 2011
Methods RCT of TVT vs TVT-O
Participants 110 women with SUI
Interventions Group A: TVT (n = 60)
Group B: TVT-O (n = 50)
Outcomes Subjective cure:
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “in a prospective randomized trial ... women were
randomized between TVT and TVT-O for treatment”
Allocation concealment (selection bias) Unclear risk No information
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No information
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Hassan 2013
Methods RCT of inside-out TOT vs outside-in TOT
Participants 250 women
Inclusion criteria: women with SUI in a university teaching hospital in Cairo, Egypt
Interventions Group A: inside-out TOT (n = 125)
Group B: outside-in TOT (n = 125)
Outcomes Primary outcomes:
• improvement of stress incontinence symptom and signs
• intraoperative time
• intra- and postoperative complications
Secondary outcomes:
• recurrence of stress incontinence at 12 months
• subjective cure at 12 months
• vascular injury/haematoma
• groin/thigh pain
• tape erosion
Notes Lost to follow-up: Group A: 23/125; Group B: 28/125
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “A prospective single-blinded ran-
domised trial”
Allocation concealment (selection bias) Unclear risk No information
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No information
Houwert 2009
Methods RCT of TVT-O and TOT (Monarc)
Participants 191 women
Inclusion criteria: women with SUI, USI and MUI. Those with MUI failed anti-cholin-
ergic medical treatment before surgical treatment
Exclusion criteria: women with recurrent UTIs; those with predominantly symptoms of
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Houwert 2009 (Continued)
UUI; post voiding residuals of > 150 ml and bladder capacity < 100ml
There was no concomitant POP surgery
Preoperative multichannel urodynamic investigation was carried in all women
Mean age (years; SD): Group A: 49.2 (8.9); Group B: 49.5 (10.3)
SUI: Group A: 74/93 (80%); Group B: 74 /98 (76%)
MUI: Group A: 19/93 (20%); Group B: 23/98 (24%)
Postmenopausal: Group A: 33/93; Group B: 34/98
Previous incontinence surgery: Group A: 8/93; Group B: 9/98
Previous POP surgery: Group A: 19/93; Group B: 15/98
Urethral hypermobility: Group A: 80/93; Group B: 90/98
POP ≥ grade 1: Group A: 25/93; Group B: 24/98
ISD: Group A: 5/93; Group B: 1/98
DO: Group A: 5/93; Group B: 7/98
Interventions Group A: TVT-O (n = 93)
Group B: Monarc TOT (n = 98)
Outcomes • Cure of SUI: defined as woman stating she did not experience any loss of urine
upon physical exercise
• QoL measured with validated Dutch short forms of the IIIQ-7 and the UDI-6
• Subjective cure at 12 months (short term): A: 66/86, B: 73/95
• Subjective cure and improvement at 12 months (short term)
• Subjective cure at 2-4years (medium term)
• Subjective cure and improvement at 2-4years (medium term)
• Operating time
• Voiding dysfunction at 2 months
• Vaginal tape erosion at 12 months
• Thigh pain
• De novo urgency/UI
• Repeat incontinence surgery
• QOL: Assessed using IIQ-7 and UDI-6
• Sexual dysfunction
Notes No concomitant urogynaecological surgery performed
Follow-up occurred at 12 months and at 2 -4 years
Loss to follow-up at 12 months: Group A: 15/39; Group B: 14/36
Loss to follow-up at 4 years: Group A: 18/93; Group B: 12/98
Cystoscopy was performed only when bloody urine was encountered
Analysis of cure used the numbers that completed follow-up as denominator
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “Women with an indication for surgical
treatment of SUI were at random assigned to
either TVT-O orMonarc...”(from abstract Ver-
vest HAM 2005)
100Mid-urethral sling operations for stress urinary incontinence in women (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Houwert 2009 (Continued)
Allocation concealment (selection bias) Unclear risk No information
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No information
Jakimiuk 2012
Methods RCT comparing TVT and TVT-O: POLTOS study
Participants Multicentre RCT in Poland
35 women
Inclusion criteria: women with urodynamically proven (bladder filled to a minimum of
300 ml) SUI; no prior incontinence surgery
Exclusion criteria: women with UTI; BMI > 33 kg/m²; previous hysterectomy; neuro-
logical incontinence; POP; PVR > 150 ml; OAB and MUI
Age: 40-80 years
Interventions Group A: TVT (n = 19)
Group B: TVT-O (n = 16)
Outcomes • Subjective cure: self-reported
• Objective cure: negative cough test and pad test
• Bladder perforation
• Voiding dysfunction
• Vascular injury
• Mean procedure time
• Mean hospital stay
• QoL: used non-validated KHQ and validated SF-36 questionnaires.
Notes Follow-up at 6 months
Cystoscopy was performed in both groups
Lost to follow-up:GroupA: 4/19;GroupB: 0/16 (3 participants with bladder perforation
had the tape removed and were excluded)
Risk of bias
Bias Authors’ judgement Support for judgement
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Jakimiuk 2012 (Continued)
Random sequence generation (selection
bias)
Low risk Quote: “The randomisation was done
through a web page secured with a 128-bit
code”
Allocation concealment (selection bias) Unclear risk No information
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Quote: “every patient had extra skin in-
cisions for masking the type of procedure
(“shamoperation”). Each patient had4 skin
incisions in localization typical for needle
introduced in TVT and TVT-O proce-
dure”
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Information not clear
Juang 2007
Methods RCTof trans-obturator tension-free vaginal tape (TVT-O) versus TVT-Owithmodified
Ingelman-Sundberg (IS) procedure
Participants 96 women
Inclusion criteria: women with MUI after poor response to medical treatment
DO at baseline: Group A: 19/43; Group B: 15/49
Post menopausal: Group A: 32/43; Group B: 27/49
Interventions Group A: TVT-O (n = 47)
Group B: TVT-O plus IS: (n = 49)
Outcomes • Objective cure: defined as 1-h pad test < 2g and complete discontinuation of
antimuscarinic medication
• Objective improvement: defined as improvement of urine leakage on pad test or
decreased dosage of antimuscarinic medication
• Blood loss
• Operating time
• Mean hospital stay
• Bladder perforation
• Major vascular injury
• Tape erosion
• Post operative complications
• QOL: assessed with IIQ-7 and UDI-6
Follow-up QOL scores: Both IIQ-7 and UDI-6 demonstrated a significant decrease at
the
3-months follow-up in the TVT-O plus IS group. Scores remained relatively stable after
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Juang 2007 (Continued)
3 months of follow-up and until the end of the study
Notes The IS bladder denervation procedure is designed to disrupt most of the innervations
from the inferior hypogastric plexus to the bladder to treat refractory urgency or urge
incontinence (the vaginal epithelium and perivesical fascia were dissected off the trigone.
The plane of dissection was just within the serosal layer of the bladder. Lateral and
posterior sharp dissection was performed to obtain more extensive division in the area
of the terminal branches of the pelvic nerve)
Follow-upwas at 12-months, but urodynamic profilewas repeated at the 3-month follow-
up
Loss to follow-up: Group A: 2/47; Group B: 1/49
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “After an objective evaluation, 96
eligible patients were randomised”
Allocation concealment (selection bias) Unclear risk No information
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No information
Kamel 2009
Methods RCT of TVT vs TVT-O
Participants 120 women
Inclusion criteria: women with urodynamically proven SUI and urethral hypermobility
Exclusion criteria: not defined
Interventions A: TVT (n = 60)
B: TVT-O (n = 60)
Outcomes • Objective cure
• Bladder perforation
• Vascular injury
• Mean operative time
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Kamel 2009 (Continued)
Notes TVT group underwent cystoscopy
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Stated: “randomised”
Allocation concealment (selection bias) Unclear risk No information
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No information
Karateke 2009
Methods RCT comparing TVT and TVT-O
Participants 167 women
Inclusion criteria: women with urodynamically proven SUI
Exclusion criteria: urogenital prolapse > stage 1 (POP-Q); DO; symptoms of OAB;
urinary retention; previous anti-incontinence surgery including anterior colporrhaphy
and neurological bladder
Mean age (years; SD): Group A: 49.31 (5.00); Group B: 49.08 (4.93)
Postmenopausal: Group A: 16/83; Group B: 14/84
Mean BMI kg/m² (SD): Group A: 25.99 (1.27); Group B: 26.18 (1.88)
Interventions Group A: TVT (n = 83)
Group B: TVT-O (n = 84)
Outcomes • Subjective cure (very satisfied and satisfied)
• Obective cure (negative cough test at cystometry)
• Mean operative time
• Vascular injury/haematoma
• Bladder perforation
• Tape erosion
• Voiding dysfunction
• De novo UI
• De novo DO
• Mean hospital stay
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Karateke 2009 (Continued)
• Time to return to normal activity
• QOL: IIQ-7 and UDI 6 questionnaires
Notes Cystoscopy only performed in TVT group
Lost to follow-up: Group A: 2/83; Group B: 1/84
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “predetermined computer-generated ran-
domisation code”
Allocation concealment (selection bias) Unclear risk No information
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “two independent physicians blinded to
the different procedures”
Incomplete outcome data (attrition bias)
All outcomes
Low risk All data included
Kilic 2007
Methods RCT of TVT vs TOT
Participants 20 women
Inclusion criteria: women with SUI confirmed on urodynamics
Mean age (years; SD): Group A: 55.8 (13.7); Group B: 60.2 (12.2)
Interventions Group A: TVT (n = 10)
Group B: TOT (n = 10)
Outcomes • Primary outcome: Subjective cure: improvement of urinary incontinence (after
coughing, laughing and during stairs climbing)
• Mean operative time
Notes None lost to follow-up
Follow-up assessment at 12 months
Risk of bias
Bias Authors’ judgement Support for judgement
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Kilic 2007 (Continued)
Random sequence generation (selection
bias)
Unclear risk No information
Allocation concealment (selection bias) Unclear risk No information
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No information
Kim 2004
Methods RCT comparing the IRIS (Innovative Replacement of Incontinence Surgery) tape with
TVT and SPARC procedure
Participants 96 women with SUI were randomised
Interventions Group A: TVT (n = 32)
Group B: SPARC (n = 30)
Group C: IRIS (n = 34).
All 3 groups had comparable background characteristics
Outcomes • Subjective cure
• Objective cure
• Operating time
• Length of hospital stay
• Perioperative complications
• Bladder perforation
• Voiding dysfunction
• De no urgency/urgency urinary incontinence
• Vaginal tape erosions
Notes Follow-up was for 1 year
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “In this controlled, prospective,
randomised study ....”
Allocation concealment (selection bias) Unclear risk No information
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Kim 2004 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No information
Kim 2005
Methods RCT comparing Monarc TOT with SPARC retropubic tape
Participants 130 women
Inclusion criteria: women with SUI with similar background characteristics
Preoperative assessment included the use of voiding diaries, stress and pad tests, and
urodynamics
Mean age (years; SD): Group A: 45.7 (9.8); Group B: 45.4 (12.4)
Interventions Group A: Monarc (TOR; n = 65)
Group B: SPARC (RPR; n = 65)
Outcomes • Subjective and objective cure assessed via questionnaires and UDS respectively
• Stress and pad test and uroflowmetry with PVR
• Operative time in mins
• Perioperative complications
• Bladder perforation
• Voiding dysfunction
• De no urgency/urgency urinary incontinence
• Vaginal tape erosion
• Bladder erosion
Notes Follow-up at 3 months. Cystoscopy only in the TVT group
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “43 women withUI were randomly
assigned...”
Allocation concealment (selection bias) Unclear risk No information
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
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Kim 2005 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No information
Krofta 2010
Methods RCT of TVT vs TVT-O
Participants 300 women
Inclusion criteria: women with SUI after failed conservative treatment. All confirmed on
a positive stress test (cough provocation). Women with symptoms of MUI were included
if SUI was the predominant symptom
Exclusion criteria: DO; previous incontinence, POP surgery, or pelvic radiotherapy;
POP-Q ≥ stage 2; PVR > 100 ml; preoperative use of anticholinergics; need for con-
comitant surgery
Cough provocation test, multichannel UDS, urethral pressure profilometry and uroflom-
etry were done preoperatively and at 12-month follow-up
Interventions Group A: TVTT M (n = 149)
Group B: TVT -OTM (n = 151)
Outcomes • Objective cure (negative stress cough provocation test with 300 ml of saline in the
bladder during UDS and 1-hour pad test weight < 5g)
• Subjective cure (self-reported absence of SUI)
• Subjective improvement (women’s perception of urine loss less than the
presurgical loss)
• De novo urge/urgency urinary incontinence
• Duration of operation
• Mean blood loss
• Haematoma
• Groin/suprapubic pain
• Tape erosion/extrusion
• Quality of life: ICIQ UI- SF and CONTILIFE questionnaires used
• Sexual dysfunction: assessed using PISQ-12
Notes All women with TVT had intraoperative cystoscopy but this was not performed in those
with TVT-O
Loss to follow-up: Group A: 8/141; Group B: 4/147
Risk of bias
Bias Authors’ judgement Support for judgement
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Krofta 2010 (Continued)
Random sequence generation (selection
bias)
Low risk Quote: “women were prospectively, randomly assigned to
the study. We used the method of block randomisation with
a random-number generator”
Allocation concealment (selection bias) Unclear risk No information
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Quote: “The current randomised, non-blinded study”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk All participants were evaluated at follow-up by 3 urogynae-
cologists, blinded to the different procedures
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “In the TVT group, 141/149 patients returned for a
1-year follow-up (dropout rate of 5.3%), and in the TVT-O
group, 147/151 patients were present for the 1-year follow-
up (dropout rate of 2.6%)”
Laurikainen 2007
Methods RCT comparing TVT and TVT-O
Participants Multicenter study from7Finnish hospitals (4 university hospitals and 3 central hospitals)
267 of the 273 patients originally randomized underwent the allocated operation. After
randomisation 6 patients dropped out
Inclusion criteria: history of SUI; indication for surgical treatment of stress incontinence;
positive cough-stress test; detrusor instability score (DIS) ≤ 7
Exclusion criteria: previous incontinence surgery; PVR volume > 100 ml; lower urinary
tract anomaly; current (UTI or > 3UTI episodes within the past year; urogenital prolapse
ofmore than second degree (Baden-Walker); BMI > 35 kg/m²; previous radiation therapy
of the pelvis; active malignancy; anticoagulant therapy; haemophilia; neurogenic disease
that can be associated with bladder disorders; anticholinergic medication; duloxetine
medication; patient unable to understand the purpose of the trial; patient immobile
Interventions Group A: TVT-O (n = 131)
Group B: TVT (n = 136)
Outcomes • Objective cure: defined as a negative stress test.
• 24 hour pad test
• Subjective cure: evaluated by questionnaires through short, medium and long
term
• Perioperative complications
• Mean operating time (minutes)
• Length of hospital stay (days)
• Time to return to normal activity (weeks)
• Operative blood loss (ml)
• Major vascular injury
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Laurikainen 2007 (Continued)
• Bladder perforation
• De novo urgency/urgency urinary incontinence
• Voiding dysfunction
• Repeat incontinence surgery
• Tape erosion
• Groin pain
• Tape erosion
• QoL questionnaires include: urinary incontinence severity score (UISS), detrusor
instability score (DIS), incontinence impact questionnaire - short form (IIQ-7),
urogenital distress inventory - short form (UDI-6), EuroQOL-5D questionnaire,
Visual analogue scale (VAS-0 to 100)
Notes Cystoscopy with 70° optic was performed twice during the TVT and once during the
TVT-O to detect possible bladder injury
Follow-up was for 5 years:
• loss to follow-up: at 12 months: Group A: 2/136; Group B: 0/131
• loss to follow-up: at 36 months: Group A: 5/136; Group B: 5/131
• loss to follow-up: at 60 months: Group A: 5/136; Group B: 9/131
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk The investigator called an independent randomi-
sation centre to enter the patient participant in
the allocated group. Participant were randomized
using computer-generated random allocations in
a ratio of 1:1 in balanced blocks of 4
Allocation concealment (selection bias) Low risk The investigator called an independent randomi-
sation centre to enter the patient participant in
the allocated group. Participant were randomized
using computer-generated random allocations in
a ratio of 1:1 in balanced blocks of 4
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk The 3-year postoperative evaluation was per-
formed by an independent physician or by the
operating surgeon together with a study nurse
Incomplete outcome data (attrition bias)
All outcomes
Low risk All data accounted for
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Leanza 2009
Methods RCT of retropubic versus transobturator tension-free incontinence cystocoele treatment
(TICT) procedures
Participants 449 women with USI
Interventions Group A: r-TICT (n = 229; retropubic)
Group B: t-TICT (n = 220; transobturator)
Outcomes • Subjective cure
• QoL: using KHQ
Notes TICT, a retropubic technique developed using a polypropylene T-shaped mesh made up
by a central body (positioned under both urethra and bladder) and 2 wings that cross the
Retzius (retropubic TICT or r-TICT) and the transobturator foramen (transobturator
TICT or t-TICT). The advantage of T-shaped mesh is to give a good support both on
the mid-urethral complex (with tapes) and on the whole anterior compartment (with
body of mesh). The target consists of treating the functional (incontinence) and the
anatomical defect (cystocoele)
Average follow-up was 45 months.
Loss to follow-up: Group A: 14/229; Group B: 12/220
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “women with urodynamic stress in-
continence were randomly allocated to 2
treatment groups”
Allocation concealment (selection bias) Unclear risk No information
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No information
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Lee 2007
Methods RCT of TVT versus TVT-O
Participants 120 women
Inclusion criteria: women with USI
Exclusion criteria: predominant urge incontinence or POP
Women had similar characteristics with regard to age, parity, incontinence symptoms
and menopausal status
Interventions Group A: TVT (n = 60)
Group B: TVT-O (n = 60)
Outcomes • Duration of operation
• Intraoperative blood loss
• Postoperative pain
• Patient satisfaction
• Operative complications
• Cure: defined as no SUI symptoms and a negative cough-stress test. Participants
were considered to have improved if they had no leakage on the cough-stress test but
may have had occasional urine leakage during stress. However, this occasional leakage
did not influence daily activities or require any further treatment. Participants who did
not meet these criteria treatment were considered to have failed
Follow-up was for 12 months
Notes Cystoscopy was performed only in the TVT group
Mean follow-up 13 months
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Quote: “Patients were alternately assigned to the TVT
or TVT-O group” (Randomisation was by alternation
method)
Allocation concealment (selection bias) High risk Not concealed
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No information
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Lee 2008
Methods QRCT comparing the efficacy and safety of TVT-O and TOT (TOT, Dow Medics,
Korea)
Participants 100 women
Inclusion criteria: women with USI
Exclusion criteria: predominant urge incontinence or POP
Preoperative work-up included a medical history, physical examination, urinalysis, uro-
dynamic evaluation, and I-QOL questionnaire
Interventions Group A: TVT-O (n = 50)
Group B: TOT (n = 50)
Outcomes Surgical outcomes were evaluated by the cough-stress test and symptom questionnaire
and scored as cured, improved, or failed. Participants were considered ‘cured’ of SUI if
they had a negative cough-stress test result and there were no reports of urine leakage
during stress. Participants were considered ‘improved’ if they did not leak on the cough-
stress test but may have had occasional urine leakage during stress; this occasional leakage
did not influence their daily activities or require further treatment. Participants who did
not meet these criteria were considered to have ‘failed’ treatment
Notes Surgical outcomes in the 2 groups were compared about 1 year after surgery
TOT, Dow Medics, Korea = woven monofilament polypropylene mesh
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk 100 women with SUI were alternately as-
signed
Allocation concealment (selection bias) High risk Quasi-randomised study with no mention
of allocation concealment
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No information
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Liapis 2006
Methods RCT comparing TVT and TVT-O
Participants 89 women
Inclusion criteria: women with confirmed SUI without DO
Exclusion criteria: DO; other gynaecological disease requiring hysterectomy; other gy-
naecologic operation; failed surgical treatment for incontinence
Mean age (years): Group A: 53; Group B 52
Post menopausal: Group A: 22/46; Group B: 26/43
Interventions Group A: TVT (n = 46)
Group B: TVT-O (n = 43)
Outcomes Participants assessed by means of voiding diaries, pad test, negative cough-stress test at
UDS, unvalidated symptom questionnaire
• Objective cure: negative cough-stress test during multichannel UDS study, and 1-
h pad test with a weight of <1g
• Objective improvement: negative cough-stress test during multichannel UDS
study, and 1-h pad test with a weight of <5g
• Failure: defined as positive cough-stress test during multichannel UDS study, and
1-hr pad test with a weight of >5g
Subjective cure and failure determined by direct questions using an unvalidated ques-
tionnaire
Follow-up 12 months
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “... All patients were randomly assigned
to an operation from the outpatient department
...”
Allocation concealment (selection bias) Unclear risk No information
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Low risk No differential loss to follow-up or differential
attrition
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Liapis 2008
Methods RCT comparing Monarc TOT and TVT-O
Participants 120 women were randomised
Inclusion criteria: women with USI without DO
Exclusion criteria: preoperative maximum urethral closure pressure < 20 cm water; uro-
dynamic findings of DO; previous operation of the anterior vaginal wall or prolapse >
stage 1 according to the ICS classification
Interventions Group A: TVT-O (n = 61)
Group B: Monarc TOT (n = 53)
Outcomes • Objective cure: defined as a negative cough-stress test during multichannel
urodynamic examination and a 1-hr pad test giving a weight of <1g
• Objective improvement: defined as a negative cough-stress test and a 1-hr pad test
weight of <5g
• Failure: defined as a positive cough-stress test and urine leakage >5g in the 1-hr
pad test
• Subjective cure, improvement, and failure were assessed with the use of a simple
questionnaire administered by a blinded outcome assessor
Notes Both groups had perioperative cystoscopy.
Groin or thigh pain was resolved with simple analgesics within 1 week to 4 months
Follow-up was 12 months. 6 lost to follow-up leaving a total of 114 women
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “The patients were randomly allo-
cated on an alternative fashion to one or
another operation.”
Allocation concealment (selection bias) Unclear risk Unclear
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk No differential loss to follow-up or differ-
ential attrition
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Lim 2005
Methods RCT comparing TVT with IVS and SPARC
Participants 195 women
Inclusion criteria: women with USI were randomly allocated to suburethral slingoplasty
with either TVT, IVS or SPARC
Exclusion criteria: women with a past history of urogenital malignancy, fistula or pelvic
radiotherapy
At 6-12 weeks follow-up, 4, 5 and 4 women from the TVT, IVS and SPARC groups,
respectively, were excluded from statistical analysis because of incomplete or missing
hospital charts
Interventions Group A: TVT (n = 61)
Group B: IVS (n = 60)
Group C: SPARC (n = 61)
Outcomes • Objective cure based on UDS
• Subjective cure
• Postoperative morbidity
Notes Group A: 4 patients; Group B: 5 patients; and Group C: 4 patients were excluded from
the analysis due to incomplete or missing data
Those with missing records, those lost to follow-up and those who failed to have post-
operative UDS were assumed to be failures in the assessment of objective cure
Occult cases were excluded from subjective cure rates
Follow-up initially for 12 weeks and results reported, a follow-on study reviewed the
incidence of erosion and tape infections
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “...195 consenting patients with
urodynamic stress incontinence (USI) were
randomly allocated in a balancedway (three
groups of 65 patients each)...”
Allocation concealment (selection bias) Unclear risk No information
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Quote: “ ... and the patients were blinded
to the type of slings being implanted ...”
No description of how this was achieved
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Unclear
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Lord 2006
Methods RCT comparing TVT with SPARC sling
Participants 301 women
Inclusion criteria: women presenting with SUI whether or not they had had previous
incontinence or other pelvic surgery, or both
Exclusion criteria: < 18 years old; pregnant; had a major voiding dysfunction specified as
an abnormal flow (i.e. maximum urinary flow rate < 10 ml/s) or residual urinary volume
of > 150 ml
254 women had UDS and USI diagnosed
MUI: 47 women
Interventions Group A: TVT (n = 147)
Group B: SPARC (n = 154)
Outcomes Primary outcome:
bladder perforation
Secondary outcomes:
• blood loss
• voiding difficulty
• urgency
• cure of SUI symptoms at 6 weeks after surgery
The subjective assessments of cure were the participants’ reported use of protection, their
perceptions of the severity of their SUI symptoms and a scale of improvement (1 to 100)
. The objective definition of cure was the observed absence of urinary leakage when the
participant coughed while supine and with a comfortably full bladder
Follow-up was 6 weeks
Notes The women and the outcome assessors were blinded, but no clear description was pro-
vided for how this was achieved
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Participants were stratified based on previ-
ous UI surgery (yes, no) and the experience
of the surgeon (consultant, registrar) and
allocated to either TVT or SPARC using
computer-generated random numbers. The
biostatistician generated the random alloca-
tions, which were sealed in opaque, sequen-
tially numbered envelopes. The surgeons re-
cruited participants and accessed the allo-
cations by a telephone call to a third party.
Varying block sizes of 4, 6 and 8 were used
within each stratum to preclude prediction
of allocation by the surgeons
Allocation concealment (selection bias) Low risk Concealed
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Lord 2006 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Quote: “The analyst was unaware of the
treatment allocation, but it was obviously
not possible to ensure that the surgeonswere
unaware of treatment, although the patients
were unable to detect, from their incisions,
which sling they had received”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “The analyst was unaware of the
treatment allocation, but it was obviously
not possible to ensure that the surgeonswere
unaware of treatment, although the patients
were unable to detect, from their incisions,
which sling they had received”
Incomplete outcome data (attrition bias)
All outcomes
Low risk No differential loss to follow-up or differ-
ential attrition
Mansoor 2003
Methods RCT comparing TVT-O and TVT
Participants 102 women with SUI with or without POP
Preoperative urodynamics carried out
Interventions Group A: TVT-O (n = 48)
Group B: TVT (n = 54)
Outcomes • Subjective cure rate
• Objective cure rate
• Complications
Notes Follow-up 6 months
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “A prospectively randomised and com-
parative study.....”
Allocation concealment (selection bias) Low risk Quote:“...technique was randomly drawn using
blinded envelopes containing the same no of ...”
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
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Mansoor 2003 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No information
Mehdiyev 2010
Methods RCT of TVT vs TOT
Participants 32 women with SUI
Interventions A: TOT (n = 17)
B: TVT (n = 15)
Outcomes Subjective cure
Bladder Injury
Major vascular injury:
De novo UUI
Mean operative time
Notes I-QoL questionnaire was used
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “The patients were randomised for TOT and TVT
operations”
Allocation concealment (selection bias) Unclear risk No information
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No information
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Meschia 2006
Methods RCT of TVT compared with IVS
Participants 190 women randomised with 11 lost to follow-up, thus 179 available for analysis at 2-
year follow-up. The 2 groups were no different in terms of age, parity, BMI, previous
hysterectomy, or presence of OAB symptoms
Inclusion criteria: women with urodynamically proven SUI and urethral hypermobility
Exclusion criteria: previous anti-incontinence surgery; vaginal prolapse requiring treat-
ment; coexisting pelvic pathology; known bleeding diathesis or current anticoagulant
therapy;DO; and urethral hypomobility (Q-tip <20° from the horizontal with straining)
Interventions Group A: TVT (n = 92)
Group B: IVS (n = 87)
Outcomes Primary outcome: success rate
Secondary outcome measure: complication rate
The outcome of surgical treatment was estimated both subjectively and objectively.
Objective curewas defined as no leakage of urinewhile performing the cough provocation
test, with at least 300 ml of saline in the bladder and as a pad weight gain < 1g during the
1-h test. Test-retest reliability of the cough test and 1-hr pad test have been previously
demonstrated. Subjective cure was defined as no urine loss during ’stress’ and failure as
any reported leakage of urine during exertion
Notes IVS = multifilament threads with smaller pores with insertion similar to TVT
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “...a prospective randomised multicenter
trial ... were randomly assigned to treatments ac-
cording to a centralized computer-generated ran-
dom list.... Researchers randomly assigned partici-
pants by a telephone system to 1 of the treatment
groups”
Allocation concealment (selection bias) Low risk Concealed
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No information
120Mid-urethral sling operations for stress urinary incontinence in women (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Meschia 2007
Methods RCT of TVT versus TVT-O
Participants Inclusion criteria: women with urodynamic SUI and urethral hypermobility
Exclusion criteria: previous anti-incontinence surgery; vaginal prolapse requiring treat-
ment; coexisting pelvic pathology; known bleeding diathesis or current anticoagulant
therapy; DO and urethral hypomobility (Q-tip <20° from the horizontal with straining)
Interventions 206 women randomised, but 25 lost to follow-up
Group A: TVT (n = 114)
Group B: TVT-O (n = 117)
Outcomes Primary outcome: success rate
Secondary outcome: complication rate
Outcome of surgical treatmentwas estimated both subjectively and objectively.Objective
cure was defined as no leakage of urine whilst performing the cough provocation test.
Subjective cure was defined as no urine loss during ‘stress’, and failure as any reported
leakage of urine during exertion
ICIQ-SF,Women Irritative Prostate Symptoms Score (W-IPSS), PGI-S and PGI-I ques-
tionnaires were used to evaluate the impact of incontinence and voiding dysfunction on
QoL, and to measure the participant’s perception of incontinence severity and improve-
ment
Notes Median follow-up time was 6 months
6 women from Group A and 7 from Group B were lost to follow-up without outcome
data; reasons for loss to follow-up not explored
Cystoscopy was performed in all cases of TVT and 50% of cases of TVT-O
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Women with SUI and urethral hypermobility were ran-
domised to treatments according to a centralised com-
puter-generated random list. Researchers randomised
participants by a telephone system to one of the treat-
ment groups
Allocation concealment (selection bias) Low risk Concealed
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Low risk No differential loss to follow-up or differential attrition
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Naumann 2006
Methods RCT of classic TVT tape by Gynecare compared with LIFT by Cousin Biotech, with
the distinctive feature of a suburethral pad (assumed to be inserted as classic TVT)
Participants 254 women with SUI
Interventions Group A: TVT (n = 123)
Group B: LIFT (n = 125)
Outcomes • Subjective cure or improvement: assessed with VAS
• Subjective evaluation of QoL
• Objective cure: evaluation of preoperative and postoperative urodynamic
measurements, or results of a pad or clinical stress test
• Subjective cure, 6 months and 12 months
• Subjective cure or improvement, 6 months and 12 months
• Bladder perforation
• Excess bleeding
• Need for division of tape
• Tape erosion into bladder or urethra
• Vaginal mesh erosion
Notes Follow-up 12 months
LIFT is a woven monofilament polypropylene tape that can be passed through the
transobturator and also the retropubic routes
The study seemed to compare the 2 tapes (TVT and LIFT), which have similar charac-
teristics and were both passed through the retropubic routes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “..an open, prospective, ran-
domised, multicentric study”. How se-
quence generation was achieved not men-
tioned
Allocation concealment (selection bias) Unclear risk No information
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No information
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Nerli 2009
Methods QRCT of TVT vs TOT
Participants Inclusion criteria: women > 18 years; with SUI or MUI if SUI is the predominant
symptom; women with ISD
Exclusion criteria: predominant urge incontinence; UTI; malignancy; pregnancy; POP
stage 3 or 4
Mean age (years; SD): Group A: 39.5 (1.95); Group B: 50.2 (1.89)
Post menopausal status: Group A 8/18; Group B: 6/18
Interventions Group A: TVT (n = 18)
Group B: TOT (n = 18)
Outcomes • Objective cure: negative cough stress test
• Subjective cure: self-reported absence of SUI
• Improved: persistence of SUI not affecting daily activity or requiring further
treatment plus negative cough test
• Mean operative time
• Mean operative blood loss
• Voiding dysfunction
• Bladder perforation
• De novo urge incontinence
• Tape erosion
• Days to return to normal activity
Notes Cystoscopy performed only in the TVT group
I-QOL questionnaire assessed at 12 month F/U: significant improvement in I-QOL
total scores in both groups from the pre-operative baseline scores
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Allocation of participants by alternation (quasi randomised)
Allocation concealment (selection bias) High risk Allocation not concealed
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No information
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Nyyssonen 2014
Methods RCT of TVT (Gynecare) vs TOT (’outside-in’ Monarc)
Participants 100 women
Inclusion criteria: women with SUI or MUI with a predominant stress component, after
failed conservative treatment
Exclusion criteria: urge incontinence; previous mini invasive operation for SUI and the
need for another concomitant surgical procedure
SUI diagnosed with a positive cough test
Urodynamic testing was only done in 5 patients (10%)
Pure SUI: Group A: 38/50; Group B: 30/50
Preoperative characteristics similar between groups
Interventions Group A: TOT (n = 50)
Group B: TVT (n = 50)
Outcomes • Subjective cure at 14 and 46 months: success defined as a postoperative UISS < 8
and failure as ≥ 8
◦ At 14 months
◦ At 46 months
• Vaginal tape erosion
• Voiding dysfunction
• De novo UUI
Follow-up at 3, 14 and 46 months
Cough stress test was performed.
Subjective cure and patient satisfaction recorded with aid of UISS and Detrusor Insta-
bility Score questionnaires with a specific question about satisfaction
Notes Cystoscopy only performed in the TVT group
Number available for follow-up assessments:
14 months: Group A: 43/50; Group B: 43/50
At 46 months: Group A: 46/50; Group B: 47/50
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “This prospective randomized
study included ... 100 patients were ran-
domized either to the TVT or to the TOT”
Allocation concealment (selection bias) Low risk Quote: “randomization was performed
with sealed and numbered envelopes”
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
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Nyyssonen 2014 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Low risk No evidence suggestive of attrition bias
Okulu 2013
Methods RCT of Vypro mesh (Ethicon, USA) vs Ultrapro mesh (Ethicon) vs Prolene light mesh
(condensed monofilament non-absorbable polypropylene)
Participants 144 women with SUI in Turkey
Inclusion criteria: previous incontinence surgery or hysterectomy; SUI or USI; positive
stress test
Exclusion criteria: urodynamically MUI and DO; ≥ 100 ml PVR; contraindication to
anaesthesia; POP; pregnancy; neurogenic bladder; bladder outlet obstructions; urinary
fistula; or active urinary or vaginal infection
Mean age (years; SD): Group A: 50.06 (9.2); Group B: 50.9 (8.8); Group C: 48.1 (7.9)
Mean BMI kg/m² (SD): Group A: 27.8 (3.4); Group B: 27.9 (4.1); Group C: 27.7 (2.
9)
Post menopausal: Group A: 10/48; Group B: 11/48; Group C: 8/48
Previous incontinence surgery: Group A: 4/48; Group B: 5/48; Group C:4/48
Interventions Group A: Vypro mesh: (n = 48; multifilament)
Group B: Ultrapro mesh: (n = 48; monofilament + biological combined mesh)
Group C: Prolene light mesh: (n = 48; monofilament)
Outcomes Primary outcome: urinary continence rates at 4-year follow-up
Secondary outcomes assessed at 4-year follow-up:
• urinary retention
• suture granuloma rates at 4 years.
• cure defined as no need for pad use or pad weight of < 2g on 24-hr pad test
◦ Subjective cure at 12 months
◦ Subjective cure at 48 months
• bladder perforation
• major vascular visceral injury
• de novo urgency
• tape erosion
• mean 24hr pad weight at 12 months and 48 months
• QOL: ICIQ-SF questionnaire at pre-op, 12 months follow up and 48 months
follow up.
Notes Follow-up at 6, 12, 24 and 48 months
Loss to follow-up Group A: 2/48; Group B: 0/48; Group C: 1/48
QoL and incontinence was evaluated with the ICIQ-SF
Risk of bias
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Okulu 2013 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “The patients and the mesh mate-
rials were randomised
1:1:1 to each group in blocks of three via a
centralized computerized system to ensure
a goodbalance of participant characteristics
in each group.”
Allocation concealment (selection bias) Low risk Quote: “via a centralized computerized sys-
tem to ensure a good balance of participant
characteristics in each group”
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No information
Oliveira 2006
Methods RCT of TVT-O and TVT
Participants 45 women
Inclusion criteria: women with SUI with and without ISD
Exclusion criteria: women with stage 2 or more POP, women with ISD
Mean age of 53.9 years
Participants had preoperative UDS diagnosis
Interventions Group A: TVT (n = 17)
Group B: TVT-O (n = 28)
Outcomes • Objective cure by UDS: negative stress test at UDS and pad testing
• Complications
Notes Follow-up 12 months
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “...women with SUI were randomly assigned ...”
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Oliveira 2006 (Continued)
Allocation concealment (selection bias) Unclear risk No information
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No information
Palomba 2008
Methods RCT of TOT + mesh repair of POP vs TVT + mesh repair of POP
Participants Inclusion criteria: 15 women with cystocoele and SUI with urethral hypermobility
Exclusion criteria: BMI > 30 kg/m²; previous incontinence surgery and detrusor insta-
bility and/or intrinsic sphincter dysfunction
Interventions Group A: TOT + mesh repair of POP
Group B: TVT + mesh repair of POP
Outcomes Trial terminated due to poor recruitment, no results published
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Stated: “randomised”
Allocation concealment (selection bias) Unclear risk No information
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No information
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Paparella 2010
Methods RCT of synthetic UretexTO® vs biological PelviLaceTO® outside-inside TOT
Participants Inclusion criteria: women with SUI and USI; SUI with urethro-vesical junction hyper-
mobility without ISD
Exclusion criteria: POP > stage 1; previous urogynaecological or anti-incontinence
surgery; concurrent diseases such as psychiatric disease, diabetes, peripheral vascular dis-
ease; history of pelvic radiation; urge and mixed incontinence; DO; urgency or neuro-
logic bladder; maximum urethral closure pressure < 20 cm H2O and VLPP < 60 cm
H2O (indicators of intrinsic sphincter deficiency); maximum flow ≤ 12 ml/s; and PVR
volume ≥ 100 ml
Mean age (years; SD): Group A: 60.7 (7.1); Group B: 59.4 (8.4)
Mean BMI kg/m² (SD): Group A: 25.4 (1.8); Group B: 24.9 (1.8)
Menopausal: Group A: 26/34; Group B: 30/36 (participants in menopause were sub-
jected to at least 1 month of local hormone replacement therapy both before and after
the surgery)
QoL and sexual impact measured via: KHQ and PISQ-12
Interventions Group A: synthetic UretexTO® (n = 34)
Group B: biological PelviLaceTO® (n-36)
Outcomes • Objective cure of incontinence was defined as the absence of SUI, with a negative
cough stress test; objective improvement as the improvement of SUI, with a positive
cough stress test at a higher bladder filling than in the preoperative test; in all other
cases it was considered a failure.
• Subjective cure rates were self-evaluated by the participants as ’very satisfied’,
’satisfied’, or ’not satisfied’.
• Mean operating time
• Mean length of hospital stay days
• Perioperative complications
• Major vascular injury
• Voiding dysfunction
• Tape erosion
• QoL: assessed with KHQ
• PISQ-12 scores pre-operatively and at 2 years follow up.
Notes Group A: synthetic (UretexTO®; Bard, Covington, GA) is self-anchoring transobtura-
tor suburethral sling (1.2 cm wide and 45 cm long) made of the same monofilament
polypropylene fibres used in many modern tension-free sling devices (for example TVT,
TVT-O, TOTMonarc, TOT ARIS etc). Polypropylene is a very biocompatible material
that has been used for many years in the construction of medical-grade synthetic meshes.
The important difference is how the polypropylene fibres are knitted to form a cohesive
macroporous mesh
Group B: biological material (PelviLaceTO®; Bard, Covington, GA) is a tension-free
and self-anchoring transobturator suburethral sling (1.5 cm wide and 40 cm long). It
consists of a porcine dermal collagen implant that is intended to provide a matrix for
the incorporation of new tissue, cells and blood vessels, thanks to a natural porosity and
artificial V-shapedholes along the arms. Its collagenmatrix consists of 3 amino acid chains
arranged in a triple helix that has been cross-linked with hexamethylenediisocyanate
to improve durability making the collagen non-resorbable by the collagenase (enzymes
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Paparella 2010 (Continued)
produced by inflammatory cells and fibroblasts that increase during surgery). It is also
described as an acellular and deproteinised material so it should not cause an immune
response
Follow-up evaluation was carried out after 6 weeks, 6 months, 1, and 2 years
2-year follow-up: Group A: 16.6 (3.0); Group B: 17.2 (3.0)
Loss to follow-up: Group A: 1/34; Group B: 0/36
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Randomization was done using
sealed opaque envelopes containing com-
puter-generated random allocations in a ra-
tio of 2:2 in balanced blocks of 4”
Allocation concealment (selection bias) Low risk Quote: “Randomization was done using
sealed opaque envelopes containing com-
puter-generated random allocations in a ra-
tio of 2:2 in balanced blocks of 4”
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “Follow-up evaluation was carried
out after 6 weeks, 6 months, 1, and 2
years (and/or earlier if problems were ex-
perienced) for all patients by two indepen-
dent physicians”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “All patients in both arms com-
pleted the follow-up (2 years)”
Park 2012
Methods Pseudo RCT of TVT-O vs TOT (Monarc)
Participants 74 women
Inclusion criteria: women with SUI including those with MUI
Exclusion criteria: neurogenic bladder; POP; suspected ISD; or a past history of radical
pelvic surgery
Mean age (years): Group A: 54.4 (10.13); Group B: 55.1 (10.63)
Mean BMI kg/m²: Group A: 28.9 (0.53); Group B: 25.9 (0.48)
Urgency/UUI: Group A: 25/39; Group B: 22/35
Interventions Group A: TVT-O (n = 39)
Group B: TOT Monarc (n = 35)
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Park 2012 (Continued)
Outcomes Cure was defined as the absence of any episodes of involuntary urine leakage during
stressful activities and a stress test. Improvement was defined as a significant reduction
in urine leakage, such that it did not require further treatment
• Objective cure at 12 months and 3 years
• Subjective cure at 12 months and 3 years
• Subjective cure & improvement at 1yr and 3 years
• Voiding dysfunction
• Bladder and urethral perforation
• Groin pain
• Post operative dyspareunia
Notes Cystoscopy was performed in all women
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “were included in this randomised,
prospective, observational study”
Allocation concealment (selection bias) High risk Quote: “The procedure was performed by
a single surgeon, and patients underwent
one of the two techniques in accordance
with the scheduling order (MONARC and
TVT-O), in alternation”
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Low risk All accounted for
Peattie 2006
Methods RCT TVT-O vs Monarc TOT
Participants Inclusion criteria: women having a primary continence procedure without other surgery;
diagnosis of USI; completed course of physiotherapy; completed family
Exclusion criteria: previous continence or prolapse surgery; neurological disease; preg-
nancy; UTI or vaginal infection; DO; voiding problem; anticoagulant use
Interventions Group A: TVT-O
Group B: TOT
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Peattie 2006 (Continued)
Outcomes Primary outcomes: objective and subjective cure of USI
Secondary outcomes:
• operating time
• blood loss
• complications
• pain
• catheter use postoperatively
• voiding
Notes Note: trial started recruitment 2006 but no evidence of current status i.e. completed or
recruitment stopped or abandoned. No data published
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “patient allocation by random numbers with
blocking”
Allocation concealment (selection bias) Low risk Quote: “patient allocation by random numbers with
blocking”
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No information.
Porena 2007
Methods RCT of TVT versus TOT
Participants 145 women
Inclusion criteria: women with stress or MUI (stress component clinically predominant)
associated with urethral hypermobility (ICS definitions)
Exclusion criteria: previous anti-incontinence surgery and POP > stage 1, according to
the Half-Way system and POP-Q system classification, in any vaginal compartment
With the exception of DO, which was significantly more common in the TOT group, no
significant intergroup differences emerged with regard to surgical histories, SUI grade,
frequency of mixed incontinence, preoperative voiding or storage symptoms and preop-
erative urodynamic parameters
VLPP determined at a bladder volume of 200 mL and participants performed several
Valsalvamanoeuvers with a gradual increase in abdominal pressure. Participants stratified
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Porena 2007 (Continued)
by VLPP > 60 cm H2O or VLPP ≤ 60 cm H2O
VLPP ≤ 60 cm H2O (ISD): Group A: 25/70; Group B: 25/75
Mean age (years; SD): Group A: 61.8 (10.7); Group B: 60.6 (10)
Postmenopausal: Group A: 61/70; Group B: 64/75
SUI: Group A: 42/70; Group B: 41/75
MUI: Group A: 28/70; Group B: 34/75
DO: Group A: 4/70; Group B: 14/75
Interventions Group A: TVT (n = 70)
Group B: TOT (n = 75)
Outcomes Primary outcomes:
• objective cure: participants were classified in 2 categories: ’dry’ (no leakage during
clinical examination and/or stress test and/or reported by participants) vs ’wet’. Wet
participants were then sub-divided into ’improved’ (> 50% reduction in incontinence
episodes) or ’failure’
• operating time
• intra- and postoperative complications including bladder injury, vaginal
penetration and major vascular injury
Secondary outcomes:
• postoperative lower urinary tract dysfunctions including voiding dysfunction
• subjective and objective changes in SUI
• tape erosion
All participants completed 2 validated questionnaires on QoL, the UDI-6 and the IIQ-
7 before surgery, at 3, 6, 12 months postoperatively and then annually
Patient satisfaction outcome was measured via a VAS scale
Objective cure (dry)
Objective cure and improved (dry + wet but improved)
Subjective cure (dry)
Subjective cure and improved(dry + wet but improved)
Bladder injury
Vaginal perforation
Major vascular injury
Voiding Dysfunction
Tape erosion
Long-term follow-up (> 6 years, mean 99 ± 19 months): 83 participants (45 TOT; 38
TVT) underwent a telephone interview in October 2012
Notes TVTTM (Gynecare; Ethicon, Somerville, NJ, USA)
TOTTM was a fusion-welded, non woven, non knitted polypropylene tape (Obtapej;
Mentor-Porges, Le Plessis-Robinson, France)
All participants underwent a preoperative urodynamic assessment and intraoperative
cystoscopy
Follow-up was at 3, 6, and 12 months postoperatively, and then annually
Lower urinary tract dysfunctions and continence status were measured at each follow-
up visit by a blinded assessor
The overall median follow-up was 35 months
Risk of bias
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Porena 2007 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “prospectively randomized by a predetermined
computer-generated randomization code, to the retropu-
bic approach (TVT) or the transobturator route (TOT)”
Allocation concealment (selection bias) Low risk Quote: “ Randomization was done using sealed, opaque,
numbered envelopes, which contained the randomized al-
location”
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Outcome assessors were blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “No patient was lost during follow-up”
Rechberger 2003
Methods RCT comparing TVT and IVS
Participants 100 women
Inclusion criteria: women with USI without concomitant pelvic pathology requiring
surgery, some had had anti-incontinence surgery previously
Exclusion criteria: ISD
Interventions Group A: TVT (n = 50)
Group B: IVS (n = 50)
Outcomes • Cure rates
• Operative and postoperative complications
Participants were considered totally curedwhen free of all SUI symptoms, and cough tests
in supine and standing positions were negative. The operation was noted as a failure if the
participant still reported urine leakage during increases in intra-abdominal pressure, the
cough test with a comfortably full bladder was positive, and the woman had to change
her pads because of being wet during the day
In the improvement group the cough test was negative but participants still experienced
stress urinary leakage (much less frequent than previously) and the pads were occasionally
wet
Postoperative UDS was not performed
Notes Median follow-up of 13.5 months (range 4 to 18 months)
Risk of bias
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Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Unclear
Allocation concealment (selection bias) Unclear risk Simple randomisation was used from pseudo-random
numbers (pseudo-random number means that the
participants were operated on by the TVT or the IVS
method in a ratio of 1:1)
Generated by computer in order to allocate partici-
pant to themonofilament or themultifilament group.
Investigator KR was not involved in surgical proce-
dure but was responsible for proper
randomisation.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Blinded
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Unclear
Rechberger 2009
Methods RCT of retropubic IVS-02 vs transobturator IVS-04, multifilament type 3 tape
Participants Inclusion criteria: women with SUI with a positive cough provocation test
Exclusion criteria: presence of uterine myoma; ovarian cyst; or advanced uterine or
vaginal prolapse (POP-Q scale > grade 1)
Mean age (years; SD): Group A: 55.56 (10.19); Group B: 55.75 (11.29)
Postmenopausal: Group A: 119/269; Group B: 125/268
VLPP: leak pressure during Valsalva manoeuvre was measured. VLPP was determined
at 180 ml of bladder filling. ISD was defined as VLPP of ≤ 60 cm H2O
ISD: Group A: 45/269; Group B: 40/268
Interventions Group A: retropubic (IVS-02; n = 269)
Group B: transobturator (IVS-04; n = 268)
Outcomes • Subjective cure
• Subjective improvement
• Mean operating time
• Bladder perforation
• Major vascular injury
• De novo urgency/UI
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Rechberger 2009 (Continued)
• Voiding dysfunction
• Vaginal tape erosion
Notes The follow-up visits were at 1, 4, 6, 12, and 18 months
Cystoscopy only performed in the retropubic group
Loss to follow-up: Group A: 68/269; Group B: 71/268
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “Simple randomisation was used
frompseudorandomnumbers generated by
a computer to allocate patients into the
IVS-02 group or the IVS-04 group”
Allocation concealment (selection bias) Unclear risk Investigators Jankiewicz and Futyma were
not involved in the surgical procedures, but
they were responsible for the randomisa-
tion process
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Quote: ”the surgeon was aware of the pro-
cedure being used”
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Quote:“Only investigators Jankiewicz and
Futymawere involved in the follow-uppro-
cess, and they were blinded with regard to
the treatment procedure used”
Incomplete outcome data (attrition bias)
All outcomes
Low risk All outcome data accounted for and the
equivalent no of women were lost to fol-
low-up in the 2 groups
Rechberger 2011
Methods RCT of standard TOT vs TOT with 2-point tape fixation sutures to prevent tape dis-
placement
Participants 463 women
Inclusion criteria: women with urodynamically proven SUI, Including women with ISD
Exclusion criteria: OAB, MUI
Mean age (years; SD): Group A: 55.8 (11.3); Group B: 54.8 (9.8)
Mean BMI kg/m² (SD): Group A: 28.9 (6.7); Group B: 28.2 (3.8)
ISD: Group A: 41/232; Group B: 42/231
Interventions Group A: TOT (n = 232)
Group B: TOT with fixation (n = 231)
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Rechberger 2011 (Continued)
Outcomes • Cured: self-reported subjective cure plus negative pad test plus negative cough
stress test
• Improved: negative cough stress test, negative pad test, but occasional symptoms
persisting
• Subjective cure and improvement
• Objective cure
• Bladder perforation
• ISD cohort: Objective cure
Notes Both tapes were monofilament
Lost to follow-up: Group A: 19/232; Group B: 26/231
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “Patients were randomly allocated
to 2 groups”
Allocation concealment (selection bias) Unclear risk No information
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No information
Richter 2010
Methods RCT: multi-centre randomised equivalence trial conducted in the USA
Participants 597 women
Inclusion criteria: age >21 years; predominant SUI for >3 months (urgency UI allowed)
; positive urinary stress test; bladder volume >300 ml
Exclusion criteria: not defined
Baseline characteristics similar between groups
Mean age (years; SD): Group A: 52.7 (10.5); Group B: 53.1 (11.5)
Previous incontinence surgery: Group A: 38/297; Group B: 41/298
Previous prolapse surgery: Group A: 13/297; Group B: 10/298
Postmenopausal: Group A: 209/297; Group B: 206/298
BMI kg/m²: Group A: 30.6; Group B: 30
HRT: Group A: 81/297; Group B: 90/298
Concomitant pelvic surgery: Group A: 73/298; Group B: 78/299
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Interventions Group A: retropubic sling (TVT; n = 298)
Group B: transobturator tapes (TVT-O, and TOT Monarc; n = 299)
(Group C (?): TVT-O (inside-out) - separate data not provided)
(Group D (?): TOT (Monarch, outside-in) - separate data not provided)
Outcomes Composite primary outcomes:
• objective cure: negative stress test, dry pad test, no repeat treatment;
• subjective cure: no SUI symptoms on questionnaire, no leakage in urinary diary
Secondary outcomes:
• median blood loss
• median operative time
• bladder or urethral perforation
• vaginal perforation
• voiding dysfunction
• mesh erosion/exposure
• vascular injury
• suprapubic/groin pain
• de novo urgency incontinence
• QOL: UDI questionnaire, IIQ questionnaire,
• Sexual function: assessed via PISQ-12
Notes TOMUS trial NCT00325039
Per protocol
Lost to follow-up: Group A: 18/298; Group B: 14/299
PISQ measures dyspareunia, coital incontinence and fear of coital incontinence
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Permuted block randomisation schedule
with stratification by centre
Allocation concealment (selection bias) Unclear risk No information
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Quote: ”patients who were lost to follow-
up were considered to have had treatment
failure and when patients who were lost to
follow-up were excluded”
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Riva 2006
Methods RCT TVT versus TOT
Participants Inclusion criteria: SUI with urethral hypermobility; age 40-85 years; urethro-cystocoele
of grade 0-2
Exclusion criteria: previous prolapse or IU surgery; anterior or posterior vaginal wall
repair with mesh
No difference recorded between the 2 groups for age, parity, or incontinence severity
Interventions Group A: TOT (n = 65)
Group B: TVT (n = 66)
Outcomes Gynaecological examination, full urodynamic evaluation, voiding diary and KHQ were
performed pre- and postoperatively
Notes 12-month follow-up
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “A randomised study”. No description of how ran-
domisation was achieved or if allocation was concealed
Allocation concealment (selection bias) Unclear risk No information
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No information
Salem 2014
Methods RCT of TOT vs TVT
Participants 76 women with SUI, all had urodynamics
Interventions Group A: TOT (n = 37)
Group B: TVT (n = 39)
Outcomes • Cure of SUI: defined as no leak during Bonny test, and high leak point pressure
and urethral pressure profile
• Mean operative time
• Perioperative complications
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Salem 2014 (Continued)
• Intraoperative blood loss
• Hospital stay
• Postoperative urodynamic
• Time to return to normal activities
Notes No usable data provided
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “were included in this randomized controlled study ...
. Patients were randomly grouped”
Allocation concealment (selection bias) Unclear risk No information
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No information
Scheiner 2012
Methods RCT of TVT vs TOT (Monarc) vs TVT-O
Participants 2 public teaching hospitals in Switzerland
Inclusion criteria: women with urodynamically confirmed SUI, or MUI with predomi-
nant SUI
Exclusion criteria: missing urodynamic assessment; previous sling procedure; predomi-
nant OAB; a PVR > 100 ml
Mean age (years; SD): Group A: 57.8 (13.0); Group B: 56.6 (10.3); Group C: 59.3 (12.
1)
Mean BMI kg/m² (SD): Group A: 26.4 (3.7) Group B: 27.8 (4.6); Group C: 27.6 (4.8)
Interventions Group A: TVT (n = 80)
Group B: TOT outside-in approach (Monarc; n = 40)
Group C: TVT-O inside-out approach (Gynecare; n = 40)
Outcomes • Objective cure: negative cough test (performed with a bladder filling of 300 ml)
and a negative short-pad test (pad weight gain <3g was defined as negative)
• Subjective cure: participant’s global impression (cured, improved, failed)
• Subjective cured and improved
• Mean operation time
139Mid-urethral sling operations for stress urinary incontinence in women (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Scheiner 2012 (Continued)
• Mean blood loss
• Mean hospital stay
• Bladder perforation
• Vaginal perforation
• Thigh/groin pain
• Vascular damage
• Voiding dysfunction
• Tape erosion
• QoL: assessed by means of the validated German version of the KHQ
• Sexual function: assessed by direct questioning.
Notes Preoperatively, conservative measures for SUI were recommended, such as use of local
estrogens, pelvic floor re-education, or incontinence pessaries. A symptomatic cystocele
stage 2 or higher according to the POP-Q system was corrected first. Participants with
concomitant sling insertion to repair prolapse were included
Cystoscopy was mandatory for every procedure
Lost to follow-up: Group A: 15; Group B: 6; Group C: 3
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Predetermined computer generated block
randomisation in blocks of 8 to promote
group balance
Allocation concealment (selection bias) Unclear risk No information
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Low risk All participants accounted for
Schierlitz 2008
Methods RCT of retropubic (TVT™ ) versus transobturator (Monarc™)) sling in the treatment
of women with USI and ISD
Participants 163 women
Inclusion criteria: women with SUI who had unsuccessful conservative therapy and, on
UDS, had a diagnosis of USI and ISD
ISD was defined as either a maximum urethral closure pressure (measured both with
the bladder empty and at capacity) of <20 cm H2O and/or a pressure rise from baseline
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Schierlitz 2008 (Continued)
required to cause incontinence (Valsalva or cough leak point pressure) of ≤60 cm H2O
Exclusion criteria: presence of pelvic infection; a persistent PVR volume > 100 ml;
malignancy; fistula; or congenital or neurogenic bladder disorder
Mean age (years; SD): Group A: 60 (11.5); Group B: 60 (10.9)
Post menopausal: Group A: 66/82; Group B: 68/82
Previous incontinence surgery: Group A: 6/82; Group B: 11/82
Concomitant surgery: Group A: 29/82; Group B: 26/82
Interventions Group A: TVT (n = 81)
Group B: Monarc sling (n = 82)
Outcomes • Objective cure: absence of USI
• Subjective cure: absence of self-reported SUI
• Bladder perforation
• Major vascular injury
• Groin pain
• Voiding dysfunction
• De novo urgency
• De novo urgency incontinence
• De novo urgency and UUI
• Re-operation
• Vaginal perforation
• QoL: via UDI-6 AND IIQ-7
◦ The short forms of the UDI-6 and the IIQ-7 were used for subjective
assessment of QoL.
• Sexual function: via PISQ-12
Notes Follow-up was at 6 weeks and 6 months, then yearly for 3 years
Loss to follow-up: Group A: 5/82; Group B: 4/82
At 3-year follow-up:
Group A: 72 followed-up with 70 completing questionnaires, and 48 completing exam-
ination
Group B: 75 followed-up with 60 completing questionnaires, and 40 completing exam-
ination
The number available for follow up or number lost to follow up at 5yrs was not made
clear (authors have been contacted and response is awaited)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “... A prospective, randomised con-
trolled trial was conducted using computer
generated random allocation.”
Allocation concealment (selection bias) Unclear risk No description of how allocation was con-
cealed
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Schierlitz 2008 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk The number of participants who withdrew
or were lost to follow-up (dropouts) was
higher in the TVT group
Tanuri 2010
Methods RCT of retropubic Safyre VS adjustable sling system and Safyre T adjustable transobtu-
rator sling system
Participants 30 women
Inclusion criteria: women with SUI
Exclusion criteria: use of drugs (adrenergic, anticholinergic or serotonergic); hormone
therapywithin the previous 6months; prior pelvic radiotherapy or current chemotherapy
or hormone therapy; POP > stage 2; MUI
Interventions Group A: Safyre VS retropubic tape (n = 10)
Group B: Safyre T transobturator tape (n = 20)
Outcomes • Subjective cure: no reported SUI
• Objective cure: negative stress test or <1g urine weight at modified pad test
• Pad test
• De novo urgency incontinence
• Voiding dysfunction
• Groin pain
• Bladder perforation
• Tape erosion
• Mean QoL Scores: via KHQ
Notes Follow-up was at 1, 6 and 12 months
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Participants were randomised into 2 groups
Allocation concealment (selection bias) Unclear risk No information
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Tanuri 2010 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Low risk Data for all participants accounted for
Tarcan 2011
Methods RCT: TVT (AdvantageR) vs TOT (ObtryxR)
Participants 54 women with urodynamic SUI
SUI: n = 10; MUI: n = 35
Median age in years (range): 54 (31-76)
BMI kg/m²: Group A: 27.8 (4.6); Group B: 27.4 (4.04)
Concomittant POP surgery: Group A: 5/27; Group B: 2/27
Interventions Group A: TVT (n = 27)
Group B: TOT (n = 27)
Outcomes 12-month follow-up assessed:
• cure: negative stress provocation test
• mean operative time in minutes
2 year follow-up assessed:
• subjective cure
• mean operating time
• QoL: via SEAPI
Notes Concomitant POP surgery was performed in 7 women (6 cystocele, 1 rectocoele)
No mention of intraoperative cystoscopy
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No information
Allocation concealment (selection bias) Unclear risk No information
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
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Tarcan 2011 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No information
Teo 2011
Methods RCT of TVT vs TVT-O
Participants 127 women recruited from 2 hospitals in the UK
Inclusion criteria: women with USI
Exclusion criteria: previous continence surgery; OAB symptoms; DO; POP-Q > stage
1; presence of voiding dysfunction (defined as maximum flow rate < 15 ml/s or PVR
volume ≥ 100 ml)
Women in both groups had similar background characteristics, degree of severity of
symptoms and QoL scores
Mean age (years; SD): Group A: 52.4 (11.8); Group B: 50.9 (11.4)
Median BMI kg/m² (range): Group A: 27 (21-37); Group B: 29 (21-50)
Postmenopausal: Group A: 24/66; Group B: 19/61
Interventions Group A: TVT (n = 66)
Group B: TVT-O (n = 61)
Outcomes • Objective cure: via 24-hour pad test (cure defined as a test result of < 5 g)
• Subjective cure: self-reported on PGII scale - considered cured if they were “very
much better”
• Major vascular injury
• Voiding dysfunction
• Bladder perforation
• De novo urgency/UI
• Tape erosion
• Groin pain
• QoL: via KHQ14 and ICIQ-SF15 questionnaires
◦ Baseline scores:
⋄ Median KHQ score (range) A: 384 (122-814), B: 399 (106-814)
⋄ Median ICIQ-SF score (range): A: 15 (7-21), B: 14 (3-21)
◦ 12 months follow up scores:
⋄ Median KHQ score (range): A: 50 (0-510), B: 61 (0-748)
⋄ Median ICIQ-SF score (range): A: 4 (0-16), B: 0 (0-11)
Notes Intraoperative cystoscopy with a 70° cystoscope performed in all cases
Loss to follow-up at 12 months: Group A: 25/66; Group B: 32/61
Risk of bias
Bias Authors’ judgement Support for judgement
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Teo 2011 (Continued)
Random sequence generation (selection
bias)
Low risk Randomisation was done by a computer generated list ran-
domised in blocks to ensure balanced allocation
Allocation concealment (selection bias) Low risk Randomization was done by a computer generated list ran-
domised in blocks to ensure balanced allocation. Block size
was randomised between 4 and 10. Numbered opaque en-
velopes were opened immediately before surgery
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and assessors were not blinded to the treatment
received
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Participants and assessors were not blinded to the treatment
received
Incomplete outcome data (attrition bias)
All outcomes
High risk High numbers lost to follow-up; disproportionately higher
in TVT-O group
Tommaselli 2012
Methods RCT comparing TVT-O and a modified version of TVT-O
Participants 72 women
Inclusion criteria: urodynamically proved SUI; age > 30 years; and previously failed
pelvic floor muscle training
Exclusion criteria: previous surgery for SUI; isolated OAB; POP≥ stage 2; neurological
disease
Mean age (years; SD): Group A: 51 (9.5); Group B: 55 (6.8)
Mean BMI kg/m² (SD): Group A: 27.5 (4.9); Group B: 28.9 (3.7)
Interventions Group A: TVT-O (n = 48)
Group B: modified TVT-O (n = 24)
Outcomes • Objective cure (negative stress test)
• No intraoperative complications reported in either group.
• Voiding dysfunction
• Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Questionnaire
(QoL: via PISQ-12 and PGI-S)
Notes For the modified TVT-O: “Briefly, in contrast with the traditional technique, the parau-
rethral dissection was minimal and carried only up to the pubic ramus, without perforat-
ing the obturator membrane with the scissors The aim of this reduced dissection was to
create a passage of very limited size to introduce the guide only up to the bone, without
perforating the membrane. Thus, as opposed to the original procedure, the obturator
membrane was perforated only by the helical passer”
Lost to follow-up: Group A: 2/48; Group B: 1/24
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Tommaselli 2012 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Patients were randomised using a
randomisation list generated by computer”
Allocation concealment (selection bias) Low risk Quote: “The allocation sequence was con-
cealed from the researchers (CF and AF)
who enrolled, assessed, and assigned the
participants to the interventions in sequen-
tially numbered, opaque, sealed, and sta-
pled envelopes. The envelopes were opened
on the morning of the procedure for the
surgeon to perform the allocated proce-
dure”
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Quote: “Patients were blinded to the pro-
cedure until the end of the study”
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Low risk All data accounted for
Tseng 2005
Methods RCT comparing TVT with SPARC
Participants 62 women
Inclusion criteria: women with USI with or without POP
Exclusion criteria: those with POP > ICS stage 2 and those with previous anti-inconti-
nence surgery
Mean age was 51 years and median parity of 3. The 2 groups were similar in terms of
age, parity and menopausal status
Interventions Group A: SPARC (n = 31)
Group B: TVT (n = 31)
Outcomes Objective cure: defined as pad weight ≤1g
Improved: participants whose loss decreased to < half of the preoperative value were
considered to have improved
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Tseng 2005 (Continued)
Notes All women had routine suprapubic ultrasonography for detecting unrecognised subcuta-
neous or retropubic haematoma on the day immediately after the operation, and 7/8 of
those with retropubic haematoma of >5 cm diameter were discharged uneventfully from
the hospital within 7 days of the operation. Ultrasonography performed at the 1 month
follow-up visit revealed complete resolution of the haematoma for every participant
Follow-up at 2 years
Women and their outcome assessors were blinded, but the exact method used to achieve
this was unclear
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk By using a predetermined computer-generated
randomisation code, those subjects who acqui-
esced and satisfied the inclusion criteria were as-
signed randomly by the authors (except LHT) to
the SPARC or TVT procedure at the outpatient
clinic
Allocation concealment (selection bias) Unclear risk Unclear
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Quote: “The patients were blinded to the proce-
dure, but the principle based on the integral the-
ory was briefly explained to them”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk No differential loss to follow-up or differential
attrition
Ugurlucan 2013
Methods RCT of PELVILACETO (biological TOTmaterial) vs synthetic TOTmaterial (ALIGN
TO urethral support system)
Participants 100 women
Inclusion criteria: women >18 years with SUI, MUI or USI in whom conservative
treatment had failed. Women with or without POP were included
Exclusion criteria: women with ISD
Pre- and postoperative assessments included evaluation of urinalysis and urine culture
POP evaluation using POP-Q system, 1-hr pad test, 4-day bladder diary, stress test, Q-
tip test, and QoL assessment using the KHQ, UDI-6, and the IIQ-7. This was repeated
at the 12-month follow-up. Postoperative urodynamics was performed in all patients
accepting the procedure
Mean age (years; SD): Group A: 55.0 (12.3); Group B: 52.9 (10.6)
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Ugurlucan 2013 (Continued)
Mean BMI kg/m² (SD): Group A: 31.8 (6.6); Group B: 31.3 (4.8)
Postmenopausal: Group A: 29 (56.9%); Group B: 30 (58.8%)
Previous incontinence surgery: Group A: 2 (4%); Group B: 2 (4%)
Concomitant POP surgery: Group A: 28/50; Group B: 28/50
Interventions Group A: biological PELVILACE TO (n = 50)
Group B: synthetic TOT ALIGN ®TO (n = 50)
Outcomes Primary outcome: patient-reported improvement in urinary incontinence (either com-
pletely dry or improvement in symptoms of SUI; reported as ’cure,’ ’better than before,
’ ’no change at all,’ and ’worse than before.’)
Secondary outcomes:
• objective cure: defined as the absence of SUI and a negative stress test at 200 ml in
the standing position
• objective improvement: defined as improvement in the bladder diary and
questionnaires
• Subjective evaluation by the patients was reported as “cure,” “better than before,”
“no change at all,” and “worse than before.”
• intra- and postoperative complications
• reoperation rate
• Groin pain
• Vaginal tape erosion
• QoL: assessed via KHQ, P-QoL, UDI-6, and IIQ-7
Notes Biological tape was PELVILACE® TO system; Bard, Covington, GA, USA and the
synthetic tape was ALIGN ®TO urethral support system; Bard TOT operation. The
PELVILACE®TO system consists of a PELVICOL® self-anchoring, natural tissue sling
implant and an introducer system. This system contains a self-anchoring, 1.5 cm wide,
and 40 cm long suburethral sling of porcine dermal collagen. The ALIGN®TOurethral
support system is a suburethral sling device made of type 1 monofilament polypropylene
mesh designed for the treatment of SUI through the TOR
Postmenopausal patients received local estrogen treatment for 1 month before and after
the operation
Concomitant POP was performed in a cohort of women
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “ In this prospective randomized
study ... Randomization was carried out
using computer-generated random alloca-
tions prepared by an investigator with no
clinical involvement in the trial”
Allocation concealment (selection bias) Low risk Quote: “computer-generated random allo-
cations prepared by an investigator with no
clinical involvement in the trial”
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Ugurlucan 2013 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Quote: “The patients were blinded to the
sling material used.”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “Follow-upwas performed ... by the
same physicianwhowas blinded to the type
of sling used”
Incomplete outcome data (attrition bias)
All outcomes
Low risk All accounted for
van Leijsen 2013
Methods RCT comparing RPR and TOT
Participants Dutch multicentre diagnostic cohort study with an embedded RCT
587 women with SUI; 123 randomised to surgery
Inclusion criteria: women with urodynamically-proven SUI, or MUI with SUI as pre-
dominant symptom following failed conservative treatment
Exclusion criteria: prior incontinence surgery; POP > stage 2 POP-Q; post PVR of >150
ml (by USS or characterisation)
MUI: Group A: 18/33; Group B: 61/90
Interventions Group A: RPR (n = 33)
Group B: TOT (n = 90)
Outcomes Outcome results for TOT and RPR not reported as separate figures; we contacted the
authors who supplied separate figures
• Subjective cure: defined as self-reported absence of SUI
• Objective cure: defined as negative stress test (any leakage of urine was a defined
as a failure)
• Subjective cure3
• Objective cure
• De novo urgency incontinence
• Voiding dysfunction
• Tape release for POVD
• Repeat incontinence surgery
Notes QoL questionnaires: UDI
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “A web-based application was used for
block randomisation and computer-generated ran-
dom number list prepared by a database designer”
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van Leijsen 2013 (Continued)
Allocation concealment (selection bias) Low risk Quote: “Patient data were entered into a password-
protected web- based database”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Quote: “Participants and health professionals were
not blinded to the allocated arm and the urodynamic
results”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “Data input of subjective outcome mea-
surements was per-formed by researchers who were
blinded to the treat-ment allocation”
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No information
Wang 2006
Methods RCT of TOT (Monarc) and SPARC suburethral sling procedures
Participants 60 women with an average age of 50 years (SD 10.71 )
Inclusion criteria: women with USI
Exclusion criteria: women suffering from preoperative voiding dysfunction, which was
defined as either: free Qmax of≤ 12ml/s in repeated free uroflow studies combined with
Pdet Q max of≥20cmH2O, PVR urine ≥ 100 ml, and participants with a pad increase
of at least 10cm H2O, compared to the baseline abdominal pressure in a pressure-flow
study. Women who had previous anti-incontinence surgery and/or with pelvic prolapse
> stage 2 of the ICS grading system were also excluded
Interventions Group A: Monarc (n = 31)
Group B: SPARC (n = 29)
Outcomes Assessed via 1-hr pad test, multichannel urodynamic assessment, complications and
postoperative voiding function. Transabdominal USS to detect subcutaneous, retropubic
or obturator haematoma
Notes The women were blinded to the procedure performed
Intraoperative cystoscopy was performed in both groups
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “By using a predetermined com-
puter-generated randomisation code ...
were assigned randomly by the senior au-
thor ...”
Allocation concealment (selection bias) Unclear risk No information
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Wang 2006 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Quote: “ ... The patients were blinded to
the procedure ...” How this was achieved
was not explained
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “an independent continence advi-
sor and one of the authors both of whom
were blinded to the procedures performed
carried out the follow-up examinations and
post operative outcome assessments”
Incomplete outcome data (attrition bias)
All outcomes
Low risk No differential loss to follow-up or differ-
ential attrition
Wang 2008
Methods RCT of TVT vs TVT-O
Single-blinded
Participants 69 women
Inclusion criteria: severe female SUI with or without prolapse (< POP-Q stage 3)
Exclusion criteria: pregnancy; previous surgery for urinary incontinence
Mean BMI kg/m² (SD): Group A: 25 (3); Group B: 25 (3)
Mean age (years; SD): Group A: 52 (11); Group B: 52 (11)
Interventions Group A: TVT (n = 35)
Group B: TVT-O (n = 34)
Outcomes • Subjective cure: no self-reported leaking and negative stress test:
• Subjective cure and improvement
• Failure: 1-h pad test not reduced by 50%
• Operative time
• Blood loss
• Length of hospital stay
• Bladder/visceral perforation
• Voiding dysfunction
• Haematoma
• QoL: UDI-6 and IIQ-7 before and after surgery
Notes Concomittant surgery: some women also had transvaginal hysterectomy and prolapse
repair
Follow-up: mean 14.5 months
Cystoscopy performed in TVT group only
Articlewritten inChinese and translated to English for interpretation and data extraction
Risk of bias
Bias Authors’ judgement Support for judgement
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Wang 2008 (Continued)
Random sequence generation (selection
bias)
Low risk Computer-generated randomisation sched-
ule
Allocation concealment (selection bias) Unclear risk No information
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Single-blinded (no information about who
was blinded)
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Single-blinded (no information about who
was blinded)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “All patients were evaluable”
Wang 2009
Methods RCT of TVT vs inside-out TVT-O
55 were participants in a previous study (ref 8, Zhu 2007: 23870; 27325) - already
included
Participants 300 women
Inclusion criteria: demonstrable severe SUI, or mild to moderate SUI that failed to
respond to conservative treatment. All women had urodynamically confirmed USI (no
detrusor contraction on leakage)
Exclusion criteria: ;ISDMUI; pregnancy; UTI; UUI; PVR volume > 100 ml; neurolog-
ical disease; urogenital malignancy, fistula, or pelvic radiotherapy
Menopausal: Group A: 87/154; Group B: 88/146
Previous prolapse surgery:
Previous incontinence surgery: Group A: 5; Group B: 5
Interventions Group A: TVT (n = 154)
Group B: TVT-O (n = 146)
Outcomes • Cure: negative cough test at follow-up (possibly objective):
• Improvement: frequency of UI episodes and urine weight on pad test reduced by
> 50%
• Failure: frequency of UI episodes ad urine weight on pad test reduced by < 50%
or worse than before surgery)
• Mean operative time in minutes
• Mean blood loss
• Operative time
• Mean length of hospital stay
• Adverse effects
• Urinary retention
• De novo UUI
• Vaginal tape erosion:
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Wang 2009 (Continued)
• Groin/thigh pain
Notes Signed informed consent, approved by Ethics committee
Mean follow-up: (months; SD): Group A: 19.6 (11.9); Group B: 20.5 (10.7; twice in
first year, then yearly)
Loss to follow-up: Group A: 6; Group B: 8, + 1 withdrawn (operation postponed)
Cystoscopy only performed in the TVT group
Concomitant prolapse and other surgery
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk The 315 women were allocated to the TVT
or the TVT-O group by an SAS randomi-
sation schedule (SAS Institute Inc, Cary,
NC, USA)
Allocation concealment (selection bias) Unclear risk Stated: ‘randomly allocated’, no further in-
formation
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Outcome assessors blind: ‘independent gy-
naecologist’
Incomplete outcome data (attrition bias)
All outcomes
Low risk No differential dropout (Group A: 6;
Group B: 9)
Wang 2010
Methods RCT comparing TVT and TOT-outside/in
Participants 140 women
Inclusion criteria: women with urodynamically proven SUI
Exclusion criteria: OAB syndrome dry or wet
Age (years; SD): Group A: 60 (10.8); Group B: 58 (11.6)
Previous incontinence surgery: Group A: 5; Group B: 3
BMI kg/m² (SD): Group A: 24 (2.4); Group B: 24.6 (2.6)
Concomitant POP: Group A: 30/70; Group B: 22/70
Interventions Group A: TVT (n = 70)
Group B: TOT (n = 70)
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Wang 2010 (Continued)
Outcomes • Subjective cure
• Objective cure: negative cough test, 1-h pad test of <2g.
• Improved: persistence of SUI (though occasional) not affecting daily activities or
requiring further treatment
• Vascular injury/haematoma
• Tape erosion
• Bladder perforation
• Voiding dysfunction
• De novo urgency/UII
• QoL assessed by UDI-6) and IIQ-7-SF
Notes Cystoscopy only performedwhen bladder perforation suspected in TOTgroup. All TVT
participants cystoscoped post procedure
Concomitant surgery: All participants with POP had this repaired at the time of tape
insertion
Lost to follow-up: Group A: 0 women; Group B: 0 women
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “Our study was a single blind ran-
domised trial and the patients were ran-
domly allocated to ...”
Allocation concealment (selection bias) Unclear risk Quote: “Our study was a single blind ran-
domised trial and the patients were ran-
domly allocated to ...”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Quote: “The patients were not blinded to
the operative procedure”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “post op assessment was performed
by FMW who did not take part in the op-
eration , YFS who performed the surgery
was not involved in follow up”
Incomplete outcome data (attrition bias)
All outcomes
Low risk No participants withdrew. None were lost
to follow-up
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Wang 2011
Methods RCT comparing TVT, TVT-O and TVT-Secur
Participants Total of 102 women included in this Chinese trial
Inclusion criteria: women with urodynamically proven SUI. If MUI, then SUI was the
predominant symptom
Exclusion criteria: women with previous surgical procedures for SUI
Mean age (years; SD): Group A: 56.6 (9.6); Group B: 56.0 (9.1)
Mean BMI kg/m² (SD): Group A: 25.3 (2.0); Group B: 27.3 (1.9)
Interventions Group A: TVT (n = 32)
Group B: TVT-O (n = 36)
Group C: TVT- Secur (data not included in this review)
Outcomes • Objective cure: negative cough stress test
• Subjective cure: absence of SUI symptoms
• Improvement: negative or a positive cough stress test and reduced SUI symptoms:
• Mean length of surgery
• Bladder perforation
• Voiding dysfunction
• Groin pain
• De novo urgency or urgency incontinence
• Vascular injury
Notes Power test calculation performed
Women with SUI were put on anticholinergic treatment prior to surgery
QoL assessment was performed using the ICI-Q-SF pre-operatively; no data for post-
operative scores
Cystoscopy routinely performed in TVT. Cystoscopy only performed if bladder injury
was suspected in the TVT-O group
Follow-up 1, 3, 6 and 12 months
All women completed the trial (no loss to follow-up)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “computer generated randomisa-
tion”
Allocation concealment (selection bias) Low risk Quote: “allocation was concealed using
opaque sealed envelopes”
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
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Wang 2011 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk All participants completed follow-up. All
outcomes reported
Zhang 2011
Methods RCT comparing TVT-O with a modified version of TVT-O using a self-tailored mesh
Participants 156 women in a Chinese hospital
Inclusion criteria: women with SUI aged > 18 years
Exclusion criteria: women with urgency; persistent urinary retention (PVR > 50 ml);
dysuria; other urologic diseases and psychiatric disorders
Mean age (years; SD): Group A: 61.4 (5.4); Group B: 62.6 (3.2)
Interventions Group A: TVT-O (n = 76)
Group B: modified TVT-O (n = 80)
Outcomes • Subjective cure: disappearance of SUI symptoms
• Subjective improvement
• Mean operative time
• Mean blood loss
• Mean hospital stay in days
• Voiding dysfunction
• QOL: self-administered I-QOL
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “stratified randomisation”
Allocation concealment (selection bias) Unclear risk No information
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No information
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Zullo 2007
Methods RCT comparing TVT and TVT-O
Participants 72 women
Inclusion criteria: women affected by SUI with no contraindications to vaginal surgery
Excluded criteria: women with urogenital prolapse > stage 1; DO; symptoms of OAB;
intrinsic urethral sphincter deficiency; urinary retention; previous anti-incontinence
surgery; neurologic bladder; and psychiatric disease
Age (years; SD): Group A: 52.8 (11.8); Group B: 53.4 (10.7)
BMI kg/m²: Group A: 25.7 (2.9); Group B: 26.5 (2.7)
Menopausal: Group A: 6/35; Group B: 8/37
POP stage 1 and 2: Group A: 34/35; Group B: 35/37
Interventions Group A: TVT (n = 35)
Group B: TVT-O (n = 37)
Outcomes • Objective cure (no leakage of urine with urodynamic stress testing)
• Subjective cure: VAS used to quantify participant perception of SUI symptom
severity
• Incidence of overall perioperative complications
• De novo urgency and urge incontinence
• Tape erosion
• Voiding dysfunction
Notes Intraoperative cystoscopy only performed in the TVT group
12 participants did not return for 5-year follow-up: 3 participants were lost (2 in the
TVT group and 1 in the TVT-O group), and 9 withdrew (4 in the TVT group and 5
in the TVT-O group)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: ” .. were randomly allocated to undergo
a TVT or TVTO procedure by using a predeter-
mined computer-generated randomisation code“
Allocation concealment (selection bias) Low risk Allocation concealed
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk ” ... outcome assessors at 5 years followup blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk No differential loss to follow-up or differential
attrition
157Mid-urethral sling operations for stress urinary incontinence in women (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Abbreviations
BFLUTS: Bristol lower urinary tract symptoms questionnaires
BMI: body-mass index
DO: detrusor overactivity
DUP: distal urethral polypropylene sling
EQOL-5D: Euro Quality of life -5 Dimension
g: gram
hr: hour
HRT: hormone replacement therapy
ICIQ: International Consultation on Incontinence questionnaire
ICIQ-FLUTS: International Consultation on Incontinence questionnaire - female lower urinary tract symptoms
ICIQ- LUTSquol: International Consultation on Incontinence questionnaire - lower urinary tract quality of life questionnaire
ICIQ-SF: International Consultation on Incontinence questionnaire short form
ICIQ-SF15: International Consultation on Incontinence questionnaire short form 15
IIQ: Incontinence Impact questionnaire
ICS: International Continence Society
I-QoL: Incontinence Quality of Life questionnaire
ISD: intrinsic sphincter deficiency
IVS: intravaginal slingoplasty
KHQ: King’s Health questionnaireMUI: mixed urinary incontinence
MUCP: Maximum urethral closure pressure
MUI: mixed urinary incontinence
OAB: overactive bladder
PGI-I: Patient Global Impression of Improvment
PGI-S: Patient Global Impression of Severity
PISQ-12: pelvic organ prolapse/urinary incontinence sexual questionnaire
POP: pelvic organ prolapse
POP-Q: pelvic organ prolapse quantification
POP-Q ICS: pelvic organ prolapse quantification International Continence Society
PVR: post void residual
RCT: randomized controlled trial
RPR: retropubic route
QoL: quality of life
QRCT: quasi-randomised trial
SEAPI-QMM: Stress related leak, Empyting ability, Anatomy, Protection, Inhibition-Quality of life, Mobility and Mental status
incontinence classification system
SD: standard deviation
SIS: Single incision sling
SPARC: suprapubic arc (procedure)
SUI: stress urinary incontinence
TOR: transobturator
TOT: transobturator tape
TOT-ARIS: transobturator tape-ARIS
TVT: tension-free vaginal tape
TVT-O: transobturator tension-free vaginal tape
UDI: Urinary Distress Impact questionnaire
UDI-6: Urinary Distress Impact questionnaire short form
UDS: urodynamics study
UI: urinary incontinence
UISS: urinary incontinence severity score
USI: urodynamic stress incontinence
USS: ultrasound
UTI: urinary tract infection
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UUI: urgency urinary incontinence
VAS: visual analogue scale
VLPP: Valsalval leak point pressure
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Al-Tayyem 2007 Not an RCT
Amat 2007 Sling apparently equivalent to TVT, but too little information provided to determine equivalence
Ballert 2010 Not an RCT
Bekker 2009 Sexual function analysis of 2 retrospective studies (not RCTs)
Borrell 2005 Retrospective study, not an RCT
Bracken 2012 RCT of bupivacaine and saline versus saline only for hydrodissection during TVT
Bruschini 2005 Not an RCT
Chen 2008 Not randomized
Chen 2011 Prospective comparative study with participants assigned not randomized
Chene 2009 Was prospective, but not stated that randomized
Chong 2003 All women had TVT. Intervention groups were division vs no division of tape
Corcos 2001 Traditional slings. No minimally invasive sling
Corcos 2005 No minimally invasive sling
Cotte 2006 An ultrasound study comparing tape position between RPR and TOR
Courtney-Watson 2002 Trial stopped due to difficulty recruiting. Planned to recruit 30 participants to each arm but actually
randomized less than 15 participants in total
Debodinance 2006 Non randomized prospective study
Dietz 2005 Imaging study: aim of the study was to determine the mobility of the slings from ultrasound imaging of
slings inserted in the parent trial (SUSPEND trial, Lim 2005)
Du 2008 Not an RCT
Falconer 2001 All had TVT
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(Continued)
Fischer 2005 Not an RCT
Foote 2012 Monarc vs mini single incision sling
Goldberg 2001 No minimally invasive sling
Gopinath 2013 Qualitative analysis on nonresponders of single incision sling RCT
Harmanli 2011 RCT of antibiotic use preoperatively for TVT and TOT (surgeons discretion for what tape was used)
Jackson 2013 RCT of antibiotic vs. placebo for MUS surgery
Jeon 2008 Not an RCT
Jones 2010 Not an RCT
Karagkounis 2007 A prospective cohort study not an RCT
Kim 2005a Retrospective review of medical records
Kim 2006 Not an RCT
Kulseng-Hanssen 2004 RCT - does not meet the inclusion criteria. Not MUS vs MUS. Tradition Sling vs TVT. This trial
compares three techniques for performing sling surgery: TVT, porcine xenograft (Pelvicol) sling and the
short autologous fascial sling technique ’Sling on a string’
Kulseng-Hanssen 2007 A prospective cohort study not an RCT
Kwon 2002 Prolapse trial not urinary incontinence
Liapis 2007 RCT with randomisation based on the type of anaesthesia used for one minimally invasive sling procedure
(TVT)
Liapis 2010 RCT of TVT-O vs TVT-O plus 6 months postoperative estrodiol therapy. Both groups had TVT-O
performed
Markland 2007 RCT of Burch colposuspension versus traditional sling - SISTEr Trial. Not MUS vs MUS
McClure 2006 Statistical modelling and not a trial in itself. No minimally invasive sling
Meschia 2002 1 tape used (TVT) and only occult urinary incontinence investigated
Osman 2003 No minimally invasive sling arm in the trial
Pace 2008 Prospective study of SPARC vs Monarc TOT but no evidence of randomisation
Padilla-Fernández 2013 Randomisation based on immediate or deferred cutting and readjustment of tape
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(Continued)
Park 2008 Same tape TOT randomized to either high-tension or tension-free
Sabadell 2008 Cohort study, not an RCT
Schierlitz 2007 Investigated occult incontinence
Schostak 2001 Not an RCT and no minimally invasive sling
Seo 2007 Not an RCT, retrospective study
Shin 2010 Non randomized longitudinal study
Sivaslioglu 2007 No minimally invasive sling
Surkont 2007 Not an RCT and only 1 arm, IVS
Takeyama 2006 Improvised instrument used
Tantanasis 2013 A review article, not an RCT
Tincello 2009 RCT of colposuspension or TVT with concomitant anterior repair (1 tape)
Tinelli 2007 Same tape TVT: randomized to either immediate TVT or TVT after 21 days of preoperative estrogen
treatment
Trezza 2001 Investigated occult urinary incontinence
Wang 2001 All women received TVT. Compared types of anaesthesia
Wei 2012 RCT of women with occult stress urinary incontinence undergoing POP surgery with and without con-
comitant MUS insertion
Williams 2003 Statistical modelling and not a trial in itself
Yang 2012 Non randomised inferiority study
Yoo 2007 A comparative study but not an RCT
Yoon 2011 RCT of single incision sling and TOT
Zaccardi 2010 RCT of pelvic floor muscle training on comfort.
Zullo 2005 All hadTVT.Womenwere randomly allocated to receive TVTplus postoperative vaginal oestrogen therapy
(ET group) or TVT without adjunctive medical treatment (no ET group)
Abbreviations
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IVS: intravaginal slingoplasty
MUS: mid-urethral sling
POP: pelvic organ prolapse
RCT: randomized controlled trial
RPR: retropubic route
SIS: Single incision sling
TOR: transobturator route
TOT: transobturator tape
TVT: tension-free vaginal tape
TVT-O: tension-free vaginal tape - Obturator
Characteristics of ongoing studies [ordered by study ID]
Cavkaytar 2013
Trial name or title Prospective randomised study comparing TVT and TOT in female SUI with no ISD
Methods RCT
Participants Inclusion criteria: women aged 18-70 years; with USI; with or without POP
Exclusion criteria: previous incontinence surgery; UI or OAB; mixed incontinence; ISD; BMI > 35
Interventions Participants underwent either TVT or TOT procedures
Outcomes Primary outcome: postoperative UDI-6 and IIQ-7 score <10 and negative cough test will be defined as ’cured’
Secondary outcomes:
• objective effectiveness by cough test at 6 and 12 months postoperatively
• short-term and long-term surgical complications
• bleeding
• bladder and bowel perforation
• mesh erosion
• prevalence of voiding dysfunction at 1 and 12 months postoperatively
Starting date June 2013
Contact information
Notes NCT01903590, expected completion date June 2014
Sung 2013
Trial name or title Effects of surgical treatment enhanced with exercise for mixed urinary incontinence (ESTEEM)
Methods
Participants Women > 21 years
Inclusion criteria:
• presence of both SUI and UUI
• reporting at least ’moderate bother’ from UUI item on the UDI question “Do you usually experience
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Sung 2013 (Continued)
urine leakage associated with a feeling of urgency, that is a strong sensation of needing to go to the
bathroom?”
• reporting at least ’moderate bother’ from SUI item on the UDI question “Do you usually experience
urine leakage related to coughing, sneezing, or laughing?”
• diagnosis of SUI defined by a positive cough stress test or urodynamic evaluation within the past 18
months
• desire surgical treatment for SUI symptoms
• urinary symptoms for >3 months
• subjects understand that BPTx is a treatment option for MUI outside the ESTEEM study protocol
• urodynamics within past 18 months
Exclusion criteria:
• anterior or apical compartment prolapse at or beyond the hymen (>0 on POP-Q), regardless of
whether patient is symptomatic (women with anterior or apical prolapse above the hymen (<0) who do not
report vaginal bulge symptoms will be eligible)
• planned concomitant surgery for anterior vaginal wall or apical prolapse > 0a (women undergoing only
rectocoele repair are eligible)
• women undergoing hysterectomy for any indication
• active pelvic organ malignancy
• aged <21 years
• pregnant or plans for future pregnancy in next 12 months, or within 12 months post-partum
• PVR >150 ml on 2 occasions, or current catheter use
• participation in other trial that may influence results of this study
• unevaluated haematuria
• prior sling, synthetic mesh for prolapse, implanted nerve stimulator for incontinence
• spinal cord injury or advanced/severe neurologic conditions including multiple sclerosis and
Parkinson’s disease (women on anti-muscarinic therapy will be eligible after 3 week wash-out period)
• non-ambulatory
• history of serious adverse reaction to synthetic mesh
• not able to complete study assessments according to clinician’s judgment, or not available for 12
month follow-up
• women who only report “other IE” on bladder diary, and do not report at minimum 1 stress and 1
urge IE/3 days
• diagnosis of and/or history of bladder pain or chronic pelvic pain
• women who had intravesical Botox injection within the past 12 months
Interventions Group A: mid-urethral sling combined with peri- and postoperative behavioral/pelvic floor therapy
Group B: mid-urethral sling
Outcomes
Starting date October 2013, expected completion date October 2016
Contact information
Notes NCT01959347
Abbreviations
BMI: body-mass index
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BPTx: behavioural/pelvic floor therapy
ESTEEM: Effects of surgical treatment enhanced with exercise for mixed urinary incontinence trial
IE; incontinence event
IIQ-7: Incontinence Impact questionnaire
ISD: intrinsic sphincter deficiency
MUI: mixed urinary incontinence
OAB: overactive bladder
POP: pelvic organ prolapse
POP-Q: pelvic organ prolapse quantification
PVF: post void residual
SUI: stress urinary incontinence
TOT: transobturator tape
TVT: tension-free vaginal tape
UDI: Urinary Distress Impact questionnaire
UDI-6: Urinary Distress Impact questionnaire short form
UI: urinary incontinence
USI: urodynamic stress incontinence
UUI: urgency urinary incontinence
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D A T A A N D A N A L Y S E S
Comparison 1. Transobturator (TOR) versus retropubic route (RPR)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Subjective cure (short term, ≤ 1
year)
35 5333 Risk Ratio (M-H, Fixed, 95% CI) 0.97 [0.95, 1.00]
2 Subjective cure and improvement
(short term, ≤ 1 year)
10 1651 Risk Ratio (M-H, Fixed, 95% CI) 0.98 [0.96, 1.00]
3 Subjective cure (medium term, 1
to 5 years)
5 683 Risk Ratio (M-H, Random, 95% CI) 0.97 [0.87, 1.09]
4 Subjective cure (long term, > 5
years)
4 714 Risk Ratio (M-H, Random, 95% CI) 0.95 [0.80, 1.12]
5 Subjective cure and improvement
(long term, > 5 years)
2 340 Risk Ratio (M-H, Random, 95% CI) 0.92 [0.67, 1.28]
6 Objective cure (short term, ≤ 1
year)
39 5974 Risk Ratio (M-H, Fixed, 95% CI) 0.98 [0.96, 1.00]
7 Objective cure and improvement
(short term, ≤ 1 year)
10 1478 Risk Ratio (M-H, Fixed, 95% CI) 0.98 [0.96, 1.01]
8 Objective cure (medium term, 1
to 5 years)
5 596 Risk Ratio (M-H, Fixed, 95% CI) 1.00 [0.95, 1.06]
9 Objective cure (long term, > 5
years)
3 400 Risk Ratio (M-H, Fixed, 95% CI) 0.97 [0.90, 1.06]
10 Operative time (minutes) 31 4713 Mean Difference (IV, Random, 95% CI) -7.54 [-9.31, -5.77]
11 Operative blood loss (ml) 14 1869 Mean Difference (IV, Random, 95% CI) -6.49 [-12.33, -0.65]
12 Length of hospital stay (days) 17 2170 Mean Difference (IV, Random, 95% CI) -0.25 [-0.59, 0.09]
13 Time to return to normal
activity level (weeks)
4 626 Mean Difference (IV, Fixed, 95% CI) -0.05 [-0.15, 0.06]
14 Perioperative complications 15 2205 Risk Ratio (M-H, Fixed, 95% CI) 0.91 [0.73, 1.14]
15Major vascular or visceral injury 28 4676 Risk Ratio (M-H, Fixed, 95% CI) 0.33 [0.19, 0.55]
16 Bladder or urethral perforation 39 6173 Risk Ratio (M-H, Fixed, 95% CI) 0.12 [0.08, 0.20]
17 Voiding dysfunction 37 6200 Risk Ratio (M-H, Fixed, 95% CI) 0.53 [0.43, 0.65]
18 De novo urgency or urgency
incontinence (short term, ≤ 1
year)
31 4923 Risk Ratio (M-H, Fixed, 95% CI) 0.98 [0.82, 1.17]
19 De novo urgency or urgency
incontinence (medium term, 1
to 5 years)
4 481 Risk Ratio (M-H, Fixed, 95% CI) 0.98 [0.55, 1.73]
20 De novo urgency or urgency
incontinence (long term, > 5
years)
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
21 Detrusor overactivity 4 566 Risk Ratio (M-H, Fixed, 95% CI) 1.00 [0.58, 1.73]
22 Vaginal tape erosion 30 4568 Risk Ratio (M-H, Fixed, 95% CI) 1.03 [0.70, 1.51]
23 Bladder/urethral erosion 4 374 Risk Ratio (M-H, Fixed, 95% CI) 0.34 [0.01, 8.13]
24 Groin pain 17 3050 Risk Ratio (M-H, Fixed, 95% CI) 4.45 [2.80, 7.08]
25 Suprapubic pain 4 1105 Risk Ratio (M-H, Fixed, 95% CI) 0.29 [0.11, 0.78]
26 Repeat incontinence surgery
(short term, ≤ 1 year)
8 1221 Risk Ratio (M-H, Fixed, 95% CI) 1.69 [0.75, 3.80]
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27 Repeat incontinence surgery
(medium term , 1 to 5 years)
2 355 Risk Ratio (M-H, Fixed, 95% CI) 21.89 [4.36, 109.77]
28 Repeat incontinence surgery
(long term > 5 years)
4 695 Risk Ratio (M-H, Fixed, 95% CI) 8.79 [3.36, 23.00]
Comparison 2. Retropubic bottom-to-top approach versus retropubic top-to-bottom approach
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Subjective cure (short term, ≤ 1
year)
3 477 Risk Ratio (M-H, Fixed, 95% CI) 1.10 [1.01, 1.19]
2 Objective cure (short term, ≤ 1
year)
5 622 Risk Ratio (M-H, Random, 95% CI) 1.06 [0.97, 1.17]
3 Operative time (minutes) 2 124 Mean Difference (IV, Fixed, 95% CI) -2.15 [-4.68, 0.38]
4 Length of hospital stay (days) 2 124 Mean Difference (IV, Fixed, 95% CI) -0.03 [-0.37, 0.30]
5 Perioperative complications 4 507 Risk Ratio (M-H, Fixed, 95% CI) 0.98 [0.53, 1.84]
6 Bladder or urethral perforation 5 631 Risk Ratio (M-H, Fixed, 95% CI) 0.55 [0.31, 0.98]
7 Voiding dysfunction 5 631 Risk Ratio (M-H, Fixed, 95% CI) 0.40 [0.18, 0.90]
8 De novo urgency or urgency
incontinence
4 541 Risk Ratio (M-H, Fixed, 95% CI) 0.84 [0.52, 1.34]
9 Detrusor overactivity 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
10 Vaginal tape erosion 4 563 Risk Ratio (M-H, Fixed, 95% CI) 0.27 [0.08, 0.95]
11 QoL specific 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
Comparison 3. Obturator medial-to-lateral approach versus obturator lateral-to-medial approach
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Subjective cure (short term, ≤ 1
year)
6 759 Risk Ratio (M-H, Fixed, 95% CI) 1.00 [0.96, 1.06]
2 Subjective cure and improvement
(short term, ≤ 1 year)
5 732 Risk Ratio (M-H, Fixed, 95% CI) 1.02 [0.97, 1.08]
3 Subjective cure (medium term, 1
to 5 years)
2 235 Risk Ratio (M-H, Fixed, 95% CI) 1.06 [0.91, 1.23]
4 Subjective cure and improvement
(medium term, 1 to 5 years)
2 399 Risk Ratio (M-H, Fixed, 95% CI) 1.00 [0.90, 1.11]
5 Objective cure (short term, ≤ 1
year)
6 745 Risk Ratio (M-H, Fixed, 95% CI) 0.99 [0.95, 1.04]
6 Objective cure and improvement
(short term, ≤ 1 year)
2 214 Risk Ratio (M-H, Fixed, 95% CI) 1.00 [0.95, 1.07]
7 Operative time (minutes) 4 481 Mean Difference (IV, Random, 95% CI) 0.52 [-1.09, 2.13]
8 Operative blood loss (ml) 3 255 Mean Difference (IV, Fixed, 95% CI) 1.11 [-6.01, 8.22]
9 Length of hospital stay (days) 2 190 Mean Difference (IV, Random, 95% CI) -0.77 [-2.54, 0.99]
10 Time to return to normal
activity level
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
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11 Perioperative complications 2 214 Risk Ratio (M-H, Fixed, 95% CI) 1.30 [0.23, 7.51]
12Major vascular or visceral injury 4 622 Risk Ratio (M-H, Fixed, 95% CI) 0.71 [0.23, 2.19]
13 Vaginal perforation/injury 3 541 Risk Ratio (M-H, Fixed, 95% CI) 0.25 [0.12, 0.53]
14 Bladder or urethral perforation 6 794 Risk Ratio (M-H, Fixed, 95% CI) 0.38 [0.07, 1.92]
15 Voiding dysfunction 8 1121 Risk Ratio (M-H, Fixed, 95% CI) 1.74 [1.06, 2.88]
16 De novo urgency or urgency
incontinence
3 357 Risk Ratio (M-H, Fixed, 95% CI) 1.01 [0.46, 2.20]
17 Detrusor overactivity 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
18 Vaginal tape erosion 7 1087 Risk Ratio (M-H, Fixed, 95% CI) 0.42 [0.16, 1.09]
19 Groin/thigh pain 6 837 Risk Ratio (M-H, Fixed, 95% CI) 1.15 [0.75, 1.76]
20 Repeat incontinence surgery 2 532 Risk Ratio (M-H, Fixed, 95% CI) 0.64 [0.32, 1.30]
21 QoL specific 1 46 Mean Difference (IV, Fixed, 95% CI) 16.54 [4.84, 28.24]
Comparison 4. One method of mid-urethral tape insertion versus another method, same route
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Subjective cure (short term, up
to 1 year)
7 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
1.1 Modified TVT-O (short
tape) vs TVT-O
1 175 Risk Ratio (M-H, Fixed, 95% CI) 1.00 [0.90, 1.11]
1.2 Modified TVT
(suburethral pad) versus TVT
1 248 Risk Ratio (M-H, Fixed, 95% CI) 1.00 [0.91, 1.10]
1.3 Self-tailored TVT-O vs
TVT-O
1 156 Risk Ratio (M-H, Fixed, 95% CI) 1.02 [0.93, 1.11]
1.4 Monarc®TOT open edge
+ tension suture vs TOT®
1 93 Risk Ratio (M-H, Fixed, 95% CI) 1.04 [0.87, 1.24]
1.5 AdjustableTOT vs TOT® 1 96 Risk Ratio (M-H, Fixed, 95% CI) 1.05 [0.87, 1.28]
1.6 Synthetic vs biological 2 169 Risk Ratio (M-H, Fixed, 95% CI) 1.02 [0.86, 1.22]
2 Subjective cure and improvement
(short term, up to 1 year)
3 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
2.1 Modified TVT-O (short
tape) vs TVT-O
1 170 Risk Ratio (M-H, Fixed, 95% CI) 1.03 [0.97, 1.09]
2.2 TOT + 2-point tape
fixation vs TOT
1 418 Risk Ratio (M-H, Fixed, 95% CI) 1.07 [1.00, 1.14]
2.3 TVT versus modified
TVT (suburethral pad)
1 248 Risk Ratio (M-H, Fixed, 95% CI) 1.03 [0.98, 1.08]
3 Subjective cure (medium term, 1
to 5 years)
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
3.1 Modified TVT-O (short
tape) vs TVT-O
1 153 Risk Ratio (M-H, Fixed, 95% CI) 0.98 [0.86, 1.12]
4 Objective cure (medium term, 1
to 5 years)
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
4.1 Modified TVT-O (short
tape) vs TVT-O
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5 Objective cure (short term, ≤ 1
year)
5 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
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5.1 Modified TVT-O (less
dissection) vs TVT-O
1 69 Risk Ratio (M-H, Fixed, 95% CI) 1.02 [0.91, 1.15]
5.2 Synthetic vs biological 2 136 Risk Ratio (M-H, Fixed, 95% CI) 1.03 [0.94, 1.14]
5.3 TVT-O + IS vs TVT-O 1 93 Risk Ratio (M-H, Fixed, 95% CI) 1.45 [1.02, 2.06]
5.4 TOT + 2-point tape
fixation vs TOT
1 418 Risk Ratio (M-H, Fixed, 95% CI) 1.07 [1.01, 1.13]
6 Operative time (minutes) 2 Mean Difference (IV, Fixed, 95% CI) Subtotals only
6.1 TVT-O + IS vs TVT-O 1 96 Mean Difference (IV, Fixed, 95% CI) 12.0 [8.91, 15.09]
6.2 Self-tailored TVT-O vs
TVT-O
1 156 Mean Difference (IV, Fixed, 95% CI) -25.0 [-26.73, -23.
27]
7 Operative blood loss (ml) 3 Mean Difference (IV, Fixed, 95% CI) Subtotals only
7.1 TVT-O + IS versus
TVT-O
1 92 Mean Difference (IV, Fixed, 95% CI) 52.10 [43.73, 60.47]
7.2 Self-tailored TVT-O vs
TVT-O
1 156 Mean Difference (IV, Fixed, 95% CI) -13.00 [-16.57, -13.
43]
7.3 Synthetic vs biological 1 70 Mean Difference (IV, Fixed, 95% CI) -0.40 [-0.92, 0.12]
8 Length of hospital stay (days) 2 Mean Difference (IV, Fixed, 95% CI) Subtotals only
8.1 TVT-O + IS vs TVT-O 1 96 Mean Difference (IV, Fixed, 95% CI) 12.0 [8.91, 15.09]
8.2 Self-tailored TVT-O vs
TVT-O
1 156 Mean Difference (IV, Fixed, 95% CI) -3.0 [-3.16, -2.84]
9 Perioperative complications 2 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
9.1 Synthetic vs biological 2 170 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
10Major vascular or visceral injury 4 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
10.1 TVT-O + IS vs TVT-O 1 96 Risk Ratio (M-H, Fixed, 95% CI) 0.72 [0.17, 3.04]
10.2 Synthetic vs biological 2 170 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
10.3 AdjustableTOT vs TOT
®
1 96 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
11 Bladder/urethral perforation 4 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
11.1 TVT-O + IS vs TVT-O 1 96 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
11.2 TOT + 2-point tape
fixation vs TOT
1 463 Risk Ratio (M-H, Fixed, 95% CI) 0.75 [0.17, 3.33]
11.3 TVT versus modified
TVT (suburethral pad)
1 248 Risk Ratio (M-H, Fixed, 95% CI) 0.49 [0.05, 5.36]
11.4 AdjustableTOT vs TOT
®
1 96 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
12 Voiding dysfunction 6 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
12.1 Modified TVT-O (less
dissection) vs TVT-O
1 72 Risk Ratio (M-H, Fixed, 95% CI) 2.0 [0.13, 30.61]
12.2 TVT versus modified
TVT (suburethral pad)
1 248 Risk Ratio (M-H, Fixed, 95% CI) 2.21 [0.70, 7.00]
12.3 Self-tailored TVT-O vs
TVT-O
1 156 Risk Ratio (M-H, Fixed, 95% CI) 0.95 [0.06, 14.92]
12.4 Monarc®TOT open
edge + tension suture vs TOT
®
1 93 Risk Ratio (M-H, Fixed, 95% CI) 0.47 [0.04, 4.99]
12.5 Synthetic vs biological 2 170 Risk Ratio (M-H, Fixed, 95% CI) 5.0 [0.25, 101.58]
13 De novo urgency or urgency
incontinence
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
13.1 Modified TVT-O (short
tape) vs TVT-O
1 170 Risk Ratio (M-H, Fixed, 95% CI) 1.22 [0.51, 2.94]
14 Vaginal tape erosion 6 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
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14.1 Modified TVT-O (short
tape) vs TVT-O
1 170 Risk Ratio (M-H, Fixed, 95% CI) 0.33 [0.01, 7.88]
14.2 TVT versus modified
TVT (suburethral pad)
1 248 Risk Ratio (M-H, Fixed, 95% CI) 2.30 [0.61, 8.68]
14.3 TVT-O + IS vs TVT-O 1 93 Risk Ratio (M-H, Fixed, 95% CI) 0.94 [0.06, 14.55]
14.4 Monarc®TOT open
edge + tension suture vs TOT
®
1 93 Risk Ratio (M-H, Fixed, 95% CI) 0.13 [0.01, 2.53]
14.5 Synthetic vs biological 2 169 Risk Ratio (M-H, Fixed, 95% CI) 3.0 [0.13, 71.92]
15 Bladder/urethral erosion 1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
15.1 TVT versus modified
TVT (suburethral pad)
1 248 Risk Ratio (M-H, Fixed, 95% CI) 0.98 [0.06, 15.56]
16 Groin pain 2 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
16.1 Modified TVT-O (short
tape) vs TVT-O
1 170 Risk Ratio (M-H, Fixed, 95% CI) 1.30 [0.30, 5.64]
16.2 Synthetic vs biological 1 69 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
Comparison 5. One type of tape material versus another
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Subjective cure (short term, ≤ 1
year)
4 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
1.1 Monofilament versus
multifilament
4 546 Risk Ratio (M-H, Fixed, 95% CI) 1.03 [0.95, 1.10]
1.2 Monofilament versus
combined monofilament and
biological
1 96 Risk Ratio (M-H, Fixed, 95% CI) 0.91 [0.79, 1.05]
1.3 Combined monofilament
and biological vs multifilament
1 96 Risk Ratio (M-H, Fixed, 95% CI) 1.10 [0.96, 1.26]
2 Subjective cure (medium term, 1
to 5 years)
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
2.1 Monofilament vs
multifilament
1 96 Risk Ratio (M-H, Fixed, 95% CI) 1.03 [0.85, 1.23]
2.2 Monofilament vs
combined monofilament and
biological
1 96 Risk Ratio (M-H, Fixed, 95% CI) 0.91 [0.78, 1.06]
2.3 Combined monofilament
and biological vs multifilament
1 96 Risk Ratio (M-H, Fixed, 95% CI) 1.13 [0.96, 1.32]
3 Objective cure (short term, ≤ 1
year)
2 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
3.1 Monofilament vs
multifilament
2 349 Risk Ratio (M-H, Fixed, 95% CI) 1.07 [0.96, 1.19]
4 Operative time (minutes) 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
4.1 Monofilament vs
multifilament
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
5 Length of hospital stay (days) 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
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5.1 Monofilament vs
multifilament
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
6 Perioperative complications 2 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
6.1 Monofilament vs
multifilament
2 279 Risk Ratio (M-H, Fixed, 95% CI) 1.16 [0.36, 3.69]
7 Major vascular or visceral injury 1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
7.1 Monofilament vs
multifilament
1 96 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.2 Monofilament vs
combined monofilament and
biological
1 96 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.3 Combined monofilament
and biological vs multifilament
1 96 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
8 Bladder or urethral perforation 4 749 Risk Ratio (M-H, Fixed, 95% CI) 1.15 [0.49, 2.70]
8.1 Monofilament vs
multifilament
4 557 Risk Ratio (M-H, Fixed, 95% CI) 1.15 [0.49, 2.70]
8.2 Monofilament vs
combined monofilament and
biological
1 96 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
8.3 Combined monofilament
and biological vs multifilament
1 96 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
9 Voiding dysfunction 3 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
9.1 Monofilament vs
multifilament
3 461 Risk Ratio (M-H, Fixed, 95% CI) 2.10 [0.96, 4.59]
10 De novo urgency or urgency
incontinence
4 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
10.1 Monofilament vs
multifilament
4 545 Risk Ratio (M-H, Fixed, 95% CI) 1.11 [0.68, 1.82]
10.2 Monofilament vs
combined monofilament and
biological
1 96 Risk Ratio (M-H, Fixed, 95% CI) 2.0 [0.38, 10.41]
10.3Combinedmonofilament
and biological vs multifilament
1 96 Risk Ratio (M-H, Fixed, 95% CI) 0.4 [0.08, 1.96]
11 Detrusor overactivity 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
11.1 Monofilament vs
multifilament
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
12 Vaginal tape erosion 3 Risk Ratio (M-H, Random, 95% CI) Subtotals only
12.1 Monofilament vs
multifilament
3 445 Risk Ratio (M-H, Random, 95% CI) 0.79 [0.09, 6.84]
12.2 Monofilament vs
combined monofilament and
biological
1 96 Risk Ratio (M-H, Random, 95% CI) 3.0 [0.32, 27.83]
12.3Combinedmonofilament
and biological vs multifilament
1 96 Risk Ratio (M-H, Random, 95% CI) 0.33 [0.04, 3.09]
13 QoL specific (ICIQ) 1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
13.1 Monofilament vs
multifilament
1 96 Mean Difference (IV, Fixed, 95% CI) -0.60 [-0.76, -0.44]
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Analysis 1.1. Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 1 Subjective
cure (short term, ≤ 1 year).
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 1 Transobturator (TOR) versus retropubic route (RPR)
Outcome: 1 Subjective cure (short term,≤ 1 year)
Study or subgroup TOR RPR Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Aigmuller 2014 107/122 123/139 5.2 % 0.99 [ 0.91, 1.08 ]
Aniuliene 2009 145/150 111/114 5.7 % 0.99 [ 0.95, 1.04 ]
Barber 2008 68/75 74/85 3.1 % 1.04 [ 0.93, 1.16 ]
Barry 2008 49/58 70/82 2.6 % 0.99 [ 0.86, 1.14 ]
de Tayrac 2004 26/30 30/31 1.3 % 0.90 [ 0.77, 1.05 ]
Deffieux 2010 61/69 63/69 2.8 % 0.97 [ 0.87, 1.08 ]
Freeman 2011 59/95 55/85 2.6 % 0.96 [ 0.77, 1.20 ]
Hammoud 2011 48/50 56/60 2.3 % 1.03 [ 0.94, 1.12 ]
Jakimiuk 2012 13/16 14/15 0.7 % 0.87 [ 0.66, 1.14 ]
Karateke 2009 76/83 76/81 3.5 % 0.98 [ 0.90, 1.06 ]
Kilic 2007 8/10 7/10 0.3 % 1.14 [ 0.69, 1.90 ]
Kim 2005 56/65 56/65 2.5 % 1.00 [ 0.87, 1.15 ]
Krofta 2010 112/147 111/141 5.1 % 0.97 [ 0.85, 1.10 ]
Laurikainen 2007 122/131 121/134 5.4 % 1.03 [ 0.96, 1.11 ]
Leanza 2009 178/208 190/215 8.4 % 0.97 [ 0.90, 1.04 ]
Lee 2007 52/60 52/60 2.3 % 1.00 [ 0.87, 1.15 ]
Liapis 2006 33/43 34/46 1.5 % 1.04 [ 0.82, 1.32 ]
Mehdiyev 2010 14/17 13/15 0.6 % 0.95 [ 0.71, 1.28 ]
Meschia 2007 96/110 99/108 4.5 % 0.95 [ 0.87, 1.04 ]
Nerli 2009 16/18 16/18 0.7 % 1.00 [ 0.79, 1.26 ]
Nyyssonen 2014 36/43 40/43 1.8 % 0.90 [ 0.77, 1.05 ]
Porena 2007 58/75 50/70 2.3 % 1.08 [ 0.89, 1.31 ]
Rechberger 2009 146/197 151/201 6.7 % 0.99 [ 0.88, 1.11 ]
Richter 2010 163/285 181/280 8.2 % 0.88 [ 0.77, 1.01 ]
Riva 2006 64/65 62/66 2.8 % 1.05 [ 0.98, 1.12 ]
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(. . . Continued)
Study or subgroup TOR RPR Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Scheiner 2012 57/71 57/65 2.7 % 0.92 [ 0.79, 1.06 ]
Schierlitz 2008 55/70 63/66 2.9 % 0.82 [ 0.72, 0.94 ]
Tanuri 2010 17/19 8/9 0.5 % 1.01 [ 0.76, 1.33 ]
Tarcan 2011 20/22 20/23 0.9 % 1.05 [ 0.85, 1.28 ]
Teo 2011 26/29 35/41 1.3 % 1.05 [ 0.88, 1.25 ]
van Leijsen 2013 62/83 25/31 1.6 % 0.93 [ 0.75, 1.15 ]
Wang 2008 29/34 31/35 1.4 % 0.96 [ 0.80, 1.16 ]
Wang 2010 64/70 63/70 2.8 % 1.02 [ 0.91, 1.13 ]
Wang 2011 33/36 30/32 1.4 % 0.98 [ 0.86, 1.12 ]
Zullo 2007 33/37 32/35 1.5 % 0.98 [ 0.84, 1.13 ]
Total (95% CI) 2693 2640 100.0 % 0.97 [ 0.95, 1.00 ]
Total events: 2202 (TOR), 2219 (RPR)
Heterogeneity: Chi2 = 26.73, df = 34 (P = 0.81); I2 =0.0%
Test for overall effect: Z = 2.16 (P = 0.031)
Test for subgroup differences: Not applicable
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Analysis 1.2. Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 2 Subjective
cure and improvement (short term, ≤ 1 year).
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 1 Transobturator (TOR) versus retropubic route (RPR)
Outcome: 2 Subjective cure and improvement (short term,≤ 1 year)
Study or subgroup TOR RPR Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Aigmuller 2014 116/122 136/139 16.1 % 0.97 [ 0.93, 1.02 ]
Kim 2005 62/65 63/65 8.0 % 0.98 [ 0.92, 1.05 ]
Krofta 2010 143/147 138/141 17.9 % 0.99 [ 0.96, 1.03 ]
Lee 2007 57/60 56/60 7.1 % 1.02 [ 0.93, 1.11 ]
Nerli 2009 18/18 18/18 2.3 % 1.00 [ 0.90, 1.11 ]
Porena 2007 68/75 63/70 8.3 % 1.01 [ 0.91, 1.12 ]
Rechberger 2009 174/197 185/201 23.3 % 0.96 [ 0.90, 1.02 ]
Scheiner 2012 65/71 63/65 8.4 % 0.94 [ 0.87, 1.03 ]
Wang 2008 33/34 34/35 4.3 % 1.00 [ 0.92, 1.08 ]
Wang 2011 36/36 32/32 4.4 % 1.00 [ 0.94, 1.06 ]
Total (95% CI) 825 826 100.0 % 0.98 [ 0.96, 1.00 ]
Total events: 772 (TOR), 788 (RPR)
Heterogeneity: Chi2 = 3.57, df = 9 (P = 0.94); I2 =0.0%
Test for overall effect: Z = 1.61 (P = 0.11)
Test for subgroup differences: Not applicable
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Analysis 1.3. Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 3 Subjective
cure (medium term, 1 to 5 years).
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 1 Transobturator (TOR) versus retropubic route (RPR)
Outcome: 3 Subjective cure (medium term, 1 to 5 years)
Study or subgroup TOR RPR Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Deffieux 2010 56/65 55/67 20.5 % 1.05 [ 0.90, 1.22 ]
Laurikainen 2007 115/126 118/131 28.1 % 1.01 [ 0.94, 1.10 ]
Nyyssonen 2014 38/46 38/47 16.4 % 1.02 [ 0.84, 1.24 ]
Schierlitz 2008 60/75 71/72 24.0 % 0.81 [ 0.72, 0.91 ]
Tarcan 2011 22/27 21/27 11.0 % 1.05 [ 0.80, 1.37 ]
Total (95% CI) 339 344 100.0 % 0.97 [ 0.87, 1.09 ]
Total events: 291 (TOR), 303 (RPR)
Heterogeneity: Tau2 = 0.01; Chi2 = 11.94, df = 4 (P = 0.02); I2 =67%
Test for overall effect: Z = 0.50 (P = 0.62)
Test for subgroup differences: Not applicable
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Analysis 1.4. Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 4 Subjective
cure (long term, > 5 years).
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 1 Transobturator (TOR) versus retropubic route (RPR)
Outcome: 4 Subjective cure (long term, > 5 years)
Study or subgroup TOR RPR Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Laurikainen 2007 113/122 115/131 37.2 % 1.06 [ 0.97, 1.14 ]
Porena 2007 32/47 33/40 22.3 % 0.83 [ 0.65, 1.05 ]
Richter 2010 75/173 72/141 22.9 % 0.85 [ 0.67, 1.07 ]
Zullo 2007 23/31 21/29 17.6 % 1.02 [ 0.75, 1.39 ]
Total (95% CI) 373 341 100.0 % 0.95 [ 0.80, 1.12 ]
Total events: 243 (TOR), 241 (RPR)
Heterogeneity: Tau2 = 0.02; Chi2 = 8.51, df = 3 (P = 0.04); I2 =65%
Test for overall effect: Z = 0.65 (P = 0.52)
Test for subgroup differences: Not applicable
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Analysis 1.5. Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 5 Subjective
cure and improvement (long term, > 5 years).
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 1 Transobturator (TOR) versus retropubic route (RPR)
Outcome: 5 Subjective cure and improvement (long term, > 5 years)
Study or subgroup TOR RPR Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Laurikainen 2007 121/122 128/131 54.4 % 1.02 [ 0.98, 1.05 ]
Porena 2007 35/47 36/40 45.6 % 0.83 [ 0.68, 1.01 ]
Total (95% CI) 169 171 100.0 % 0.92 [ 0.67, 1.28 ]
Total events: 156 (TOR), 164 (RPR)
Heterogeneity: Tau2 = 0.05; Chi2 = 10.83, df = 1 (P = 0.00100); I2 =91%
Test for overall effect: Z = 0.47 (P = 0.64)
Test for subgroup differences: Not applicable
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Analysis 1.6. Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 6 Objective
cure (short term, ≤ 1 year).
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 1 Transobturator (TOR) versus retropubic route (RPR)
Outcome: 6 Objective cure (short term,≤ 1 year)
Study or subgroup TOR RPR Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Aigmuller 2014 196/233 215/247 8.1 % 0.97 [ 0.90, 1.04 ]
Alkady 2009 15/30 15/30 0.6 % 1.00 [ 0.60, 1.66 ]
Andonian 2007 64/77 69/80 2.6 % 0.96 [ 0.84, 1.10 ]
Aniuliene 2009 142/150 108/114 4.7 % 1.00 [ 0.94, 1.06 ]
Araco 2008 83/100 108/108 4.0 % 0.83 [ 0.76, 0.91 ]
Barber 2008 62/75 73/85 2.6 % 0.96 [ 0.84, 1.10 ]
Barry 2008 48/58 64/82 2.1 % 1.06 [ 0.90, 1.25 ]
Chen 2010 101/110 70/77 3.2 % 1.01 [ 0.92, 1.11 ]
Chen 2012 85/103 89/102 3.5 % 0.95 [ 0.84, 1.06 ]
David-Montefiore 2006 40/46 37/42 1.5 % 0.99 [ 0.84, 1.16 ]
de Tayrac 2004 27/30 26/31 1.0 % 1.07 [ 0.88, 1.30 ]
Deffieux 2010 67/69 65/69 2.5 % 1.03 [ 0.96, 1.11 ]
El-Hefnawy 2010 18/21 18/19 0.7 % 0.90 [ 0.74, 1.11 ]
Enzelsberger 2005 45/53 45/52 1.8 % 0.98 [ 0.84, 1.15 ]
Jakimiuk 2012 14/16 14/15 0.6 % 0.94 [ 0.75, 1.18 ]
Kamel 2009 55/60 54/60 2.1 % 1.02 [ 0.91, 1.14 ]
Karateke 2009 73/83 72/81 2.8 % 0.99 [ 0.89, 1.11 ]
Kim 2005 17/21 18/22 0.7 % 0.99 [ 0.74, 1.32 ]
Krofta 2010 130/147 127/141 5.0 % 0.98 [ 0.91, 1.06 ]
Laurikainen 2007 122/131 128/134 4.9 % 0.97 [ 0.92, 1.03 ]
Liapis 2006 39/43 41/46 1.5 % 1.02 [ 0.89, 1.17 ]
Mansoor 2003 46/48 50/54 1.8 % 1.04 [ 0.94, 1.14 ]
Meschia 2007 98/110 99/108 3.9 % 0.97 [ 0.89, 1.06 ]
Nerli 2009 16/18 16/18 0.6 % 1.00 [ 0.79, 1.26 ]
Oliveira 2006 37/42 38/42 1.5 % 0.97 [ 0.84, 1.13 ]
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Study or subgroup TOR RPR Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Porena 2007 58/75 50/70 2.0 % 1.08 [ 0.89, 1.31 ]
Rechberger 2009 146/197 151/201 5.8 % 0.99 [ 0.88, 1.11 ]
Richter 2010 233/285 232/280 9.1 % 0.99 [ 0.91, 1.07 ]
Riva 2006 58/65 59/66 2.3 % 1.00 [ 0.89, 1.12 ]
Scheiner 2012 64/71 60/65 2.4 % 0.98 [ 0.88, 1.08 ]
Schierlitz 2008 48/71 53/67 2.1 % 0.85 [ 0.70, 1.05 ]
Tanuri 2010 16/19 8/9 0.4 % 0.95 [ 0.70, 1.28 ]
Tarcan 2011 19/22 20/23 0.8 % 0.99 [ 0.79, 1.25 ]
Teo 2011 25/29 33/41 1.1 % 1.07 [ 0.87, 1.32 ]
van Leijsen 2013 57/59 13/13 0.8 % 0.99 [ 0.89, 1.11 ]
Wang 2009 106/118 103/115 4.0 % 1.00 [ 0.92, 1.09 ]
Wang 2010 64/70 65/70 2.5 % 0.98 [ 0.89, 1.08 ]
Wang 2011 33/36 30/32 1.2 % 0.98 [ 0.86, 1.12 ]
Zullo 2007 33/37 32/35 1.3 % 0.98 [ 0.84, 1.13 ]
Total (95% CI) 3028 2946 100.0 % 0.98 [ 0.96, 1.00 ]
Total events: 2600 (TOR), 2568 (RPR)
Heterogeneity: Chi2 = 24.86, df = 38 (P = 0.95); I2 =0.0%
Test for overall effect: Z = 1.90 (P = 0.057)
Test for subgroup differences: Not applicable
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Analysis 1.7. Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 7 Objective
cure and improvement (short term, ≤ 1 year).
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 1 Transobturator (TOR) versus retropubic route (RPR)
Outcome: 7 Objective cure and improvement (short term,≤ 1 year)
Study or subgroup TOR RPR Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Alkady 2009 15/15 14/15 2.0 % 1.07 [ 0.89, 1.28 ]
Chen 2012 96/103 99/102 14.0 % 0.96 [ 0.90, 1.02 ]
David-Montefiore 2006 46/46 42/42 6.2 % 1.00 [ 0.96, 1.04 ]
de Tayrac 2004 28/30 29/31 4.0 % 1.00 [ 0.87, 1.14 ]
Kim 2005 21/21 22/22 3.1 % 1.00 [ 0.92, 1.09 ]
Krofta 2010 144/147 139/141 20.0 % 0.99 [ 0.96, 1.02 ]
Liapis 2006 42/43 44/46 6.0 % 1.02 [ 0.95, 1.10 ]
Porena 2007 68/75 63/70 9.2 % 1.01 [ 0.91, 1.12 ]
Rechberger 2009 138/156 131/140 19.4 % 0.95 [ 0.88, 1.02 ]
Wang 2009 115/118 113/115 16.1 % 0.99 [ 0.95, 1.03 ]
Total (95% CI) 754 724 100.0 % 0.98 [ 0.96, 1.01 ]
Total events: 713 (TOR), 696 (RPR)
Heterogeneity: Chi2 = 4.84, df = 9 (P = 0.85); I2 =0.0%
Test for overall effect: Z = 1.35 (P = 0.18)
Test for subgroup differences: Not applicable
0.5 0.7 1 1.5 2
FavoursTOR Favours RPR
179Mid-urethral sling operations for stress urinary incontinence in women (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.8. Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 8 Objective
cure (medium term, 1 to 5 years).
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 1 Transobturator (TOR) versus retropubic route (RPR)
Outcome: 8 Objective cure (medium term, 1 to 5 years)
Study or subgroup TOR RPR Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
David-Montefiore 2006 32/37 27/34 10.5 % 1.09 [ 0.88, 1.35 ]
Deffieux 2010 65/65 61/67 22.6 % 1.10 [ 1.01, 1.19 ]
El-Hefnawy 2010 28/35 31/36 11.4 % 0.93 [ 0.75, 1.15 ]
Laurikainen 2007 113/126 124/131 45.4 % 0.95 [ 0.88, 1.02 ]
Wang 2009 25/30 29/35 10.0 % 1.01 [ 0.81, 1.25 ]
Total (95% CI) 293 303 100.0 % 1.00 [ 0.95, 1.06 ]
Total events: 263 (TOR), 272 (RPR)
Heterogeneity: Chi2 = 8.42, df = 4 (P = 0.08); I2 =52%
Test for overall effect: Z = 0.00 (P = 1.0)
Test for subgroup differences: Not applicable
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Analysis 1.9. Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 9 Objective
cure (long term, > 5 years).
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 1 Transobturator (TOR) versus retropubic route (RPR)
Outcome: 9 Objective cure (long term, > 5 years)
Study or subgroup TOR RPR Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Laurikainen 2007 106/122 111/131 62.7 % 1.03 [ 0.93, 1.13 ]
Porena 2007 33/47 35/40 22.2 % 0.80 [ 0.64, 1.00 ]
Zullo 2007 27/31 25/29 15.1 % 1.01 [ 0.83, 1.23 ]
Total (95% CI) 200 200 100.0 % 0.97 [ 0.90, 1.06 ]
Total events: 166 (TOR), 171 (RPR)
Heterogeneity: Chi2 = 4.13, df = 2 (P = 0.13); I2 =52%
Test for overall effect: Z = 0.62 (P = 0.53)
Test for subgroup differences: Not applicable
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Analysis 1.10. Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 10 Operative
time (minutes).
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 1 Transobturator (TOR) versus retropubic route (RPR)
Outcome: 10 Operative time (minutes)
Study or subgroup TOR RPR
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Aigmuller 2014 269 16.8 (8.8) 285 21 (12.22) 3.6 % -4.20 [ -5.97, -2.43 ]
Aniuliene 2009 150 19 (5.6) 114 27 (7.1) 3.6 % -8.00 [ -9.58, -6.42 ]
Araco 2008 120 34 (11) 120 48 (7) 3.5 % -14.00 [ -16.33, -11.67 ]
Barber 2008 88 28 (7) 82 29 (10) 3.5 % -1.00 [ -3.61, 1.61 ]
Barry 2008 58 14.6 (6) 82 18.5 (6.5) 3.6 % -3.90 [ -5.99, -1.81 ]
Chen 2010 45 20 (13.5) 77 48.2 (21.9) 2.5 % -28.20 [ -34.48, -21.92 ]
Chen 2012 103 18.5 (7.4) 102 27.3 (13.3) 3.4 % -8.80 [ -11.75, -5.85 ]
Darabi Mahboub 2012 40 64 (9.48) 40 64.5 (9.04) 3.1 % -0.50 [ -4.56, 3.56 ]
David-Montefiore 2006 46 17 (6.6) 42 21 (9.5) 3.3 % -4.00 [ -7.45, -0.55 ]
de Tayrac 2004 30 14.8 (4.3) 31 26.5 (7.7) 3.4 % -11.70 [ -14.82, -8.58 ]
Deffieux 2010 74 18.7 (8) 75 20.3 (9) 3.4 % -1.60 [ -4.33, 1.13 ]
El-Hefnawy 2010 21 19.6 (5) 19 23.8 (5) 3.4 % -4.20 [ -7.30, -1.10 ]
Enzelsberger 2005 53 15 (7) 52 26 (10) 3.3 % -11.00 [ -14.31, -7.69 ]
Freeman 2011 99 28 (15.0416) 88 30 (14.159) 3.1 % -2.00 [ -6.19, 2.19 ]
Jakimiuk 2012 16 12.4 (3.52) 19 47.75 (42.89) 0.7 % -35.35 [ -54.71, -15.99 ]
Karateke 2009 84 18.6 (2.47) 83 31.27 (4.73) 3.7 % -12.67 [ -13.82, -11.52 ]
Kilic 2007 10 26 (9.5) 10 32 (5.3) 2.4 % -6.00 [ -12.74, 0.74 ]
Kim 2005 65 26.8 (11.8) 65 31.6 (9.6) 3.2 % -4.80 [ -8.50, -1.10 ]
Krofta 2010 151 23.76 (12.01) 149 32.62 (9.3) 3.5 % -8.86 [ -11.29, -6.43 ]
Laurikainen 2007 131 29 (8) 136 29 (16) 3.4 % 0.0 [ -3.02, 3.02 ]
Lee 2007 60 11.5 (1.4) 60 15.2 (1.8) 3.7 % -3.70 [ -4.28, -3.12 ]
Liapis 2006 43 17.4 (6.9) 46 26.7 (8.6) 3.3 % -9.30 [ -12.53, -6.07 ]
Meschia 2007 117 17 (7) 114 26 (9) 3.6 % -9.00 [ -11.08, -6.92 ]
Nerli 2009 18 18.4 (1.85) 18 21.4 (2.75) 3.7 % -3.00 [ -4.53, -1.47 ]
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Study or subgroup TOR RPR
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Rechberger 2009 268 12 (4) 201 23 (5) 3.7 % -11.00 [ -11.84, -10.16 ]
Scheiner 2012 40 25.8 (9.7) 80 26.7 (11.5) 3.2 % -0.90 [ -4.82, 3.02 ]
Tarcan 2011 27 33.4 (13.9) 27 39.1 (17.7) 2.0 % -5.70 [ -14.19, 2.79 ]
Wang 2006 31 33.83 (8.4) 29 39.71 (12.18) 2.8 % -5.88 [ -11.21, -0.55 ]
Wang 2008 35 18 (5) 35 27 (5) 3.5 % -9.00 [ -11.34, -6.66 ]
Wang 2011 36 16.2 (1.5) 32 34.5 (6.3) 3.5 % -18.30 [ -20.54, -16.06 ]
Zullo 2007 37 16.9 (6.2) 35 28.3 (9.8) 3.2 % -11.40 [ -15.21, -7.59 ]
Total (95% CI) 2365 2348 100.0 % -7.54 [ -9.31, -5.77 ]
Heterogeneity: Tau2 = 21.65; Chi2 = 656.66, df = 30 (P<0.00001); I2 =95%
Test for overall effect: Z = 8.36 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 1.11. Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 11 Operative
blood loss (ml).
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 1 Transobturator (TOR) versus retropubic route (RPR)
Outcome: 11 Operative blood loss (ml)
Study or subgroup TOR RPR
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Alkady 2009 15 22 (7.15) 15 26 (10.23) 8.3 % -4.00 [ -10.32, 2.32 ]
Barry 2008 58 49 (31.2) 82 64 (41.4) 6.6 % -15.00 [ -27.03, -2.97 ]
Chen 2012 103 15 (17.6) 102 18 (15.4) 8.7 % -3.00 [ -7.53, 1.53 ]
El-Hefnawy 2010 21 40 (13) 19 52 (14) 7.7 % -12.00 [ -20.40, -3.60 ]
Freeman 2011 96 48.7 (45.9) 83 61.7 (65.03) 5.2 % -13.00 [ -29.73, 3.73 ]
Krofta 2010 151 32.26 (34.8) 149 31.57 (31.92) 7.9 % 0.69 [ -6.86, 8.24 ]
Laurikainen 2007 131 46 (57) 136 55 (86) 5.0 % -9.00 [ -26.44, 8.44 ]
Lee 2007 60 31.1 (28.6) 60 40 (23.8) 7.4 % -8.90 [ -18.31, 0.51 ]
Meschia 2007 117 27 (33) 114 31 (25) 7.9 % -4.00 [ -11.54, 3.54 ]
Nerli 2009 18 18.4 (1.85) 18 38.7 (5.09) 9.0 % -20.30 [ -22.80, -17.80 ]
Scheiner 2012 40 31.5 (22.2) 80 34.4 (36.5) 7.0 % -2.90 [ -13.45, 7.65 ]
Wang 2006 31 117.2 (79.43) 29 125.13 (81.2) 1.7 % -7.93 [ -48.61, 32.75 ]
Wang 2008 34 20 (7) 35 21 (6) 8.9 % -1.00 [ -4.08, 2.08 ]
Zullo 2007 37 42.5 (8.6) 35 38.9 (9.4) 8.7 % 3.60 [ -0.57, 7.77 ]
Total (95% CI) 912 957 100.0 % -6.49 [ -12.33, -0.65 ]
Heterogeneity: Tau2 = 97.23; Chi2 = 158.23, df = 13 (P<0.00001); I2 =92%
Test for overall effect: Z = 2.18 (P = 0.030)
Test for subgroup differences: Not applicable
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Analysis 1.12. Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 12 Length of
hospital stay (days).
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 1 Transobturator (TOR) versus retropubic route (RPR)
Outcome: 12 Length of hospital stay (days)
Study or subgroup TOR RPR
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Alkady 2009 15 1.2 (0.9) 15 1.1 (1) 5.5 % 0.10 [ -0.58, 0.78 ]
Aniuliene 2009 150 1.5 (0.5) 114 4 (1.6) 6.7 % -2.50 [ -2.80, -2.20 ]
Chen 2010 77 5 (2.4) 45 4 (2.2) 4.9 % 1.00 [ 0.16, 1.84 ]
Chen 2012 13 3.1 (1.8) 102 3.4 (2.1) 4.2 % -0.30 [ -1.36, 0.76 ]
Darabi Mahboub 2012 40 2.52 (0.47) 40 2.56 (0.51) 6.9 % -0.04 [ -0.25, 0.17 ]
David-Montefiore 2006 46 1.4 (0.5) 42 1.8 (1.7) 6.0 % -0.40 [ -0.93, 0.13 ]
de Tayrac 2004 30 1.2 (1.3) 31 1.1 (0.4) 6.2 % 0.10 [ -0.39, 0.59 ]
Jakimiuk 2012 16 2 (0.0001) 19 2.41 (1.37) 5.7 % -0.41 [ -1.03, 0.21 ]
Karateke 2009 84 1.25 (0.66) 83 1.36 (0.76) 6.9 % -0.11 [ -0.33, 0.11 ]
Laurikainen 2007 131 0.71 (0.58) 136 0.58 (0.42) 7.0 % 0.13 [ 0.01, 0.25 ]
Liapis 2006 43 1.04 (0.21) 46 1.26 (1.34) 6.4 % -0.22 [ -0.61, 0.17 ]
Meschia 2007 117 1.6 (0.8) 114 1.8 (1) 6.8 % -0.20 [ -0.43, 0.03 ]
Scheiner 2012 40 3.2 (0.5) 80 3.5 (1.1) 6.7 % -0.30 [ -0.59, -0.01 ]
Wang 2006 31 3.44 (1.48) 29 3.92 (1.4) 5.3 % -0.48 [ -1.21, 0.25 ]
Wang 2008 34 3.2 (2.2) 35 3.9 (4.4) 2.7 % -0.70 [ -2.33, 0.93 ]
Wang 2009 146 3.9 (2.8) 154 3.6 (2.9) 5.6 % 0.30 [ -0.35, 0.95 ]
Zullo 2007 37 1.1 (0.3) 35 1.2 (1.1) 6.5 % -0.10 [ -0.48, 0.28 ]
Total (95% CI) 1050 1120 100.0 % -0.25 [ -0.59, 0.09 ]
Heterogeneity: Tau2 = 0.43; Chi2 = 264.87, df = 16 (P<0.00001); I2 =94%
Test for overall effect: Z = 1.43 (P = 0.15)
Test for subgroup differences: Not applicable
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Analysis 1.13. Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 13 Time to
return to normal activity level (weeks).
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 1 Transobturator (TOR) versus retropubic route (RPR)
Outcome: 13 Time to return to normal activity level (weeks)
Study or subgroup TOR RPR
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Karateke 2009 84 2.43 (2.02) 83 2.7 (2.4) 2.5 % -0.27 [ -0.94, 0.40 ]
Laurikainen 2007 131 1.71 (0.57) 136 1.71 (0.57) 60.7 % 0.0 [ -0.14, 0.14 ]
Lee 2007 60 4.9 (3.3) 60 5.2 (3.3) 0.8 % -0.30 [ -1.48, 0.88 ]
Zullo 2007 37 2 (0.2) 35 2.1 (0.5) 36.0 % -0.10 [ -0.28, 0.08 ]
Total (95% CI) 312 314 100.0 % -0.05 [ -0.15, 0.06 ]
Heterogeneity: Chi2 = 1.39, df = 3 (P = 0.71); I2 =0.0%
Test for overall effect: Z = 0.83 (P = 0.41)
Test for subgroup differences: Not applicable
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Analysis 1.14. Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 14
Perioperative complications.
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 1 Transobturator (TOR) versus retropubic route (RPR)
Outcome: 14 Perioperative complications
Study or subgroup TOR RPR Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Andonian 2007 11/77 6/80 4.2 % 1.90 [ 0.74, 4.90 ]
Araco 2008 6/120 21/120 15.0 % 0.29 [ 0.12, 0.68 ]
Barry 2008 0/58 2/82 1.5 % 0.28 [ 0.01, 5.75 ]
David-Montefiore 2006 5/46 9/42 6.7 % 0.51 [ 0.18, 1.39 ]
Enzelsberger 2005 6/53 10/52 7.2 % 0.59 [ 0.23, 1.50 ]
Kim 2005 1/21 2/22 1.4 % 0.52 [ 0.05, 5.36 ]
Laurikainen 2007 32/131 22/136 15.4 % 1.51 [ 0.93, 2.46 ]
Liapis 2006 2/43 11/46 7.6 % 0.19 [ 0.05, 0.83 ]
Meschia 2007 6/99 7/107 4.8 % 0.93 [ 0.32, 2.66 ]
Porena 2007 14/75 13/70 9.6 % 1.01 [ 0.51, 1.99 ]
Riva 2006 4/65 4/66 2.8 % 1.02 [ 0.27, 3.89 ]
Schierlitz 2008 7/82 3/80 2.2 % 2.28 [ 0.61, 8.50 ]
Wang 2006 4/31 2/29 1.5 % 1.87 [ 0.37, 9.46 ]
Wang 2009 27/146 24/154 16.6 % 1.19 [ 0.72, 1.96 ]
Zullo 2007 2/37 5/35 3.7 % 0.38 [ 0.08, 1.82 ]
Total (95% CI) 1084 1121 100.0 % 0.91 [ 0.73, 1.14 ]
Total events: 127 (TOR), 141 (RPR)
Heterogeneity: Chi2 = 25.53, df = 14 (P = 0.03); I2 =45%
Test for overall effect: Z = 0.78 (P = 0.43)
Test for subgroup differences: Not applicable
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Analysis 1.15. Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 15 Major
vascular or visceral injury.
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 1 Transobturator (TOR) versus retropubic route (RPR)
Outcome: 15 Major vascular or visceral injury
Study or subgroup TOR RPR Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Aigmuller 2014 3/269 3/285 5.1 % 1.06 [ 0.22, 5.20 ]
Alkady 2009 0/15 1/15 2.6 % 0.33 [ 0.01, 7.58 ]
Aniuliene 2009 0/150 1/114 3.0 % 0.25 [ 0.01, 6.17 ]
Araco 2008 0/120 6/120 11.5 % 0.08 [ 0.00, 1.35 ]
Barber 2008 0/82 1/88 2.6 % 0.36 [ 0.01, 8.65 ]
Chen 2010 0/110 1/77 3.1 % 0.23 [ 0.01, 5.67 ]
Deffieux 2010 0/74 0/75 Not estimable
Diab 2012 0/31 2/32 4.3 % 0.21 [ 0.01, 4.13 ]
El-Hefnawy 2010 0/35 3/36 6.1 % 0.15 [ 0.01, 2.74 ]
Jakimiuk 2012 0/16 2/19 4.1 % 0.24 [ 0.01, 4.57 ]
Kamel 2009 0/60 2/60 4.4 % 0.20 [ 0.01, 4.08 ]
Karateke 2009 2/84 4/83 7.1 % 0.49 [ 0.09, 2.62 ]
Krofta 2010 0/151 1/149 2.7 % 0.33 [ 0.01, 8.01 ]
Laurikainen 2007 0/131 4/136 7.8 % 0.12 [ 0.01, 2.12 ]
Lee 2007 0/60 0/60 Not estimable
Liapis 2006 1/43 3/46 5.1 % 0.36 [ 0.04, 3.30 ]
Mehdiyev 2010 0/17 1/15 2.8 % 0.30 [ 0.01, 6.77 ]
Porena 2007 0/75 1/70 2.7 % 0.31 [ 0.01, 7.52 ]
Rechberger 2009 0/268 4/269 7.9 % 0.11 [ 0.01, 2.06 ]
Scheiner 2012 0/71 1/65 2.8 % 0.31 [ 0.01, 7.37 ]
Schierlitz 2008 0/82 0/82 Not estimable
Teo 2011 1/61 1/66 1.7 % 1.08 [ 0.07, 16.92 ]
Wang 2006 0/31 0/29 Not estimable
Wang 2008 0/34 1/35 2.6 % 0.34 [ 0.01, 8.13 ]
Wang 2009 2/146 2/154 3.4 % 1.05 [ 0.15, 7.39 ]
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Study or subgroup TOR RPR Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Wang 2010 0/70 0/70 Not estimable
Wang 2011 1/36 2/32 3.7 % 0.44 [ 0.04, 4.67 ]
Zullo 2007 0/37 1/35 2.7 % 0.32 [ 0.01, 7.50 ]
Total (95% CI) 2359 2317 100.0 % 0.33 [ 0.19, 0.55 ]
Total events: 10 (TOR), 48 (RPR)
Heterogeneity: Chi2 = 7.12, df = 22 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 4.23 (P = 0.000024)
Test for subgroup differences: Not applicable
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Analysis 1.16. Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 16 Bladder or
urethral perforation.
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 1 Transobturator (TOR) versus retropubic route (RPR)
Outcome: 16 Bladder or urethral perforation
Study or subgroup TOR RPR Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Aigmuller 2014 0/269 11/285 6.6 % 0.05 [ 0.00, 0.78 ]
Alkady 2009 0/15 1/15 0.9 % 0.33 [ 0.01, 7.58 ]
Andonian 2007 0/77 11/80 6.7 % 0.05 [ 0.00, 0.75 ]
Aniuliene 2009 0/150 1/114 1.0 % 0.25 [ 0.01, 6.17 ]
Araco 2008 0/120 3/120 2.1 % 0.14 [ 0.01, 2.74 ]
Barber 2008 0/82 7/88 4.3 % 0.07 [ 0.00, 1.23 ]
Barry 2008 1/58 7/82 3.4 % 0.20 [ 0.03, 1.60 ]
Chen 2010 0/110 4/77 3.1 % 0.08 [ 0.00, 1.43 ]
Chen 2012 0/103 5/102 3.3 % 0.09 [ 0.01, 1.61 ]
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Study or subgroup TOR RPR Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
David-Montefiore 2006 0/46 4/42 2.8 % 0.10 [ 0.01, 1.83 ]
de Tayrac 2004 0/30 3/31 2.0 % 0.15 [ 0.01, 2.74 ]
Deffieux 2010 2/74 5/75 2.9 % 0.41 [ 0.08, 2.02 ]
El-Hefnawy 2010 0/42 3/45 2.0 % 0.15 [ 0.01, 2.87 ]
Enzelsberger 2005 0/53 4/52 2.7 % 0.11 [ 0.01, 1.98 ]
Freeman 2011 0/100 2/92 1.5 % 0.18 [ 0.01, 3.79 ]
Jakimiuk 2012 0/16 3/19 1.9 % 0.17 [ 0.01, 3.03 ]
Kamel 2009 0/60 5/60 3.3 % 0.09 [ 0.01, 1.61 ]
Kim 2005 0/65 4/65 2.7 % 0.11 [ 0.01, 2.02 ]
Laurikainen 2007 0/131 1/136 0.9 % 0.35 [ 0.01, 8.42 ]
Lee 2007 0/60 2/60 1.5 % 0.20 [ 0.01, 4.08 ]
Liapis 2006 0/43 3/46 2.0 % 0.15 [ 0.01, 2.87 ]
Mansoor 2003 0/48 6/54 3.6 % 0.09 [ 0.00, 1.49 ]
Mehdiyev 2010 0/17 1/15 0.9 % 0.30 [ 0.01, 6.77 ]
Meschia 2007 0/117 5/114 3.3 % 0.09 [ 0.00, 1.58 ]
Nerli 2009 0/18 1/18 0.9 % 0.33 [ 0.01, 7.68 ]
Oliveira 2006 0/42 3/42 2.1 % 0.14 [ 0.01, 2.68 ]
Porena 2007 1/75 2/70 1.2 % 0.47 [ 0.04, 5.03 ]
Rechberger 2009 0/268 13/269 8.0 % 0.04 [ 0.00, 0.62 ]
Richter 2010 0/299 16/298 9.8 % 0.03 [ 0.00, 0.50 ]
Riva 2006 0/65 1/66 0.9 % 0.34 [ 0.01, 8.16 ]
Scheiner 2012 0/80 3/80 2.1 % 0.14 [ 0.01, 2.72 ]
Schierlitz 2008 0/82 7/80 4.5 % 0.07 [ 0.00, 1.12 ]
Tanuri 2010 0/20 0/10 Not estimable
Teo 2011 0/61 0/66 Not estimable
Wang 2006 0/31 1/29 0.9 % 0.31 [ 0.01, 7.38 ]
Wang 2008 0/34 0/35 Not estimable
Wang 2010 1/70 3/70 1.8 % 0.33 [ 0.04, 3.13 ]
Wang 2011 0/36 1/32 0.9 % 0.30 [ 0.01, 7.05 ]
Zullo 2007 0/37 2/35 1.5 % 0.19 [ 0.01, 3.81 ]
Total (95% CI) 3104 3069 100.0 % 0.12 [ 0.08, 0.20 ]
Total events: 5 (TOR), 154 (RPR)
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Study or subgroup TOR RPR Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Heterogeneity: Chi2 = 10.55, df = 35 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 9.06 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 1.17. Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 17 Voiding
dysfunction.
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 1 Transobturator (TOR) versus retropubic route (RPR)
Outcome: 17 Voiding dysfunction
Study or subgroup TOR RPR Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Aigmuller 2014 1/269 4/285 1.7 % 0.26 [ 0.03, 2.35 ]
Alkady 2009 1/15 2/15 0.9 % 0.50 [ 0.05, 4.94 ]
Aniuliene 2009 5/150 18/114 8.9 % 0.21 [ 0.08, 0.55 ]
Araco 2008 0/100 12/108 5.3 % 0.04 [ 0.00, 0.72 ]
Barber 2008 2/82 5/88 2.1 % 0.43 [ 0.09, 2.15 ]
Barry 2008 6/58 7/82 2.5 % 1.21 [ 0.43, 3.42 ]
Chen 2010 5/110 7/77 3.6 % 0.50 [ 0.16, 1.52 ]
Chen 2012 2/103 2/102 0.9 % 0.99 [ 0.14, 6.90 ]
de Tayrac 2004 8/30 10/31 4.3 % 0.83 [ 0.38, 1.81 ]
Deffieux 2010 2/65 6/67 2.6 % 0.34 [ 0.07, 1.64 ]
Enzelsberger 2005 3/53 4/52 1.8 % 0.74 [ 0.17, 3.13 ]
Freeman 2011 5/100 5/95 2.2 % 0.95 [ 0.28, 3.18 ]
Jakimiuk 2012 0/16 2/19 1.0 % 0.24 [ 0.01, 4.57 ]
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Study or subgroup TOR RPR Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Karateke 2009 6/84 8/83 3.5 % 0.74 [ 0.27, 2.04 ]
Kim 2005 4/65 5/65 2.2 % 0.80 [ 0.22, 2.85 ]
Laurikainen 2007 2/131 1/136 0.4 % 2.08 [ 0.19, 22.62 ]
Lee 2007 0/60 0/60 Not estimable
Mansoor 2003 1/48 5/54 2.1 % 0.23 [ 0.03, 1.86 ]
Meschia 2007 6/99 11/107 4.6 % 0.59 [ 0.23, 1.53 ]
Nerli 2009 2/18 3/18 1.3 % 0.67 [ 0.13, 3.53 ]
Nyyssonen 2014 4/46 7/47 3.0 % 0.58 [ 0.18, 1.86 ]
Oliveira 2006 3/42 5/42 2.2 % 0.60 [ 0.15, 2.35 ]
Porena 2007 6/75 7/70 3.2 % 0.80 [ 0.28, 2.26 ]
Rechberger 2009 7/268 10/269 4.4 % 0.70 [ 0.27, 1.82 ]
Richter 2010 5/299 16/298 7.0 % 0.31 [ 0.12, 0.84 ]
Riva 2006 0/65 1/66 0.7 % 0.34 [ 0.01, 8.16 ]
Scheiner 2012 2/80 3/80 1.3 % 0.67 [ 0.11, 3.88 ]
Schierlitz 2008 4/82 9/80 4.0 % 0.43 [ 0.14, 1.35 ]
Tanuri 2010 0/20 1/10 0.9 % 0.17 [ 0.01, 3.94 ]
Teo 2011 1/61 3/66 1.3 % 0.36 [ 0.04, 3.38 ]
van Leijsen 2013 7/80 5/31 3.2 % 0.54 [ 0.19, 1.58 ]
Wang 2006 7/31 16/29 7.2 % 0.41 [ 0.20, 0.85 ]
Wang 2008 4/34 4/35 1.7 % 1.03 [ 0.28, 3.79 ]
Wang 2009 4/146 6/154 2.6 % 0.70 [ 0.20, 2.44 ]
Wang 2010 6/70 8/70 3.5 % 0.75 [ 0.27, 2.05 ]
Wang 2011 1/36 3/32 1.4 % 0.30 [ 0.03, 2.71 ]
Zullo 2007 0/37 1/35 0.7 % 0.32 [ 0.01, 7.50 ]
Total (95% CI) 3128 3072 100.0 % 0.53 [ 0.43, 0.65 ]
Total events: 122 (TOR), 222 (RPR)
Heterogeneity: Chi2 = 21.14, df = 35 (P = 0.97); I2 =0.0%
Test for overall effect: Z = 5.98 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 1.18. Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 18 De novo
urgency or urgency incontinence (short term, ≤ 1 year).
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 1 Transobturator (TOR) versus retropubic route (RPR)
Outcome: 18 De novo urgency or urgency incontinence (short term,≤ 1 year)
Study or subgroup TOR RPR Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Aigmuller 2014 24/233 26/247 12.3 % 0.98 [ 0.58, 1.65 ]
Andonian 2007 6/77 5/80 2.4 % 1.25 [ 0.40, 3.92 ]
Araco 2008 6/100 8/108 3.7 % 0.81 [ 0.29, 2.25 ]
Barber 2008 21/75 27/85 12.3 % 0.88 [ 0.55, 1.42 ]
Barry 2008 0/58 1/82 0.6 % 0.47 [ 0.02, 11.31 ]
David-Montefiore 2006 4/46 6/42 3.0 % 0.61 [ 0.18, 2.01 ]
de Tayrac 2004 2/30 2/31 1.0 % 1.03 [ 0.16, 6.87 ]
El-Hefnawy 2010 3/35 0/36 0.2 % 7.19 [ 0.39, 134.39 ]
Freeman 2011 4/95 4/85 2.1 % 0.89 [ 0.23, 3.47 ]
Karateke 2009 5/83 6/81 2.9 % 0.81 [ 0.26, 2.56 ]
Kim 2005 1/21 1/22 0.5 % 1.05 [ 0.07, 15.69 ]
Krofta 2010 20/147 9/141 4.5 % 2.13 [ 1.00, 4.52 ]
Laurikainen 2007 3/131 2/134 1.0 % 1.53 [ 0.26, 9.03 ]
Lee 2007 4/60 0/60 0.2 % 9.00 [ 0.50, 163.58 ]
Liapis 2006 6/43 5/46 2.3 % 1.28 [ 0.42, 3.90 ]
Mansoor 2003 2/48 4/54 1.8 % 0.56 [ 0.11, 2.94 ]
Mehdiyev 2010 1/17 3/15 1.5 % 0.29 [ 0.03, 2.54 ]
Meschia 2007 4/99 6/107 2.8 % 0.72 [ 0.21, 2.48 ]
Nerli 2009 2/18 3/18 1.5 % 0.67 [ 0.13, 3.53 ]
Oliveira 2006 9/42 8/42 3.9 % 1.13 [ 0.48, 2.63 ]
Porena 2007 4/36 5/35 2.5 % 0.78 [ 0.23, 2.66 ]
Rechberger 2009 10/197 17/201 8.2 % 0.60 [ 0.28, 1.28 ]
Richter 2010 1/285 0/280 0.2 % 2.95 [ 0.12, 72.05 ]
Schierlitz 2008 16/70 23/66 11.5 % 0.66 [ 0.38, 1.13 ]
Tanuri 2010 1/19 1/9 0.7 % 0.47 [ 0.03, 6.74 ]
0.5 0.7 1 1.5 2
Favours TOR Favours RPR
(Continued . . . )
193Mid-urethral sling operations for stress urinary incontinence in women (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(. . . Continued)
Study or subgroup TOR RPR Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Teo 2011 6/29 3/41 1.2 % 2.83 [ 0.77, 10.39 ]
van Leijsen 2013 25/83 9/30 6.4 % 1.00 [ 0.53, 1.90 ]
Wang 2006 3/31 3/29 1.5 % 0.94 [ 0.20, 4.27 ]
Wang 2009 6/146 9/154 4.3 % 0.70 [ 0.26, 1.93 ]
Wang 2010 4/70 1/70 0.5 % 4.00 [ 0.46, 34.90 ]
Wang 2011 6/36 5/32 2.6 % 1.07 [ 0.36, 3.16 ]
Total (95% CI) 2460 2463 100.0 % 0.98 [ 0.82, 1.17 ]
Total events: 209 (TOR), 202 (RPR)
Heterogeneity: Chi2 = 21.41, df = 30 (P = 0.87); I2 =0.0%
Test for overall effect: Z = 0.25 (P = 0.81)
Test for subgroup differences: Not applicable
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Analysis 1.19. Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 19 De novo
urgency or urgency incontinence (medium term, 1 to 5 years).
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 1 Transobturator (TOR) versus retropubic route (RPR)
Outcome: 19 De novo urgency or urgency incontinence (medium term, 1 to 5 years)
Study or subgroup TOR RPR Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
David-Montefiore 2006 10/37 7/34 34.5 % 1.31 [ 0.56, 3.06 ]
Laurikainen 2007 7/126 8/131 37.1 % 0.91 [ 0.34, 2.43 ]
Nyyssonen 2014 2/46 5/47 23.4 % 0.41 [ 0.08, 2.00 ]
Zullo 2007 2/31 1/29 4.9 % 1.87 [ 0.18, 19.55 ]
Total (95% CI) 240 241 100.0 % 0.98 [ 0.55, 1.73 ]
Total events: 21 (TOR), 21 (RPR)
Heterogeneity: Chi2 = 1.94, df = 3 (P = 0.59); I2 =0.0%
Test for overall effect: Z = 0.07 (P = 0.94)
Test for subgroup differences: Not applicable
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Analysis 1.20. Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 20 De novo
urgency or urgency incontinence (long term, > 5 years).
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 1 Transobturator (TOR) versus retropubic route (RPR)
Outcome: 20 De novo urgency or urgency incontinence (long term, > 5 years)
Study or subgroup TOR RPR Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Laurikainen 2007 3/122 4/131 0.81 [ 0.18, 3.53 ]
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Analysis 1.21. Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 21 Detrusor
overactivity.
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 1 Transobturator (TOR) versus retropubic route (RPR)
Outcome: 21 Detrusor overactivity
Study or subgroup TOR RPR Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Araco 2008 3/100 2/108 8.4 % 1.62 [ 0.28, 9.50 ]
Enzelsberger 2005 6/53 5/52 22.0 % 1.18 [ 0.38, 3.62 ]
Karateke 2009 10/83 12/81 52.9 % 0.81 [ 0.37, 1.78 ]
Liapis 2006 4/43 4/46 16.8 % 1.07 [ 0.29, 4.01 ]
Total (95% CI) 279 287 100.0 % 1.00 [ 0.58, 1.73 ]
Total events: 23 (TOR), 23 (RPR)
Heterogeneity: Chi2 = 0.65, df = 3 (P = 0.89); I2 =0.0%
Test for overall effect: Z = 0.01 (P = 0.99)
Test for subgroup differences: Not applicable
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Analysis 1.22. Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 22 Vaginal
tape erosion.
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 1 Transobturator (TOR) versus retropubic route (RPR)
Outcome: 22 Vaginal tape erosion
Study or subgroup TOR RPR Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Alkady 2009 0/15 1/15 3.0 % 0.33 [ 0.01, 7.58 ]
Andonian 2007 2/77 0/80 1.0 % 5.19 [ 0.25, 106.44 ]
Araco 2008 3/100 1/108 1.9 % 3.24 [ 0.34, 30.64 ]
Barber 2008 1/75 5/85 9.4 % 0.23 [ 0.03, 1.90 ]
Barry 2008 3/58 1/82 1.7 % 4.24 [ 0.45, 39.76 ]
David-Montefiore 2006 0/46 0/46 Not estimable
de Tayrac 2004 0/30 0/31 Not estimable
Deffieux 2010 1/65 0/67 1.0 % 3.09 [ 0.13, 74.52 ]
Diab 2012 2/31 2/32 4.0 % 1.03 [ 0.15, 6.88 ]
Enzelsberger 2005 1/53 1/52 2.0 % 0.98 [ 0.06, 15.28 ]
Freeman 2011 3/95 2/85 4.3 % 1.34 [ 0.23, 7.84 ]
Karateke 2009 2/83 4/81 8.2 % 0.49 [ 0.09, 2.59 ]
Kim 2005 0/65 0/65 Not estimable
Krofta 2010 2/147 2/141 4.1 % 0.96 [ 0.14, 6.72 ]
Laurikainen 2007 1/136 0/134 1.0 % 2.96 [ 0.12, 71.93 ]
Lee 2007 0/60 0/60 Not estimable
Liapis 2006 0/43 1/46 2.9 % 0.36 [ 0.01, 8.51 ]
Nerli 2009 0/18 0/18 Not estimable
Nyyssonen 2014 2/43 0/43 1.0 % 5.00 [ 0.25, 101.18 ]
Oliveira 2006 1/42 2/42 4.0 % 0.50 [ 0.05, 5.31 ]
Porena 2007 3/75 0/70 1.0 % 6.54 [ 0.34, 124.38 ]
Rechberger 2009 5/197 4/201 8.0 % 1.28 [ 0.35, 4.68 ]
Richter 2010 2/285 10/280 20.3 % 0.20 [ 0.04, 0.89 ]
Riva 2006 2/65 1/66 2.0 % 2.03 [ 0.19, 21.85 ]
Scheiner 2012 4/71 1/65 2.1 % 3.66 [ 0.42, 31.92 ]
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Study or subgroup TOR RPR Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Tanuri 2010 0/19 0/9 Not estimable
Teo 2011 1/29 3/41 5.0 % 0.47 [ 0.05, 4.31 ]
Wang 2009 3/146 3/154 5.9 % 1.05 [ 0.22, 5.14 ]
Wang 2010 2/70 1/70 2.0 % 2.00 [ 0.19, 21.56 ]
Zullo 2007 1/31 2/29 4.2 % 0.47 [ 0.04, 4.89 ]
Total (95% CI) 2270 2298 100.0 % 1.03 [ 0.70, 1.51 ]
Total events: 47 (TOR), 47 (RPR)
Heterogeneity: Chi2 = 18.77, df = 23 (P = 0.71); I2 =0.0%
Test for overall effect: Z = 0.14 (P = 0.89)
Test for subgroup differences: Not applicable
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Analysis 1.23. Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 23
Bladder/urethral erosion.
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 1 Transobturator (TOR) versus retropubic route (RPR)
Outcome: 23 Bladder/urethral erosion
Study or subgroup TOR RPR Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
David-Montefiore 2006 0/46 0/46 Not estimable
de Tayrac 2004 0/30 1/31 100.0 % 0.34 [ 0.01, 8.13 ]
Kim 2005 0/65 0/65 Not estimable
Teo 2011 0/39 0/52 Not estimable
Total (95% CI) 180 194 100.0 % 0.34 [ 0.01, 8.13 ]
Total events: 0 (TOR), 1 (RPR)
Heterogeneity: not applicable
Test for overall effect: Z = 0.66 (P = 0.51)
Test for subgroup differences: Not applicable
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Analysis 1.24. Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 24 Groin pain.
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 1 Transobturator (TOR) versus retropubic route (RPR)
Outcome: 24 Groin pain
Study or subgroup TOR RPR Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Chen 2012 3/103 0/102 2.4 % 6.93 [ 0.36, 132.54 ]
Deffieux 2010 1/65 0/67 2.3 % 3.09 [ 0.13, 74.52 ]
Enzelsberger 2005 5/53 0/52 2.4 % 10.80 [ 0.61, 190.44 ]
Freeman 2011 8/95 1/85 5.0 % 7.16 [ 0.91, 56.06 ]
Krofta 2010 8/147 0/141 2.4 % 16.31 [ 0.95, 279.97 ]
Laurikainen 2007 1/131 0/131 2.4 % 3.00 [ 0.12, 72.97 ]
Lee 2007 8/60 5/60 23.6 % 1.60 [ 0.56, 4.61 ]
Meschia 2007 6/117 0/114 2.4 % 12.67 [ 0.72, 222.33 ]
Oliveira 2006 7/42 1/42 4.7 % 7.00 [ 0.90, 54.44 ]
Richter 2010 2/285 3/280 14.3 % 0.65 [ 0.11, 3.89 ]
Riva 2006 2/65 0/66 2.3 % 5.08 [ 0.25, 103.73 ]
Schierlitz 2008 3/82 1/82 4.7 % 3.00 [ 0.32, 28.25 ]
Tanuri 2010 1/19 0/9 3.2 % 1.50 [ 0.07, 33.61 ]
Teo 2011 14/61 1/66 4.5 % 15.15 [ 2.05, 111.78 ]
Wang 2006 4/31 0/29 2.4 % 8.44 [ 0.47, 150.15 ]
Wang 2009 12/146 4/154 18.4 % 3.16 [ 1.04, 9.59 ]
Wang 2011 5/36 0/32 2.5 % 9.81 [ 0.56, 170.76 ]
Total (95% CI) 1538 1512 100.0 % 4.45 [ 2.80, 7.08 ]
Total events: 90 (TOR), 16 (RPR)
Heterogeneity: Chi2 = 13.19, df = 16 (P = 0.66); I2 =0.0%
Test for overall effect: Z = 6.30 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 1.25. Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 25
Suprapubic pain.
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 1 Transobturator (TOR) versus retropubic route (RPR)
Outcome: 25 Suprapubic pain
Study or subgroup TOR RPR Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Deffieux 2010 1/65 2/67 11.5 % 0.52 [ 0.05, 5.55 ]
Krofta 2010 0/147 6/141 38.7 % 0.07 [ 0.00, 1.30 ]
Lee 2007 0/60 5/60 32.1 % 0.09 [ 0.01, 1.61 ]
Richter 2010 3/285 3/280 17.7 % 0.98 [ 0.20, 4.83 ]
Total (95% CI) 557 548 100.0 % 0.29 [ 0.11, 0.78 ]
Total events: 4 (TOR), 16 (RPR)
Heterogeneity: Chi2 = 3.98, df = 3 (P = 0.26); I2 =25%
Test for overall effect: Z = 2.45 (P = 0.014)
Test for subgroup differences: Not applicable
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Analysis 1.26. Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 26 Repeat
incontinence surgery (short term, ≤ 1 year).
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 1 Transobturator (TOR) versus retropubic route (RPR)
Outcome: 26 Repeat incontinence surgery (short term,≤ 1 year)
Study or subgroup TOR RPR Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Andonian 2007 2/77 0/80 5.3 % 5.19 [ 0.25, 106.44 ]
Barber 2008 1/75 4/85 40.7 % 0.28 [ 0.03, 2.48 ]
David-Montefiore 2006 0/46 0/42 Not estimable
Deffieux 2010 1/69 2/69 21.7 % 0.50 [ 0.05, 5.39 ]
Laurikainen 2007 1/131 2/134 21.4 % 0.51 [ 0.05, 5.57 ]
Riva 2006 2/65 0/66 5.4 % 5.08 [ 0.25, 103.73 ]
Schierlitz 2008 7/82 0/80 5.5 % 14.64 [ 0.85, 252.13 ]
van Leijsen 2013 0/90 0/30 Not estimable
Total (95% CI) 635 586 100.0 % 1.69 [ 0.75, 3.80 ]
Total events: 14 (TOR), 8 (RPR)
Heterogeneity: Chi2 = 7.82, df = 5 (P = 0.17); I2 =36%
Test for overall effect: Z = 1.26 (P = 0.21)
Test for subgroup differences: Not applicable
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Analysis 1.27. Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 27 Repeat
incontinence surgery (medium term , 1 to 5 years).
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 1 Transobturator (TOR) versus retropubic route (RPR)
Outcome: 27 Repeat incontinence surgery (medium term , 1 to 5 years)
Study or subgroup TOR RPR Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Araco 2008 17/100 0/108 32.0 % 37.77 [ 2.30, 619.95 ]
Schierlitz 2008 15/75 1/72 68.0 % 14.40 [ 1.95, 106.22 ]
Total (95% CI) 175 180 100.0 % 21.89 [ 4.36, 109.77 ]
Total events: 32 (TOR), 1 (RPR)
Heterogeneity: Chi2 = 0.31, df = 1 (P = 0.57); I2 =0.0%
Test for overall effect: Z = 3.75 (P = 0.00018)
Test for subgroup differences: Not applicable
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Analysis 1.28. Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 28 Repeat
incontinence surgery (long term > 5 years).
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 1 Transobturator (TOR) versus retropubic route (RPR)
Outcome: 28 Repeat incontinence surgery (long term > 5 years)
Study or subgroup TOR RPR Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Araco 2008 17/100 0/108 10.7 % 37.77 [ 2.30, 619.95 ]
Laurikainen 2007 3/122 2/131 42.8 % 1.61 [ 0.27, 9.48 ]
Porena 2007 4/47 1/40 24.0 % 3.40 [ 0.40, 29.24 ]
Schierlitz 2008 15/75 1/72 22.6 % 14.40 [ 1.95, 106.22 ]
Total (95% CI) 344 351 100.0 % 8.79 [ 3.36, 23.00 ]
Total events: 39 (TOR), 4 (RPR)
Heterogeneity: Chi2 = 5.55, df = 3 (P = 0.14); I2 =46%
Test for overall effect: Z = 4.43 (P < 0.00001)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours TOR Favours RPR
203Mid-urethral sling operations for stress urinary incontinence in women (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 2.1. Comparison 2 Retropubic bottom-to-top approach versus retropubic top-to-bottom
approach, Outcome 1 Subjective cure (short term, ≤ 1 year).
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 2 Retropubic bottom-to-top approach versus retropubic top-to-bottom approach
Outcome: 1 Subjective cure (short term,≤ 1 year)
Study or subgroup Bottom-to-top Top-to-bottom Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Kim 2004 31/32 29/30 15.8 % 1.00 [ 0.91, 1.10 ]
Lim 2005 48/58 45/57 23.9 % 1.05 [ 0.88, 1.25 ]
Lord 2006 128/147 117/153 60.4 % 1.14 [ 1.02, 1.27 ]
Total (95% CI) 237 240 100.0 % 1.10 [ 1.01, 1.19 ]
Total events: 207 (Bottom-to-top), 191 (Top-to-bottom)
Heterogeneity: Chi2 = 4.41, df = 2 (P = 0.11); I2 =55%
Test for overall effect: Z = 2.25 (P = 0.024)
Test for subgroup differences: Not applicable
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Analysis 2.2. Comparison 2 Retropubic bottom-to-top approach versus retropubic top-to-bottom
approach, Outcome 2 Objective cure (short term, ≤ 1 year).
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 2 Retropubic bottom-to-top approach versus retropubic top-to-bottom approach
Outcome: 2 Objective cure (short term,≤ 1 year)
Study or subgroup Bottom-to-top Top-to-bottom Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Andonian 2005 40/42 34/41 17.4 % 1.15 [ 0.98, 1.34 ]
Kim 2004 31/32 29/30 25.1 % 1.00 [ 0.91, 1.10 ]
Lim 2005 51/58 42/58 14.4 % 1.21 [ 1.01, 1.46 ]
Lord 2006 143/147 148/152 31.3 % 1.00 [ 0.96, 1.04 ]
Tseng 2005 27/31 25/31 11.8 % 1.08 [ 0.87, 1.34 ]
Total (95% CI) 310 312 100.0 % 1.06 [ 0.97, 1.17 ]
Total events: 292 (Bottom-to-top), 278 (Top-to-bottom)
Heterogeneity: Tau2 = 0.01; Chi2 = 13.50, df = 4 (P = 0.01); I2 =70%
Test for overall effect: Z = 1.28 (P = 0.20)
Test for subgroup differences: Not applicable
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Analysis 2.3. Comparison 2 Retropubic bottom-to-top approach versus retropubic top-to-bottom
approach, Outcome 3 Operative time (minutes).
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 2 Retropubic bottom-to-top approach versus retropubic top-to-bottom approach
Outcome: 3 Operative time (minutes)
Study or subgroup Bottom-to-top Top-to-bottom
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Kim 2004 32 27.5 (2.7) 30 28.1 (7.5) 79.2 % -0.60 [ -3.44, 2.24 ]
Tseng 2005 31 32.74 (8.43) 31 40.77 (13.29) 20.8 % -8.03 [ -13.57, -2.49 ]
Total (95% CI) 63 61 100.0 % -2.15 [ -4.68, 0.38 ]
Heterogeneity: Chi2 = 5.47, df = 1 (P = 0.02); I2 =82%
Test for overall effect: Z = 1.66 (P = 0.096)
Test for subgroup differences: Not applicable
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Analysis 2.4. Comparison 2 Retropubic bottom-to-top approach versus retropubic top-to-bottom
approach, Outcome 4 Length of hospital stay (days).
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 2 Retropubic bottom-to-top approach versus retropubic top-to-bottom approach
Outcome: 4 Length of hospital stay (days)
Study or subgroup Bottom-to-top Top-to-bottom
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Kim 2004 32 2.5 (0.9) 30 2.3 (0.6) 77.3 % 0.20 [ -0.18, 0.58 ]
Tseng 2005 31 3.14 (1.38) 31 3.97 (1.43) 22.7 % -0.83 [ -1.53, -0.13 ]
Total (95% CI) 63 61 100.0 % -0.03 [ -0.37, 0.30 ]
Heterogeneity: Chi2 = 6.44, df = 1 (P = 0.01); I2 =84%
Test for overall effect: Z = 0.20 (P = 0.84)
Test for subgroup differences: Not applicable
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Analysis 2.5. Comparison 2 Retropubic bottom-to-top approach versus retropubic top-to-bottom
approach, Outcome 5 Perioperative complications.
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 2 Retropubic bottom-to-top approach versus retropubic top-to-bottom approach
Outcome: 5 Perioperative complications
Study or subgroup Bottom-to-top Top-to-bottom Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Andonian 2005 0/40 3/41 19.6 % 0.15 [ 0.01, 2.75 ]
Kim 2004 6/32 7/30 41.0 % 0.80 [ 0.30, 2.12 ]
Lord 2006 6/147 4/154 22.2 % 1.57 [ 0.45, 5.46 ]
Tseng 2005 5/32 3/31 17.3 % 1.61 [ 0.42, 6.19 ]
Total (95% CI) 251 256 100.0 % 0.98 [ 0.53, 1.84 ]
Total events: 17 (Bottom-to-top), 17 (Top-to-bottom)
Heterogeneity: Chi2 = 2.85, df = 3 (P = 0.41); I2 =0.0%
Test for overall effect: Z = 0.05 (P = 0.96)
Test for subgroup differences: Not applicable
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Analysis 2.6. Comparison 2 Retropubic bottom-to-top approach versus retropubic top-to-bottom
approach, Outcome 6 Bladder or urethral perforation.
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 2 Retropubic bottom-to-top approach versus retropubic top-to-bottom approach
Outcome: 6 Bladder or urethral perforation
Study or subgroup Bottom-to-top Top-to-bottom Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Andonian 2005 10/43 10/41 36.9 % 0.95 [ 0.44, 2.05 ]
Kim 2004 3/32 3/30 11.2 % 0.94 [ 0.20, 4.29 ]
Lim 2005 1/61 7/61 25.2 % 0.14 [ 0.02, 1.13 ]
Lord 2006 1/147 3/154 10.6 % 0.35 [ 0.04, 3.32 ]
Tseng 2005 0/31 4/31 16.2 % 0.11 [ 0.01, 1.98 ]
Total (95% CI) 314 317 100.0 % 0.55 [ 0.31, 0.98 ]
Total events: 15 (Bottom-to-top), 27 (Top-to-bottom)
Heterogeneity: Chi2 = 5.46, df = 4 (P = 0.24); I2 =27%
Test for overall effect: Z = 2.03 (P = 0.042)
Test for subgroup differences: Not applicable
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Analysis 2.7. Comparison 2 Retropubic bottom-to-top approach versus retropubic top-to-bottom
approach, Outcome 7 Voiding dysfunction.
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 2 Retropubic bottom-to-top approach versus retropubic top-to-bottom approach
Outcome: 7 Voiding dysfunction
Study or subgroup Bottom-to-top Top-to-bottom Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Andonian 2005 4/43 2/41 10.3 % 1.91 [ 0.37, 9.86 ]
Kim 2004 0/32 3/30 18.1 % 0.13 [ 0.01, 2.49 ]
Lim 2005 2/61 2/61 10.0 % 1.00 [ 0.15, 6.87 ]
Lord 2006 0/147 10/154 51.5 % 0.05 [ 0.00, 0.84 ]
Tseng 2005 1/31 2/31 10.0 % 0.50 [ 0.05, 5.23 ]
Total (95% CI) 314 317 100.0 % 0.40 [ 0.18, 0.90 ]
Total events: 7 (Bottom-to-top), 19 (Top-to-bottom)
Heterogeneity: Chi2 = 7.02, df = 4 (P = 0.13); I2 =43%
Test for overall effect: Z = 2.22 (P = 0.026)
Test for subgroup differences: Not applicable
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Analysis 2.8. Comparison 2 Retropubic bottom-to-top approach versus retropubic top-to-bottom
approach, Outcome 8 De novo urgency or urgency incontinence.
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 2 Retropubic bottom-to-top approach versus retropubic top-to-bottom approach
Outcome: 8 De novo urgency or urgency incontinence
Study or subgroup Bottom-to-top Top-to-bottom Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Kim 2004 3/32 1/30 3.1 % 2.81 [ 0.31, 25.58 ]
Lim 2005 8/58 9/58 26.8 % 0.89 [ 0.37, 2.14 ]
Lord 2006 12/147 17/154 49.4 % 0.74 [ 0.37, 1.49 ]
Tseng 2005 5/31 7/31 20.8 % 0.71 [ 0.25, 2.01 ]
Total (95% CI) 268 273 100.0 % 0.84 [ 0.52, 1.34 ]
Total events: 28 (Bottom-to-top), 34 (Top-to-bottom)
Heterogeneity: Chi2 = 1.39, df = 3 (P = 0.71); I2 =0.0%
Test for overall effect: Z = 0.74 (P = 0.46)
Test for subgroup differences: Not applicable
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Analysis 2.9. Comparison 2 Retropubic bottom-to-top approach versus retropubic top-to-bottom
approach, Outcome 9 Detrusor overactivity.
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 2 Retropubic bottom-to-top approach versus retropubic top-to-bottom approach
Outcome: 9 Detrusor overactivity
Study or subgroup Bottom-to-top Top-to-bottom Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Lim 2005 2/58 1/58 2.00 [ 0.19, 21.45 ]
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Analysis 2.10. Comparison 2 Retropubic bottom-to-top approach versus retropubic top-to-bottom
approach, Outcome 10 Vaginal tape erosion.
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 2 Retropubic bottom-to-top approach versus retropubic top-to-bottom approach
Outcome: 10 Vaginal tape erosion
Study or subgroup Bottom-to-top Top-to-bottom Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Andonian 2005 0/43 1/41 14.0 % 0.32 [ 0.01, 7.59 ]
Kim 2004 0/32 0/30 Not estimable
Lim 2005 2/58 8/58 72.7 % 0.25 [ 0.06, 1.13 ]
Lord 2006 0/147 1/154 13.3 % 0.35 [ 0.01, 8.50 ]
Total (95% CI) 280 283 100.0 % 0.27 [ 0.08, 0.95 ]
Total events: 2 (Bottom-to-top), 10 (Top-to-bottom)
Heterogeneity: Chi2 = 0.04, df = 2 (P = 0.98); I2 =0.0%
Test for overall effect: Z = 2.04 (P = 0.041)
Test for subgroup differences: Not applicable
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Analysis 2.11. Comparison 2 Retropubic bottom-to-top approach versus retropubic top-to-bottom
approach, Outcome 11 QoL specific.
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 2 Retropubic bottom-to-top approach versus retropubic top-to-bottom approach
Outcome: 11 QoL specific
Study or subgroup Bottom-to-top Top-to-bottom
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Andonian 2005 43 45.3 (18.4) 41 49.9 (25.6) -4.60 [ -14.17, 4.97 ]
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Analysis 3.1. Comparison 3 Obturator medial-to-lateral approach versus obturator lateral-to-medial
approach, Outcome 1 Subjective cure (short term, ≤ 1 year).
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 3 Obturator medial-to-lateral approach versus obturator lateral-to-medial approach
Outcome: 1 Subjective cure (short term,≤ 1 year)
Study or subgroup Medial-to-lateral Lateral-to-medial Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
But 2008 59/60 59/60 17.7 % 1.00 [ 0.95, 1.05 ]
Hassan 2013 102/102 95/97 29.4 % 1.02 [ 0.99, 1.06 ]
Houwert 2009 66/86 73/95 20.8 % 1.00 [ 0.85, 1.17 ]
Liapis 2008 49/61 41/53 13.2 % 1.04 [ 0.86, 1.26 ]
Park 2012 35/39 32/35 10.1 % 0.98 [ 0.85, 1.14 ]
Scheiner 2012 29/37 28/34 8.8 % 0.95 [ 0.76, 1.20 ]
Total (95% CI) 385 374 100.0 % 1.00 [ 0.96, 1.06 ]
Total events: 340 (Medial-to-lateral), 328 (Lateral-to-medial)
Heterogeneity: Chi2 = 1.29, df = 5 (P = 0.94); I2 =0.0%
Test for overall effect: Z = 0.19 (P = 0.85)
Test for subgroup differences: Not applicable
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Analysis 3.2. Comparison 3 Obturator medial-to-lateral approach versus obturator lateral-to-medial
approach, Outcome 2 Subjective cure and improvement (short term, ≤ 1 year).
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 3 Obturator medial-to-lateral approach versus obturator lateral-to-medial approach
Outcome: 2 Subjective cure and improvement (short term,≤ 1 year)
Study or subgroup Medial-to-lateral Lateral-to-medial Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Abdel-Fattah 2010 121/149 111/143 35.9 % 1.05 [ 0.93, 1.18 ]
Houwert 2009 79/86 89/95 26.8 % 0.98 [ 0.90, 1.06 ]
Liapis 2008 57/61 47/53 16.0 % 1.05 [ 0.94, 1.18 ]
Park 2012 37/39 33/35 11.0 % 1.01 [ 0.90, 1.12 ]
Scheiner 2012 34/37 31/34 10.2 % 1.01 [ 0.87, 1.16 ]
Total (95% CI) 372 360 100.0 % 1.02 [ 0.97, 1.08 ]
Total events: 328 (Medial-to-lateral), 311 (Lateral-to-medial)
Heterogeneity: Chi2 = 1.50, df = 4 (P = 0.83); I2 =0.0%
Test for overall effect: Z = 0.76 (P = 0.45)
Test for subgroup differences: Not applicable
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Analysis 3.3. Comparison 3 Obturator medial-to-lateral approach versus obturator lateral-to-medial
approach, Outcome 3 Subjective cure (medium term, 1 to 5 years).
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 3 Obturator medial-to-lateral approach versus obturator lateral-to-medial approach
Outcome: 3 Subjective cure (medium term, 1 to 5 years)
Study or subgroup Medial-to-lateral Lateral-to-medial Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Houwert 2009 54/75 56/86 62.3 % 1.11 [ 0.90, 1.36 ]
Park 2012 33/39 30/35 37.7 % 0.99 [ 0.82, 1.19 ]
Total (95% CI) 114 121 100.0 % 1.06 [ 0.91, 1.23 ]
Total events: 87 (Medial-to-lateral), 86 (Lateral-to-medial)
Heterogeneity: Chi2 = 0.70, df = 1 (P = 0.40); I2 =0.0%
Test for overall effect: Z = 0.77 (P = 0.44)
Test for subgroup differences: Not applicable
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Analysis 3.4. Comparison 3 Obturator medial-to-lateral approach versus obturator lateral-to-medial
approach, Outcome 4 Subjective cure and improvement (medium term, 1 to 5 years).
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 3 Obturator medial-to-lateral approach versus obturator lateral-to-medial approach
Outcome: 4 Subjective cure and improvement (medium term, 1 to 5 years)
Study or subgroup Medial-to-lateral Lateral-to-medial Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Abdel-Fattah 2010 93/126 81/112 55.4 % 1.02 [ 0.87, 1.19 ]
Houwert 2009 63/75 74/86 44.6 % 0.98 [ 0.86, 1.11 ]
Total (95% CI) 201 198 100.0 % 1.00 [ 0.90, 1.11 ]
Total events: 156 (Medial-to-lateral), 155 (Lateral-to-medial)
Heterogeneity: Chi2 = 0.20, df = 1 (P = 0.65); I2 =0.0%
Test for overall effect: Z = 0.02 (P = 0.99)
Test for subgroup differences: Not applicable
0.5 0.7 1 1.5 2
Favours lateral-to-medial Favours medial-to-lateral
214Mid-urethral sling operations for stress urinary incontinence in women (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 3.5. Comparison 3 Obturator medial-to-lateral approach versus obturator lateral-to-medial
approach, Outcome 5 Objective cure (short term, ≤ 1 year).
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 3 Obturator medial-to-lateral approach versus obturator lateral-to-medial approach
Outcome: 5 Objective cure (short term,≤ 1 year)
Study or subgroup Medial-to-lateral Lateral-to-medial Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Abdel-Fattah 2010 114/121 96/109 30.0 % 1.07 [ 0.99, 1.16 ]
But 2008 54/60 58/60 17.2 % 0.93 [ 0.85, 1.03 ]
Chen 2010 60/65 41/45 14.4 % 1.01 [ 0.90, 1.14 ]
Lee 2008 43/50 46/50 13.6 % 0.93 [ 0.81, 1.07 ]
Liapis 2008 53/61 48/53 15.2 % 0.96 [ 0.84, 1.09 ]
Scheiner 2012 33/37 31/34 9.6 % 0.98 [ 0.84, 1.14 ]
Total (95% CI) 394 351 100.0 % 0.99 [ 0.95, 1.04 ]
Total events: 357 (Medial-to-lateral), 320 (Lateral-to-medial)
Heterogeneity: Chi2 = 6.03, df = 5 (P = 0.30); I2 =17%
Test for overall effect: Z = 0.27 (P = 0.79)
Test for subgroup differences: Not applicable
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Analysis 3.6. Comparison 3 Obturator medial-to-lateral approach versus obturator lateral-to-medial
approach, Outcome 6 Objective cure and improvement (short term, ≤ 1 year).
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 3 Obturator medial-to-lateral approach versus obturator lateral-to-medial approach
Outcome: 6 Objective cure and improvement (short term,≤ 1 year)
Study or subgroup Medial-to-lateral Lateral-to-medial Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Lee 2008 48/50 48/50 47.3 % 1.00 [ 0.92, 1.08 ]
Liapis 2008 58/61 50/53 52.7 % 1.01 [ 0.92, 1.10 ]
Total (95% CI) 111 103 100.0 % 1.00 [ 0.95, 1.07 ]
Total events: 106 (Medial-to-lateral), 98 (Lateral-to-medial)
Heterogeneity: Chi2 = 0.02, df = 1 (P = 0.90); I2 =0.0%
Test for overall effect: Z = 0.14 (P = 0.89)
Test for subgroup differences: Not applicable
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Analysis 3.7. Comparison 3 Obturator medial-to-lateral approach versus obturator lateral-to-medial
approach, Outcome 7 Operative time (minutes).
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 3 Obturator medial-to-lateral approach versus obturator lateral-to-medial approach
Outcome: 7 Operative time (minutes)
Study or subgroup Medial-to-lateral Lateral-to-medial
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Chen 2010 65 26.9 (16.8) 45 20 (13.5) 7.0 % 6.90 [ 1.22, 12.58 ]
Houwert 2009 93 16 (5) 98 16 (6) 35.7 % 0.0 [ -1.56, 1.56 ]
Lee 2008 50 11.2 (2.6) 50 11.5 (1.9) 46.2 % -0.30 [ -1.19, 0.59 ]
Scheiner 2012 40 27.4 (10) 40 25.8 (9.7) 11.1 % 1.60 [ -2.72, 5.92 ]
Total (95% CI) 248 233 100.0 % 0.52 [ -1.09, 2.13 ]
Heterogeneity: Tau2 = 1.26; Chi2 = 6.62, df = 3 (P = 0.08); I2 =55%
Test for overall effect: Z = 0.63 (P = 0.53)
Test for subgroup differences: Not applicable
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Analysis 3.8. Comparison 3 Obturator medial-to-lateral approach versus obturator lateral-to-medial
approach, Outcome 8 Operative blood loss (ml).
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 3 Obturator medial-to-lateral approach versus obturator lateral-to-medial approach
Outcome: 8 Operative blood loss (ml)
Study or subgroup Medial-to-lateral Lateral-to-medial
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Houwert 2009 39 54.9 (34.2) 36 55.6 (34.5) 20.9 % -0.70 [ -16.26, 14.86 ]
Lee 2008 50 33.1 (19.2) 50 32.9 (23.1) 72.9 % 0.20 [ -8.13, 8.53 ]
Scheiner 2012 40 49.4 (89.6) 40 31.5 (22.2) 6.2 % 17.90 [ -10.71, 46.51 ]
Total (95% CI) 129 126 100.0 % 1.11 [ -6.01, 8.22 ]
Heterogeneity: Chi2 = 1.42, df = 2 (P = 0.49); I2 =0.0%
Test for overall effect: Z = 0.30 (P = 0.76)
Test for subgroup differences: Not applicable
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Analysis 3.9. Comparison 3 Obturator medial-to-lateral approach versus obturator lateral-to-medial
approach, Outcome 9 Length of hospital stay (days).
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 3 Obturator medial-to-lateral approach versus obturator lateral-to-medial approach
Outcome: 9 Length of hospital stay (days)
Study or subgroup Medial-to-lateral Lateral-to-medial
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Chen 2010 65 2.3 (0.8) 45 4 (2.2) 48.5 % -1.70 [ -2.37, -1.03 ]
Scheiner 2012 40 3.3 (0.8) 40 3.2 (0.5) 51.5 % 0.10 [ -0.19, 0.39 ]
Total (95% CI) 105 85 100.0 % -0.77 [ -2.54, 0.99 ]
Heterogeneity: Tau2 = 1.55; Chi2 = 23.20, df = 1 (P<0.00001); I2 =96%
Test for overall effect: Z = 0.86 (P = 0.39)
Test for subgroup differences: Not applicable
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Analysis 3.10. Comparison 3 Obturator medial-to-lateral approach versus obturator lateral-to-medial
approach, Outcome 10 Time to return to normal activity level.
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 3 Obturator medial-to-lateral approach versus obturator lateral-to-medial approach
Outcome: 10 Time to return to normal activity level
Study or subgroup Medial-to-lateral Lateral-to-medial
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Lee 2008 50 5.1 (3) 50 5.7 (3.1) -0.60 [ -1.80, 0.60 ]
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Analysis 3.11. Comparison 3 Obturator medial-to-lateral approach versus obturator lateral-to-medial
approach, Outcome 11 Perioperative complications.
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 3 Obturator medial-to-lateral approach versus obturator lateral-to-medial approach
Outcome: 11 Perioperative complications
Study or subgroup Medial-to-lateral Lateral-to-medial Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Lee 2008 0/50 0/50 Not estimable
Liapis 2008 3/61 2/53 100.0 % 1.30 [ 0.23, 7.51 ]
Total (95% CI) 111 103 100.0 % 1.30 [ 0.23, 7.51 ]
Total events: 3 (Medial-to-lateral), 2 (Lateral-to-medial)
Heterogeneity: not applicable
Test for overall effect: Z = 0.30 (P = 0.77)
Test for subgroup differences: Not applicable
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Analysis 3.12. Comparison 3 Obturator medial-to-lateral approach versus obturator lateral-to-medial
approach, Outcome 12 Major vascular or visceral injury.
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 3 Obturator medial-to-lateral approach versus obturator lateral-to-medial approach
Outcome: 12 Major vascular or visceral injury
Study or subgroup Medial-to-lateral Lateral-to-medial Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Chen 2010 0/65 0/45 Not estimable
Hassan 2013 5/125 7/125 100.0 % 0.71 [ 0.23, 2.19 ]
Houwert 2009 0/93 0/98 Not estimable
Scheiner 2012 0/37 0/34 Not estimable
Total (95% CI) 320 302 100.0 % 0.71 [ 0.23, 2.19 ]
Total events: 5 (Medial-to-lateral), 7 (Lateral-to-medial)
Heterogeneity: not applicable
Test for overall effect: Z = 0.59 (P = 0.56)
Test for subgroup differences: Not applicable
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Analysis 3.13. Comparison 3 Obturator medial-to-lateral approach versus obturator lateral-to-medial
approach, Outcome 13 Vaginal perforation/injury.
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 3 Obturator medial-to-lateral approach versus obturator lateral-to-medial approach
Outcome: 13 Vaginal perforation/injury
Study or subgroup Medial-to-lateral Lateral-to-medial Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Abdel-Fattah 2010 3/170 17/171 53.1 % 0.18 [ 0.05, 0.59 ]
But 2008 1/60 9/60 28.2 % 0.11 [ 0.01, 0.85 ]
Scheiner 2012 4/40 6/40 18.8 % 0.67 [ 0.20, 2.18 ]
Total (95% CI) 270 271 100.0 % 0.25 [ 0.12, 0.53 ]
Total events: 8 (Medial-to-lateral), 32 (Lateral-to-medial)
Heterogeneity: Chi2 = 3.54, df = 2 (P = 0.17); I2 =43%
Test for overall effect: Z = 3.60 (P = 0.00032)
Test for subgroup differences: Not applicable
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Analysis 3.14. Comparison 3 Obturator medial-to-lateral approach versus obturator lateral-to-medial
approach, Outcome 14 Bladder or urethral perforation.
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 3 Obturator medial-to-lateral approach versus obturator lateral-to-medial approach
Outcome: 14 Bladder or urethral perforation
Study or subgroup Medial-to-lateral Lateral-to-medial Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Abdel-Fattah 2010 1/170 2/171 38.7 % 0.50 [ 0.05, 5.49 ]
Chen 2010 0/65 0/45 Not estimable
Houwert 2009 0/39 1/36 30.2 % 0.31 [ 0.01, 7.34 ]
Liapis 2008 0/61 1/53 31.1 % 0.29 [ 0.01, 6.98 ]
Park 2012 0/39 0/35 Not estimable
Scheiner 2012 0/40 0/40 Not estimable
Total (95% CI) 414 380 100.0 % 0.38 [ 0.07, 1.92 ]
Total events: 1 (Medial-to-lateral), 4 (Lateral-to-medial)
Heterogeneity: Chi2 = 0.10, df = 2 (P = 0.95); I2 =0.0%
Test for overall effect: Z = 1.17 (P = 0.24)
Test for subgroup differences: Not applicable
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Analysis 3.15. Comparison 3 Obturator medial-to-lateral approach versus obturator lateral-to-medial
approach, Outcome 15 Voiding dysfunction.
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 3 Obturator medial-to-lateral approach versus obturator lateral-to-medial approach
Outcome: 15 Voiding dysfunction
Study or subgroup Medial-to-lateral Lateral-to-medial Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Abdel-Fattah 2010 12/170 9/171 39.8 % 1.34 [ 0.58, 3.10 ]
But 2008 8/60 3/60 13.3 % 2.67 [ 0.74, 9.57 ]
Chen 2010 3/65 2/45 10.5 % 1.04 [ 0.18, 5.97 ]
Houwert 2009 10/93 3/98 13.0 % 3.51 [ 1.00, 12.37 ]
Lee 2008 0/50 0/50 Not estimable
Liapis 2008 3/61 2/53 9.5 % 1.30 [ 0.23, 7.51 ]
Park 2012 3/39 2/35 9.3 % 1.35 [ 0.24, 7.59 ]
Scheiner 2012 1/37 1/34 4.6 % 0.92 [ 0.06, 14.12 ]
Total (95% CI) 575 546 100.0 % 1.74 [ 1.06, 2.88 ]
Total events: 40 (Medial-to-lateral), 22 (Lateral-to-medial)
Heterogeneity: Chi2 = 2.73, df = 6 (P = 0.84); I2 =0.0%
Test for overall effect: Z = 2.17 (P = 0.030)
Test for subgroup differences: Not applicable
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Analysis 3.16. Comparison 3 Obturator medial-to-lateral approach versus obturator lateral-to-medial
approach, Outcome 16 De novo urgency or urgency incontinence.
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 3 Obturator medial-to-lateral approach versus obturator lateral-to-medial approach
Outcome: 16 De novo urgency or urgency incontinence
Study or subgroup Medial-to-lateral Lateral-to-medial Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Houwert 2009 2/71 4/72 34.9 % 0.51 [ 0.10, 2.68 ]
Lee 2008 2/50 1/50 8.8 % 2.00 [ 0.19, 21.36 ]
Liapis 2008 8/61 6/53 56.4 % 1.16 [ 0.43, 3.13 ]
Total (95% CI) 182 175 100.0 % 1.01 [ 0.46, 2.20 ]
Total events: 12 (Medial-to-lateral), 11 (Lateral-to-medial)
Heterogeneity: Chi2 = 1.05, df = 2 (P = 0.59); I2 =0.0%
Test for overall effect: Z = 0.01 (P = 0.99)
Test for subgroup differences: Not applicable
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Analysis 3.17. Comparison 3 Obturator medial-to-lateral approach versus obturator lateral-to-medial
approach, Outcome 17 Detrusor overactivity.
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 3 Obturator medial-to-lateral approach versus obturator lateral-to-medial approach
Outcome: 17 Detrusor overactivity
Study or subgroup Medial-to-lateral Lateral-to-medial Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Liapis 2008 5/61 5/53 0.87 [ 0.27, 2.84 ]
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Analysis 3.18. Comparison 3 Obturator medial-to-lateral approach versus obturator lateral-to-medial
approach, Outcome 18 Vaginal tape erosion.
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 3 Obturator medial-to-lateral approach versus obturator lateral-to-medial approach
Outcome: 18 Vaginal tape erosion
Study or subgroup Medial-to-lateral Lateral-to-medial Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Abdel-Fattah 2010 3/153 5/149 36.0 % 0.58 [ 0.14, 2.40 ]
But 2008 0/60 0/60 Not estimable
Hassan 2013 1/102 0/97 3.6 % 2.85 [ 0.12, 69.23 ]
Houwert 2009 1/86 4/95 27.0 % 0.28 [ 0.03, 2.42 ]
Lee 2008 0/50 0/50 Not estimable
Liapis 2008 0/61 0/53 Not estimable
Scheiner 2012 0/37 4/34 33.3 % 0.10 [ 0.01, 1.83 ]
Total (95% CI) 549 538 100.0 % 0.42 [ 0.16, 1.09 ]
Total events: 5 (Medial-to-lateral), 13 (Lateral-to-medial)
Heterogeneity: Chi2 = 2.65, df = 3 (P = 0.45); I2 =0.0%
Test for overall effect: Z = 1.78 (P = 0.075)
Test for subgroup differences: Not applicable
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Analysis 3.19. Comparison 3 Obturator medial-to-lateral approach versus obturator lateral-to-medial
approach, Outcome 19 Groin/thigh pain.
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 3 Obturator medial-to-lateral approach versus obturator lateral-to-medial approach
Outcome: 19 Groin/thigh pain
Study or subgroup Medial-to-lateral Lateral-to-medial Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Abdel-Fattah 2010 27/150 19/147 55.9 % 1.39 [ 0.81, 2.39 ]
Houwert 2009 0/86 1/95 4.2 % 0.37 [ 0.02, 8.91 ]
Lee 2008 7/50 9/50 26.2 % 0.78 [ 0.31, 1.93 ]
Liapis 2008 3/61 1/53 3.1 % 2.61 [ 0.28, 24.31 ]
Park 2012 1/39 0/35 1.5 % 2.70 [ 0.11, 64.20 ]
Scheiner 2012 1/37 3/34 9.1 % 0.31 [ 0.03, 2.81 ]
Total (95% CI) 423 414 100.0 % 1.15 [ 0.75, 1.76 ]
Total events: 39 (Medial-to-lateral), 33 (Lateral-to-medial)
Heterogeneity: Chi2 = 3.85, df = 5 (P = 0.57); I2 =0.0%
Test for overall effect: Z = 0.63 (P = 0.53)
Test for subgroup differences: Not applicable
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Analysis 3.20. Comparison 3 Obturator medial-to-lateral approach versus obturator lateral-to-medial
approach, Outcome 20 Repeat incontinence surgery.
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 3 Obturator medial-to-lateral approach versus obturator lateral-to-medial approach
Outcome: 20 Repeat incontinence surgery
Study or subgroup Medial-to-lateral Lateral-to-medial Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Abdel-Fattah 2010 7/170 15/171 79.3 % 0.47 [ 0.20, 1.12 ]
Houwert 2009 5/93 4/98 20.7 % 1.32 [ 0.36, 4.76 ]
Total (95% CI) 263 269 100.0 % 0.64 [ 0.32, 1.30 ]
Total events: 12 (Medial-to-lateral), 19 (Lateral-to-medial)
Heterogeneity: Chi2 = 1.70, df = 1 (P = 0.19); I2 =41%
Test for overall effect: Z = 1.23 (P = 0.22)
Test for subgroup differences: Not applicable
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Analysis 3.21. Comparison 3 Obturator medial-to-lateral approach versus obturator lateral-to-medial
approach, Outcome 21 QoL specific.
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 3 Obturator medial-to-lateral approach versus obturator lateral-to-medial approach
Outcome: 21 QoL specific
Study or subgroup Medial-to-lateral Lateral-to-medial
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Houwert 2009 24 22.93 (26.01) 22 6.39 (12.8) 100.0 % 16.54 [ 4.84, 28.24 ]
Total (95% CI) 24 22 100.0 % 16.54 [ 4.84, 28.24 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.77 (P = 0.0056)
Test for subgroup differences: Not applicable
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Analysis 4.1. Comparison 4 One method of mid-urethral tape insertion versus another method, same
route, Outcome 1 Subjective cure (short term, up to 1 year).
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 4 One method of mid-urethral tape insertion versus another method, same route
Outcome: 1 Subjective cure (short term, up to 1 year)
Study or subgroup Method A Method B Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Modified TVT-O (short tape) vs TVT-O
de Leval 2011 78/88 77/87 100.0 % 1.00 [ 0.90, 1.11 ]
Subtotal (95% CI) 88 87 100.0 % 1.00 [ 0.90, 1.11 ]
Total events: 78 (Method A), 77 (Method B)
Heterogeneity: not applicable
Test for overall effect: Z = 0.03 (P = 0.98)
2 Modified TVT (suburethral pad) versus TVT
Naumann 2006 109/125 107/123 100.0 % 1.00 [ 0.91, 1.10 ]
Subtotal (95% CI) 125 123 100.0 % 1.00 [ 0.91, 1.10 ]
Total events: 109 (Method A), 107 (Method B)
Heterogeneity: not applicable
Test for overall effect: Z = 0.05 (P = 0.96)
3 Self-tailored TVT-O vs TVT-O
Zhang 2011 75/80 70/76 100.0 % 1.02 [ 0.93, 1.11 ]
Subtotal (95% CI) 80 76 100.0 % 1.02 [ 0.93, 1.11 ]
Total events: 75 (Method A), 70 (Method B)
Heterogeneity: not applicable
Test for overall effect: Z = 0.40 (P = 0.69)
4 Monarc TOT open edge + tension suture vs TOT
Cho 2010 41/48 37/45 100.0 % 1.04 [ 0.87, 1.24 ]
Subtotal (95% CI) 48 45 100.0 % 1.04 [ 0.87, 1.24 ]
Total events: 41 (Method A), 37 (Method B)
Heterogeneity: not applicable
Test for overall effect: Z = 0.42 (P = 0.68)
5 AdjustableTOT vs TOT
Elbadry 2014 40/48 38/48 100.0 % 1.05 [ 0.87, 1.28 ]
Subtotal (95% CI) 48 48 100.0 % 1.05 [ 0.87, 1.28 ]
Total events: 40 (Method A), 38 (Method B)
Heterogeneity: not applicable
Test for overall effect: Z = 0.52 (P = 0.60)
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(. . . Continued)
Study or subgroup Method A Method B Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
6 Synthetic vs biological
Paparella 2010 28/33 30/36 45.8 % 1.02 [ 0.83, 1.25 ]
Ugurlucan 2013 35/50 34/50 54.2 % 1.03 [ 0.79, 1.34 ]
Subtotal (95% CI) 83 86 100.0 % 1.02 [ 0.86, 1.22 ]
Total events: 63 (Method A), 64 (Method B)
Heterogeneity: Chi2 = 0.00, df = 1 (P = 0.95); I2 =0.0%
Test for overall effect: Z = 0.28 (P = 0.78)
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Analysis 4.2. Comparison 4 One method of mid-urethral tape insertion versus another method, same
route, Outcome 2 Subjective cure and improvement (short term, up to 1 year).
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 4 One method of mid-urethral tape insertion versus another method, same route
Outcome: 2 Subjective cure and improvement (short term, up to 1 year)
Study or subgroup Method A Method B Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Modified TVT-O (short tape) vs TVT-O
de Leval 2011 84/86 80/84 100.0 % 1.03 [ 0.97, 1.09 ]
Subtotal (95% CI) 86 84 100.0 % 1.03 [ 0.97, 1.09 ]
Total events: 84 (Method A), 80 (Method B)
Heterogeneity: not applicable
Test for overall effect: Z = 0.86 (P = 0.39)
2 TOT + 2-point tape fixation vs TOT
Rechberger 2011 191/205 186/213 100.0 % 1.07 [ 1.00, 1.14 ]
Subtotal (95% CI) 205 213 100.0 % 1.07 [ 1.00, 1.14 ]
Total events: 191 (Method A), 186 (Method B)
Heterogeneity: not applicable
Test for overall effect: Z = 2.01 (P = 0.044)
3 TVT versus modified TVT (suburethral pad)
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(. . . Continued)
Study or subgroup Method A Method B Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Naumann 2006 122/125 117/123 100.0 % 1.03 [ 0.98, 1.08 ]
Subtotal (95% CI) 125 123 100.0 % 1.03 [ 0.98, 1.08 ]
Total events: 122 (Method A), 117 (Method B)
Heterogeneity: not applicable
Test for overall effect: Z = 1.04 (P = 0.30)
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Analysis 4.3. Comparison 4 One method of mid-urethral tape insertion versus another method, same
route, Outcome 3 Subjective cure (medium term, 1 to 5 years).
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 4 One method of mid-urethral tape insertion versus another method, same route
Outcome: 3 Subjective cure (medium term, 1 to 5 years)
Study or subgroup Method A Method B Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Modified TVT-O (short tape) vs TVT-O
de Leval 2011 66/79 63/74 100.0 % 0.98 [ 0.86, 1.12 ]
Subtotal (95% CI) 79 74 100.0 % 0.98 [ 0.86, 1.12 ]
Total events: 66 (Method A), 63 (Method B)
Heterogeneity: not applicable
Test for overall effect: Z = 0.27 (P = 0.79)
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Analysis 4.4. Comparison 4 One method of mid-urethral tape insertion versus another method, same
route, Outcome 4 Objective cure (medium term, 1 to 5 years).
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 4 One method of mid-urethral tape insertion versus another method, same route
Outcome: 4 Objective cure (medium term, 1 to 5 years)
Study or subgroup Method A Method B Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Modified TVT-O (short tape) vs TVT-O
de Leval 2011 50/57 48/56 1.02 [ 0.89, 1.18 ]
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Analysis 4.5. Comparison 4 One method of mid-urethral tape insertion versus another method, same
route, Outcome 5 Objective cure (short term, ≤ 1 year).
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 4 One method of mid-urethral tape insertion versus another method, same route
Outcome: 5 Objective cure (short term,≤ 1 year)
Study or subgroup Method A Method B Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Modified TVT-O (less dissection) vs TVT-O
Tommaselli 2012 22/23 43/46 100.0 % 1.02 [ 0.91, 1.15 ]
Subtotal (95% CI) 23 46 100.0 % 1.02 [ 0.91, 1.15 ]
Total events: 22 (Method A), 43 (Method B)
Heterogeneity: not applicable
Test for overall effect: Z = 0.39 (P = 0.70)
2 Synthetic vs biological
Paparella 2010 30/33 33/36 51.2 % 0.99 [ 0.86, 1.15 ]
Ugurlucan 2013 35/36 28/31 48.8 % 1.08 [ 0.95, 1.22 ]
Subtotal (95% CI) 69 67 100.0 % 1.03 [ 0.94, 1.14 ]
Total events: 65 (Method A), 61 (Method B)
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(. . . Continued)
Study or subgroup Method A Method B Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Heterogeneity: Chi2 = 0.70, df = 1 (P = 0.40); I2 =0.0%
Test for overall effect: Z = 0.66 (P = 0.51)
3 TVT-O + IS vs TVT-O
Juang 2007 34/48 22/45 100.0 % 1.45 [ 1.02, 2.06 ]
Subtotal (95% CI) 48 45 100.0 % 1.45 [ 1.02, 2.06 ]
Total events: 34 (Method A), 22 (Method B)
Heterogeneity: not applicable
Test for overall effect: Z = 2.08 (P = 0.038)
4 TOT + 2-point tape fixation vs TOT
Rechberger 2011 195/205 189/213 100.0 % 1.07 [ 1.01, 1.13 ]
Subtotal (95% CI) 205 213 100.0 % 1.07 [ 1.01, 1.13 ]
Total events: 195 (Method A), 189 (Method B)
Heterogeneity: not applicable
Test for overall effect: Z = 2.39 (P = 0.017)
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Analysis 4.6. Comparison 4 One method of mid-urethral tape insertion versus another method, same
route, Outcome 6 Operative time (minutes).
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 4 One method of mid-urethral tape insertion versus another method, same route
Outcome: 6 Operative time (minutes)
Study or subgroup Method A Method B
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 TVT-O + IS vs TVT-O
Juang 2007 49 28.3 (10.2) 47 16.3 (4.1) 100.0 % 12.00 [ 8.91, 15.09 ]
Subtotal (95% CI) 49 47 100.0 % 12.00 [ 8.91, 15.09 ]
Heterogeneity: not applicable
Test for overall effect: Z = 7.62 (P < 0.00001)
2 Self-tailored TVT-O vs TVT-O
Zhang 2011 80 24 (6) 76 49 (5) 100.0 % -25.00 [ -26.73, -23.27 ]
Subtotal (95% CI) 80 76 100.0 % -25.00 [ -26.73, -23.27 ]
Heterogeneity: not applicable
Test for overall effect: Z = 28.33 (P < 0.00001)
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Analysis 4.7. Comparison 4 One method of mid-urethral tape insertion versus another method, same
route, Outcome 7 Operative blood loss (ml).
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 4 One method of mid-urethral tape insertion versus another method, same route
Outcome: 7 Operative blood loss (ml)
Study or subgroup Method A Method B
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 TVT-O + IS versus TVT-O
Juang 2007 49 82.4 (25.1) 43 30.3 (15.2) 100.0 % 52.10 [ 43.73, 60.47 ]
Subtotal (95% CI) 49 43 100.0 % 52.10 [ 43.73, 60.47 ]
Heterogeneity: not applicable
Test for overall effect: Z = 12.20 (P < 0.00001)
2 Self-tailored TVT-O vs TVT-O
Zhang 2011 80 55 (5) 76 70 (5) 100.0 % -15.00 [ -16.57, -13.43 ]
Subtotal (95% CI) 80 76 100.0 % -15.00 [ -16.57, -13.43 ]
Heterogeneity: not applicable
Test for overall effect: Z = 18.73 (P < 0.00001)
3 Synthetic vs biological
Paparella 2010 34 10.4 (1) 36 10.8 (1.2) 100.0 % -0.40 [ -0.92, 0.12 ]
Subtotal (95% CI) 34 36 100.0 % -0.40 [ -0.92, 0.12 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.52 (P = 0.13)
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Analysis 4.8. Comparison 4 One method of mid-urethral tape insertion versus another method, same
route, Outcome 8 Length of hospital stay (days).
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 4 One method of mid-urethral tape insertion versus another method, same route
Outcome: 8 Length of hospital stay (days)
Study or subgroup Method A Method B
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 TVT-O + IS vs TVT-O
Juang 2007 49 28.3 (10.2) 47 16.3 (4.1) 100.0 % 12.00 [ 8.91, 15.09 ]
Subtotal (95% CI) 49 47 100.0 % 12.00 [ 8.91, 15.09 ]
Heterogeneity: not applicable
Test for overall effect: Z = 7.62 (P < 0.00001)
2 Self-tailored TVT-O vs TVT-O
Zhang 2011 80 5 (0.5) 76 8 (0.5) 100.0 % -3.00 [ -3.16, -2.84 ]
Subtotal (95% CI) 80 76 100.0 % -3.00 [ -3.16, -2.84 ]
Heterogeneity: not applicable
Test for overall effect: Z = 37.46 (P < 0.00001)
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Analysis 4.9. Comparison 4 One method of mid-urethral tape insertion versus another method, same
route, Outcome 9 Perioperative complications.
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 4 One method of mid-urethral tape insertion versus another method, same route
Outcome: 9 Perioperative complications
Study or subgroup Method A Method B Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Synthetic vs biological
Paparella 2010 0/34 0/36 Not estimable
Ugurlucan 2013 0/50 0/50 Not estimable
Subtotal (95% CI) 84 86 Not estimable
Total events: 0 (Method A), 0 (Method B)
Heterogeneity: not applicable
Test for overall effect: not applicable
0.02 0.1 1 10 50
Favours method A Favours method B
236Mid-urethral sling operations for stress urinary incontinence in women (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 4.10. Comparison 4 One method of mid-urethral tape insertion versus another method, same
route, Outcome 10 Major vascular or visceral injury.
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 4 One method of mid-urethral tape insertion versus another method, same route
Outcome: 10 Major vascular or visceral injury
Study or subgroup Method A Method B Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 TVT-O + IS vs TVT-O
Juang 2007 3/49 4/47 100.0 % 0.72 [ 0.17, 3.04 ]
Subtotal (95% CI) 49 47 100.0 % 0.72 [ 0.17, 3.04 ]
Total events: 3 (Method A), 4 (Method B)
Heterogeneity: not applicable
Test for overall effect: Z = 0.45 (P = 0.65)
2 Synthetic vs biological
Paparella 2010 0/34 0/36 Not estimable
Ugurlucan 2013 0/50 0/50 Not estimable
Subtotal (95% CI) 84 86 Not estimable
Total events: 0 (Method A), 0 (Method B)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 AdjustableTOT vs TOT
Elbadry 2014 0/48 0/48 Not estimable
Subtotal (95% CI) 48 48 Not estimable
Total events: 0 (Method A), 0 (Method B)
Heterogeneity: not applicable
Test for overall effect: not applicable
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Analysis 4.11. Comparison 4 One method of mid-urethral tape insertion versus another method, same
route, Outcome 11 Bladder/urethral perforation.
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 4 One method of mid-urethral tape insertion versus another method, same route
Outcome: 11 Bladder/urethral perforation
Study or subgroup Method A Method B Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 TVT-O + IS vs TVT-O
Juang 2007 0/49 0/47 Not estimable
Subtotal (95% CI) 49 47 Not estimable
Total events: 0 (Method A), 0 (Method B)
Heterogeneity: not applicable
Test for overall effect: not applicable
2 TOT + 2-point tape fixation vs TOT
Rechberger 2011 3/231 4/232 100.0 % 0.75 [ 0.17, 3.33 ]
Subtotal (95% CI) 231 232 100.0 % 0.75 [ 0.17, 3.33 ]
Total events: 3 (Method A), 4 (Method B)
Heterogeneity: not applicable
Test for overall effect: Z = 0.37 (P = 0.71)
3 TVT versus modified TVT (suburethral pad)
Naumann 2006 1/125 2/123 100.0 % 0.49 [ 0.05, 5.36 ]
Subtotal (95% CI) 125 123 100.0 % 0.49 [ 0.05, 5.36 ]
Total events: 1 (Method A), 2 (Method B)
Heterogeneity: not applicable
Test for overall effect: Z = 0.58 (P = 0.56)
4 AdjustableTOT vs TOT
Elbadry 2014 0/48 0/48 Not estimable
Subtotal (95% CI) 48 48 Not estimable
Total events: 0 (Method A), 0 (Method B)
Heterogeneity: not applicable
Test for overall effect: not applicable
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Analysis 4.12. Comparison 4 One method of mid-urethral tape insertion versus another method, same
route, Outcome 12 Voiding dysfunction.
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 4 One method of mid-urethral tape insertion versus another method, same route
Outcome: 12 Voiding dysfunction
Study or subgroup Method A Method B Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Modified TVT-O (less dissection) vs TVT-O
Tommaselli 2012 1/24 1/48 100.0 % 2.00 [ 0.13, 30.61 ]
Subtotal (95% CI) 24 48 100.0 % 2.00 [ 0.13, 30.61 ]
Total events: 1 (Method A), 1 (Method B)
Heterogeneity: not applicable
Test for overall effect: Z = 0.50 (P = 0.62)
2 TVT versus modified TVT (suburethral pad)
Naumann 2006 9/125 4/123 100.0 % 2.21 [ 0.70, 7.00 ]
Subtotal (95% CI) 125 123 100.0 % 2.21 [ 0.70, 7.00 ]
Total events: 9 (Method A), 4 (Method B)
Heterogeneity: not applicable
Test for overall effect: Z = 1.35 (P = 0.18)
3 Self-tailored TVT-O vs TVT-O
Zhang 2011 1/80 1/76 100.0 % 0.95 [ 0.06, 14.92 ]
Subtotal (95% CI) 80 76 100.0 % 0.95 [ 0.06, 14.92 ]
Total events: 1 (Method A), 1 (Method B)
Heterogeneity: not applicable
Test for overall effect: Z = 0.04 (P = 0.97)
4 Monarc TOT open edge + tension suture vs TOT
Cho 2010 1/48 2/45 100.0 % 0.47 [ 0.04, 4.99 ]
Subtotal (95% CI) 48 45 100.0 % 0.47 [ 0.04, 4.99 ]
Total events: 1 (Method A), 2 (Method B)
Heterogeneity: not applicable
Test for overall effect: Z = 0.63 (P = 0.53)
5 Synthetic vs biological
Paparella 2010 0/34 0/36 Not estimable
Ugurlucan 2013 2/50 0/50 100.0 % 5.00 [ 0.25, 101.58 ]
Subtotal (95% CI) 84 86 100.0 % 5.00 [ 0.25, 101.58 ]
Total events: 2 (Method A), 0 (Method B)
Heterogeneity: not applicable
Test for overall effect: Z = 1.05 (P = 0.29)
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Analysis 4.13. Comparison 4 One method of mid-urethral tape insertion versus another method, same
route, Outcome 13 De novo urgency or urgency incontinence.
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 4 One method of mid-urethral tape insertion versus another method, same route
Outcome: 13 De novo urgency or urgency incontinence
Study or subgroup Method A Method B Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Modified TVT-O (short tape) vs TVT-O
de Leval 2011 10/86 8/84 100.0 % 1.22 [ 0.51, 2.94 ]
Subtotal (95% CI) 86 84 100.0 % 1.22 [ 0.51, 2.94 ]
Total events: 10 (Method A), 8 (Method B)
Heterogeneity: not applicable
Test for overall effect: Z = 0.44 (P = 0.66)
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Analysis 4.14. Comparison 4 One method of mid-urethral tape insertion versus another method, same
route, Outcome 14 Vaginal tape erosion.
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 4 One method of mid-urethral tape insertion versus another method, same route
Outcome: 14 Vaginal tape erosion
Study or subgroup Method A Method B Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Modified TVT-O (short tape) vs TVT-O
de Leval 2011 0/86 1/84 100.0 % 0.33 [ 0.01, 7.88 ]
Subtotal (95% CI) 86 84 100.0 % 0.33 [ 0.01, 7.88 ]
Total events: 0 (Method A), 1 (Method B)
Heterogeneity: not applicable
Test for overall effect: Z = 0.69 (P = 0.49)
2 TVT versus modified TVT (suburethral pad)
Naumann 2006 7/125 3/123 100.0 % 2.30 [ 0.61, 8.68 ]
Subtotal (95% CI) 125 123 100.0 % 2.30 [ 0.61, 8.68 ]
Total events: 7 (Method A), 3 (Method B)
Heterogeneity: not applicable
Test for overall effect: Z = 1.23 (P = 0.22)
3 TVT-O + IS vs TVT-O
Juang 2007 1/48 1/45 100.0 % 0.94 [ 0.06, 14.55 ]
Subtotal (95% CI) 48 45 100.0 % 0.94 [ 0.06, 14.55 ]
Total events: 1 (Method A), 1 (Method B)
Heterogeneity: not applicable
Test for overall effect: Z = 0.05 (P = 0.96)
4 Monarc TOT open edge + tension suture vs TOT
Cho 2010 0/48 3/45 100.0 % 0.13 [ 0.01, 2.53 ]
Subtotal (95% CI) 48 45 100.0 % 0.13 [ 0.01, 2.53 ]
Total events: 0 (Method A), 3 (Method B)
Heterogeneity: not applicable
Test for overall effect: Z = 1.34 (P = 0.18)
5 Synthetic vs biological
Paparella 2010 0/33 0/36 Not estimable
Ugurlucan 2013 1/50 0/50 100.0 % 3.00 [ 0.13, 71.92 ]
Subtotal (95% CI) 83 86 100.0 % 3.00 [ 0.13, 71.92 ]
Total events: 1 (Method A), 0 (Method B)
Heterogeneity: not applicable
Test for overall effect: Z = 0.68 (P = 0.50)
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Analysis 4.15. Comparison 4 One method of mid-urethral tape insertion versus another method, same
route, Outcome 15 Bladder/urethral erosion.
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 4 One method of mid-urethral tape insertion versus another method, same route
Outcome: 15 Bladder/urethral erosion
Study or subgroup Method A Method B Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 TVT versus modified TVT (suburethral pad)
Naumann 2006 1/125 1/123 100.0 % 0.98 [ 0.06, 15.56 ]
Subtotal (95% CI) 125 123 100.0 % 0.98 [ 0.06, 15.56 ]
Total events: 1 (Method A), 1 (Method B)
Heterogeneity: not applicable
Test for overall effect: Z = 0.01 (P = 0.99)
0.01 0.1 1 10 100
Favours method A Favours method B
242Mid-urethral sling operations for stress urinary incontinence in women (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 4.16. Comparison 4 One method of mid-urethral tape insertion versus another method, same
route, Outcome 16 Groin pain.
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 4 One method of mid-urethral tape insertion versus another method, same route
Outcome: 16 Groin pain
Study or subgroup Method A Method B Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Modified TVT-O (short tape) vs TVT-O
de Leval 2011 4/86 3/84 100.0 % 1.30 [ 0.30, 5.64 ]
Subtotal (95% CI) 86 84 100.0 % 1.30 [ 0.30, 5.64 ]
Total events: 4 (Method A), 3 (Method B)
Heterogeneity: not applicable
Test for overall effect: Z = 0.35 (P = 0.72)
2 Synthetic vs biological
Paparella 2010 0/33 0/36 Not estimable
Subtotal (95% CI) 33 36 Not estimable
Total events: 0 (Method A), 0 (Method B)
Heterogeneity: not applicable
Test for overall effect: not applicable
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Analysis 5.1. Comparison 5 One type of tape material versus another, Outcome 1 Subjective cure (short
term, ≤ 1 year).
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 5 One type of tape material versus another
Outcome: 1 Subjective cure (short term,≤ 1 year)
Study or subgroup Method A Method B Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Monofilament versus multifilament
Lim 2005 93/115 50/56 30.8 % 0.91 [ 0.80, 1.03 ]
Meschia 2006 80/92 68/87 32.0 % 1.11 [ 0.97, 1.28 ]
Okulu 2013 41/48 41/48 18.8 % 1.00 [ 0.85, 1.18 ]
Rechberger 2003 44/50 40/50 18.3 % 1.10 [ 0.93, 1.31 ]
Subtotal (95% CI) 305 241 100.0 % 1.03 [ 0.95, 1.10 ]
Total events: 258 (Method A), 199 (Method B)
Heterogeneity: Chi2 = 5.77, df = 3 (P = 0.12); I2 =48%
Test for overall effect: Z = 0.66 (P = 0.51)
2 Monofilament versus combined monofilament and biological
Okulu 2013 41/48 45/48 100.0 % 0.91 [ 0.79, 1.05 ]
Subtotal (95% CI) 48 48 100.0 % 0.91 [ 0.79, 1.05 ]
Total events: 41 (Method A), 45 (Method B)
Heterogeneity: not applicable
Test for overall effect: Z = 1.32 (P = 0.19)
3 Combined monofilament and biological vs multifilament
Okulu 2013 45/48 41/48 100.0 % 1.10 [ 0.96, 1.26 ]
Subtotal (95% CI) 48 48 100.0 % 1.10 [ 0.96, 1.26 ]
Total events: 45 (Method A), 41 (Method B)
Heterogeneity: not applicable
Test for overall effect: Z = 1.32 (P = 0.19)
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Analysis 5.2. Comparison 5 One type of tape material versus another, Outcome 2 Subjective cure (medium
term, 1 to 5 years).
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 5 One type of tape material versus another
Outcome: 2 Subjective cure (medium term, 1 to 5 years)
Study or subgroup Method A Method B Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Monofilament vs multifilament
Okulu 2013 40/48 39/48 100.0 % 1.03 [ 0.85, 1.23 ]
Subtotal (95% CI) 48 48 100.0 % 1.03 [ 0.85, 1.23 ]
Total events: 40 (Method A), 39 (Method B)
Heterogeneity: not applicable
Test for overall effect: Z = 0.27 (P = 0.79)
2 Monofilament vs combined monofilament and biological
Okulu 2013 40/48 44/48 100.0 % 0.91 [ 0.78, 1.06 ]
Subtotal (95% CI) 48 48 100.0 % 0.91 [ 0.78, 1.06 ]
Total events: 40 (Method A), 44 (Method B)
Heterogeneity: not applicable
Test for overall effect: Z = 1.22 (P = 0.22)
3 Combined monofilament and biological vs multifilament
Okulu 2013 44/48 39/48 100.0 % 1.13 [ 0.96, 1.32 ]
Subtotal (95% CI) 48 48 100.0 % 1.13 [ 0.96, 1.32 ]
Total events: 44 (Method A), 39 (Method B)
Heterogeneity: not applicable
Test for overall effect: Z = 1.47 (P = 0.14)
0.5 0.7 1 1.5 2
Favours method B Favours method A
245Mid-urethral sling operations for stress urinary incontinence in women (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 5.3. Comparison 5 One type of tape material versus another, Outcome 3 Objective cure (short
term, ≤ 1 year).
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 5 One type of tape material versus another
Outcome: 3 Objective cure (short term,≤ 1 year)
Study or subgroup Method A Method B Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Monofilament vs multifilament
Lim 2005 93/116 44/54 47.3 % 0.98 [ 0.84, 1.15 ]
Meschia 2006 79/92 65/87 52.7 % 1.15 [ 0.99, 1.33 ]
Subtotal (95% CI) 208 141 100.0 % 1.07 [ 0.96, 1.19 ]
Total events: 172 (Method A), 109 (Method B)
Heterogeneity: Chi2 = 2.01, df = 1 (P = 0.16); I2 =50%
Test for overall effect: Z = 1.25 (P = 0.21)
Test for subgroup differences: Not applicable
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Analysis 5.4. Comparison 5 One type of tape material versus another, Outcome 4 Operative time (minutes).
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 5 One type of tape material versus another
Outcome: 4 Operative time (minutes)
Study or subgroup Method A Method B
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Monofilament vs multifilament
Meschia 2006 92 27 (6) 87 27 (4) 0.0 [ -1.49, 1.49 ]
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Analysis 5.5. Comparison 5 One type of tape material versus another, Outcome 5 Length of hospital stay
(days).
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 5 One type of tape material versus another
Outcome: 5 Length of hospital stay (days)
Study or subgroup Method A Method B
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Monofilament vs multifilament
Meschia 2006 92 2.5 (1) 87 2.3 (1) 0.20 [ -0.09, 0.49 ]
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Analysis 5.6. Comparison 5 One type of tape material versus another, Outcome 6 Perioperative
complications.
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 5 One type of tape material versus another
Outcome: 6 Perioperative complications
Study or subgroup Method A Method B Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Monofilament vs multifilament
Meschia 2006 3/92 4/87 80.4 % 0.71 [ 0.16, 3.08 ]
Rechberger 2003 3/50 1/50 19.6 % 3.00 [ 0.32, 27.87 ]
Subtotal (95% CI) 142 137 100.0 % 1.16 [ 0.36, 3.69 ]
Total events: 6 (Method A), 5 (Method B)
Heterogeneity: Chi2 = 1.13, df = 1 (P = 0.29); I2 =11%
Test for overall effect: Z = 0.25 (P = 0.81)
Test for subgroup differences: Not applicable
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Analysis 5.7. Comparison 5 One type of tape material versus another, Outcome 7 Major vascular or visceral
injury.
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 5 One type of tape material versus another
Outcome: 7 Major vascular or visceral injury
Study or subgroup Method A Method B Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Monofilament vs multifilament
Okulu 2013 0/48 0/48 Not estimable
Subtotal (95% CI) 48 48 Not estimable
Total events: 0 (Method A), 0 (Method B)
Heterogeneity: not applicable
Test for overall effect: not applicable
2 Monofilament vs combined monofilament and biological
Okulu 2013 0/48 0/48 Not estimable
Subtotal (95% CI) 48 48 Not estimable
Total events: 0 (Method A), 0 (Method B)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Combined monofilament and biological vs multifilament
Okulu 2013 0/48 0/48 Not estimable
Subtotal (95% CI) 48 48 Not estimable
Total events: 0 (Method A), 0 (Method B)
Heterogeneity: not applicable
Test for overall effect: not applicable
Test for subgroup differences: Chi2 = 0.0, df = -1 (P = 0.0), I2 =0.0%
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Analysis 5.8. Comparison 5 One type of tape material versus another, Outcome 8 Bladder or urethral
perforation.
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 5 One type of tape material versus another
Outcome: 8 Bladder or urethral perforation
Study or subgroup Method A Method B Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Monofilament vs multifilament
Lim 2005 8/122 2/60 27.5 % 1.97 [ 0.43, 8.98 ]
Meschia 2006 3/92 3/87 31.6 % 0.95 [ 0.20, 4.56 ]
Okulu 2013 0/48 0/48 Not estimable
Rechberger 2003 3/50 4/50 41.0 % 0.75 [ 0.18, 3.18 ]
Subtotal (95% CI) 312 245 100.0 % 1.15 [ 0.49, 2.70 ]
Total events: 14 (Method A), 9 (Method B)
Heterogeneity: Chi2 = 0.87, df = 2 (P = 0.65); I2 =0.0%
Test for overall effect: Z = 0.31 (P = 0.75)
2 Monofilament vs combined monofilament and biological
Okulu 2013 0/48 0/48 Not estimable
Subtotal (95% CI) 48 48 Not estimable
Total events: 0 (Method A), 0 (Method B)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Combined monofilament and biological vs multifilament
Okulu 2013 0/48 0/48 Not estimable
Subtotal (95% CI) 48 48 Not estimable
Total events: 0 (Method A), 0 (Method B)
Heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 408 341 100.0 % 1.15 [ 0.49, 2.70 ]
Total events: 14 (Method A), 9 (Method B)
Heterogeneity: Chi2 = 0.87, df = 2 (P = 0.65); I2 =0.0%
Test for overall effect: Z = 0.31 (P = 0.75)
Test for subgroup differences: Not applicable
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Analysis 5.9. Comparison 5 One type of tape material versus another, Outcome 9 Voiding dysfunction.
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 5 One type of tape material versus another
Outcome: 9 Voiding dysfunction
Study or subgroup Method A Method B Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Monofilament vs multifilament
Lim 2005 4/122 2/60 30.5 % 0.98 [ 0.19, 5.22 ]
Meschia 2006 5/92 4/87 46.8 % 1.18 [ 0.33, 4.26 ]
Rechberger 2003 11/50 2/50 22.7 % 5.50 [ 1.28, 23.56 ]
Subtotal (95% CI) 264 197 100.0 % 2.10 [ 0.96, 4.59 ]
Total events: 20 (Method A), 8 (Method B)
Heterogeneity: Chi2 = 3.25, df = 2 (P = 0.20); I2 =38%
Test for overall effect: Z = 1.87 (P = 0.062)
Test for subgroup differences: Not applicable
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Analysis 5.10. Comparison 5 One type of tape material versus another, Outcome 10 De novo urgency or
urgency incontinence.
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 5 One type of tape material versus another
Outcome: 10 De novo urgency or urgency incontinence
Study or subgroup Method A Method B Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Monofilament vs multifilament
Lim 2005 17/116 6/54 29.8 % 1.32 [ 0.55, 3.16 ]
Meschia 2006 8/92 10/87 37.4 % 0.76 [ 0.31, 1.83 ]
Okulu 2013 4/48 5/48 18.2 % 0.80 [ 0.23, 2.80 ]
Rechberger 2003 8/50 4/50 14.6 % 2.00 [ 0.64, 6.22 ]
Subtotal (95% CI) 306 239 100.0 % 1.11 [ 0.68, 1.82 ]
Total events: 37 (Method A), 25 (Method B)
Heterogeneity: Chi2 = 2.17, df = 3 (P = 0.54); I2 =0.0%
Test for overall effect: Z = 0.43 (P = 0.67)
2 Monofilament vs combined monofilament and biological
Okulu 2013 4/48 2/48 100.0 % 2.00 [ 0.38, 10.41 ]
Subtotal (95% CI) 48 48 100.0 % 2.00 [ 0.38, 10.41 ]
Total events: 4 (Method A), 2 (Method B)
Heterogeneity: not applicable
Test for overall effect: Z = 0.82 (P = 0.41)
3 Combined monofilament and biological vs multifilament
Okulu 2013 2/48 5/48 100.0 % 0.40 [ 0.08, 1.96 ]
Subtotal (95% CI) 48 48 100.0 % 0.40 [ 0.08, 1.96 ]
Total events: 2 (Method A), 5 (Method B)
Heterogeneity: not applicable
Test for overall effect: Z = 1.13 (P = 0.26)
Test for subgroup differences: Chi2 = 2.05, df = 2 (P = 0.36), I2 =2%
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Analysis 5.11. Comparison 5 One type of tape material versus another, Outcome 11 Detrusor overactivity.
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 5 One type of tape material versus another
Outcome: 11 Detrusor overactivity
Study or subgroup Method A Method B Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Monofilament vs multifilament
Lim 2005 3/116 2/54 0.70 [ 0.12, 4.06 ]
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Analysis 5.12. Comparison 5 One type of tape material versus another, Outcome 12 Vaginal tape erosion.
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 5 One type of tape material versus another
Outcome: 12 Vaginal tape erosion
Study or subgroup Method A Method B Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Monofilament vs multifilament
Lim 2005 10/116 1/54 34.2 % 4.66 [ 0.61, 35.45 ]
Meschia 2006 0/92 8/87 26.6 % 0.06 [ 0.00, 0.95 ]
Okulu 2013 3/48 3/48 39.2 % 1.00 [ 0.21, 4.71 ]
Subtotal (95% CI) 256 189 100.0 % 0.79 [ 0.09, 6.84 ]
Total events: 13 (Method A), 12 (Method B)
Heterogeneity: Tau2 = 2.49; Chi2 = 6.46, df = 2 (P = 0.04); I2 =69%
Test for overall effect: Z = 0.22 (P = 0.83)
2 Monofilament vs combined monofilament and biological
Okulu 2013 3/48 1/48 100.0 % 3.00 [ 0.32, 27.83 ]
Subtotal (95% CI) 48 48 100.0 % 3.00 [ 0.32, 27.83 ]
Total events: 3 (Method A), 1 (Method B)
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(. . . Continued)
Study or subgroup Method A Method B Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Heterogeneity: not applicable
Test for overall effect: Z = 0.97 (P = 0.33)
3 Combined monofilament and biological vs multifilament
Okulu 2013 1/48 3/48 100.0 % 0.33 [ 0.04, 3.09 ]
Subtotal (95% CI) 48 48 100.0 % 0.33 [ 0.04, 3.09 ]
Total events: 1 (Method A), 3 (Method B)
Heterogeneity: not applicable
Test for overall effect: Z = 0.97 (P = 0.33)
Test for subgroup differences: Chi2 = 1.90, df = 2 (P = 0.39), I2 =0.0%
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Analysis 5.13. Comparison 5 One type of tape material versus another, Outcome 13 QoL specific (ICIQ).
Review: Mid-urethral sling operations for stress urinary incontinence in women
Comparison: 5 One type of tape material versus another
Outcome: 13 QoL specific (ICIQ)
Study or subgroup Method A Method B
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Monofilament vs multifilament
Okulu 2013 48 1.5 (0.3) 48 2.1 (0.5) 100.0 % -0.60 [ -0.76, -0.44 ]
Subtotal (95% CI) 48 48 100.0 % -0.60 [ -0.76, -0.44 ]
Heterogeneity: not applicable
Test for overall effect: Z = 7.13 (P < 0.00001)
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A D D I T I O N A L T A B L E S
Table 1. Tabulated Results of Included Studies
Study Outcome data
Abdel-Fattah 2010 Group A: TVT-O (n = 170)
Group B: TOT (n = 171)
Loss to follow up at 1yr: A: 18/170, B: 24/171
Loss to follow up at 3yrs: A: 44/170, B: 59/171
Objective cure: A: 114/121, B: 96/109
Subjective success: A: 121/149, B: 111/143
Bladder/urethral perforation: A: 1/170, B: 2/171
Voiding dysfunction: A: 12/170, B: 9/171
Tape erosion: A: 3/153, B: 5/149
Groin pain: A: 27/150, B: 19/147
Repeat continence surgery: A: 7/170, B: 15/171
QoL assessed via: King’s Health Questionnaire (KHQ) [10], Birmingham Bowel Urinary Symptom
(BBUSQ-22) [11] and Pelvic Organ Prolapse/Incontinence Sexual Function Questionnaire (PISQ-12).
In addition Patient Global Impression of Improvement (PGI-I) [13] and International Consultation on
Incontinence Questionnaire- Short form (ICIQ-SF) [14] questionnaires. QOL scores were much improve
following surgery with no significant inter group (A vs B) differences
Sexual dysfunction: PISQ-12 employed. 199 patients completed this assessment and in most domains
a significant improvement in postoperative PISQ-12 scores was found with no significant difference
demonstrated between the two groups
Intermediate (3 yr) Subjective success (very much & much improved) on PGI-I: A: 93/126, B: 81/112
Aigmuller 2014 Group A: TVT: (n = 285; 38 of whom were lost to follow-up)
Group B: TVT-O: (n = 269; 36 of whom were lost to follow-up)
Participants were evaluated at 3 months, with a further evaluation scheduled at 5 years
• Objective cure of SUI: defined as a negative cough stress test and stable cystometry to 300 ml
• Subjective cure defined on PGI as ’very much better’ and ’better’
• Objective cure: A: 215/247, B: 196/233
• Subjective cure A: 123/139, B: 107/122
• Subjective cure and improvement: A: 136/139, B: 116/122
• Operating time (minutes; SD): A: 21±12.22, B: 16.8±8.8
• Bladder perforation: A: 11/285, B:0/269
• Vascular injury: A: 2/285, B: 3/269
• Voiding dysfunction: A: 4/285, B: 1/269
• Major visceral injury: A: 1/285, B: 0/269
• Infection: A: 1/285, B: 0/269
• De novo OAB: A: 26/247, B: 24/233
At 5-year review:
• A negative cough stress test was seen in 83% of patients after TVT and 76% of patients after TVT-
O.
• No pad use was reported by 56% of patients after TVT and 58% of patients after TVT-O. None of
these differences reached statistical significance.
• One tape exposure was noted after TVT and 3 after TVT-O.
• There were 9 (6%) re-operation after TVT and 5 (3%) after TVT-
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Table 1. Tabulated Results of Included Studies (Continued)
Alkady 2009 Group A: TVT (n = 15)
Group B: TVT-O (n = 15)
• Objective cure: absence of SUI and a negative stress test
• Objective improvement: lower volume and frequency of SUI, but positive stress test
• Objective cure: A 13/15, B: 13/15
• Objective cure & improvement: A 14/15, B: 15/15
• Mean blood loss (ml)s (SD): A: 26(10.23), B: 22(7.15)
• Mean hospital stay (days)s (SD): A: 1.1(1.0), B: 1.2(0.9)
• Bladder perforation: A: 1/15, B: 0/15
• Major vascular injury: A: 1/15, B: 0/15
• Voiding dysfunction: A: 2/15, B: 1/15
• Tape erosion: A: 1/15, B: 0/15
Andonian 2005 Group A: SPARC
Group B: TVT
• Objective Cure: A: 34/41, B: 40/42
• Perioperative complications: A: 3/41, B: 0/40
• Bladder perforation: A: 10/41, B: 10/43
• Voiding dysfunction: A: 2/41, B: 4/43
• Tape erosion: A: 1/41, B: 0/41
Andonian 2007 Group A: Obtape (n = 78)
Group B: DUPS (n = 32) - suspended
Group C: TVT (n = 80)
• Objective cure short term: A: 64/77, B: 69/80
• Perioperative complications: A: 11/77, B: 6/80
• Bladder perforation: A: 0/77, B: 11/80
• De novo urgency or urgency incontinence: A: 6/77, B: 5/80
• Tape erosion: A: 2/77, B: 0/80
• Repeat incontinence surgery: A: 2.77, B:0/80
Aniuliene 2009 Group A: TVT-O (n = 150)
Group B: TVT (n = 114)
• Objective cure: negative stress provocation test with 300 ml of urine in the bladder: A: 142/150, B:
108/114
• Subjective cure: self-reported absence of SUI with or without mild urgency incontinence. A: 145/
150, B: 111/114
• Mean duration of procedure (SD): A: 19 (5.6), B: 27 (7.1)
• Mean hospital stay days (SD) A: 1.5 (0.5), B: 4.0 (1.6)
• Bladder perforation: A: 0/150, B: 1/114
• Post operative urinary retention: A: 5/150, B: 18/114
• Haematoma: A: 0/150, B: 1/114
Araco 2008 Group A: TVT-O (n = 120)
Group B: TVT (n = 120)
• Objective cure short term: A: 83/100, B: 108/108
• Operative time in minutes (standard deviation): A: 34 (11), B: 48 (7)
• Perioperative complications: A: 6/120, B: 21/120
• Major vascular injury: A: 0/120, B: 6/120
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• Bladder perforation: A: 0/120, B: 3/120
• Voiding dysfunction: A: 0/100, B: 12/108
• de novo urgency/UUI: A: 6/100, B: 8/108
• Detrusor overactivity: A: 3/100, B: 2/108
• Vaginal tape erosion: A: 3/100, B: 1/108
• Repeat incontinence surgery medium term (1-5 years): A: 17/100 B: 1/108
Barber 2008 Group A: TVT (n = 88)
Group B: TOT (n = 82)
• subjective cure (self-reported): A: 74/85, B: 68/75
• objective cure (negative cough stress test): A: 73/85, B: 62/75
• mean operating time (minutes; no concomitant surgery): A: 29(10), B: 28(7)
• bladder perforation: A: 7/88, B: 0/82
• major vascular injury: A: 1/88, B: 0/82
• vaginal tape erosion: A: 5/85, B: 1/75
• de novo urgency/UUI: A: 27/85, B: 21/75
• voiding dysfunction: A: 5/88, B: 2/82
• re-operation: A: 4/85, B: 1/75
• QoL: overall improvement in QoL and sexual function scores at follow-up assessments compared
with preoperative baseline scores. No difference between the groups.Used PFDI-20, PFIQ-7, PISQ-12
• sexual dysfunction assessed using PISQ-12. Scores improved post operatively and at 12 months
follow up in both groups, though the relative change in scores post-operatively was small (1.9%)
showing moderate responsiveness to incontinence specific outcome measures. There was no significant
difference reported between the two groups.
Barry 2008 Group A: TOT (n = 58)
Group B: TVT (n = 82)
• Subjective cure: A: 49/58, B: 70/82
• Objective cure: A: 48/58, B: 64/82
• Operating time: A: 14.6 (6), B: 58 (18.5)
• Operative blood loss in mls A: 49 (31.2), B: 64 (41.4)
• Peri-operative complications: A: 0/58, B: 2/82
• Bladder perforation: A: 1/58, B: 7/82
• Voiding dysfunction: A: 6/58, B: 7/82
• de novo urgency/UUI: A: 0/58, B: 1/82
• Vaginal tape erosionL A: 3/58, B: 1/82
But 2008 Group A: TVT-O (n = 60)
Group B: TOT (n = 60)
• Objective cure rates: negative pad test. A: 54/60, B 58/60
• Subjective cure rates: absence of reported SUI: A: 59/60, B 59/60
• Post operative voiding difficulties: A: 8/60, B: 3/60
• Tape erosion: A: 0/60, B: 0/60
• Duration of operation:
• Duration and intensity of postoperative pain according to a modified VAS
• QoL (UDI) significantly improved post operatively in each group with no significant intergroup
difference.
Cervigni 2006 Numbers in each group unreported. It was, thus, impossible to abstract results
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Chen 2010 Group A: TVT (n = 77)
Group B: TOT (n = 45)
Group C: TVT-O (n = 65)
• Objective cure: negative stress test: A: 70/77, B: 41/45, C: 60/65
• Mean operative time in minutes (SD): A: 48.2 (21.9), B: 20 (13.5), C: 26.9 (16.8)
• Mean postoperative hospital stay days (SD): A: 5.0 (2.4), B: 4.0 (2.2), C: 2.3 (0.8)
• Bladder perforation: A: 4/77, B: 0/45, C: 0/65
• Vascular injury: A: 1/77, B: 0/45, C: 0/65
• Voiding dysfunction: A: 7/77, B: 2/45, C: 3/65
Chen 2012 A: TVT (n = 102)
B: TVT-O (n = 103)
• Objective cure: negative pad test and stress test
• Objective cure: A: 89/102, B: 85/103
• Cure and improvement: A: 99/102, B: 96/103
• Operative time (mean minutes (SD)): A: 27.3 (13.3) 102, B: 18.5 (7.4)
• Blood loss (ml): A: 18 (15.4), B: 18.5 (7.4)
• Length of stay (days): A: 3.4 (2.1), B: 3.1 (1.8)
• Bladder injury: A: 5/102, B: 0/103
• Voiding dysfunction: A: 2/102, B: 2/103
• Groin pain: A: 0/102, B: 3/103
Cho 2010 Group A: Monarc TOT (n = 48)
Group B: TOT (n = 45)
• Subjective cure: A: 41/48, B: 37/45
• Voiding dysfunction: A: 1/48, B: 2/45
• Tape erosion: A: 0/48, B: 3/45
Choe 2013 We were not able to use the data provided, as the number in each group was not specified
Darabi Mahboub 2012 Group A: TOT (n = 40)
Group B: TVT (n = 40)
Operative time (minutes (SD): A: 64.50 (9.04), B: 64.00 (9.48)
Mean hospital stay (days): A: 2.56 (0.51), B: 2.52 (0.47)
David-Montefiore 2006 Group A: RPR (n = 42)
Group B: TOR (n = 46)
• 4 year objective cure A: 27/34, B: 32/37. There is a significant reduction in cure at 4 years in
comparison to 1 year.
• De novo urgency and urge incontinence: A: 7/34, B: 10/37
de Leval 2011 Group A: TVT-O (n = 87)
Group B: modified TVT-O (n = 88)
• subjective cure: disappearance of SUI using symptom scoring system: A: 77/84, B: 78/86.
• subjective cure and improvement: A: 80/84, B: 84/86
• Intraoperative complications: A: 0/87, B: 0/88
• de novo urgency: A: 8/84 B: 10/86
• mesh erosion: A: 1/84, B: 0/86
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• groin pain: A: 3/84, B: 4/86
At 3-year follow-up:
• objective cure: negative cough test A: 48/56, B: 50/57
• subjective cure: A: 63/74, B: 66/79
de Tayrac 2004 Group: A: TOT (n = 30)
Group: B: TVT (n = 31)
• Subjective cure: A: 26/30, B: 30/31
• Objective cure (negative cough stress test): A: 27/30, B: 26/31
• Objective cure and improvement: A: 28/30, B: 29/31
• Mean operating time (minutes): A: 14.8(4.3), B: 26.5(7.7)
• Mean length of hospital stay (days): A: 1.2(1.3), B: 1.1(0.4)
• Bladder perforation: A: 0/30, B: 3/31
• Vaginal tape erosion: A: 0/30, B: 0/31
• Urethral tape erosion: A: 0/30, B: 1/31
• De novo urgency/UUI: A: 2/30, B: 2/31
• Voiding dysfunction: A: 8/30, B: 10/31
• Sexual dysfunction measured using mean VAS score. No significant difference between the 2 groups
in terms of improvement of sexual function: A: Pre-operatively 8.73 (2.18), post operatively: 9.86 (0.54),
B: Pre-operatively 8.12 (2.93), post operatively: 8.25 (4.12)
Deffieux 2010 Group A: TVT (n = 75)
Group B: TVT-O (n = 74)
• Subjective cure (self-reported via questionnaires) short term: A: 63/69 , B: 61/69
• Subjective cure at 24 months: A: 55/67, B: 56/65
• Objective cure (negative cough stress test) short term: A: 65/69 , B: 67/69
• Objective cure at 24 months: A: 61/67, B: 65/65
• Bladder injury: A: 5/75, B: 2/74
• Major vascular injury: A: 0/75, B: 0/74
• Tape erosion: A: 0/67, B: 1/65
• Voiding dysfunction: A: 6/67, B: 2/65
• Groin/suprapubic pain: A: 2/67, B: 1/65
• Re-operation rates: A: 2/67, B: 1/65
Diab 2012 Group A: TOT (n = 31)
Group B: TVT (n = 32)
• Retropubic haematoma: A: 0/31, B: 2/32.
• Vaginal tape extrusion: A: 2/31, B: 2/32
All the preoperative parameters were comparable in both groups. Themean operative time was significantly
longer and bladder injury was significantly higher in the TVT group
There were no significant difference in cure rates, voiding dysfunction, de novo urgency and reoperation
rate. The postoperative groin/thigh pain was higher in the TOT group
El-Hefnway 2010 Preliminary results:
Group A: TVT: (n = 19)
Group B: TOT: (n = 21)
At 24 months:
Group A: TVT: (n = 45)
Group B: TOT: (n = 42)
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• Objective cure: negative stress test, 1-h pad test < 2g, and no re-treatment for stress incontinence
• 12 months negative stress test: A: 18/19, B: 18/21
• 24 months negative stress test: A: 31/36, B: 28/35
• 24 months negative 1hr pad test: A:29/36, B: 26/35
• Subjective cure: no reported SUI
• Mean operative time in minutes (SD): A: 23.8(5), B: 19.6(5)
• Mean blood loss (ml): A: 52(14), B: 40(13)
• Vascular injury: A 3/36, B: 0/35
• Bladder injury: A: 3/45, B: 0/42
• Groin pain: A: 0/36, B: 2/35 (no report of suprapubic pain)
• Tape erosion: A: 0/19, B: 1/21
• De novo urgency: A: 0/36 , B 3/35
• QOL: Pre-operative UDI-6 mean scores (SD): A: 13 (3), B: 15(3)
• Pre-operative IIQ-7 mean scores (SD): A: 17 (3), B: 17 (4)
• UDI-6 at 12- and 24-month follow-up (SD): A: 2.8 (3), B: 4.7 (6)
• IQ-7 at 12- and 24-month follow-up (SD): A: 3.2 (5), B: 4.3 (7)
• 24 month follow up UDI-6 (SD): A: 3.5 (4), B: 4.6 (4)
• 24 month follow up IIQ-7: A: 3.6 (6), B: 3.0 (4)
Elbadry 2014 Group A: adjustable TOT (n = 48)
Group B: TOT: (n = 48)
• cure rates: A: 40/48, B: 38/48.
• Mean operative time in group 2 was significantly shorter than that in group A (11 minutes versus
20 minutes, respectively).
• Major vascular injury: A: 0/48, B: 0/48
• bladder injury: A: 0/48, B: 0/48
• Postoperative adjustment of the tape was only required in 3 cases in group
• Length of hospital stay: No statistically significant difference was found between the 2 group
Enzelsberger 2005 Group A: TOT (n = 56)
Group B: TVT (n = 54)
• Objective cure rate: A: 45/53, B: 45/52
• Operative complications: A: 6/53, B: 10/52
• Operative time in minutes (standard deviation): A: 15 (7), B: 26 (10)
• Bladder perforation: A: 0/53, B: 4/52
• Voiding dysfunction: A: 3/53, B: 4/52
• Detrusor overactivity: A: 6/53, B: 5/52
• Tape erosion: A: 1/53, B: 1/52
• Groin pain: A: 5/53, B: 0/52
Freeman 2011 Group A: Monarc TOT (n = 100)
Group B: Gynaecare TVT (n = 92)
• Subjective cure: A: 59/95, B: 55/85
• Mean operation time (minutes), SD): A: 28 (15), B: 30 (14.2)
• Operative blood loss (ml) SD: A: 49 (46), B: 62 (65)
• Bladder perforation: A: 0/100, B:2/92
• Vaginal perforation: A: 4/100, B: 0/92
• Tape erosion: A: 3/95, B: 2/85
• Voiding dysfunction: A: 5/100, B: 5/95
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• De novo OAB: A: 4/95, B: 4/85
• Groin pain: A: 8/95 , B: 1/85
• Sexual function: assessed via ICIQ-LUTSqol scores. QoL were improved by both operations from
baseline scores without a significant difference between the groups at 12 months follow up. Percentage of
women reporting moderate or severe impact of incontinence on sexual function reduced post-operatively
by 27.9% in the TVT group and by 30.7% in the TOT group.
Hammoud 2011 Group A: TVT (n = 60)
Group B: TVT-O (n = 50)
Subjective cure: A: 56/60, B: 48/50
Hassan 2013 Group A: inside-out TOT (n = 125)
Group B: outside-in TOT (n = 125)
• subjective cure at 12 months: A: 102/102, B: 95/97
• vascular injury/haematoma: A: 5/125, B: 7/125
• groin/thigh pain: A: 91/125, B: 84/125
• tape erosion: A: 1/102, B: 0/97
Houwert 2009 Group A: TVT-O (n = 93)
Group B: Monarc TOT (n = 98)
• Subjective cure at 12 months (short term): A: 66/86, B: 73/95
• Subjective cure and improvement at 12 months (short term): A: 79/86, B: 89/95
• Subjective cure at 2-4years (medium term): A: 54/75, B: 56/86
• Subjective cure and improvement at 2-4years (medium term): A: 63/75, B: 74/86
• Operating time (minutes) (SD): A: 16 (5), B: 16 (6)
• Voiding dysfunction at 2 months: A: 10/93, B: 3/98
• Vaginal tape erosion at 12 months: A: 1/86, B: 4/95
• Thigh pain: A: 0/86, B: 1/95
• De novo urgency/UI: A: 2/71, B: 4/72
• Repeat incontinence surgery: A: 5/93, B: 4/98
• QOL: both the IIQ-7 and UDI-6 demonstrated a statistically significant increase in QoL decrease
in impairment caused by symptoms of SUI after 2 months, 1 year, and 2-4 years in both TOT groups.
• Sexual dysfunction: Rates of post operative dyspareunia were low with only 1 patient in each group
reporting the complication at 12 months, and by 24 months this had resolved in the TOT group.
Jakimiuk 2012 Group A: TVT (n = 19)
Group B: TVT-O (n = 16)
• Subjective cure: self-reported: A: 14/15, B: 13/16
• Objective cure: negative cough test and pad test: A: 14/15, B: 14/16
• Bladder perforation: A: 3/19, B: 0/16
• Voiding dysfunction: A: 2/19, B: 0/16
• Vascular injury: A: 2/19, B: 0/16
• Mean procedure time (minutes) (SD): A: 47.75 (42.89), B: 12.4 (3.52)
• Mean hospital stay (days) (SD): A: 2.41 (1.37), B: 2.0 (0)
• QoL: used non-validated KHQ and validated SF-36 questionnaires the result showed post
operative improvement from baseline scores in all domains with no significant differences demonstrated
between groups.
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Juang 2007 Group A: TVT-O (n = 47)
Group B: TVT-O plus IS: (n = 49)
• Objective cure: A:22/45, B:34/48
• Objective improvement: A:5/45, B:5/48
• Blood loss (mls) (SD): A: 30.3 (15.2), B: 82.4 (25.1)
• Operating time (minutes) (SD): A: 16.3 (4.1), B: 28.3 (10.2)
• Mean hospital stay (days) (SD): A: 1.7 (0.8), B: 3.2 (2.8)
• Bladder perforation: A: 0/47, B: 0/49
• Major vascular injury: A: 1/47, B: 3/49
• Tape erosion: A: 1/45, B: 1/48
• Complications: One subject in the TVT-O plus IS group, who presented with temporary adductor
muscle weakness and a numbness sensation in the medial aspect of right thigh, was noted to have
obturator nerve injury, which resolved at 3-months follow-up after conservative treatment, with
resolution of symptoms. At the 1-yr follow-up, about 25% of subjects in the TVT-O plus IS group still
needed antimuscarinics,whereas about 45% of subjects in the TVT-O alone group still needed some
antimuscarinic medication
Kamel 2009 A: TVT (n = 60)
B: TVT-O (n = 60)
• Objective cure: A: 54/60, B: 55/60
• Bladder perforation: A: 5/60, B: 0/60
• Vascular injury: A: 2/60, B: 0/60
• Mean operative time (minutes): A: 30 mins, B: 15 mins
Karateke 2009 Group A: TVT (n = 83)
Group B: TVT-O (n = 84)
• Subjective cure (very satisfied and satisfied): A: 76/81, B: 76/83
• Obective cure: A: 72/81, B: 73/83
• Mean operative time (minutes) (SD): A: 31.27 (4.73), B: 18.64 (2.47)
• Vascular injury/haematoma: A: 4/83, B: 2/84
• Bladder perforation: A: 3/83, B: 0/84
• Tape erosion: A: 4/81, B: 2/83
• Voiding dysfunction: A: 8/83, B: 6/84
• De novo UI: A: 6/81, B: 5/83
• De novo DO: A: 12/81, B: 10/83
• Mean hospital stay (days) (SD): A: 1.36 (0.76) B: 1.25 (0.66)
• Time to return to normal activity (weeks): A: 2.7 (2.4), B: 2.43 (2.02)
• QOL: Mean IIQ-7 scores; mean (SD): TVT A: Preop 13.83 (3.88), Postop 6.94 (3.40), TVT-O B:
Preop 13.83 (3.88), Postop 6.88 (3.38)
Kilic 2007 Group A: TVT (n = 10)
Group B: TOT (n = 10)
• Subjective cure: A: 7/10, B: 8/10
• Mean operative time in mins (standard deviation): A: 32 (5.3), B: 26 (9.5)
Kim 2004 Group A: TVT (n = 32)
Group B: SPARC (n = 30)
Group C: IRIS (n = 34).
• Subjective cure: A: 31/32, B: 29/30
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• Objective cure: A: 31/32, B: 29/30
• Operating time in mins (standard deviation): A: 27.5 (2.7), B: 28.1 (7.5)
• Length of hospital stay (days): A: 2.5 (0.9), B: 2.3 (0.6)
• Perioperative complications: A: 6/32, B: 7/30
• Bladder perforation: A: 3/32, B: 3/30
• Voiding dysfunction: A: 0/32, B: 3/30
• De no urgency/urgency urinary incontinence: A: 3/32, B: 1/30
• Vaginal tape erosions: A: 0/32, B: 0/30
Kim 2005 Group A: Monarc (n = 65)
Group B: SPARC (n = 65)
• Subjective cure: A: 56/65, B: 56/65
• Subjective cure and improvement: A: 62/65, B: 63/65
• Objective cure: A: 17/21, B: 18/22
• Objective cure and improvement: A: 21/21, B: 22/22
• Operative time in mins (standard deviation): A: 26.8 (11.8), B: 31.6 (9.6)
• Perioperative complications: A: 1/21, B: 2/22
• Bladder perforation: A: 0/65, B: 4/65
• Voiding dysfunction: A: 4/65, B: 5/65
• De no urgency/urgency urinary incontinence: A: 1/21, B: 1/22
• Vaginal tape erosion: A: 0/65, B: 0/65
• Bladder erosion: A: 0/65, B: 0/65
Krofta 2010 Group A: TVTTM (n = 149)
Group B: TVT -OTM (n = 151)
• Objective cure: A: 127/141, B: 130/147
• Subjective cure: A: 111/141, B: 12/147
• Subjective improvement: A: 27/141, B: 31/147
• De novo urge: A: 9/141, B: 20/147
• Duration of operation (minutes) (SD): A: 32.62 (9.3) B: 23.76 (12.01)
• Mean blood loss (SD): A: 31.57 (31.92), TVT-O: 32.26 (34.80)
• Haematoma: A: 1/149, B: 0/151
• Groin/suprapubic pain: A: 6/141, B: 8/147
• Tape erosion/extrusion: A: 2/141, B: 2/147
• QOL: ICIQ UI- SF and CONTILIFE questionnaires were used pre- postoperatively both showing
significant improvement in mean QoL scores following surgery with no significant difference between
the two comparators.
• Sexual dysfunction: assessed using PISQ-12 which showed a significant improvement post
operatively from baseline scores but not significant difference between the groups.
Laurikainen 2007 Group A: TVT-O (n = 131)
Group B: TVT (n = 136)
• Objective cure short term: A: 122/131, B: 128/134
• Objective cure medium term: A: 113/126, B: 124/131
• Objective cure long term: A: 106/122, B: 111/131
• Subjective cure short term: A: 122/131, B: 121/134
• Subjective cure medium term: A: 115/126, B: 118/131
• Subjective cure long term: A: 113/122, B: 115/131
• Subjective cure and improvement long term: A: 121/122, B: 128/131
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• Perioperative complications: A: 32/131, B: 22/136
• Mean operating time (minutes) (standard deviation): A: 29 (8), B: 29 (16)
• Length of hospital stay (days) (standard deviation): A: 0.71 (0.58), B: 0.58 (0.42)
• Time to return to normal activity (weeks) (standard deviation): A: 1.71 (0.57), B: 1.71 (0.57)
• Operative blood loss (mls) (standard deviation): A: 46 (57), B: 55 (86)
• Major vascular injury: A: 0/131, B: 4/136
• Bladder perforation: A: 0/131, B: 1/136
• De novo urgency/urgency urinary incontinence: A: 4/131, B: 6/134
• De novo urgency/urgency urinary incontinence long term: A: 3/122, B: 4/131
• Voiding dysfunction: A: 2/131, B: 1/136
• Repeat incontinence surgery: A: 1/131, B: 2/134
• Repeat incontinence surgery long term: A: 3/122, B: 2/131
• Vaginal tape erosion: A: 1/131, B: 2/134
• Groin pain at 2 months: A: 21/131, B: 2/136
• Groin pain at 12 months: A: 0/131, B: 0/131
• Tape erosion: A: 1/131, B: 0/136
• Tape erosion long term: A: 0/122, B: 0/131
QoL: The scores of the condition specific quality of life questionnaires were significantly lower at the 3
and 5 year follow up compared with pre-operative scores. This improvements were statistically significant,
but with no difference between the groups
84% of women with pre-operative moderate and severe frequency and urgency symptoms were cured of
these symptoms at the 5 year follow up
Leanza 2009 Group A: r-TICT (n = 229; retropubic)
Group B: t-TICT (n = 220; transobturator)
Subjective cure: A: 190/215, B: 178/208
Lee 2007 Group A: TVT (n = 60)
Group B: TVT-O (n = 60)
• Subjective cure: A: 52/60, B: 52/60
• Subjective cure and improvement: A: 56/60, B: 57/60
• Duration of operation mins (standard deviation): A: 15.2 (1.8), B: 11.5 (1.4)
• Intraoperative blood loss mls (standard deviation): A: 40 (23.8), B: 31.1 (28.6)
• Postoperative pain: A:
• Major vascular injury: A: 0/60, B: 0/60
• Time to return to normal activities in weeks (SD): A: 5.2 (3.3), B: 4.9 (3.3)
• Bladder perforation: A: 2/60, B: 0/60
• Voiding dysfunction: A: 0/60, B: 0/60
• De novo urgency/urgency urinary incontinence: A: 0/60, B: 4/60
• Vaginal tape erosion: A: 0/60, B: 0/60
• Groin pain: A: 5/60, B: 8/60
• Suprapubic pain: A: 5/60, B: 0/60
Lee 2008 Group A: TVT-O (n = 50)
Group B: TOT (n = 50)
• Subjective cure short term: A: 43/50, B: 46/50
• Objective cure and improvement: A: 48/50, B: 48/50
• Operative time minutes (SD): A: 11.2 (2.6), B: 11.5 (1.9)
• Operative blood loss mls (SD): A: 33.1 (19.2), B: 32.9 (23.1)
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• Time to return to normal activity in weeks (SD): A: 5.1 (3), B: 5.7 (3.1)
• Perioperative complications: A: 0/50, B: 0/50
• Voiding dysfunction: A: 0/50, B: 0/50
• De novo urgency/urgency urinary incontinence: A: 2/50, B: 1/50
• Vaginal tape erosion: A: 0/50, B: 0/50
• Groin pain: A: 7/50, B: 9/50
Liapis 2006 Group A: TVT (n = 46)
Group B: TVT-O (n = 43)
• Subjective cure short term: A: 34/46, B: 33/42
• Objective cure: A: 41/46, B: 39/43
• Objective cure and improvement: A: 44/46, B: 42/43
• Operative time in mins (SD): A: 26.7 (8.6), B: 17.4 (6.9)
• Length of hospital stay days (SD): A: 1.26 (1.34), B: 1.04 (0.21)
• Perioperative complications: A: 11/46, B: 2/43
• Major vascular injury: A: 3/46, B: 1/43
• Bladder perforation: A: 3/46, B: 0/43
• De novo urgency/urgency urinary incontinence: A: 5/46, B: 6/43
• Detrusor activity: A: 4/46, B: 4/43
• Vaginal tape erosion: A: 1/46, B: 0/43
Liapis 2008 Group A: TVT-O (n = 61)
Group B: Monarc TOT (n = 53)
• Short term subjective cure: A: 49/61, B: 41/53
• Subjective cure and improvement: A: 57/61, B: 47/53
• Objective cure short term: A: 53/61, B: 48/53
• Objective cure and improvement: A: 58/61, B: 50/53
• Peri-operative complications: A: 3/61, B: 2/53
• Bladder perforation: A: 0/61, B: 1/53
• Voiding dysfunction: A: 3/61, B: 2/53
• De novo urgency/urgency urinary incontinence: A: 8/61, B: 6/53
• Detrusor activity: A: 5/61, B: 5/53
• Vaginal tape erosion: A: 0/61, B: 0/51
• Groin pain: A: 3/61, B: 1/53
Lim 2005 Group A: TVT (n = 61)
Group B: IVS (n = 60)
Group C: SPARC (n = 61)
• Subjective cure: A: 48/58, B: 50/56, C: 45/57
• Objective cure: A: 51/58, B: 44/54, C: 42/58
• Bladder perforation: A: 1/61, B: 2/60, C: 7/61
• Voiding dysfunction: A: 2/61, B: 2/60, C: 2/61
• De novo urgency/urgency urinary incontinence: A: 8/58, B: 6/54, C: 9/58
• Detrusor activity: A: 2/58, B: 2/54, C: 1/58
• Vaginal tape erosion: A: 2/58, B: 1/54, C: 8/58
Lord 2006 Group A: TVT (n = 147)
Group B: SPARC (n = 154)
• Subjective cure: A: 128/147, B: 117/153
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• Objective cure: A: 143/147, B: 148/152
• Perioperative complications: A: 6/147, B: 4/154
• Bladder perforation: A: 1/147, B: 3/154
• Voiding dysfunction: A: 0/147, B: 10/154
• De novo urgency/urgency urinary incontinence: A: 12/147, B: 17/154
• Vaginal tape erosion: A: 0/147, B: 1/154
Mansoor 2003 Group A: TVT-O (n = 48)
Group B: TVT (n = 54)
• Objective cure: A: 46/48, B: 50/54
• Bladder perforation: A: 0/48, B: 6/54
• Voiding dysfunction: A: 1/48, B: 5/54
• De novo urgency/urgency urinary incontinence: A: 2/48, B: 4/54
Mehdiyev 2010 A: TOT (n = 17)
B: TVT (n = 15)
• Subjective cure: A: 14/17, B: 13/15
• Bladder Injury: A: 0/17, B: 1/15
• Major vascular injury: A: 0/17, B: 1/15
• De novo urgency/urgency urinary incontinence: A: 1/17, B: 3/15
• The mean operation time of TOT group (13.5 min) was significantly shorter than TVT groups
(18.3 min).
Meschia 2006 Group A: TVT (n = 92)
Group B: IVS (n = 87)
• Subjective cure: A: 80/92, B: 68/87
• Objective cure: A: 79/92, B: 65/87
• Mean operating time mins (SD): A: 27 (6), B: 27 (4)
• Length of hospital stay days (SD): A: 2.5 (1), B: 2.3 (1)
• Perioperative complications: A: 3/92, B: 4/87
• Bladder perforation: A: 3/92, B: 3/87
• Voiding dysfunction: A: 5/92, B: 4/87
• De novo urgency/urgency urinary incontinence: A: 8/92, B: 10/87
• Vaginal tape erosion: A: 0/92, B: 8/87
Meschia 2007 Group A: TVT-O (n = 117)
Group B: TVT (n = 114)
• Subjective cure: A: 96/110, B: 99/108
• Objective cure: A: 98/110, B: 99/108
• Operative time mins (SD): A: 17 (7), B: 26 (9)
• Operative blood loss mls (SD): A: 27 (33), B: 31 (25)
• Length of hospital stay days (SD): A: 1.6 (0.8), B: 1.8 (1)
• Perioperative complications: A: 6/99, B: 7/107
• Bladder perforation: A: 0/117, B: 5/114
• Voiding dysfunction: A: 6/99, B: 11/107
• De novo urgency/urgency urinary incontinence: A: 4/99, B: 6/107
• Groin pain: A: 6/117, B: 0/114
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Naumann 2006 Group A: TVT (n = 123)
Group B: LIFT (n = 125)
• Subjective cure, 6 months: A: 90/123, B: 92/125
• Subjective cure, 12 months: A: 107/123, B: 109/125
• Subjective cure or improvement, 6 months: A: 118/123, B: 119/125
• Subjective cure or improvement, 12 months: A: 117/123, B: 122/125
• Bladder perforation: A: 2/123, B: 1/125
• Excess bleeding: A: 2/123, B: 0/125
• Need for division of tape: A: 4/123, B: 9/125
• Tape erosion into bladder or urethra: A: 1/123, B: 1/125
• Vaginal mesh erosion: A: 3/123, B: 7/125
Nerli 2009 Group A: TVT (n = 18)
Group B: TOT (n = 18)
• Objective cure: A: 16/18, B: 16/18
• Subjective cure: A: 16/18, B: 16/18
• Improved: A: 2/18, B: 2/18
• Mean operative time in minutes (SD): A 21.4 (2.75), B: 18.4 (1.85)
• Mean operative blood loss in ml (SD): A: 38.7 (5.09), B: 37.2 (4.53)
• Voiding dysfunction: A: 3/18, B: 2/18
• Bladder perforation: A:1/18, B: 0/18
• De novo urge incontinence: A: 2/18, B: 3/18
• Tape erosion: A: 0/18, B: 0/18
• Days to return to normal activity (SD): A: 4.8 (3.2), B: 5.1 (3.1)
Nyyssonen 2014 Group A: TOT (n = 50)
Group B: TVT (n = 50)
• Subjective cure at 14 and 46 months:
◦ At 14 months: A: 36/43, B: 40/43
◦ At 46 months: A: 38/46, B: 38/47
• Vaginal tape erosion: A: 2/43, B: 0/43
• Voiding dysfunction: A: 4/46, B: 7/47
• De novo UUI: A: 2/46, B: 5/47
Okulu 2013 Group A: Vypro mesh: (n = 48; multifilament)
Group B: Ultrapro mesh: (n = 48; monofilament + biological combined mesh)
Group C: Prolene light mesh: (n = 48; monofilament)
• cure:
◦ Subjective cure at 12 months: A: 41/46, B: 45/48, C: 41/47
◦ Subjective cure at 48 months: A: 39/46, B: 44/48, C: 40/47
• bladder perforation: A: 0/48, B: 0/48, C: 0/48
• major vascular visceral injury: A: 0/48, B: 0/48, C: 0/48
• de novo urgency/urgency incontinence: A: 5/46, B: 2/48, C: 4/47
• vaginal tape erosion: A: 3/46, B: 1/48, C: 3/47
• mean 24hr pad weight (g) (SD):
◦ Preop: A: 27.2 (9.1), B: 28.7 (9.3), C: 32.4 (0.2)
◦ Post op 12 months: A: 2.1 (1.4), B: 2.0 (1.1), C: 2.4 (3.8)
◦ Post op 48 months: A: 2.3 (1.1), B: 1.3 (0.8), C: 2.4 (1.1)
• Mean Total ICIQ-SF score (SD):
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◦ Preop: A: 19.3 (1.2), B: 20.1 (0.4), C: 18.8 (1.4)
◦ Post op 12 months: A: 2.0 (0.7), B: 1.2 (0.6), C: 1.7 (0.4)
◦ Post op 48 months: A: 2.1 (0.5), B: 0.8 (0.5), C: 1.5 (0.3)
Oliveira 2006 Group A: TVT (n = 17)
Group B: TVT-O (n = 28)
• Objective cure: A: 38/42, B: 37/42
• Bladder perforation: A: 3/42, B: 0/42
• Voiding dysfunction: A: 5/42, B: 3/42
• de novo urgency/urgency incontinence: A: 8/42, B: 9/42
• vaginal tape erosion: A: 2/42, B: 1/42
• Groin pain: A: 1/42, B: 7/42
Palomba 2008 Trial terminated.
Paparella 2010 Group A: synthetic UretexTO® (n = 34)
Group B: biological PelviLaceTO® (n-36)
• Objective cure: A: 30/33, B: 33/36
• Subjective cure: A: 28/33, B: 30/36
• Mean operating time (minutes) (SD): A: 10.4 (1.0), B: 10.8 (1.2)
• Mean length of hospital stay days (SD): A: 2.1 (0.3), B: 2.1 (0.4)
• Perioperative complications: A: 0/34, B: 0/36
• Major vascular injury: A: 0/34, B: 0/36
• Voiding dysfunction: A: 0/34, B: 0/36
• Tape erosion: A: 0/33, B: 0/36
• QoL: assessed with KHQ improved in most domains from preoperative values but no significant
difference between the groups
• Mean PISQ-12 scores
◦ Preoperative: A: 24 (2), B: 24.4 (2.4)
◦ 2yrs Follow up: A: 16.6 (3.0), B: 17.2 (3.0)
Park 2012 Group A: TVT-O (n = 39)
Group B: TOT Monarc (n = 35)
• Objective cure at 1yr: A: 35/39, B: 32/35
• Subjective cure at 1yr: A: 35/39, B: 32/35
• Objective cure at 3yrs: A: 33/39, B: 30/35
• Subjective cure at 3yrs: A: 33/39, B: 30/35
• Subjective cure & improvement at 1yr: A: 37/39, B: 33/35
• Subjective cure & improved at 3yr: A: 36/39, B: 33/35
• Voiding dysfunction: A: 3/39, B: 2/35
• Bladder and urethral perforation: A: 0/39, B: 0/35
• Groin pain: A: 1/39, B: 0/35
• Post operative dyspareunia: A: 1/39, B: 1/35
Peattie 2006 No published data.
Porena 2007 Group A: TVT (n = 70)
Group B: TOT (n = 75)
• Objective cure (dry): A: 50/70, B: 58/75
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• Objective cure and improved (dry + wet but improved): A: 63/70, B: 68/75
• Subjective cure (dry): A: 50/70, B: 58/75
• Subjective cure and improved (dry + wet but improved): A: 63/70, B: 68/75
• Bladder injury: A: 2/70, B:1/75
• Vaginal perforation: A: 0/70, B: 4/75
• Major vascular injury: A: 1/70, B: 0/75
• Voiding Dysfunction: A: 7/70, B: 6/75
• Tape erosion: A: 0/70, B: 3/75
• Subjective cure long term: A: 30/38, B: 27/45
Rechberger 2003 Group A: TVT (n = 50)
Group B: IVS (n = 50)
• Subjective cure: A: 80/92, B: 68/87
• Perioperative complications: A: 3/92, B: 4/87
• Bladder perforation: A: 3/50, B: 4/50
• Voiding dysfunction: A: 11/50, B: 2/50
• de novo urgency/urgency incontinence: A: 8/50, B: 4/50
Rechberger 2009 Group A: retropubic (IVS-02; n = 269)
Group B: transobturator (IVS-04; n = 268)
• Subjective cure: A: 151/201, B: 146/197
• Subjective improvement: A: 34/201, B: 28/197
• Mean operating time in minutes (SD): A: 23(5), B: 12(4)
• Bladder perforation: A: 13/269, B: 0/268
• Major vascular injury: A: 4/269, B: 0/268
• De novo urgency/UI: A: 17/201 ,B: 10/197
• Voiding dysfunction: A: 10/269, B: 7/268
• Vaginal tape erosion: A: 4/201, B: 5/197
Rechberger 2011 Group A: TOT (n = 232)
Group B: TOT with fixation (n = 231)
• Subjective cure and improvement: A: 186/213, B: 191/205
• Objective cure: A: 189/213, B: 195/205
• Bladder perforation: A: 4/232, B: 3/231
• ISD cohort: Objective cure: A: 31/41, B: 39/42
Richter 2010 Group A: retropubic sling (TVT; n = 298)
Group B: transobturator tapes (TVT-O, and TOTMonarc; n = 299)
(Group C (?): TVT-O (inside-out) - separate data not provided)
(Group D (?): TOT (Monarch, outside-in) - separate data not provided)
Objective cure at 1 year: A: 232/280 (80.8%), B: 233/285 (77.7%)
Subjective cure at 1 year: A: 181/280 (62.2%), B: 163/285 (55.8%)
Secondary outcomes:
• median blood loss (ml): A: 50mls; B: 25mls p=0.001
• median operative time (minutes): A: 30mins; B: 25mins p=0.001
• bladder or urethral perforation: A: 16/298, B: 0/299
• vaginal perforation: A: 6/298, B: 13/299
• voiding dysfunction: A: 16/298, B: 5/229
• mesh erosion/exposure A: 10/280, B: 2/285
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• vascular injury: A: 20/298, B: 7/299
• suprapubic/groin pain: A: 3/280, B: 2/285
• de novo urgency incontinence: A: 0/280, B: 1/285
• mean (SD) of change in UDI score Total: A: 106.7 (48), B: 110.3 (51.2) P=0.47
• mean of change in IIQ score Total: A: 126.8 (94.5), B: 132.9 (97.8) P=0.41
PISQ-12 (Prolapse / urinary incontinence sexual questionnaire): Analysis of results for group A and group
B combined showed significant improvement in sexual function in both groups with a mean PISQ-12
score increase from 32.8+/-7.1 at baseline to 37.3+/- 6 at 24 months. These changes are >0.6 SD units,
which reflects “medium” improvement in the PISQ-12 score after surgery. Compared with women with
successful surgery, women who experienced surgical failure, regardless of assigned type of surgery, reported
worse adjusted sexual function scores at all postoperative time points. Improvement in PISQ-12 scores
was consistent with change in the 3 specific items from the sexual function measure of interest: (1) the
experience of pain during sexual activity, (2) UI during sexual activity, and (3) fear of incontinence during
sexual activities. Pain with intercourse was reported by 153 of 406 of sexually active women (38%) at
baseline and decreased to 27% at 12 months after surgery (P.003)
Self-reported UI and the fear of incontinence occurring during sexual activity also significantly improved
by 12 months after surgery, regardless of sling route. To specifically investigate the association of synthetic
mesh slings on dyspareunia, we repeated the analysis on the 247 women who underwent MUS only (no
concurrent procedures) and who completed baseline and 12-month assessments. In this subset of women,
dyspareunia decreased from 57% at baseline to 43% at 12 months after surgery (P .03)
5-year data provided, but without numbers in each group, so could not be used for meta-analysis
Riva 2006 Group A: TOT (n = 65)
Group B: TVT (n = 66)
Salem 2014 Group A: TOT (n = 37)
Group B: TVT (n = 39)
No significant difference was noticed between the two groups as regard the mean operative time, peri-
operative complications, intraoperative blood loss, hospital stay, and time to return to normal activities.
The mean of abdominal leak point pressure and urethral closure pressure showed marked and maintained
improvement for 5 years later in group I whereas in group II, they showed marked and maintained im-
provement for only one year then shows significant decline in comparison with group I. As regard themean
of objective SEAPI score shows marked decrease (improvement) in both groups and this was maintained
for the five years in group I but in group II, it increased after one year later
No usable data provided.
Scheiner 2012 Group A: TVT (n = 80)
Group B: TOT outside-in approach (Monarc; n = 40)
Group C: TVT-O inside-out approach (Gynecare; n = 40)
• Objective cure: A: 60/65, B: 31/34, C: 33/37
• Subjective cure: A: 57/65, B: 28/34, C: 29/37
• Subjective cure and improvement: A: 63/65, B: 31/34, C: 34/37
• Mean operation time (minutes) (SD) A: 26.7 (11.5), B: 25.8 (9.7) C: 27.4 (10.0)
• Mean blood loss (ml) A: 34.4 (36.5), B: 31.5 (22.2), C: 49.4 (89.6)
• Mean hospital stay in days (SD): A: 3.5 (1.1), B: 3.2 (0.5), C: 3.3 (0.8)
• Bladder perforation A: 3/80, B: 0/40, C: 0/40
• Vaginal perforation A: 1/80, B: 6/40, C: 4/40
• Thigh/groin pain: B: 3/34, C: 1/37
• Vascular damage: A: 1/65, B: 0/34, C: 0/37
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• Voiding dysfunction: A: 3/80, B: 1/40, C: 1/40
• Tape erosion: A: 1/65, B: 4/34, C: 0/37
• Sexual function: Two percent (1/52) of sexually active patients after TVT, 17% (5/29) after TOT,
but 0% (0/25) after TVTO reported de novo female sexual dysfunction (P=0.011). Complaints included
de novo dyspareunia in one TVT and two TOT, a feeling of vaginal narrowing in two TOT, and
neuralgiform pain at the ischiocrural tape exit point in one TOT. In two patients with TOT, de novo
FSD subsided after 12 months. The other four patients preferred an expectant procedure. No association
between tape exposure or FSD and surgeon was found.
Schierlitz 2008 Group A: TVT (n = 81)
Group B: Monarc sling (n = 82)
• Objective cure: absence of USI: A: 53/67, B: 48/71
• Subjective cure: absence of self-reported SUI: A: 63/66, B: 55/70
• Bladder perforation: A: 7/82, B: 0/82
• Major vascular injury: A: 0/82, B: 0/82
• Groin pain: A: 1/82, B: 3/82
• Voiding dysfunction: A: 9/82, B: 4/82
• De novo urgency: A: 14/66, B: 7/70
• De novo urgency incontinence: A: 9/66, B: 9/70
• De novo urgency and UUI: A: 23/66, B: 16/70
• Re-operation: A: 0/82, B: 9/82
• Vaginal perforation: A: 0/82, B: 4/82
• QOL: The baseline QoL assessment (UDI-6, IIQ-7) did not differ between the two groups. In
both the TVT and transobturator tape groups, there was an overall marked improvement postoperatively
in UDI-6 and IIQ-7 scores with no difference in improvement between groups.
• Sexual function: Comparison of pre-operative and post-operative mean total PISQ-12 scores
revealed a significant improvement in both groups at 6 months, which was maintained at 12 months.
There was a significant difference between the TVT and the Monarc mean score at 6 months, with the
TVT score being greater. At 12 months, there was no difference between slings, coital incontinence and
fear of incontinence were significantly reduced in both treatment groups at 6 and 12 months with no
difference between slings. No change to dyspareunia or orgasm intensity was detected in either sling
group, and no difference existed between the two slings at 6 or 12 month. At least 8 of 57 (14%) women
who were not sexually active prior to their surgery had resumed intercourse at 6 months post-operatively,
and this was unchanged at 12 months 7 of 57 (12%). No change to dyspareunia or orgasm intensity was
detected in either sling group, and no difference existed between the two slings at 6 or 12 months.
• The 3-year primary end point was symptomatic stress incontinence considered as failure requiring a
repeat procedure on request of the patient.
• Repeat incontinence surgery: A: 1/72, B: 15/75
• Subjective cure @ 3 yrs (intermediate term): A: 71/72, B: 60/75
• The baseline quality-of- life assessment (Urogenital Distress Inventory short form, Incontinence
Impact Questionnaire short form) did not differ between groups. At 36 months on average, the overall
mean UDI short form and IIQ short form scores improved by 5.8 (SD 4.34) and 6.0 (SD 5.48),
respectively (P<.001); no between-group difference was found.
• 5yrs Follow up:
• Mean follow up in months was A: 63, B: 64
• Primary outcome was subjective SUI requiring repeat surgery
• Subj cure at 5yrs A: 69/72, B: 56/75
• Repeat surgery: A: 3/82, B: 19/82
• Median time to repeat surgery months (25th to 75th percentile): A: 82 (43 to 82), B: 24 (12 to 52)
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Both groups showed improvement in QoL scores post surgery at 5 yrs follow up but no difference
between the groups.
Tanuri 2010 Group A: Safyre VS retropubic tape (n = 10)
Group B: Safyre T transobturator tape (n = 20)
• Objective cure: A: 8/9, B: 16/19
• Subjective cure: A: 8/9, B: 17/19
• Pad test: mean weight of urine grams (SD) A: 0.0(0.0), B: 1.2(5.4)
• De novo urgency incontinence: A: 1/9, B: 1/19
• Voiding dysfunction: A: 1/10, B: 0/20
• Groin pain: A: 0/9, B: 1/19
• Bladder perforation: A: 0/10, B: 0/20
• Tape erosion: A: 0/9 B: 0/19
• Mean QoL Scores: via KHQ
◦ Improvement in the domains between baseline pre-op scores and 12 months scores without a
significant difference between the two groups.
Tarcan 2011 Group A: TVT (n = 27)
Group B: TOT (n = 27)
12-month follow-up assessed:
• cure: negative stress provocation test
◦ objective cure rates: A: 20/23, B: 19/22
◦ subjective cure rate: A: 20/23, B: 20/22
• mean operative time in minutes (SD) A: 32.6 (16.6), B: 31.6 (7.7)
2 year follow-up assessed:
• subjective cure: A: 21/27, B: 22/27
• mean operating time in mins (SD): A: 39.1 (17.7), B: 33.4 (13.9)
• QoL: via SEAPI
◦ scores were significantly improved in both groups post-operatively with no significant
difference between groups
• No significant post operative complications in either group.
Teo 2011 Group A: TVT (n = 66)
Group B: TVT-O (n = 61)
• Objective cure: A: 33/41, B: 25/29
• Subjective cure: A: 35/41, B: 26/29
• Major vascular injury: A: 1/66, B: 1/61
• Voiding dysfunction: A: 3/66, B: 1/61
• Bladder perforation: A: 0/66, B: 0/61
• De novo urgency incontinence: A: 3/41, B: 6/29
• Tape erosion A: 3/41, B: 1/29
• Groin pain: A: 1/66, B: 14/61
• There was a significant improvement in quality of life, symptom severity and pad use from baseline
in both groups
• QoL:
◦ Baseline scores:
⋄ Median KHQ score (range): A: 384 (122-814), B: 399 (106-814)
⋄ Median ICIQ-SF score (range): A: 15 (7-21), B: 14 (3-21)
◦ 12 months follow up scores:
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⋄ Median KHQ score (range): A: 50 (0-510) B: 61 (0-748)
⋄ Median ICIQ-SF score (range): A: 4 (0-16) B: 0 (0-11)
Tommaselli 2012 Group A: TVT-O (n = 48)
Group B: modified TVT-O (n = 24)
• Objective cure: A: 43/46, B:22/23
• No leakage with urodynamic studies: A: 43/46, B: 21/23 (91.3)
• No intraoperative complications reported in either group.
• Voiding dysfunction: A: 1/48, B: 1/24
• QOL/sexual function:
• The PISQ-12 score showed a slight decrease after the procedure in both groups, but did not reach
statistical significance (A: 18.8±6.7 vs 12±5.3, P00.3; B: 16.9±5.3 vs 12.6±4.9, P00.6). No differences
were observed between groups before or after the procedure. The PGI-S score was significantly lower 6
months after surgery in both groups (P<0.001).
Tseng 2005 Group A: SPARC (n = 31)
Group B: TVT (n = 31)
• Objective cure: A: 25/31, B: 27/31
• Operative time in mins(SD): A: 40.77 (13.29) B: 32.74 (8.43)
• Length of hospital stay (days) (SD): A: 3.97 (1.43), B: 3.14 (1.38)
• Perioperative complications: A: 3/31, B: 5/32
• Bladder perforation: A: 4/31, B: 0/31
• Denovo U/UUI: A: 7/31, B: 5/31
• voiding dysfunction: A: 2/31, B: 1/31
Ugurlucan 2013 Group A: biological PELVILACE TO (n = 50)
Group B: synthetic TOT ALIGN ®TO (n = 50)
• Subjective cure: A: 34/50, B: 35/50
• Objective cure: A: 28/31, B: 35/36
• groin pain: A: 2/50, B: 1/50
• voiding dysfunction: A: 0/50, B: 2/50
• vaginal tape erosion: A: 0/50, B; 1/50
• QOL: There was an improvement in quality of life in both groups in all domains when the
preoperative and postoperative KHQ, P-QoL, UDI-6, and IIQ-7 were compared. There was no
difference between the two groups regarding the improvement in quality of life.
van Leijsen 2013 Group A: RPR (n = 33)
Group B: TOT (n = 90)
• Subjective cure: A: 25/31, B: 62/83
• Objective cure: A: 13/13, B: 57/59
• De novo urgency incontinence: A: 9/30, B: 25/83
• Voiding dysfunction: A: 5/31, B: 7/80
• Tape release for POVD: A: 1/31, B: 1/80
• Repeat incontinence surgery: A: 0/33, B: 0/90
Wang 2006 Group A: Monarc (n = 31)
Group B: SPARC (n = 29)
• Operative time in mins (SD): A: 33.83 (8.4) B: 39.21 (12.18)
• Blood loss ml (SD): A: 117.2 (79.43), B: 125.13 (81.2)
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Table 1. Tabulated Results of Included Studies (Continued)
• Length of hospital stay (days) (SD): A: 3.44 (1.48), B: 3.92 (1.40)
• Perioperative complications: A: 4/31, B: 2/29
• Major vascular injury: A: 0/31, B: 0/29
• Bladder perforation: A: 0/31, B: 1/29
• Denovo U/UUI: A: 3/31, B: 3/29
• voiding dysfunction: A: 7/31, B: 16/29
• Vaginal tape erosion: A: 4/31, B: 0/29
Wang 2008 Group A: TVT (n = 35)
Group B: TVT-O (n = 34)
• Subjective cure: A: 31/35, B: 29/34
• Subjective cure and improvement: A: 34/35, B: 33/34
• Failure: A: 1/35, B: 1/34
• Operative time in minutes; mean (SD): A: 27 (5) 35, B: 18 (5)
• Blood loss ml (SD): A: 21 (6) B: 20 (7)
• Length of hospital stay (days) (SD): A: 3.9 (4.4), B: 3.2 (2.2)
• Bladder/visceral perforation: A: 0/35, B: 0/34
• Voiding dysfunction: A: 4/35, B: 4/34
• Haematoma: A: 1/35, B; 0/34
• No significant differences in postoperative complications: including tape erosion, pain in thigh or
behind pubis
Wang 2009 Group A: TVT (n = 154)
Group B: TVT-O (n = 146)
◦ 6 months
⋄ cured: A: 144/154, B: 133/146
⋄ Improved: A 8, B 10
⋄ Failed: A 2, B 3
◦ 12 months
⋄ cured: A: 103/115, B: 106/118
⋄ Improved: A 10, B 9
⋄ Failed: A 2, B 3
◦ 24 months
⋄ cured: A: 68/78, B: 75/87
⋄ Improved: A 8, B 10
⋄ Failed: A 2, B 2
◦ 36 months
⋄ cured: A: 29/35, B: 25/30
⋄ Improved: A 5, B 4
⋄ Failed: A 1, B 1
• Mean operative time in minutes (SD) N: A: 25.1 (4.8) 68, B: 18.4 (4) 68, P<0.001
• Mean blood loss in ml (SD) N): A: 22.5 (12.5) 68, B: 20.7 (11.8) 68 P=0.18
• With concomitant prolapse surgery:
◦ Operative time (mean mins (SD) N): A: 46.6 (16.3) 86, B: 54.9 (24.4) 78 P=0.06
◦ Blood loss (mean ml (SD) N): A: 47.9 (35.3) 86, B: 60.8 (41.8) 78 P=0.12
• Mean length of hospital stay (days) (SD) N: A: 3.6 (2.9) 154, B: 3.9 (2.8) 146
• Adverse effects:
◦ Any: A: 24/154, B: 27/146
◦ haematoma: A: 2, B: 2
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Table 1. Tabulated Results of Included Studies (Continued)
◦ wound infection: A: 0, B: 0
• Urinary retention: A: 6, B: 4
• De novo UUI: A: 9/154, B: 6/146
• Vaginal tape erosion: A: 3/154, B: 3/146 (no urethral or bladder erosion)
• Groin/thigh pain: A: 4/154, B: 12/146 (no incapacitating pain)
Wang 2010 Group A: TVT (n = 70)
Group B: TOT (n = 70)
• Subjective cure: A: 63/70, B: 64/70
• Objective cure: A: 65/70, B: 64/70
• Vascular injury/haematoma: A: 0/70, B: 0/70
• Tape erosion: A: 1/70, B: 2/70
• Bladder perforation: A: 3/70, B: 1/70
• Voiding dysfunction: A: 8/70, B: 6/70
• De novo urgency/UII: A: 1/70 B: 4/70
• QoL assessed by UDI-6 and IIQ-7-SF
• QoL Scores:
• Pre-op UDI-6: A: 49 (21), 1 yr f/u: 15 (15), Pre-op UDI-6: B: 46 (20), 1 yr f/u: 14 (17)
• Pre-op IIQ-7: A: 40 (21), 1 yr f/u: 13 (12), Pre-op IIQ-7: B: 42 (20), 1 yr f/u: 10 (12)
• Lost to follow up: A: 0 women, B: 0 women
Wang 2011 Group A: TVT (n = 32)
Group B: TVT-O (n = 36)
• Objective cure: A: 30/32, B: 33/36
• Subjective cure: A: 30/32, B: 33/36
• Improvement: A: 2/32, B: 3/36
• Mean length of surgery (minutes) (SD): A: 34.5 (6.3), B: 16.2 (1.5)
• Bladder perforation: A: 1/32, B: 0/36
• Voiding dysfunction: A: 3/32 , B: 1/36
• Groin pain: A: 0/32, B: 0/36
• De novo urgency or UI: A: 5/32, B: 6/36
• Vascular injury: A: 2/32, B: 1/36
Zhang 2011 Group A: TVT-O (n = 76)
Group B: modified TVT-O (n = 80)
• Subjective cure: A: 70/76, B: 75/80
• Subjective improvement: A: 6/76, B: 5/80
• Mean operative time (minutes) (SD): A: 49 (5), B: 24 (6)
• Mean blood loss in (mls); SD: A 70 (5), B: 55 (5)
• Mean hospital stay in days (SD): A: 8 (0.5),B: 5 (0.5)
• Voiding dysfunction: A: 1/76, B: 1/80
• QOL: self-administered I-QOL: A: 23.9 (2.7), B: 24.6 (3.5)
Zullo 2007 Group A: TVT (n = 35)
Group B: TVT-O (n = 37)
• Objective cure: A: 25/29, B: 27/31
• Subjective cure: A: 21/29, B: 23/31
• Incidence of overall perioperative complications
• De novo urgency and urge incontinence: A: 1/29, B: 2/31
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Table 1. Tabulated Results of Included Studies (Continued)
• Tape erosion: A: 2/29, B: 1/31
• Voiding dysfunction: A: 0/35, B: 0/37
Abbreviations
BFLUTS: Bristol lower urinary tract symptoms questionnaires
BMI: body-mass index
DO: detrusor overactivity
DUP: distal urethral polypropylene sling
EQOL-5D: Euro Quality of life -5 Dimension
hr: hour/s
HRT: hormone replacement therapy
ICIQ: International Consultation on Incontinence questionnaire
ICIQ-FLUTS: International Consultation on Incontinence questionnaire - female lower urinary tract symptoms
ICIQ- LUTSquol: International Consultation on Incontinence questionnaire - lower urinary tract quality of life questionnaire
ICIQ-SF: International Consultation on Incontinence questionnaire short form
ICIQ-SF15: International Consultation on Incontinence questionnaire short form 15
IIQ: Incontinence Impact questionnaire
ICS: International Continence Society
I-QoL: Incontinence Quality of Life questionnaire
ISD: intrinsic sphincter deficiency
IVS: intravaginal slingoplasty
KHQ: King’s Health questionnaireMUI: mixed urinary incontinence
MUCP: Maximum urethral closure pressure
MUI: mixed urinary incontinence
OAB: overactive bladder
PGI-I: Patient Global Impression of Improvment
PGI-S: Patient Global Impression of Severity
PISQ-12: pelvic organ prolapse/urinary incontinence sexual questionnaire
POP: pelvic organ prolapse
POP-Q: pelvic organ prolapse quantification
POP-Q ICS: pelvic organ prolapse quantification International Continence Society
PVR: post void residual
RCT: randomized controlled trial
RPR: retropubic route
QoL: quality of life
QRCT: quasi-randomised trial
SEAPI-QMM: Stress related leak, Empyting ability, Anatomy, Protection, Inhibition-Quality of life, Mobility and Mental status
incontinence classification system
SD: standard deviation
SIS: Single incision sling
SPARC: suprapubic arc (procedure)
SUI: stress urinary incontinence
TOR: transobturator
TOT: transobturator tape
TOT-ARIS: transobturator tape-ARIS
TVT: tension-free vaginal tape
TVT-O: transobturator tension-free vaginal tape
UDI: Urinary Distress Impact questionnaire
UDI-6: Urinary Distress Impact questionnaire short form
UDS: urodynamics study
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UI: urinary incontinence
UISS: urinary incontinence severity score
USI: urodynamic stress incontinence
USS: ultrasound
UTI: urinary tract infection
UUI: urgency urinary incontinence
VAS: visual analogue scale
VLPP: Valsalval leak point pressure
A P P E N D I C E S
Appendix 1. Searches performed for the 2014 version of this review
Cochrane Incontinence Group Specialised Register
The terms used to search the Incontinence Group Specialised Register 26 June 2014 are given below:
(TOPIC.URINE.INCON*)
AND
({DESIGN.CCT*} OR {DESIGN.RCT*})
AND
{INTVENT.SURG.SLIN*} OR {INTVENT.SURG.SUBURETHRAL SLING.} OR {INTVENT.SURG.ABDO.SLING.}
(All searches were of the keyword field of Reference Manager 2012.)
Embase and Embase Classic (on OVID SP) was searched from 1947 toWeek 25 20014 on 26 June 2014 and was limited to those years
not fully covered by the Embase search for CENTRAL carried out by the Cochrane Collaboration. Limited to: (2010* to 2014*).em.
The following search strategy was used:
1. Randomized Controlled Trial/
2. crossover procedure/ or double blind procedure/ or parallel design/ or single blind procedure/
3. Placebo/
4. placebo$.tw,ot.
5. random$.tw,ot.
6. ((singl$ or doubl$ or trebl$ or tripl$) adj25 (blind$ or mask$)).tw,ot.
7. crossover.tw,ot.
8. cross over$.tw,ot.
9. allocat$.tw,ot.
10. trial.ti.
11. parallel design/
12. triple blind procedure/
13. or/1-12
14. exp animals/ or exp invertebrate/ or animal experiment/ or animal model/ or animal tissue/ or animal cell/
15. exp human/ or exp “human tissue, cells or cell components”/
16. 14 and 15
17. 14 not 16
18. 13 not 17
19. incontinence/ or mixed incontinence/ or stress incontinence/ or urge incontinence/ or urine incontinence/
20. continence/
21. overactive bladder/
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22. micturition disorder/ or lower urinary tract symptom/ or pollakisuria/
23. urinary dysfunction/ or bladder instability/ or detrusor dyssynergia/ or neurogenic bladder/ or urinary urgency/ or urine extrava-
sation/
24. (incontinen$ or continen$).tw.
25. ((bladder or detrusor or vesic$) adj5 (instab$ or stab$ or unstab* or irritab$ or hyperreflexi$ or dys?ynerg$ or dyskinesi$ or
irritat$)).tw.
26. (urin$ adj2 leak$).tw.
27. ((bladder or detrusor or vesic$) adj2 (hyper$ or overactiv$)).tw.
28. (bladder$ adj2 (neuropath$ or neurogen* or neurolog$)).tw.
29. (nervous adj pollakisur$).tw.
30. or/19-29
31. (tape* or sling*).tw.
32. 18 and 30 and 31
33. (2010* or 2011* or 2012* or 2013* or 2014*).em.
34. 32 and 33
WHO ICTRP (on http://www.who.int/ictrp/en/) was searched on 30 June 2014 using the following search string: Continent OR
continence OR incontinent OR incontinence AND tape* OR sling* AND random*
Appendix 2. Search terms for the first version of this review published in 2009
The terms that we used to search the Incontinence Group Specialised Register are given below:
(TOPIC.URINE.INCON*)
AND
({DESIGN.CCT*} OR {DESIGN.RCT*})
AND
{INTVENT.SURG.SLIN*} OR {INTVENT.SURG.SUBURETHRAL SLING.} OR {INTVENT.SURG.ABDO.SLING.}
(All searches were of the keyword field of Reference Manager 9.5 N, ISI ResearchSoft). Date of last search: 20 March 2008.
The review authors also searchedMEDLINE (January 1950 to April 2008), EMBASE (January 1988 to April 2008), CINAHL (January
1982 to April 2008), and AMED (January 1985 to April 2008) on 28 April 2008.
The following terms were used to search these electronic databases:
(Urinary incontinence OR urodynamic stress incontinence OR urgency urinary incontinence OR urge incontinence urinary)
AND
(suburethral slings OR tension free vaginal tape OR tvt OR transvaginal tape OR transobturator tape OR tot OR tvt-o OR ivs OR
uretrex OR safyre OR I-stop OR sparc OR lynx OR monarc OR obtryx OR obtape OR aris)
The review authors also searched the UK National Research Register and ClinicalTrials.gov on 28 April 2008 using the term: urinary
incontinence.
Appendix 3. Search strategies for brief economic commentary
We performed additional searches for the Brief Economic Commentary (BECs). These were conducted in MEDLINE(1 January 1946
to March 2017), Embase (1 January 1980 to 2017 Week 12) and NHS EED (1st Quarter 2016). All searches were conducted on 6
April 2017. We used two different search strategies on MEDLINE and EMBASE (OvidSP) and one on NHS EED (OVID). Details of
the searches run and the search terms used can be found below. There were no year, publication type or language restrictions applied.
NHS EED (Ovid) (1st Quarter 2016)
NHS EED was searched using the following search strategy:
1. Urinary incontinence/
2. Urinary incontinence, stress/
3. ((stress$ or mix$ or urg$ or urin$) adj3 incontinen$).tw.
4. Colporrhaphy.tw.
5. Colpoperineoplast$.tw.
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6. Sling procedure$.tw.
7. Sling$ procedure$.tw.
8. Bladder neck needle suspension$.tw.
9. Anterior vaginal repair$ .tw.
10. Or/1-9
MEDLINE (1 January 1946 to March 2017) and Embase (1 January 1980 to 2017 Week 12)
We used two different search strategies on MEDLINE and Embase (OvidSP) - these are given below.
Search strategy 1:
1. Economics, Pharmaceutical/ or Economics, Medical/ or Economics/ or Economics, Hospital/ or economics.mp. or Economics,
Nursing/
2. exp “costs and cost analysis”/
3. “Value of Life”/
4. exp “fees and charges”/
5. exp budgets/
6. budget*.ti,ab.
7. cost*.ti.
8. (economic* or pharmaco?economic*).ti.
9. (price* or pricing*).ti,ab.
10. (cost* adj2 (effective* or utilit* or benefit* or minimi* or unit* or estimat* or variable*)).ab.
11. (financ* or fee or fees).ti,ab.
12. (value adj2 (money or monetary)).ti,ab.
13. ((energy or oxygen) adj cost).ti,ab.
14. (metabolic adj cost).ti,ab.
15. ((energy or oxygen) adj expenditure).ti,ab.
16. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15
17. exp Urinary Incontinence/
18. ((stress* or mix* or urg* or urin*) adj3 incontinen*).tw.
19. Urodynamics/ or Urinary Incontinence, Stress/ or Urinary Incontinence/ or Suburethral Slings/ or mixed incontinence.mp. or
Urinary Bladder/ or Urinary Incontinence, Urge/
20. 17 or 18 or 19
21. anterior vaginal repair*.tw.
22. 16 and 20 and 21
23. anterior colporrhaphy*.tw.
24. 21 or 23
25. 16 and 20 and 23
26. bladder neck needle suspension$.tw.
27. 16 and 20
28. 26 and 27
29. open abdominal retropubic colposuspension*.tw.
30. retropubic colposuspension*.tw.
31. burch colposuspension*.tw.
32. 29 or 30 or 31
33. 27 and 32
34. laparoscopic retropubic colposuspension*.tw.
35. laparoscopic colposuspension*.tw.
36. 34 or 35
37. 27 and 36
38. traditional suburethral retropubic sling procedure$*.tw.
39. traditional sling procedure$*.tw.
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40. suburethral retropubic sling procedure$*.tw.
41. retropubic sling procedure$*.tw.
42. traditional suburethral sling*.tw.
43. Suburethral Slings/ or Urinary Incontinence, Stress/ or Urologic Surgical Procedures/
44. 27 and 43
45. remove duplicates from 44
Search strategy 2:
1. economics.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, fs]
2. value of life.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, fs]
3. exp “costs and cost analysis”/
4. exp economics, hospital/
5. exp economics, medical/
6. economics, nursing.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, fs]
7. economics, pharmaceutical.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, fs]
8. exp “fees and charges”/
9. exp budgets/
10. budget*.ti,ab.
11. cost*.ti.
12. (economic* or pharmaco?economic*).ti.
13. (price* or pricing*).ti,ab.
14. (cost* adj2 (effective* or utilit* or benefit* or minimi* or unit* or estimat* or variable*)).ab.
15. (financ* or fee or fees).ti,ab.
16. (value adj2 (money or monetary)).ti,ab.
17. or/1-16
18. economics.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, fs]
19. value of life.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, fs]
20. exp “costs and cost analysis”/
21. exp economics, hospital/
22. exp economics, medical/
23. economics, nursing.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, fs]
24. economics, pharmaceutical.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, fs
25. exp “fees and charges”/
26. exp budgets/
27. budget*.ti,ab.
28. cost*.ti.
29. (economic* or pharmaco?economic*).ti.
30. (price* or pricing*).ti,ab.
31. (cost* adj2 (effective* or utilit* or benefit* or minimi* or unit* or estimat* or variable*)).ab.
32. (financ* or fee or fees).ti,ab.
33. (value adj2 (money or monetary)).ti,ab.
34. 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33
35. ((energy or oxygen) adj cost).ti,ab.
36. (metabolic adj cost).ti,ab.
37. ((energy or oxygen) adj expenditure).ti,ab.
38. 34 or 35 or 36 or 37
39. urinary incontinence.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]
40. ((stress$ or mix$ or urg$ or urin$) adj3 incontinen$).tw.
41. URINARY INCONTINENCE, STRESS.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]
42. stress urinary incontinence*.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]
43. 39 or 40 or 41 or 42
44. intervention surgery*.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]
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45. colporrhaphy.tw.
46. Bologna procedure*.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]
47. Kelly-Kennedy.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]
48. Marion Kelly.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]
49. Diaphragmplasty.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]
50. Vaginal urethrocystopexy.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]
51. Cystocele repair.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]
52. Kelly plication.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]
53. anterior vaginal repair$.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]
54. anterior colporrhaphy.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]
55. 45 or 46 or 47 or 48 or 49 or 50 or 51 or 52 or 53 or 54
56. 38 and 43 and 55
57. remove duplicates from 56
58. Bladder neck needle suspension$.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]
59. 38 and 43 and 58
60. burch colposuspension.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]
61. open abdominal retropubic colposuspension.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]
62. Paravaginal defect repair.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]
63. Marshall-Marchetti-Krantz.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]
64. abdominal burch.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]
65. abdominal colposuspension.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]
66. endopelvic Fascia Plication.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]
67. 60 or 61 or 62 or 63 or 64 or 65 or 66
68. 38 and 43
69. 67 and 68
70. laparoscopic retropubic colposuspension.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]
71. laparoscopic colposuspension.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]
72. retropubic colposuspension.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]
73. 70 or 71 or 72
74. 68 and 73
75. remove duplicates from 74
76. suburethral sling.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]
77. abdominal sling.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]
78. traditional sling procedure$*.tw.
79. suburethral sling procedure.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]
80. 76 or 77 or 78 or 79
81. 68 and 80
82. remove duplicates from 81
83. mid$urethral sling.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]
84. retropubic sling procedure$*.tw.
85. transobturator sling procedure$.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]
86. 83 or 84 or 85
87. remove duplicates from 86
88. 68 and 87
89. TVT-Secur.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]
90. mini-arc.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]
91. ajust.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]
92. needleless.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]
93. solyx.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]
94. single$incision sling$.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]
95. miniarc.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]
96. mini$sling.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]
97. Ophira.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]
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98. Tissue Fixation System.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]
99. 89 or 90 or 91 or 92 or 93 or 94 or 95 or 96 or 97 or 98
100. 68 and 99
101. remove duplicates from 100
102. ((urethra$ or periurethra$ or transurethra$) adj3 (agent$ or bulk$ or injection$ or injectable$)).tw.
103. injection therapy.tw.
104. injectable$.tw.
105. (injectable$ adj2 agent$).tw.
106. (bulk$ adj3 agent$).tw.
107. Peri$urethral injection$.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]
108. Autologous fat.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]
109. Macroplastique.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]
110. Calcium hydroxylapatite.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]
111. Hyaluronic acid with dextranomer.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]
112. Porcine dermal implant.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]
113. Ethylene vinyl alcohol copolymer.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]
114. Silicon particles.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]
115. 102 or 103 or 104 or 105 or 106 or 107 or 108 or 109 or 110 or 111 or 112 or 113 or 114
116. 68 and 115
117. remove duplicates from 116
WH A T ’ S N E W
Last assessed as up-to-date: 26 June 2014.
Date Event Description
10 July 2017 Amended Brief economic commentary (BEC) added. Economics re-
lated sections revised: the Abstract, Plain language sum-
mary, Background, Methods (outcomes, search
methods), and Discussion were amended. Appendix
added with details of search strategies for BECs
10 July 2017 New citation required but conclusions have not changed Brief economic commentary (BEC) added. Economics-
related sections revised
H I S T O R Y
Protocol first published: Issue 1, 2007
Review first published: Issue 4, 2009
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Date Event Description
21 May 2015 New citation required but conclusions have not
changed
Following new trials were added in this update:
Abdel-Fattah 2010; Aigmuller 2014; Alkady 2009;
Aniuliene 2009; Barber 2008; But 2008; Chen
2010; Chen 2012; Cho 2010; Choe 2013; Darabi
Mahboub 2012; David-Montefiore 2006; Deffieux
2010; de Leval 2011; Diab 2012; Elbadry 2014;
El-Hefnawy 2010; Freeman 2011; Hammoud 2011;
Hassan 2013; Houwert 2009; Jakimiuk 2012; Juang
2007; Kamel 2009; Karateke 2009; Kilic 2007; Krofta
2010; Laurikainen 2007; Leanza 2009; Mehdiyev
2010; Nerli 2009; Nyyssonen 2014; Okulu 2013;
Palomba 2008; Paparella 2010; Park 2012; Peattie
2006; Rechberger 2009; Rechberger 2011; Richter
2010; Ross 2009; Salem 2014; Scheiner 2012;
Schierlitz 2008; Tanuri 2010; Tarcan 2011; Teo 2011;
Tommaselli 2012; Ugurlucan 2013; van Leijsen 2013;
Wang 2008; Wang 2009; Wang 2010; Wang 2011;
Zhang 2011
21 May 2015 New search has been performed Following new trials were added in this update:
Abdel-Fattah 2010; Aigmuller 2014; Alkady 2009;
Aniuliene 2009; Barber 2008; But 2008; Chen
2010; Chen 2012; Cho 2010; Choe 2013; Darabi
Mahboub 2012; David-Montefiore 2006; Deffieux
2010; de Leval 2011; Diab 2012; Elbadry 2014;
El-Hefnawy 2010; Freeman 2011; Hammoud 2011;
Hassan 2013; Houwert 2009; Jakimiuk 2012; Juang
2007; Kamel 2009; Karateke 2009; Kilic 2007; Krofta
2010; Laurikainen 2007; Leanza 2009; Mehdiyev
2010; Nerli 2009; Nyyssonen 2014; Okulu 2013;
Palomba 2008; Paparella 2010; Park 2012; Peattie
2006; Rechberger 2009; Rechberger 2011; Richter
2010; Ross 2009; Salem 2014; Scheiner 2012;
Schierlitz 2008; Tanuri 2010; Tarcan 2011; Teo 2011;
Tommaselli 2012; Ugurlucan 2013; van Leijsen 2013;
Wang 2008; Wang 2009; Wang 2010; Wang 2011;
Zhang 2011
16 September 2009 Amended changed conclusion in abstract, typographical error
4 March 2008 Amended Converted to new review format.
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C O N T R I B U T I O N S O F A U T H O R S
Abigail Ford and Joseph Ogah wrote the text of the main review.
Abigail Ford performed the initial screening of studies for inclusion into the review, assessment ofmethodological quality, data extraction,
and analysis of results.
Joseph Ogah performed the second and confirmatory screening of studies for inclusion, assessment of methodological quality, and data
extraction.
Abigail Ford, Joseph Ogah, June Cody and Lynne Rogerson assisted in the analysis and interpretation of the results.
Abigail Ford, Joseph Ogah and Lynne Rogerson were also responsible for the clinical input for the review and made a significant input
to the writing of the final review.
For the July 2017 addition of the BECs to this review: Patricia Aluko was responsible for the entire BECs-related work on this review,
i.e. she ran the search for studies, screened the search results, extracted data from relevant studies, revised any existing economics-related
text, added the BECs-related text, and responded to any peer referee comments. All authors had the opportunity to comment on the
revised review.
D E C L A R A T I O N S O F I N T E R E S T
Abigail A Ford: For the 2015 review: Johnson and Johnson for part sponsorship to attend International Urogynaecology Association
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to attend workshops by Johnson and Johnson and Speciality European Pharma. All these sponsorships are unrelated to this review. For
the 2017 BECs review update: None known.
Patricia Aluko: For the 2017 BECs review: This project, to add Brief Economic Commentaries to our ’Surgery for UI in women’
reviews, was supported by the National Institute for Health Research (NIHR), via the Cochrane Review Incentive Scheme 2016, to
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External sources
• The National Institute for Health Research (NIHR), UK.
This project was supported by the National Institute for Health Research, via Cochrane Infrastructure funding to the Cochrane
Incontinence Group. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the
Systematic Reviews Programme, NIHR, NHS or the Department of Health. The NIHR is the largest single funder of the Cochrane
Incontinence Group.
• National Institute for Health Research, UK.
This project, to add Brief Economic Commentaries to our surgery for UI in women reviews, was supported by the National Institute
for Health Research (NIHR), via the Cochrane Review Incentive Scheme 2016, to the Cochrane Incontinence Group. The views and
opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR,
NHS or the Department of Health.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
The review authors decided to focus this update on the use ofminimally invasivemid-urethral slings inwomenwith urinary incontinence,
as this has become the gold standard for surgery for stress urinary incontinence (SUI). The alternative surgical treatments, including
single incision slings, have been addressed in linked Cochrane reviews and are therefore not included, but are summarised and referenced
in the Discussion. Conservative and pharmacological treatments will be addressed in a future Cochrane review. This review therefore
now addresses the effectiveness of mid-urethral slings in the treatment of SUI in women compared to another mid-urethral sling.
The primary outcome remains the same, but has been measured in time scales that differ from those previously set out; short term (less
than 12 months), medium term (one to five years) and long term (over five years). This was done after the first review showed evidence
of tape efficacy to establish whether this procedure continued to be effective in the longer term. The primary outcome was repeated as
a secondary outcome and this repetition has been amended.
A Dealing with missing data section has been added into the review. Very few trials reported outcome data for clinically relevant
subgroups, therefore no subgroup analyses were performed.
July 2017 update: we have added Brief Economic Commentaries (BECs) to all of our ’Surgery for UI in women’ Cochrane Reviews.
We have revised the economic elements throughout the review; if incorrect, we have stripped them out. We have added new economics-
related text. This involved revisions to the Background section, Methods section, e.g. search section referring to added Appendix,
Discussion section, Abstract and Plain Language Summary. We have added an appendix with details of the economics searches. The
Conclusions section of the review has not changed. The rest of the review has not changed.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Suburethral Slings [adverse effects]; Pain, Postoperative [etiology]; Postoperative Complications [etiology]; Quality of Life; Random-
ized Controlled Trials as Topic; Reoperation [statistics & numerical data]; Urethra [injuries]; Urinary Bladder [injuries]; Urinary In-
continence, Stress [∗surgery]; Urologic Surgical Procedures [adverse effects; ∗methods]
MeSH check words
Adult; Female; Humans
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